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Abstract 
Cellular and extracellular host-pathogen interactions are important in the progression of 
infection. Extracellular survival and growth can be significant for pathogen 
dissemination. Equally, intracellular pathways, such as autophagy, can be employed in 
host cell defence. Autophagy is a cellular self-degradation process that recycles 
cellular components through lysosomal degradation. Primarily for regulating starvation 
and housekeeping pathways, autophagy is also important for degradation of invading 
intracellular pathogens. Selective autophagy receptors can also target pathogens for 
autophagic degradation. However, some intracellular pathogens are able to subvert or 
block host cell autophagy. Cryptococcus neoformans and Staphylococcus aureus 
represent fungal and bacterial pathogens which can reside either intracellularly or 
extracellularly. The role of host cell autophagy in C. neoformans and S. aureus 
infection is unclear. Infection of zebrafish with C. neoformans or S. aureus enabled in 
vivo imaging of host-pathogen interactions, to examine infection growth dynamics and 
dissemination, in addition to cellular level imaging of pathogen interactions with host 
cell autophagy components.  
Cryptococcal infection can cause cryptococcal meningitis, frequently associated with 
cerebral infarcts. Analysis of cryptococcal proliferation during infection suggested that 
formation of intravascular cryptococcal masses precedes invasion of surrounding 
tissue. Vessel integrity analysis highlighted cryptococcal-mediated vascular damage, 
potentially providing a route for tissue dissemination. Vasculature damage may explain 
the origin of cortical infarcts in disease.  
Autophagy mutant zebrafish were generated to analyse host autophagy in pathogen 
infection. Characterisation of mutant larvae revealed a clear survival and growth defect, 
indicating autophagy is required for larval development. Autophagy mutants were 
subsequently used to analyse the role of autophagy during infection through analysis of 
pathogenic burden and pathogen association with autophagosome marker LC3-II. LC3-
II recruitment to pathogens was reduced in autophagy mutant neutrophils. Additionally, 
selective autophagy receptor p62 was recruited to S. aureus and C. neoformans within 
neutrophils, highlighting the involvement of host cell autophagy during infection. 
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Chapter 1: Introduction  
Autophagy is a conserved homeostatic process activated in response to starvation or 
damage. It enables cells to recycle the components of proteins and organelles 
following their degradation (Mizushima et al. 2008; Tanida 2011). An autophagosome 
is characterised by a double membrane vesicle, which surrounds the cargo selected for 
degradation. Fusion of lysosomes, containing lysosomal hydrolases, leads to the 
degradation of the contents of the autophagosome (Mizushima 2007). In addition to its 
homeostatic function, autophagy plays a fundamental role in immunity (Crotzer & Blum 
2010). Intracellular pathogens can be targeted to the autophagic pathway, whereby 
pathogens inside the cell are degraded (Levine et al. 2011). Both Cryptococcus 
neoformans and Staphylococcus aureus can survive as intracellular pathogens, and as 
such, may be targeted to the autophagy pathway.  
Diverse survival strategies are used by pathogens to infect and replicate inside a host 
cell. Unsurprisingly, pathogens also have different means to block or subvert the 
autophagy pathway, allowing their continuing survival (Mizushima 2007). Research into 
the role of autophagy employed by host cells in their defence against pathogens, and 
conversely how pathogens confront or evade host cell autophagy, may develop a 
greater understanding of how pathogens could be targeted therapeutically. 
Investigating infection within a complete organism is useful in the study of immune 
response to infection. In vivo experiments provide an environment in which the 
pathogen interacts with multiple extracellular, cellular and sub-cellular host 
components, in conditions which exist in a living animal. These interactions are much 
more complex than the conditions that can be created in in vitro analysis, and enable 
analysis of how pathogens truly interact with a large range of host defence 
mechanisms. Consequently, a model organism is valuable to study the role autophagy 
plays within infection. Consideration of the many attributes of the zebrafish (Danio 
rerio) as an in vivo model, such as in vivo imaging potential, genetic manipulation and 
similarity of the immune system, highlights zebrafish as an ideal model organism for 
investigation of the immune response to infection in vertebrates (Renshaw & Trede 
2012; Goldsmith & Jobin 2012). Therefore, the zebrafish model has been chosen for 
investigation of infection progression dynamics and the role of host cell autophagy in 
Cryptococcus neoformans and Staphylococcus aureus infection. 
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1.1 Innate immune system  
1.1.1 Role of the innate immune system in infection 
The innate immune system is involved in the first line of defence against pathogens 
that have invaded the host. The innate immune system is a non-specific defence 
against invading pathogens, and is comprised of: a physical barrier to infection, anti-
microbial molecules and innate immune cells. The role of the innate immune system is 
to block access of pathogens from the host and to recognise invading pathogens and 
molecules related to the pathogen. The innate immune system can raise an 
appropriate anti-pathogen response, for example degrading the pathogen or promoting 
other immune responses, such as phagocyte cell recruitment, to block the spread of 
the pathogen throughout the host. The innate immune system provides a rapid and 
non-specific response, through generation of cytokines and chemokines, activation of 
phagocytes and other innate immune cells, and ultimately leads to the activation of the 
adaptive immune system. There are several components of the innate immune system 
which enable this.  
1.1.2 Components of the innate immune system 
The first line of host defence is the physical barring of pathogens from entry into the 
host tissue. Epithelial surfaces are potential routes of entry to pathogens, however also 
represent a major barrier to infectious particles. Tight-junctions between epithelial cells 
provide a continuous physical barrier between cells, for example in the skin, respiratory 
tract or gastrointestinal tract (Guttman & Finlay 2009; Anderson & Van Itallie 2009). 
Pathogens are able to invade the host when the epithelial layer is broken, for example 
in a skin wound, or are able to directly target tight-junctions. For example, Clostridium 
perfringens, a food poisoning causing bacteria, employs a toxin which binds to 
claudins, major tight-junction proteins, resulting in loss of tight junction integrity from 
epithelial cells (Sonoda et al. 1999). The physical barriers to infection are supported by 
antimicrobial molecules which help to prevent pathogen entry. For example, saliva, 
sweat, tears, stomach acid, secreted enzymes and antimicrobial proteins act to prevent 
pathogen access to host tissue. Mucus (and cilia movement) in the lung promote the 
expulsion of inhaled pathogens, by preventing interaction with the epithelial layer 
(Murphy 2012). Although physical barriers are generally effective in blocking pathogen 
access, where pathogens are able to gain entry into the host such as in injury or 
pathogen mediated mechanisms, further immune responses are required.   
In cases where pathogens are able to access host tissues, rapid responses from innate 
immune cells are used as an initial defence. The innate cell types which first encounter 
invading pathogens recognise them through the use of pattern recognition receptors 
(PRRs). PRRs include Toll-like receptors (TLRs), RIG-like receptors (RLRs), and NOD-
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like receptors (NLRs) which are located in cellular membranes (TLRs) or cytoplasm 
(RLRs and NLRs). PRRs recognise PAMPs (pathogen associated molecular patterns), 
specific pathogen antigens, and also DAMPS (danger associated molecular patterns), 
which may result from host cell damage caused by pathogens or inflammation. Cells 
which recognise PAMPS or DAMPS enable the activation of immune pathways 
responsible for pathogen degradation through signalling cascades which results in 
phagocytosis, cytokine secretion, immune cell chemotaxis and inflammation (Hato & 
Dagher 2015).  
Phagocytic cells represent a large majority of innate cells and includes macrophages, 
neutrophils and dendritic cells. Neutrophils are the most abundant white blood cells, 
and effectively kill and degrade phagocytosed pathogens (discussed in section 1.1.4). 
Macrophages and dendritic cells (DCs), as professional antigen presenting cells, 
degrade foreign objects and later stimulate the adaptive immune response. Another 
phagocytic cell type, eosinophils, can phagocytose pathogens, but are largely involved 
in cytotoxic degradation of parasitic infections. Eosinophils also have an ability to co-
ordinate the innate immune response (Shamri et al. 2011). Natural killer (NK) cells are 
not phagocytic, but act to kill infected host cells when “self-antigens” normally 
presented by cells are missing and no longer inhibit the NK cells from killing the host 
cells (Klas Kärre et al. 1986). Importantly, innate immune cells are able to release 
cytokines and influence the immune response after recognition and phagocytosis of 
pathogens.  
 
The innate immune system has a non-specific route for promoting phagocytosis of 
foreign objects, the complement cascade. This cascade “complements” the host 
immune system, through improvement of phagocytosis, direct interactions with 
microbes and recruitment of phagocytic cells. There are three routes of activation of the 
complement cascade, classical, lectin and alternative. All three pathways can be 
activated in an innate immune response (Janeway et al. 2001d). The complement 
system is a cascade of proteolytic activation and cleavage. Pathogenic stimulation 
causes proteolytic cleavage of precursors of complement components, which are 
subsequently activated have their own proteolytic capabilities on further downstream 
components (Sim & Tsiftsoglou 2004). In each of the three activation pathways, C3 
convertase is produced and subsequent complement components and fragments are 
created. For example C3b (complement fragment 3b), or iC3b (the proteolytic inactive 
form) are able to coat foreign objects as opsonins, and through binding of complement 
receptors on phagocytic cells promote phagocytosis (Merle et al. 2015). The 
complement system is not limited to increased phagocytosis. A membrane attack 
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complex is formed from multiple complement components, resulting in pore formation 
in the membrane of bacteria (Merle et al. 2015), highlighting that complement directly 
attacks pathogens. Complement can also attract immune cells to the infection site, C5a 
is important in the chemotaxis of neutrophils (Ehrengruber et al. 1994). Complement 
uses several mechanisms to target pathogens, and is therefore an important innate 
defence. 
Phagocytosis of invading pathogens by innate immune cells results in pathogen 
degradation, cytokine release and antigen presentation. An important function of innate 
immune cells that have phagocytosed a foreign pathogen, is to alert other immune cells 
to the tissue invasion. Cytokine and chemokine release from infected innate immune 
cells promotes activation and recruitment of other innate immune cells. After 
phagocytosis, many cells (including lymphocytes and epithelial cells) are able to 
release cytokines, but macrophages play a primary role in releasing inflammatory 
cytokines including TNF-a, IL1, IL-6, IL-8 and IL-12 in addition to chemokines. Cytokine 
and chemokine secretion promote the influx of more inflammatory cells, the activation 
of macrophages and ultimately the correct immune response to pathogen invasion 
(Arango Duque & Descoteaux 2014). Additionally IL8 and TNF-α leads to activation of 
neutrophils (Janeway et al. 2001b). The role of cytokine secretion in the promotion of 
an immune response is key for the coordination of a correct host response.  
The initial role of the innate immune system during invasion by a pathogen is to 
recognise the foreign object and if possible to degrade it. However, the innate immune 
system also acts to alert the adaptive immune system to pathogen invasion.  
 
1.1.3 Innate immune system links to the adaptive immune system 
Activation of the innate immune system can lead to the activation of the adaptive 
immune system. The adaptive immune system is the targeted response to specific 
invading pathogens. The adaptive immune system provides long lasting immune 
defences against (previously encountered) pathogens.  
The adaptive immune system requires professional antigen presenting cells (APCs) 
such as macrophages or dendritic cells to phagocytose and degrade pathogens and to 
subsequently present pathogen antigens on major-histocompatibility complex class II 
(MHC-II) molecules (Al-Daccak et al. 2004). The APC may migrate to lymph nodes in 
order to activate CD4+ T helper cells (Itano & Jenkins 2003). CD4+ T cells specifically 
recognise antigens displayed on the MHC-II molecules, through T cell receptors 
leading to the activation of CD4+ T helper cells. Once active, CD4+ T cells are able to 
secrete pro-inflammatory cytokines and activate CD8+ cytotoxic T cells and B cells 
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(Janeway et al. 2001a). CD4+ T helper cells can be spilt into two groups: Th1 or Th2. 
The Th1 group secrete pro-inflammatory cytokines, IFN-γ (a potent macrophage 
activator). By contrast Th2 CD4+ cells promote an anti-inflammatory response through 
secretions of IL4, IL5 and IL10 (Romagnani 2000). In host defence against pathogens 
a Th1 profile is required, however excessive pro-inflammatory responses can be 
harmful for the host tissue and a Th1-Th2 balance is therefore needed (Romagnani 
2000). 
Non-professional APCs are important for the action of CD8+ cytotoxic T cells. Non-
professional APCs present phagocytosed and degraded pathogen antigens on major-
histocompatibility complex class I (MHC-I) molecules. Antigens presented by MHC-I 
molecules are recognised by CD8+ T cells which are then able to target and kill cells 
that contain pathogens (Janeway et al. 2001c).  
An important part of the adaptive immune response is the production of antigen-
specific antibodies. It is therefore important that B cells are activated to be able to 
produce antibodies. B cells can be activated by T helper cells, or through direct contact 
with foreign antigens (Janeway et al. 2001a). For B cells activated by T helper cells, 
initial internalisation of antigen leads to presentation (of antigen) on MHC-II molecules 
which stimulates CD4+ T helper cells. CD4+ T cells then provide B cells stimulus to 
produce antibodies (Janeway et al. 2001a).  
The adaptive immune response provides long-lasting immune defence against 
pathogens, with a key role for CD4+ cells in the activation of further adaptive immune 
responses and in co-ordinating an appropriate pro-inflammatory response.  
 
1.1.4 Phagocytic cells: macrophages and neutrophils 
Macrophages and neutrophils represent important phagocytic cells. Both macrophages 
and neutrophils are of the myeloid lineage. Multipotent haematopoietic stem cells have 
the ability to generate multiple types of blood cells and can differentiate into myeloid 
progenitor stem cells or lymphoid progenitor stem cells. Lymphoid progenitor stem cells 
are able to differentiate into natural killer cells, T cells and B cells. Myeloid progenitor 
cells differentiate into erythrocytes, mast cells and myeloblast cells. Myeloblast cells 
are able to further differentiate into important innate immune cells basophils, 
neutrophils, eosinophils and monocytes, where monocytes are precursors to 
macrophage cells and dendritic cells (Kondo 2010; Kondo et al. 2003).  
Neutrophils 
20 
 
Neutrophils are the most abundant white blood cells in the human body and, as a 
phagocytic cell, provide an important defence against invading pathogens. Neutrophils 
are polymorphonucelar cells, due to the multi-lobed nucleus, this enables neutrophils to 
squeeze through small spaces in the extracellular matrix, which may not be possible 
with a larger circular nucleus typical of most cells (Kondo et al. 2003). Usually 
circulating in the blood, neutrophils respond to cytokine and chemokine signalling and 
migrate to sites of damage or infection. Recognition of pathogens through TLRs leads 
to phagocytosis by neutrophils (Hayashi et al. 2003). Phagocytosis by neutrophils leads 
to pathogen degradation, through generation of reactive oxygen species (ROS). 
Furthermore, granules (vesicles which are specialised lysosomes) which contain 
antimicrobial molecules and degradative enzymes are used by neutrophils to degrade 
pathogens (Kumar & Sharma 2010). Granules fuse with phagosomes containing the 
pathogen leading to degradation. Additionally, neutrophils undergo a specialised form 
of cell death (termed NETosis) which releases nuclear genomic material, antimicrobial 
molecules and granules into the extracellular environment, in a process leading to the 
formation of neutrophil extracellular traps (NETs). NET formation traps extracellular 
pathogens and can also lead to their degradation (Brinkmann et al. 2004).  
In addition to their important role as effector cells in pathogen degradation neutrophils 
also play a role in immune system activation and modulation. The role of immune 
system regulation by neutrophils has been reviewed in detail elsewhere, but includes 
secretion of chemokines and cytokines, which may be pro- or anti- inflammatory, 
provide help to B-cells and the modulation of the activity of macrophage and dendritic 
cells (Selders et al. 2017; Jaillon et al. 2013; Perobelli et al. 2015).  
Macrophages 
Monocytes develop into macrophages after leaving the blood stream, following 
chemokine signalling (Auffray et al. 2007). Tissue resident macrophages are localised 
to certain tissues to provide rapid responses, particularly in organs or tissues which 
may experience pathogen invasion often, such as the lungs or gut. Some tissue 
resident macrophages which are not derived from monocyte lineage are self-renewing, 
and are specialised to certain tissues, for example microglial cells in the brain, and 
alveolar macrophages (Yona et al. 2013).  
Macrophages are phagocytic cells that actively monitor and search the tissue for 
pathogens. Macrophages recognise pathogens or pathogen associated damage 
through PRRs, including TLRs (Weiss & Schaible 2015). Macrophages are able to 
degrade pathogens through degradative enzymes. After phagocytosis, the phagosome 
(vesicle containing the pathogen formed from plasma membrane in phagocytosis) 
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fuses with other cellular vesicles, endosomes, lysosomes and autophagosomes 
resulting in an acidic pH (in the phagosome). Degradation of pathogens by hydrolases 
occurs, which are delivered to the pathogen vesicle by lysosome and late endosome 
fusion (Weiss & Schaible 2015). Therefore macrophages play an important role in the 
recognition and clearance of pathogens.  
Macrophages may become activated and secrete cytokines to alert the immune system 
and recruit additional immune cells. Macrophages are activated by multiple stimuli, 
which can lead to specialisation of activation sate, broadly leading two activation 
groups, classically activated macrophages (M1), and alternatively activated 
macrophages (M2), reviewed elsewhere. M1 and M2 are named to match with Th1 pro-
inflammatory, or Th2 anti-inflammatory subsets of T helper cells. As such, M1 
macrophages are pro-inflammatory, important in pathogen killing whereas M2 are 
generally immunomodulatory, but still useful for pathogen killing (Martinez & Gordon 
2014). 
Macrophages also promote the activation of the adaptive immune system as 
professional antigen presenting cells, through presentation of pathogen antigens on 
MHC-II molecules to T-cells (Weiss & Schaible 2015). This leads to the activation of 
the adaptive immune response, as introduced above.  
 
1.2 Cryptococcus neoformans  
1.2.1 C. neoformans microbiology  
Cryptococcus neoformans is an encapsulated yeast of the Cryptococcus genus, in the 
phylum basidiomycota within the kingdom of fungi. There are two variants of C. 
neoformans species, var. neoformans and var. grubii, containing 3 serotypes; A (var. 
grubii), D (var. neoformans) and a hybrid AD (Kwon-Chung et al. 1978). C. gattii, a 
related species, was initially included, but after genetic analysis, a clear difference 
between variants was found and it was proposed as a separate species (Kwon-Chung 
et al. 2002). C. neoformans has been detected in soil, pigeon excrement and in rotting 
vegetables and wood (Voelz et al. 2010) and is found globally. In contrast C. gattii is 
almost exclusively found in tropical and subtropical areas (Voelz & May 2010). 
C. neoformans is a basidiomycetous yeast (spore forming) and as such has a sexual, 
in addition to an asexual form during its life cycle.  The sexual stage requires contact 
between two fungal mating types, a and α, for reproduction (Kwon-Chung 1976). In the 
much more common, asexual stage, C. neoformans is in a yeast form. The yeast 
reproduces through budding and this is the form that has been isolated from human 
infection.  
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1.2.2 Route of C. neoformans infection  
C. neoformans (var. grubii) is a human fungal pathogen which is found in the 
environment globally (Bovers et al. 2008). C. neoformans infection of healthy 
individuals can be controlled by the host immune system. C. neoformans infection is 
not controlled in immuno-compromised individuals and can lead to life-threatening 
disease. 
Initial infection occurs through inhalation of environmental spores deep into the lung.  It 
is thought that initial infection occurs in childhood since an antibody profile appears 
with age, indicating latent or repeated infection (Goldman et al. 2001). After inhalation 
of cryptococcal spores, they are believed to be encountered and phagocytosed by 
alveolar macrophages (Nicola et al. 2012). In healthy individuals, an immune response 
(discussed in section 1.2.4) is generated which can result in granuloma formation and 
ultimately clearance of cryptococcal cells (Shibuya et al. 2005). Cryptococcal cell 
survival within granulomas was shown in C. neoformans infection in a rat model 
(Goldman et al. 2001). Evidence of re-activation of cryptococcal infection was 
investigated through comparison of the geographical location of cryptoccocal strains 
and their occurrence in new locations. It was shown that individuals who were in the 
original location several years before had infection in new locations caused by the 
strain from the original location (Garcia-Hermoso et al. 1999). Indicating the 
cryptococcal cells were surviving within individuals overtime before causing clinical 
infection. C. neoformans infection in immuno-competent individuals can therefore lead 
to a subclinical infection; a latent stage. 
In immunocompromised individuals, initial infection is not efficiently controlled. In these 
cases, pulmonary infection is likely to be followed by systemic spread where C. 
neoformans is able to escape the lung, and gain access to the blood stream. A 
potential mechanism of this extra-pulmonary dissemination is via an alveolar 
macrophage “Trojan horse”, in a similar manner to B. anthracis spores. Spores rather 
than yeast may be more likely to leave the lung in this way due to the ease of which 
cryptococcal spores are phagocytosed, in comparison to cryptococcal fungal cells 
(Guidi-Rontani 2002; Botts & Hull 2010). C. neoformans has a tropism towards the 
central nervous system (CNS), particularly to the brain. Cryptococcal cells in the blood 
stream are able to migrate into the brain parenchyma, although exactly how C. 
neoformans targets the CNS is unknown. Several mechanisms of how C. neoformans 
is able to cross the BBB have been described (discussed in section 1.2.5). Life-
threatening diseases such as cryptococcal meningitis, and meningoencephalitis are 
caused when C. neoformans is able to invade the CNS.  
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 1.2.2 Cryptococcus gattii  
C. neoformans causes infection primarily in immunocompromised patients. On the 
other hand C. gattii is known to infect otherwise healthy individuals. There are four 
molecular subtypes of C. gattii, VGI, VGII, VGIII and VGIV. Subtypes VGIII and VGIV 
primarily infect immunocompromised hosts. However, subtypes VGI and VGII are 
known to infect immunocompetent individuals, causing infection in the CNS (VGI) and 
pulmonary infection (VGII). 
C. gattii differs from C. neoformans by exhibiting a reduced ability to replicate within 
macrophages (Voelz et al. 2014) and a slower replication rate in the blood 
(Ngamskulrungroj et al. 2012). Furthermore, using a murine infection model C. gattii is 
shown to more often cause pulmonary infection than a CNS infection via inhalation, but 
could cause severe cryptococcal meningitis through intravenous infection 
(Ngamskulrungroj et al. 2012). These data suggest that through the inhalation infection 
route, C. gattii is not able to efficiently escape out of the lung to cause CNS invasion. 
C. gattii was also shown to invoke a reduced immune response from the host, including 
reduced neutrophil recruitment and reduced pro-inflammatory cytokines, in comparison 
to C. neoformans (Cheng et al. 2009). This reduced immune response may represent 
immune evasion by C. gattii, and it was suggested that this may enable infection of 
immunocompetent hosts through increased persistence. In contrast to this, a strain of 
C. gattii responsible for infection of immunocompetent people in the Vancouver Island 
outbreak was shown to have an increased ability to replicate within macrophages. It 
was determined that cryptococcal mitochondria can become tubular, which may protect 
against fungal cell death, and additionally is directly proportional to intracellular 
proliferation (Ma et al. 2009). Perhaps a reduced immune response associated with an 
increase in C. gattii persistence in immunocompetent hosts, coupled with increased 
intracellular proliferation provides the ability of outbreak strains to cause infection in 
otherwise healthy individuals. 
1.2.3 Pathology of cryptococcosis  
Cryptococcus neoformans is an opportunistic fungal pathogen, causing infection 
primarily within immunocompromised individuals. C. neoformans is therefore an 
important pathogen for HIV/AIDs patients, where infection is responsible for high 
mortality rates, for example up to 70% mortality in sub-Sharan Africa (Park et al. 2009; 
Mitchell & Perfect 1995). Indeed, 15% of HIV/AIDs related deaths worldwide are 
caused by cryptococcal meningitis (Rajasingham et al. 2017). Very different infection 
outcomes occur between immunocompromised and healthy individuals after initial 
infection with C. neoformans, with infection controlled in healthy individuals. It is 
thought that as immune efficiency declines in HIV-associated cryptococcal infection, 
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the host immune defence is unable to either eradicate or suppress infection, leading to 
clinical disease (Bovers et al. 2008). 
Cryptococcus neoformans has a tropism to the CNS. Exactly how fungal cells target 
the CNS is not established, however the cryptococcal cells do employ several virulence 
factors which help the fungal cells to cross the BBB. If cryptococcal cells invade the 
brain, life-threatening cryptococcal meningitis or meningoencephalitis occurs. 
Cryptococcal meningitis (CM) is a subacute meningoencephalitis, where 
infection/inflammation occurs in the meninges (three layers of membrane surrounding 
and protecting the brain) and in the subarachnoid spaces (fluid filled spaces between 
the meninges). CM is caused by the invasion of cryptococcal cells into the meninges or 
subarachnoid spaces (Williamson et al. 2017). In HIV associated CM, cryptococcal 
cells are observed in the brain parenchyma and meninges often in large masses. By 
contrast in non-HIV associated CM, cryptococcal cells are observed in perivascular 
spaces and meninges, in most cases with fewer cryptococci present (Lee et al. 1996). 
Differences in cryptococcal infection outcome between HIV associated and non-HIV 
associated CM are caused by different immune profiles and responses. The vast 
majority of cryptococcal infection occurs in immunocompromised individuals, such as 
HIV positive patients, with a reduced number of CD4+ T cells. It is known that CD4+ T 
cells are key in the control of cryptococcal infection (Jarvis & Harrison 2007). CD4+ 
cells can be grouped into Th1 pro-inflammatory, or Th2 anti-inflammatory subsets. The 
CD4+ cell profile changes over time in HIV/AIDS patients, becoming predominantly 
Th2 (Altfeld et al. 2000). It was later demonstrated that the CD4+ profile is important in 
the outcome of HIV associated cryptococcal meningitis, with a pro-inflammatory profile 
associated with increased survival and reduced fungal burden (Jarvis et al. 2013). The 
lack of control of cryptococcal infection in immunocompromised patients enables 
continued cryptococcal growth and eventual progression to CM.  
Non-HIV associated CM occurs often in immunocompromised individuals, such as 
organ transplant receivers, who also have reduced CD4+ cell counts (Taylor et al. 
2005). Most non-HIV CM cases have underlying illness, with ~40% being 
immunocompromised (Pappas 2013; Taylor et al. 2005). Of note some apparently 
healthy individuals still had cryptococcal infection, occurring in ~12% of a retrospective 
study (Kiertiburanakul et al. 2006). However, in healthy patients, cryptococcal infection 
is likely to remain as a pulmonary infection. In healthy individuals, CM is rare (Li et al. 
2010), due to the ability of the immune system to control cryptococcal infection, 
therefore there is limited data on the normal response to cryptococcal infection.  
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Cryptococcal meningitis is the major cause of death in C. neoformans infection. Clinical 
studies have shown that in a proportion of cryptococcal meningitis cases, vascular 
damage results in infarcts, areas of necrotic tissue caused by a lack of blood supply 
(Mishra et al. 2017). Furthermore, the incidence of cortical infarcts is non-trivial, 
occurring in 30.3% of cryptococcal meningitis patients, most often observed in severe 
cases (Mishra et al. 2017). The physiological cause of infarcts in CM is currently 
unknown. Of note, cerebral infarcts are also observed in tuberculosis meningitis (Lan et 
al. 2001). This may suggest that in infective meningitis, blood vessels in the brain 
become damaged, potentially through physical damage or through toxins from the 
pathogen. For tuberculous meningitis, vascular damage is suggested to be caused by 
direct interaction of the bacterium and vessel wall, in addition to immune mediated 
damage (Lammie et al. 2009). Recent clinical studies and case reports have 
highlighted a potential role of blood vessel damage resulting from infection with C. 
neoformans. This may provide some  understanding of the cause of infarcts in CM, that 
cryptococcal infection leads to vasculitis and brain vasculature damage and may 
ultimately result in infarcts (Aharon-Peretz et al. 2004; Rosario et al. 2012; Leite et al. 
2004). Additionally, clinical dissection reports show cryptococcal cells invading the 
brain, observed both in the perivascular spaces and located next to brain capillaries 
which have cryptococcal cells present (Lee et al., 1996; Loyse et al., 2010). This may 
represent dissemination across the BBB, potentially at sites of vascular damage.  
 
1.2.4 Host defence interactions with C. neoformans  
The interactions that occur between the host and pathogen are key to the outcome of 
infection. The host response to C. neoformans infection involves both innate and 
adaptive immunity. 
Cryptococcal spores are initially located in the lungs. The lungs provide some first line 
defences against C. neoformans. Firstly, adaptations of the lung enable particles larger 
than 2µm to be expelled, for example mucus and mucocilary transport and coughing 
(Nicod 2005). For this reason it is thought that the infectious propagule of C. 
neoformans is the cryptococcal spore, which is smaller at ~2-2.5µm than the fungal 
cells at ~4-8µm (Velagapudi et al. 2009).  
Surfactant is a film of proteins and lipids which provides surface tension for alveoli. The 
presence of surfactant in the lung additionally promotes trafficking of particles (or 
pathogens) towards the alveoli, therefore promoting interactions with immune cells, 
such as alveolar macrophages (Schurch et al. 1992). Proteins within the surfactant are 
known to directly interact with C. neoformans. Surfactant protein A (SPA) and 
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surfactant protein D (SPD) acts to opsonise pathogens, therefore promoting their 
phagocytosis by neutrophils and macrophages (Kishore et al. 2005; Wright 2004). SPD 
has been shown to bind to C. neoformans and in particular to promote phagocytosis of 
acapsular cryptococcal cells (Geunes-Boyer et al. 2009). However, it was later 
demonstrated that mice lacking SPD had a reduced severity of cryptococcal infection, 
suggesting that SPD is useful for cryptococcal pathogenesis (Geunes-Boyer et al. 
2012).  
After alveolar macrophage phagocytosis of cryptococcal cells, an immune response 
generates formation of a granuloma (Haugen & Baker 1954). This encloses 
cryptococcal infection within a well organised structure composed of immune cells. The 
function of granulomas is to contain and resolve C. neoformans infection. C. gattii 
infection also induces pulmonary  granuloma formation (Torda et al. 2001). In healthy 
patients, cryptococcal granulomas are usually located in the lung. Interestingly, using a 
rat cryptococcal intravenous infection, intravascular granulomas were observed, likely 
composed of monocytes, rather than alveolar macrophages (Yamaoka et al. 1996).  
Cryptococcal granulomas are composed of (alveolar) macrophages, multi-nucleated 
giant cells (formed by fusion of macrophages or monocyte cells), and an outer layer of 
CD4+ T cells (Shibuya et al. 2005).  Macrophages and multi-nucleated giant cells 
which contain cryptococcal cells are centrally located in the granuloma, observed in 
limited case reports (Takata et al. 2011; Haugen & Baker 1954; Izumikawa et al. 2008). 
Pulmonary C. neoformans infection using a rat model demonstrated infection is 
controlled in the lung through recruitment of macrophages and lymphocytes 
contributing to granuloma formation, ultimately resulting in a reduced fungal burden 
(Goldman et al. 2001). Together, these data suggest that granuloma formation in 
healthy individuals resolves cryptococcal infection.  
In immunocompromised patients, cryptococcal granulomas are not composed of the 
same types of innate cells and the location of granulomas are not limited to the lung. A 
case study reports granulomas located in the brain in an immunocompromised patient 
(Taneja et al. 2008). In these cases, granulomas are composed of macrophages and 
multi-nucleated giant cells, (which contain proliferative cryptococcal cells) but 
importantly are lacking the outer layer of CD4+ T cells (Shibuya et al. 2005). 
Incomplete granuloma response, due to the lack of CD4+ T cells in 
immunocompromised patients, may account for the lack of pulmonary infection control 
in these cases.  
Several molecules have been implicated in promoting the formation of a cryptococcal 
granuloma. Monocyte chemoattractant protein 1 (MCP-1) has previously been linked to 
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induced granuloma formation in rats, where alveolar macrophages provide a source of 
MCP-1 (Flory et al. 1993). MCP-1 production from alveolar macrophages occurs before 
granuloma formation. It was later demonstrated that phagocytosis of C. neoformans 
induced MCP-1 production by alveolar macrophages (He et al. 2003). Therefore, 
phagocytosis of cryptococcal cells results in further macrophage recruitment and may 
initiate the granuloma formation. A requirement of host sphingosine kinase 1 (SK1)  in 
order to form a proper granuloma response to exclusively intracellular resident 
cryptococcal cells, was demonstrated using a murine model (McQuiston et al. 2010), 
although this was not seen in “wild-type” cryptococcal cells which can survive 
extracellularly. SK1 phosphorylates sphingosine to sphingosine-1-phosphate (S1P). 
S1P is able to induce immune cell activation and migration. This may enable 
recruitment of immune cells for the generation of a granuloma (Farnoud et al. 2015; 
McQuiston et al. 2010).  
Two mouse models have been established, which illicit either a Th1 or Th2 response 
after C. neoformans inoculation. In a Th1 response, granuloma formation occurs. It was 
then demonstrated that metalloproteinase-2 (MMP-2) was highly expressed in the 
murine lung only in a Th1 response. It was therefore suggested that MMP-2 
expression, (which provides immune cells help in terms of movement by degradation of 
extra-cellular matrix components) therefore may be associated with granuloma 
formation in healthy individuals (Majka et al. 2002).  
Unsurprisingly, the common aspect which is involved in granuloma formation, is to 
allow recruitment of immune cells to generate a granuloma. Some factors which 
promote innate cell recruitment, such as MCP-1, are released after initial host 
interactions with cryptococcal cells. This host response and subsequent innate immune 
cell attractant release may be key in co-ordinating the correct granuloma formation 
response to cryptococcal infection.  
 
The role of complement in C. neoformans infection 
The complement system, (as described above) improves innate cell phagocytosis, has 
direct interactions with microbes and promotes the recruitment of phagocytic cells. In 
C. neoformans infection, the alternative pathway is used to activate complement as a 
host defence (Kozel et al. 1991). In each of the three activation pathways, C3 
convertase and C3b is produced, and subsequently C5a and C5b components are 
created. Both C5 and C3 components are implicated in C. neoformans infection. C5 is 
important in the chemotaxis of immune cells. C5 deficient mice are more susceptible to 
cryptococcal infection (Rhodes et al. 1980), as may be expected by a lack of immune 
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cell recruitment. C3 is accumulated on the cryptococcal capsule, which aids in the 
phagocytosis of the fungal cell. However, to promote phagocytosis C3 is required to be 
at the surface of the capsule. If C3 is dispersed through the entire capsule structure 
there is a reduction in the help C3 provides in phagocytosis (Gates & Kozel 2006; 
Zaragoza et al. 2003). As with other innate immune responses, C. neoformans has 
strategies it uses to avoid the complement system. C. neoformans can reduce C3 
deposition in the capsule through the use of lactonohydrolase, a hydrolytic enzyme 
produced by cryptococcal cells (Park et al. 2014). Additionally, as mentioned below 
complement has useful roles in neutrophil phagocytosis and killing of C. neoformans.  
 
C. neoformans interactions with macrophages 
In the host innate defence, the initial response to infection with Cryptococcus 
neoformans include phagocytosis, primarily by alveolar macrophages. The complement 
cascade also acts to promote phagocytosis (Voelz & May 2010). Despite this, 
cryptococcal cells are able to survive, replicate and escape from macrophages. 
The macrophage response to phagocytosis of microbes is to acidify the cryptococcal 
phagosome to enable degradation. However, as a fungal pathogen, a low pH is 
preferable for cryptococcal growth, and the low pH of a phagosome is not detrimental. 
When cryptococcal phagosome acidification is blocked, there is a reduction in 
cryptococcal replication (Levitz et al. 1997), demonstrating that an acidic intracellular 
environment is preferable for cryptococcal proliferation. Despite this, in some cases the 
phagocytosed C. neoformans is presumed to be degraded within the phagocyte. The 
fungicidal activity of macrophages is dependent on the activation status of the 
macrophages. Through in vitro treatment of cytokines on macrophages, it was 
demonstrated that Th1 and Th17 type macrophages have improved fungicidal activity 
in comparison to Th2 macrophages (Voelz et al. 2009). Macrophages, primarily 
classically activated (Th1), are able to degrade C. neoformans through oxidative and 
nitrosative molecules (Alspaugh & Granger 1991). Macrophages are also able to kill 
extracellular C. neoformans. IFNγ treated macrophages (Th1) were shown to reduce 
growth of, and kill extracellular cryptococcal cells, and that this was likely mediated by 
secreted proteins (Flesch et al. 1989). Macrophages are therefore important 
phagocytes in the control of cryptococcal infection.  
Although C. neoformans did not evolve to be a human pathogen, it exhibits many 
virulence factors (as discussed in section 1.2.5) and attributes which enable its survival 
during human infection. A key attribute is the ability for C. neoformans to survive, 
replicate and even escape from within macrophages. Cryptococcal cells were first 
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shown to be able to replicate within macrophages. In vitro studies showed that 
macrophages did not kill phagocytosed cryptococcal cells and in fact intracellular 
cryptococcal growth occurred (Diamond & Bennett 1973). Cryptococcal cells have 
been shown to survive intracellularly within phagolysosomes (Levitz et al. 1999), and 
may be able to gain access to the cytoplasm (Tucker & Casadevall 2002). Replication 
within the host cell has been suggested as a route of cryptococcal macrophage 
escape, by causing physical damage to the plasma membrane of the macrophage 
(Tucker & Casadevall 2002). Host macrophage lysis can allow cryptococcal escape 
from the macrophage and from there enable dissemination throughout the host.  
C. neoformans can also utilise a phagosome emptying (into extracellular space) 
mechanism, termed “vomocytosis”, in which the cryptococcal cell and macrophage 
remain alive after cryptococcal escape. Vomocytosis occurs frequently, with 29.9% of 
cryptococcal cells being able to escape in vitro and 44% in vivo (Nicola et al. 2011). 
However, the macrophage does employ an actin-cage blocking mechanism against 
vomocytosis (Johnston & May 2010). C. neoformans has also been observed to move 
from one macrophage to another in vitro (Alvarez & Casadevall 2007), although the 
whether this is a host defence, or fungal mediated evasion is unclear, but does allow 
the fungal cell to avoid the extracellular space.  
In addition to routes of escape from macrophages, after phagocytosis, C. neoformans 
alters the macrophage/phagosome environment for its own end (Rahman & McFadden 
2011). Several host macrophage factors are manipulated by cryptococcal cells, 
including the actin cytoskeleton, cell surface signalling molecules, vesicle transport and 
autophagy (Qin et al. 2011). Within the host cell, C. neoformans influences these 
factors to promote its own survival and replication. Like other pathogens, intracellular 
C. neoformans is able to prevent activation of the host macrophage through 
manipulation of the NF-kB pathway (Hayes et al. 2016). This will help prevent a larger 
host immune response to infection. Interestingly, phagolysosomal damage, which 
occurs increasingly with intracellular cryptococcal growth, was suggested to be 
beneficial for C. neoformans, through a self-perpetuating cycle of phagosome damage 
increasing cryptococcal growth (Davis et al. 2015). Additionally, reports that C. 
neoformans manipulates phagosome maturation, for example incomplete acidification 
and altered Rab protein association (Smith et al. 2015) suggest that C. neoformans is 
manipulating the host environment, although the mechanism behind this is unclear. 
Other fungal pathogens, including Candida albicans and Histoplasma capsulatum, are 
able to alter the phagosome maturation process (Kasper et al. 2014; Strasser et al. 
1999), similar mechanisms may be present between these fungal pathogens to 
promote fungal survival.  
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C. neoformans interactions with neutrophils 
Neutrophils are able to phagocytose and degrade cryptococcal cells, however, unlike 
macrophages, neutrophils do not play a key role in the control of cryptoccocal infection. 
Neutrophils are not considered important in the control of C. neoformans infection due 
to the lack of clinical evidence of any increased susceptibility to cryptococcal infection 
in neutrophil disorders, such as neutropenia. Furthermore, in mice depleted of 
neutrophils no change in fungal burden was observed after pulmonary infection in 
comparison to mice which had neutrophils (Wozniak et al. 2012). This suggests that 
neutrophils are not key in the clearance of cryptococcal cells.  
Neutrophils, are however, very much capable of degrading C. neoformans. There is 
evidence that in vivo, neutrophils play a key role in the degradation of cryptococcal 
cells in the brain vasculature, as when neutrophils were depleted in a murine model, 
the fungal burden in the brain increased (Zhang et al. 2016). Neutrophils employ 
oxidative and non-oxidative strategies to kill cryptococcal cells. Oxidative killing of 
phagocytosed cryptococcal cells was demonstrated by blocking myeloperoxidase 
function (an enzyme involved in production of microbicidal hypochlorous acid) which 
led to reduced fungicidal activity of neutrophils (Diamond et al. 1972). Neutrophils also 
use non-oxidative methods to kill C. neoformans. Calprotectin may mediate fungistatic 
effects through nutritional zinc depravation and is abundantly present in neutrophils. 
Defensins present in neutrophil granules also promote fungal killing (Mambula et al. 
2000).  
C. neoformans is also able to defend against neutrophil killing. C. neoformans uses 
mannitol to protect against oxidative species, where mannitol acts to scavenge 
oxidative species. Furthermore the amount of mannitol produced during infection is 
proportional to the fungal load (Chaturvedi et al. 1996; Wong et al. 1990). C. 
neoformans is able to reduce the killing ability of neutrophils, likely through a secreted 
cryptococcal factor, although the mechanism for this is currently unknown (Qureshi et 
al. 2011). Another demonstration of cryptococcal modulation of neutrophils was shown 
in vitro where cryptococcal capsule inhibits neutrophil NET formation (Rocha et al. 
2015).  
There is an emerging role of complement (described above) in neutrophil phagocytosis 
of cryptococcal cells. In vitro and ex vivo studies have demonstrated that complement 
(C5) signalling is important in neutrophil movement towards cryptococcal cells and is 
required for phagocytosis and killing by neutrophils (Sun et al. 2016b).  In a murine 
model, neutrophil swarming in the lungs in response to C. neoformans, is dependent 
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on complement activation and subsequent leukotriene B4 (LTB4, immune cell 
attractant) release from neutrophils which have encountered cryptococcal cells (Sun & 
Shi 2016). It is suggested that complement (specifically C5) which is required for 
intravascular recruitment of neutrophils, could be targeted therapeutically, to promote 
neutrophil clearance of cryptococcal cells in the brain (Sun et al. 2016a). Due to the 
effective killing of cryptococcal cells by neutrophils, if complement activation were 
targeted therapeutically, it may represent a promising approach to target cryptococcal 
cells in human infection.  
 
C. neoformans interactions with other innate immune cells 
Eosinophils can degrade C. neoformans, and are able to activate the adaptive immune 
response, despite not being professional antigen presenting cells. In a rat in vitro model 
of cryptococcal infection, eosinophils up regulated MHC-II molecules (after 
cryptococcal phagocytosis), and stimulate T cells to adopt a Th1 profile, suggesting 
these cells are important in the formation of an adaptive immune response (Garro et al. 
2010). It was later shown in vivo that cryptococcal activation promotes eosinophil 
migration to lymph nodes, where they can interact with T cells to initiate an appropriate 
adaptive immune response. It was also demonstrated that this incurred long lasting 
immunity to cryptococcus in rats later re-infected with C. neoformans (Garro et al. 
2011). These data suggest that eosinophils have a role in organising the correct Th1 
response and induce long lasting adaptive immunity in C. neoformans infection.  
Dendritic cells (DCs) are also involved in the immune response to cryptococcal 
infection. DCs phagocytose, degrade and present pathogen antigen to T cells of the 
adaptive immune system, linking together innate and adaptive immune systems. DCs 
are the most important antigen presenting cell in C. neoformans infection, despite the 
key role of alveolar macrophages early in infection (Syme et al. 2002). However, DCs 
require opsonins, such as complement molecules or antibodies, to efficiently 
phagocytose cryptococcal cells (Kelly et al. 2005). DCs are able to phagocytose and 
degrade C. neoformans using oxidative and non-oxidative methods. After 
phagocytosis, cryptococcal particles are displayed on MHC-II molecules to enable 
activation of T cells and promote a suitable adaptive immune response. A murine 
model highlighted that DCs are able to phagocytose cryptoccocal cells in vivo, and that 
these DCs were subsequently able to activate T cells in vitro (Wozniak et al. 2006). 
Overall, DCs have an important role in coordinating the adaptive immune response to 
C. neoformans.  
 
32 
 
The adaptive immune system in C. neoformans infection 
The adaptive immune system plays a key role in response to cryptococcal infection. 
The adaptive immune response is clearly implicated in C. neoformans infection, 
through the existence of antibodies against C. neoformans and the known link between 
individuals with reduced CD4+ T cell numbers and their increased susceptibility to C. 
neoformans. After initial innate immune cell interactions with C. neoformans, antigen 
presentation leads to adaptive immune response, which enable T cells and B cells to 
play important roles. 
T cells are lymphocytes which are involved in cell mediated immune responses, and 
have a variety of types including, T helper cells (CD4+), T memory cells, natural killer T 
cells or cytotoxic T cells (CD8+). HIV positive patients increased susceptibility to 
infection is caused by a reduction in the number of CD4+ T cells (Jarvis & Harrison 
2007). The role of T helper cells in C. neoformans infection in particularly important in 
helping activate innate immune cells to effectively kill C. neoformans. T helper cells 
recognise antigens displayed by APCs (such as macrophages or DCs), and 
subsequently release cytokines to induce a different immune responses, such as a Th1 
or Th2 profile. CD4+ T cells are key in the control of cryptococcal infection.  
B cells are lymphocytes which can produce antibodies against specific antigens when 
they are activated. Antibodies against C. neoformans are present from a young age, 
indicating that an adaptive immune response occurs after encountering environmental 
cryptococcal cells (Goldman et al. 2001). It has been demonstrated with an in vivo 
murine model that B cells are responsible for antibody production in response to 
pulmonary cryptococcal challenge, and that depletion of B cells causes enhanced 
susceptibility and reduced survival (Rivera et al. 2005). Furthermore, a reduction in 
memory B cells (IgM+) is associated with a higher risk of cryptococcal disease in 
HIV/AIDS patients  (Subramaniam et al. 2009). Together these studies demonstrate 
that B cells and antibody production are important in preventing cryptococcal infection.   
1.2.5 C. neoformans virulence factors and pathogenesis  
To counteract the host innate and adaptive immune responses C. neoformans has 
several virulence factors which promote its survival. Of high importance is the ability of 
pathogens to be able to live and reproduce within the host in order to survive. The 
ability of C. neoformans to survive and replicate at 37ºC is key to enabling infection of 
humans (Perfect 2006).  
The cryptococcal capsule is an important virulence factor for C. neoformans which 
surrounds the cryptococcal cell. The capsule consists of polysaccharides, 
glucuronoxylomannan (GXM), and galactoxylomannan (GalXM). In addition 
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mannoproteins (MP) may be associated with the capsule. Capsule size varies 
depending upon conditions (e.g. capsule size is upregulated in infection conditions) 
and is a known required virulence factor for infection. In mice acapsular yeast have a 
reduced ability to cause infection (Chang & Kwon-Chung 1994; Fromtling et al. 1982). 
An increase in capsule size may present a challenge for phagocytosis. The capsule 
allows the yeast to avoid phagocytosis, with acapsular yeast more frequently and easily 
phagocytosed than yeast possessing a capsule (Kozel & Mastroianni 1976). The 
cryptococcal capsule has multiple immunomodulatory effects, as reviewed by Coelho 
et al. 2014, which include a reduction in immune cell migration, reduced MHC 
presentation and reduced cytokine secretion (Coelho et al. 2014). The capsule also 
functions to prevent ROS from reaching the cryptococcal cell. Together these studies 
demonstrate the importance of the capsule in promoting cryptococcal infection, 
especially by preventing phagocytosis.  
If the cryptococcal cell is phagocytosed, nutrients are required for the fungal cell to 
survive. As mentioned above, C. neoformans replicates preferentially at an acidic pH, 
and therefore can reside within a phagosome, or phagolysosome (Levitz et al. 1997).  
However, how cryptococcal cells obtain nutrients for growth (from within the 
phagosome) in not fully understood. C. neoformans up-regulates autophagy pathways 
to enable increased re-cycling of host cell components to provide nutrients for growth 
(Palmer et al. 2008). It has also been shown that the phagolysosome membrane 
becomes damaged due to cryptococcal growth. This may represent a route for 
cryptococcal cell to access cytoplasmic nutrients (Tucker & Casadevall 2002). It is 
likely that several mechanisms of nutrient acquisition are used by cryptococcal cells 
within the host cell.  
C. neoformans utilises secreted factors to promote its survival. Melanin, an antioxidant, 
which is able to scavenge  radicals, is a key virulence factor which protects the yeast 
from oxidative damage (Wang et al. 1995). Laccase, another cryptococcal virulence 
factor, is responsible for promoting the synthesis of melanin and as such is important in 
the protection of C. neoformans from oxidative species. Additionally, laccase is capable 
of immuno-modulation, through promotion of a Th2 rather than the host protective Th1 
profile (Qiu et al. 2012). Another secreted virulence factor is urease, which reduces the 
pH of the surrounding environment through hydrolysis of urea, although in C. 
neoformans infection this does not appear to be necessary. In C. neoformans infection, 
urease promotes the trapping of cryptococcal cells in micro-capillary vessels, (Shi et al. 
2010), potentially important in the tropism of fungal cells to the brain. Virulence factors 
phospholipase B (Plb) and associated secretion factor, Sec14, are required for 
dissemination and vomocytosis (Chayakulkeeree et al. 2011). Plb1 is utilised by C. 
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neoformans for degradation of phospholipids (Chen et al. 2000), it is suggested that 
this may enable degradation of the cryptococcal vesicle and allow access to nutrients 
in the host cell cytoplasm. Interestingly, Plb1 is required for the cryptococcal escape 
from macrophages through vomocytosis (Chayakulkeeree et al. 2011), highlighting a 
potential role of Plb1 in cryptococcal dissemination.   
Well studied virulence factors have been described here, this list is non-exhaustive, 
many more cryptococcal virulence factors exist including multiple secreted molecules, 
which are reviewed elsewhere (Coelho et al. 2014; Buchanan 1998).  
 
C. neoformans invasion of the brain 
In order for C. neoformans to cause cryptococcal meningitis, cryptoccocal cells are 
required to migrate from the site of infection, the lungs, to the brain. When infection in 
the lungs is not controlled, cryptococcal cells are able to escape into the blood stream, 
and gain access to the brain. This means that the cryptococcal cells must cross the 
blood brain barrier (BBB). Cryptococcal passage across the BBB has been described 
to occur by several mechanisms. 
Firstly, a “Trojan-horse” mechanism whereby cryptococcal cells residing within a 
macrophage are transported across the BBB and subsequently escape in the brain. 
This was demonstrated in vivo when depletion of macrophages in mice led to a 
reduced fungal burden in the brain (Charlier et al. 2009). Recently, the Trojan-horse 
macrophage mechanism was shown to enable passage of cryptococcal mutants which 
cannot cross through other mechanisms. Furthermore it was demonstrated that the 
macrophages pass through trans-endothelial pores in the BBB (Santiago-Tirado et al. 
2017). Another route for C. neoformans to cross the BBB is via an intercellular 
mechanism. Evidence to support this was shown when tight-junction protein occludin 
was damaged in the presence of C. neoformans, suggesting that tight-junctions 
between endothelial cells in the BBB are broken (Chen et al. 2003). Finally, in vitro 
data suggests that C. neoformans can actively transcytose through cells in the BBB. 
Cryptococcal cells were able to pass through a layer of human brain microvascular 
endothelial cells (Chen et al. 2003). Together these mechanisms of cryptococcal cells 
crossing the BBB highlight that C. neoformans is first present in the blood stream 
before invasion of the brain.  
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1.3 Staphylococcus aureus  
1.3.1 Microbiology of S. aureus  
Staphylococcus aureus is a bacteria of the Staphylococcus genus in the bacteria 
kingdom. S. aureus is a gram-positive bacterium, with a 1µm diameter and a spherical 
shape. S. aureus is a facultative anaerobe, aerobic respiration is used under normal 
circumstances, but the bacteria are also able to survive and replicate in environments 
where oxygen is absent. During replication S. aureus can from “clumps” of bacteria. 
These “grape-like” clusters are created when S. aureus replicates through binary 
fission where daughter cells do not fully separate. Bacteria replicate in a pre-
determined format and are (partially) separated by enzymes, which results in the 
grape-like cluster formation (Koyama et al. 1977).  S. aureus is found globally, 
colonising the nasal passage and skin in 20% of the human population (Kluytmans et 
al. 1997). In these cases S. aureus are found commensally, and do not result in 
infection or disease.  
 
1.2.2 S. aureus route of infection  
S. aureus is found commensally in the nasal passage, persistently so in 20% of the 
human population, and intermittently in 60% (Kluytmans et al. 1997). S. aureus 
spreads person to person, however, rather than directly via aerosols, it is spread 
through nasal secretions, contaminated clothing and skin, which can then be spread 
when disturbed (Hare & Thomas 1956). Interestingly, improved cleaning of a university 
gym drastically reduced the presence of S. aureus on the students and gym 
environment (Oller et al. 2010), indicating that presence of S. aureus in the 
environment causes colonisation of individuals.  
Colonised individuals have an increased risk of developing pathogenic S. aureus 
infection. Indeed, in a hospital based study of the source of S. aureus in bacteraemia, it 
was found that for 82% of patients, the bacteria in the blood was from the nares within 
the same individual, suggesting that the commensal bacteria was the source of 
infection (von Eiff et al. 2001). It is suggested that commensal S. aureus becomes 
pathogenic when gene expression alters the virulence factors expressed by bacteria, 
resulting in a pathogenic bacteria (Jenkins et al. 2015). These changes may occur 
when bacteria gain entry into the host, from their commensal sites, for example into the 
blood stream through skin injury.  
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1.2.3 S. aureus disease and significance  
S. aureus colonises the human respiratory tract, primarily in the nasal passage but also 
on the skin, and causes infection when the skin or mucosal barriers are broken 
allowing access into the host tissue. S. aureus infection causes a large range of 
infections, from largely superficial infections such as skin lesions and abscesses, and 
more serious infections such as food poisoning, meningitis or pneumonia, to life-
threatening infections, caused by bacteraemia such as sepsis, endocarditis, or toxic 
shock (Lowy 1998). 
Bacteraemia (where S. aureus gains access to the blood stream) is a common, and 
important S. aureus infection. The incidence rate of S. aureus bacteraemia is non-
trivial, with a range of 19-50 cases per 100,000 people, varying by country (van Hal et 
al. 2012). The mortality rate associated with S. aureus bacteraemia is high, 20-30% of 
bacteraemia patients do not survive (van Hal et al. 2012). Although this is reduced from 
the pre-antibiotic era where bacteraemia mortality was 80%. As noted by van Hal et al. 
2012, S. aureus bacteraemia is responsible for more deaths than AIDs, tuberculosis 
and viral hepatitis related deaths together. Bacteraemia caused by S. aureus is 
therefore a significant human infection. 
Treatment of S. aureus infection is usually completed through antibiotic courses. 
However, evolution of antibiotic resistant S. aureus has led to the development of 
methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant 
Staphylococcus aureus (VRSA). Both MRSA and VRSA present a major hurdle in the 
successful treatment of S. aureus infections, particularly as more strains become 
resistant to antibiotics (Foster 2005). Indeed the mortality rate associated with 
bacteraemia caused by MRSA is increased in comparison to antibiotic-susceptible 
strains as demonstrated in a hospital based study (Yilmaz et al. 2016).  
A large number of MRSA infections occur within the hospital environment. MRSA has 
been a known hospital acquired infection since the 1960s. Risk factors of infection, 
such as a urinary catheter, a central line or exposed site of surgery, which may be 
more likely during lengthy hospital stays, make certain individuals more susceptible to 
hospital acquired MRSA (HA-MRSA) (Carnicer-Pont et al. 2006). These risk factors 
may allow the bacteria passage into the host tissue. Therefore long and/or frequent 
hospital visits are associated with an increased chance of S. aureus exposure which 
may increase the risk of bacterial infection.  
Blocking S. aureus transmission in hospitals is particularly important in MRSA infection. 
S. aureus present in the environment, or present on people who work in the hospital 
may facilitate bacterial transmission within the hospital. This highlights the requirement 
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of improved methods for the treatment and containment of S. aureus infection. It was 
suggested that abolishing commensal nasal S. aureus (through nasal antibiotic 
treatment) in patients before surgical procedures can help to reduce the likelihood of S. 
aureus infection post-surgery (Wenzel et al. 1995).  
More recently since the 1990s, MRSA is causing infection outside of hospital sites, 
known as community acquired MRSA (CA-MRSA). It is likely that many CA-MRSA 
strains originate from hospital environments (Rollason et al. 2008). A retrospective 
study in a Californian medical centre compared CA-MRSA to HA-MRSA infections. It 
was demonstrated that 45% of MRSA infections were community acquired, but that 
most infections were skin/soft tissue lesions. It was noticed that the risk factors for 
contracting each type of MRSA was different, with CA-MRSA linked to injection drug 
use in at least 49% of cases (Huang et al. 2006). These data suggest that CA-MRSA is 
spread largely by intravenous drug users.  
Overall, it is clear that S. aureus causes a wide range of infections, some of which are 
life-threatening. Evolution of antibiotic resistant strains, which may be hospital or 
community acquired represent a hurdle for the treatment of S. aureus. 
 
1.3.4 S. aureus host-pathogen interactions  
S. aureus causes pathogenic infection when it gains access host tissue, for example, in 
an injury where the skin layer is exposed. The host immune system has several 
defences to stop the invasion and spread of bacteria within the host. The first step in 
the response is recognition of the pathogen. 
The innate immune system is able to recognise S. aureus through several PRRs, each 
able to recognise different bacterial components or secreted molecules. Toll-like 
receptors (TLRs) are important in host recognition of S. aureus. TLR signalling, via 
MyD88, results in NF-kB translocation to the nucleus which causes altered gene 
expression and leads to cytokine release, important in the formation of an immune 
response. An increase in susceptibility to S. aureus infection, and a decrease in 
survival was observed in mice lacking TLR2, and in mice lacking MyD88 (part of the 
TLR signalling pathway) (Takeuchi et al. 2000). TLR2 recognises peptidoglycan (PGN) 
and lipoteichoic acid (LTA), both components of gram-positive bacteria such as S. 
aureus, as PAMPs (Schwandner et al. 1999). Furthermore TLR2 is important in 
recognition of S. aureus lipoproteins. Generation of bacterial mutants demonstrated 
that lipoprotein recognition was important in host immune responses particularly, in 
blocking abscess formation (Wardenburg et al. 2006). Therefore TLR2 is important in 
the recognition of extracellular S. aureus, and promoting an immune response.  
38 
 
Nod-like receptors (NLRs) sense PAMPs in the cytoplasm, and cause pro-inflammatory 
cytokine release through the NF-kB pathway signalling. Nod2 recognises 
peptidoglycans isolated from S. aureus in macrophages (Girardin et al. 2003). This 
demonstrates further how the host pro-inflammatory response is dependent on the 
sensing of bacterial presence.  
The complement system promotes phagocytosis of S. aureus. It was demonstrated that 
complement is activated in S. aureus bacteraemia in clinical studies (Hallett & Cooper 
1980). It was also demonstrated that complement is also involved in blocking the 
attachment of S. aureus to endothelial cells, important in reducing the pathogenesis of 
bacteria in the blood stream. In vitro, S. aureus was able to bind less efficiently to 
endothelial cells when exposed to complement, in comparison to when complement 
molecules were absent (Cunnion & Frank 2003). This demonstrates that complement is 
acting as host defence and reduces the bacteria’s ability to bind to endothelial cells. 
However, in the same study it was shown that complement activation by S. aureus, 
also increases endothelial cell susceptibility to S. aureus adherence. A potential 
explanation for this could be that S. aureus uses a secreted protein Efb (extracellular 
fibrinogen-binding protein) which can bind to C3 and therefore reduce complement  
mediated opsonisation (Lee et al. 2004). Another staphylococcal secreted protein Eap 
(extracellular adherence protein) is able block C3 activation and therefore stop binding 
by complement opsonins (Woehl et al. 2014). Indeed several staphylococcal factors 
target complement activation. Together these studies demonstrate that although 
complement may have a useful role as an opsonin for S. aureus, complement is also 
targeted by S. aureus to evade this important host response.  
 
Intracellular handling of S. aureus  
Phagocytosis of S. aureus allows bacterial clearance and degradation. Both neutrophils 
and macrophages are able to phagocytose S. aureus.  In the zebrafish model it was 
demonstrated that macrophages represent the major type of phagocytic cell which 
responds to S. aureus infection. Individual macrophages can phagocytose more S. 
aureus in comparison to neutrophils, but that neutrophils represent an intracellular 
niche in which S. aureus can reside (Prajsnar et al. 2008; Prajsnar et al. 2012). It was 
demonstrated in the zebrafish model that a population bottle-neck is mediated by 
neutrophils, whereby a small number of bacteria which successfully evade neutrophil 
degradation eventually replicate and cause uncontrolled infection (Prajsnar et al. 2012). 
Evidence of this occurring in macrophages also exists. In vitro macrophage studies 
have shown that S. aureus promotes the survival of its host cell, through upregulation 
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of anti-apoptotic genes (Koziel et al. 2009), this may represent another intracellular 
survival strategy. By promoting host macrophage survival, or residing within a 
neutrophils, S. aureus gains time to replicate before being exposed to the extracellular 
environment.  
Neutrophil phagocytosis of S. aureus is aided with the binding of complement and 
antibodies which can then be recognised by complement receptors and FcRs 
(receptors to the Fc region of antibodies) respectively. After phagocytosis, neutrophils 
are required to degrade the bacteria. In order to kill and degrade the bacteria, 
neutrophils utilise the fusion of granules to the phagosome. Granules contain anti-
bacterial molecules, for example myeloperoxidase, (MPO). MPO generates 
hypochlorous acid which is efficient at killing bacterial pathogens (Klebanoff et al. 
2013). When lysosomes fuse with the bacterial phagosome an acidic phagolysosome 
is formed. In these conditions lysozymes (delivered by the lysosome) are able to 
activate auto-lytic enzymes found in the bacterial cell wall, to promote digestion (Wecke 
et al. 1982). However, it has been demonstrated that S. aureus uses a membrane 
protein OatA to block lysozyme effects, demonstrated with increased sensitivity to 
lysozyme in OatA deficient bacteria (Bera et al. 2004).  
Neutrophils also use ROS mediated mechanisms to degrade phagocytosed S. aureus. 
ROS mediated bacterial damage is very important in bacterial killing, individuals with 
dysfunctional phagocyte NADPH oxidase, have an increased susceptibility to bacterial 
pathogens (Heyworth et al. 2003). Neutrophils use phagocyte NADPH oxidase to 
generate the production of superoxide, and subsequently other reactive oxygen 
species. ROS are very toxic to S. aureus, and can therefore lead to bacterial 
degradation. However, S. aureus has strategies to overcome ROS mediated 
degradation. Superoxide dismutase and catalase production help to remove ROS, by 
degrading superoxide and hydrogen peroxide respectively (Mandell 1975). In addition 
to other virulence factors which defend against ROS (discussed in section 1.3.5). This 
demonstrates that although the neutrophil uses diverse bacterial killing strategies, S. 
aureus has defences which allow continued survival with the neutrophil.  
S. aureus is able to survive, replicate and eventually escape from within neutrophils, or 
other host cells, for example macrophages or endothelial cells (Bhakdi & Tranum-
Jensen 1991; Vandenesch et al. 2012; Heyworth et al. 2003; Schröder et al. 2006; 
Bayles et al. 1998). S. aureus is able to replicate within the phagosome or cytoplasm of 
host cells. In macrophages S. aureus is able to replicate within the phagosome 
(Heyworth et al. 2003). In endothelial cells, S. aureus can replicate within the lysosome 
(Schröder et al. 2006). Additionally S. aureus can replicate in the cytoplasm, following 
phagosomal escape, shown using epithelial cells (Bayles et al. 1998). Exactly how the 
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phagosome is escaped by S. aureus is unknown, but likely caused by toxins or 
membrane rupture due to growth. Once in the cytoplasm, hemolysins (discussed in 
section 1.3.5) are able to cause the lysis of phagocytic cells, and ultimately allow the 
escape of S. aureus into the extracellular environment (Bhakdi & Tranum-Jensen 1991; 
Vandenesch et al. 2012).  
S. aureus interactions with innate immune cells 
In addition to neutrophils and macrophages, the host defence includes other innate 
immune cells. S. aureus is known to be phagocytosed and killed by eosinophils. In a 
human blood assay, where phagocytes were exposed to S. aureus, phagocytosis by 
eosinophils occurred at ~50% of the rate in comparison to neutrophils. Additionally, 
eosinophils were capable of killing S. aureus, but only after phagocytosing 15 or more 
bacteria (Yazdanbakhsh et al. 1986). It was suggested this is because eosinophils 
required further activation to be able to release sufficient ROS. However, like other 
elements of the immune system, S. aureus is able to attack eosinophils to promote 
bacterial survival. S. aureus is able to effectively kill eosinophils. The supernatant of S. 
aureus cultures induced eosinophil death, but not the death of neutrophils. It was 
demonstrated that the bacterial factor causing eosinophil death was α-hemolysin, as  
an α-hemolysin deficient bacterial strain was unable to cause eosinophil death (Prince 
et al. 2012). Interestingly, increased eosinophil death through lysis may lead to 
formation of eosinophil extra-cellular traps (EETs), including granules which are useful 
in degradation of extracellular S. aureus (Persson 2015; Ueki et al. 2013). Eosinophils 
represent another cellular host defence which degrade S. aureus.  
Dendritic cells (DCs) are also implicated as a host defence in S. aureus infection. The 
role of DCs in the host immune response to pathogens is to activate the adaptive 
immune system, after encountering a pathogen. Immature DCs sample the host 
environment for pathogens, and when they encounter a pathogen, DCs mature and 
migrate to lymph nodes to activate T cells and consequently the adaptive immune 
system. In a comparison of phagocytosis rates, immature DCs were able to 
phagocytose at a similar rate to neutrophils, whereas mature DCs had a reduced ability 
phagocytose S. aureus. Furthermore, while neutrophils were able to effectively 
degrade phagocytosed S. aureus, both immature and mature DCs did not, and in fact 
the bacteria was able to replicate within DCs (Nagl et al. 2002). This is indicative of the 
role DCs play in comparison to neutrophils in host defence. DCs are required to 
phagocytose in the immature state, but once a pathogen has been encountered the 
DCs are required to alert the adaptive immune system. In contrast, neutrophils are 
required to clear infection. After S. aureus phagocytosis, DCs have been shown to 
activate type I interferon expression (cytokines which affect immune regulation) through 
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TLR9 signalling. However, in TLR9 deficient mice, the bacterial burden was reduced 
after pulmonary S. aureus infection. This suggests that DCs type I interferon production 
is actually detrimental to the host (Parker & Prince 2012). This may suggest that S. 
aureus subverts DC function to promote pathogenesis and highlights how DCs are able 
to influence the immune response to infection.  
DCs are important regulators in the co-ordination of the immune response to S. aureus. 
In vitro human blood assays highlighted that a subset of peripheral blood DCs are able 
to release pro-inflammatory cytokines, including IL-1β and TNF-α after phagocytosis of 
S. aureus. Furthermore this DC subset is able to efficiently activate T cell production of 
IFN-γ (Jin et al. 2014), an important pro-inflammatory cytokine used in infection 
resolution. DCs therefore may represent an important immune cell type involved in the 
generation of a Th1 response in S. aureus bacteraemia infection. In a mouse model of 
bacteraemia, depletion of DCs led to increased bacterial burden, and increased 
mortality. It was suggested that reduced neutrophil bactericidal activity (despite 
increased neutrophil recruitment) may have been caused by a lack of (DC derived) IL-
12 (Schindler et al. 2012). Indeed, IL-12 is known to activate neutrophils (Moreno et al. 
2006). This suggest that DCs can provide IL-12 which is able to promote a Th1 profile, 
important in host defence and key in the coordination of the correct immune response. 
DCs therefore represent an important role in the regulation of the activation of the 
adaptive immune system. 
 
The adaptive immune system in S. aureus infection 
Neutrophil and complement-assisted phagocytosis act as a primary innate host 
defence. The adaptive immune system has the ability to enhance innate immune cell 
activity, and to coordinate the immune defence against S. aureus. 
T cells are able to influence S. aureus infection in a variety of ways. Firstly, cytotoxic T 
cells (CD8+) can directly kill infected host cells to release bacteria surviving 
intracellularly. T helper cells (CD4+) are able to recruit and active phagocytic cells. T 
helper cells are also used to help active B cells to produce antibodies and 
subsequently increase phagocytosis by opsonisation of the bacteria. Additionally T 
cells are important in dampening the inflammation response, important after bacterial 
infection has been cleared (Bröker et al. 2016). Memory Th1 cells are important in the 
production of IFN-γ, as shown when a successive inoculum of S. aureus led to a 
greater Th1 response and IFN-γ production in a murine model, in comparison to the 
initial inoculum which did cause limited IFN-γ production (Brown et al. 2015). This 
suggests that T cells provide lasting immunity against S. aureus. However, like many 
42 
 
host defences, S. aureus has strategies to overcome T cell interactions. While early in 
S. aureus infection T cells are effective at S. aureus killing and required to contain 
infection, T cells become unresponsive to S. aureus antigen presentation after longer 
exposure (e.g. in persistent infection) (Ziegler et al. 2011). Whether this is a S. aureus 
mediated defence, a host mediated prevention of inflammation damage, or a 
combination of both is unknown.  
The role of B cells in S. aureus infection is not clear cut. Antibodies against a S. aureus 
cytotoxin (LukAB) were present in a child (Thomsen et al. 2017), and IgM, IgA and IgG 
antibodies (against S. aureus) are present in individuals from childhood. Antibodies are 
produced on exposure to S. aureus antigens in healthy and currently infected 
individuals (Dryla et al. 2005), indicating that B cells  produce antibodies in response to 
S. aureus exposure.  
Interestingly, within infected individuals, specific antibodies for S. aureus antigens were 
missing. These missing antibodies were present in healthy individuals (Dryla et al. 
2005). This may suggest that some B cells are a target of S. aureus attack. A reduction 
of B cell binding of S. aureus, (in comparison to Staphylococcus epidermis) was 
caused by secreted S. aureus virulence factors (Nygaard et al. 2016). In mice it was 
shown that S. aureus superantigen protein A mediates a B cell specific attack, by 
directly binding to antigen receptors on the B cell surface. This results in B cell 
apoptosis and reduced antibody production (Silverman et al. 2000; Goodyear & 
Silverman 2003). In humans, Protein A is suggested to act as an immunodominant 
antigen, through binding a high percentages of B cells, and therefore blocking B cell 
recognition of other S. aureus antigens (Pauli et al. 2014). S. aureus is therefore 
capable of influencing the adaptive immune response through blocking B cell antibody 
production.  
 
1.3.5 S. aureus virulence factors and pathogenesis  
S. aureus can cause pathogenic infection in the same individual it commensally 
inhabits. It is suggested that when S. aureus gains access to host tissue, perhaps 
through puncture of the skin, that S. aureus undergoes gene expression changes 
which includes upregulation of virulence factor expression. S. aureus utilises varied 
virulence factors during infection. These include a polysaccharide capsule and 
extracellular enzymes and toxins. Virulence factor expression was compared between 
S. aureus clinical samples from the nares, blood stream, and from lesions in the heart, 
chosen to represent commensal bacteria, and pathogenic bacteria from two sites. 
Virulence factors, including for toxins and immune evasion, were up-regulated in 
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pathogenic bacterial locations in comparison to commensal bacteria location (Jenkins 
et al. 2015). For example, in bacteraemia S. aureus increases expression of factors 
required for adhesion, most likely to increase binding with endothelial cells in the 
vasculature (Jenkins et al. 2015). Exactly how these gene expression changes occur 
upon entry into host tissue is unknown, but it is likely in response to the bacterium’s 
new environment.  
 
Bacterial cell surface factors 
The S. aureus capsule is composed of hexosaminuronic acids and polysaccharides. 
Highly encapsulated S. aureus strains are often found in human disease (O’Riordan & 
Lee 2004). The S. aureus capsule, much like C. neoformans, benefits S. aureus by 
reducing bacterial phagocytosis (Lee et al. 1987). Reduced phagocytosis enables more 
bacterial survival within the host. Staphyloxanthin is a carotenoid pigment produced by 
S. aureus, resulting in its characteristic golden colour. However this pigment also acts 
as an antioxidant, useful in the prevention of damage from host cell oxidative species, 
which helps facilitate evasion of degradation by a neutrophil (Liu et al. 2005).  
Protein A, is a surface protein, which remains attached to S. aureus. Protein A is 
capable of binding to the Fc region of immunoglobin G (IgG), and IgM, blocking the 
opsonising potential of these antibodies and reducing the rate of phagocytosis 
(Forsgren & Nordström 1974; Falugi et al. 2013). Some Protein A does not remain 
attached to the bacterial cell. In vitro studies of co-culture of S. aureus with non-surface 
associated Protein A and white blood cells (whole human blood) show white blood cells 
had a reduced phagocytic ability (O’Halloran et al. 2015), indicating that non-surface 
associated Protein A is able to reduced host neutrophil phagocytosis. However, in 
humans deficient in B cells or antibody production, there is no increased susceptibility 
to S. aureus infection, suggesting that infection is not controlled by antibody production. 
S. aureus also expresses several binding proteins which promote bacterial binding to 
host components. Fibronectin in an extracellular glycoprotein which binds to integrins, 
collagen and extracellular molecules. Fibronectin binding proteins A and B (FnBPA and 
FnBPB) enable to adhesion and invasion of integrin (the host fibronectin receptor) 
expressing host cells, such as endothelial and epithelial cells (Sinha et al. 1999). This 
is important in the pathogenic ability of S. aureus to invade host tissue. Indeed it was 
shown that FnBPA and FnBPB are sufficient to enable invasion of tissue, when both 
proteins were coated onto inert beads, which when coated were subsequently able to 
invade epithelial cells (Sinha et al. 2000).  
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Clumping factor proteins A and B (ClfA and ClfB) enable S. aureus clumping and 
binding to fibrinogen (a blood clotting factor), in the presence of fibronectin (Ní Eidhin et 
al. 1998; McDevitt et al. 1994). ClfA is also able to reduce phagocytosis of S. aureus by 
polymorphonuclear leucocytes (Higgins et al. 2006). Additionally, ClfA can bind to 
human platelets directly (Siboo et al. 2001), this may improve bacterial survival during 
infection. FnBPA, FnBPB, ClfA and ClfB, are all under the regulation of Sortase A 
(which in involved in the retention of these proteins on the bacterial surface). Sortase A 
expression may reduce the spread of bacteria in the host. Bacteria which lack Sortase 
A, a hyper-spreading phenotype was observed, (measured by growth on TSB agar 
plates). This suggests that when these proteins (FnBPA, FnBPB, ClfA and ClfB) are 
absent, increased bacterial spreading occurs (Tsompanidou et al. 2012). This may 
represent a bacterial response to loss of adhesion, or simply the lack of adhesion leads 
to increased spreading.  
Together, S. aureus cell surface factors reduced phagocytosis, reduces oxidative 
damage, promote cellular adhesion and promote invasion of cells/tissues. These varied 
host defence mechanisms contribute to the pathogenesis of S. aureus.  
 
S. aureus enzyme and toxin virulence factors 
Extracellular enzymes and toxins are released from the bacteria, including 
haemolysins, nucleases, lipases and proteases, which promote the pathogenesis of S. 
aureus through escape of host cells and spreading through infected tissues (Dinges et 
al. 2000).  
S. aureus is capable of damaging the host cell plasma membrane through several 
secreted factors. α-hemolysin is able to form transmembrane pores in the plasma 
membrane of red blood cells (and other blood cells), which results in osmotic mediated 
host cell lysis (Bhakdi & Tranum-Jensen 1991). Forming pores in the plasma 
membrane is not the only tactic used by S. aureus for membrane damage. β-
hemolysin, does not form pores, but actively degrades plasma membrane component 
sphingomyelin (Vandenesch et al. 2012). Plasma membrane damage can also be 
caused by peptides, including γ-hemolysin, however the mechanism of this membrane 
degradation is currently not clear (Vandenesch et al. 2012). Together, these toxins 
cause plasma membrane damage which leads to host cell lysis and bacterial escape. 
S. aureus produces enzymes used to promote bacterial survival and invasion in the 
host. For example, two coagulase enzymes are produced by S. aureus, which induces 
clotting of the blood (McAdow et al. 2012). This may be useful for bacteria in formation 
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of lesions and evading phagocytic cells. Hyaluronidases are enzymes which breaks 
down hyaluronate (an extracellular glycosaminoglycan), and are expressed by S. 
aureus as a virulence factor (Hynes & Walton 2000), thought to be important in the 
spreading of bacteria throughout tissue. In addition S. aureus uses lipase, and 
nuclease enzymes to degrade lipids and DNA respectively. Lipase is important in 
biofilm formation, and nucleases are used to evade NETs (Kiedrowski et al. 2014; Hu 
et al. 2012). In addition, S. aureus uses staphylokinase, this enzyme indirectly results 
in the digestion of fibrin networks (often used by the host to contain infection), which 
further enables the spreading of bacteria (Bokarewa et al. 2006).  
Toxins released by S. aureus are important in bacterial pathogenesis, particularly in 
sepsis outcome (where an excessive host immune defence response becomes 
detrimental for the host). S. aureus releases super antigens (SAGs) which are able to 
cause massive activation of T cells. Importantly, SAG mediated T cell activation is non-
specific, and results in activation of up to 20% of the T cells within the host (Li et al. 
1999). Over activation of T cells leads to massive cytokine production, deregulation of 
the adaptive immune system and ultimately leads to life-threatening host outcomes, for 
example food poisoning, toxic shock syndrome, or organ failure (Llewelyn & Cohen 
2002). S. aureus releases several SAGs, including toxic shock syndrome toxin (TSST), 
staphylococcal enterotoxins (SEs), and exfoliative toxins (ETs) (Bukowski et al. 2010; 
Dinges et al. 2000). SAGs promote S. aureus survival and spread within the human 
host.  
 
1.4 Autophagy  
Autophagy is a conserved, intracellular self-degradation pathway which recycles  
cellular components including, long-lived proteins, damaged organelles and damaged 
proteins, through trafficking to the lysosome (or vacuole in yeast/plants) for degradation 
(Mizushima et al. 2008; Tanida 2011). In fact the term “autophagy” means self-eating 
and was first used to describe cellular components being degraded by lysosomes in 
mammalian cells (Ashford & Porter 1962). Important studies and screens primarily 
using budding yeast, Saccharomyces cerevisiae, have led to the rapid identification of 
multiple autophagy genes, and their role in autophagy regulation, initiation and function 
(Nakatogawa et al. 2009).  
There are three autophagic pathways in mammalian cells. These include 
macroautophagy, microautophagy, and chaperone mediated autophagy (CMA) (Figure 
1.1) which use distinct pathways to target cargo for degradation (Boya et al. 2013; 
Glick et al. 2010). Macroautophagy is characterised with the formation of a double 
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membrane vesicle, termed “autophagosome”, which engulfs cargo for degradation and 
subsequently fuses with lysosomes. Microautophagy is the engulfment of cargo directly 
into the lysosome. Chaperone mediated autophagy is mediated by a chaperone protein 
which brings cargo to the lysosome which ultimately results in cargo translocation 
within the lysosome. All three autophagy pathways result in the lysosomal degradation 
of cargo. 
In addition, within the macroautophagy (and microautophagy) pathway, there are also a 
number of selective pathways for the degradation of specific cellular components. In 
macroautophagy, selective autophagy pathways include mitophagy, aggrephagy and 
ribophagy, which target damaged mitochondria, protein aggregates and ribosomes 
respectively, to the autophagosome for degradation (Kubli & Gustafsson 2012; Lamark 
& Johansen 2012; Bakowska-Zywicka & Tyczewska 2009). 
 
 
 
Figure 1.1 Types of autophagy 
Different types of autophagy use different mechanisms to cause degradation of 
the cargo in the lysosome. A Macroautophagy is characterised by a double 
membrane vesicle which surrounds cargo for degradation and fuses with a 
lysosome resulting in degradation of contents. B Microautophagy is the direct 
engulfment of cargo into the lysosome. C In chaperone mediated autophagy, 
cargo for degradation binds to a chaperone protein which takes the cargo to a 
receptor on the lysosome surface. The cargo then passes through the receptor 
and is degraded within the lysosome.   
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1.4.1 The role of macroautophagy  
Macroautophagy (hereafter termed autophagy) is the most studied autophagic 
pathway. Autophagy is a non-selective cellular degradation system, which can degrade 
a wide array of cellular components. This is in contrast to the other major cellular 
degradation processes completed by proteasomes, which degrade ubiquitinated 
proteins in a selective manner (by ubiquitination). The non-selective autophagy 
pathway enables autophagy to have multiple cellular roles.  
It is thought autophagy evolved in order to allow cells to adapt and survive in starvation 
conditions. Autophagy, through degradation of cellular components, creates new 
material for the cell to use, significant in starvation situations (Mizushima et al. 2008).  
A cellular reduction in nutrients, for example amino acids or ATP can induce 
autophagy. After cargo is degraded by lysosomal hydrolases, the degraded 
components can be recycled back into the cytoplasm for alternative use by the cell. 
Transfer of components back into the cytoplasm (out of the lysosome) can occur 
through lysosomal permeases. For example, a probable sugar efluxer, Spinster, may 
promote passage of sugars into the cytoplasm (Rong et al. 2011). In yeast, autophagy 
gene ATG22 has been shown to be an amino acid efluxer (Yang et al. 2006), although 
an equivalent mammalian mechanism to transfer amino acids has not been identified. 
Autophagic cellular recycling, induced under starvation conditions, may also be 
important in enabling synthesis of proteins specifically required by cells in starvation 
conditions (Onodera & Ohsumi 2005).  
Autophagy is not only used for recycling of cellular components under basal and 
starvation conditions. Autophagy is used to degrade damage-causing cellular 
components, such as damaged mitochondria or protein aggregates. In these cases, 
autophagy promotes cellular survival. Furthermore autophagy provides degradation of 
long-lived proteins, used for cellular homeostasis, which are no longer required 
(Mizushima et al. 2008). Autophagy is also important in development, highlighted by 
fact that the majority of murine knock-out models in autophagy genes lead to lethality at 
the embryonic or neonatal stages (Mizushima et al. 2010). Furthermore, autophagy has 
roles in regulation of the immune system, for example in the release of IL1-β (Dupont et 
al. 2011) and in loading of the MHC-II molecules in DC and epithelial cells (Schmid et 
al. 2007).  
Since autophagy has multiple important cellular roles, when autophagic components or 
pathways do not function properly, cells are unable to maintain homeostasis, and this 
can lead to disease. A role of dysfunctional autophagy is promoting cancerous cell 
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survival, where autophagy may prevent necrotic cell death, has been demonstrated 
(Degenhardt et al. 2006). However evidence exists that the role of autophagy in cancer 
can be beneficial or detrimental for cancerous cells, differences may be caused by 
specific tumour cell types. Autophagy is also important in the clearance of protein 
aggregates, and dis-functional autophagy therefore is implicated in neurodegenerative 
diseases. In Alzheimer’s disease, impaired autophagy induction and autophagosome 
formation may result in a lack of clearance of protein aggregates (Orr & Oddo 2013).  
In other human diseases single nucleotide polymorphisms SNPs in ATG5 have been 
linked to auto-immune diseases, such as asthma and systemic lupus erythematosus 
(López et al. 2013; Poon et al. 2012). Furthermore, SNPs in autophagy receptor p62 
(sequestosome 1, or SQSTM1) and other autophagy genes including ATG5 and 
ATG16 increases the likelihood of Paget’s disease, a bone disease (Usategui-Martín et 
al. 2015; Chamoux et al. 2009). Interestingly, a lack of human diseases associated with 
complete loss of function in core autophagy genes indicates that autophagy genes are 
necessary for human development. The important role of autophagy in infectious 
disease is discussed in section 1.4.6. Several pathogens are targeted to the 
autophagosome, resulting in pathogen degradation, providing an important host 
defence against pathogens.  
 
1.4.2 Microautophagy and chaperone mediated autophagy  
Microautophagy and chaperone-mediated autophagy have not been as well studied as 
macroautophagy, although both also result in the lysosomal degradation of cellular 
components. Microautophagy is the engulfment of cargo directly into the lysosome, 
where invagination of the lysosomal membrane enables small proportions of the 
cytoplasm to be degraded in a non-selective manner (Marzella et al. 1981). However, 
selective microautophagy occurs for organelles, including micro-mitophagy, micro-
pexophagy (peroxisome degradation), and in micro-nucleophagy (Mijaljica et al. 2011; 
Sahu et al. 2011).  
Chaperone mediated autophagy is facilitated by a chaperone protein which transports 
cargo to the lysosome. This ultimately results in cargo translocation across the 
lysosome membrane for degradation. In CMA, only soluble proteins are targeted for 
degradation. The chaperone protein is heat shock cognate protein of 70 kDa (Hsc70), 
which recognises proteins for degradation via a KFERQ sequence (Dice 1990; Chiang 
et al. 1989). The lysosome-associated membrane protein type 2A (LAMP-2A) is a 
receptor for Hsc70 (Cuervo & Dice 1996), which leads to the protein for degradation 
being translocated into the lysosome and degradation.  
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1.4.3 The macroautophagy pathway  
The autophagy pathway is a complex pathway involving many proteins, however the 
pathways can be broken into four key steps: vesicle nucleation, vesicle elongation, 
lysosome fusion, and lysosomal degradation of cargo (Tanida 2011; Mizushima 2007). 
A general overview of the pathway begins with the generation of a double membrane 
vesicle, which engulfs cargo for degradation forming an autophagosome. A lysosome 
then fuses with the autophagosome and releases acid hydrolases which cause 
degradation of the contents. A diagram of the autophagy process is shown in figure 
1.3. The autophagy pathway is highly regulated, resulting in a complex pathway 
involving several key proteins (Table 1.1). 
The first step, vesicle nucleation, begins after autophagy induction signals  cause 
inactivation of a key negative regulator of autophagy, mammalian target of rapamycin 
(mTOR) (Crotzer & Blum 2010). This leads to the activation of the protein kinase ULK-1 
complex, which itself is normally inhibited by mTOR (Hosokawa et al. 2009). The ULK-
1 complex then binds to the phosphatidylinositol 3-kinase (PI3K) complex, which is 
known to form a pre-autophagosomal structure (PAS) in yeast, which is also thought to 
occur in mammals (Mizushima et al. 2011). The next step is the formation of an 
omegasome from the endoplasmic reticulum (ER) which is regulated by the PI3K 
complex (Axe et al. 2011; Crotzer & Blum 2010). The omegasome is named after the 
similarity in shape to the Greek omega symbol. The isolation membrane is 
subsequently formed from the omegasome and is released from the ER (Mizushima et 
al. 2011). The source of the membrane used in autophagosome formation is not fully 
understood. It is thought that membrane from the Golgi, endosomes, plasma 
membrane or mitochondria may also be used (Chan & Tang 2013). 
Vesicle elongation starts at this point, utilising two protein ubiquitin-like conjugation 
systems the ATG12-ATG5-ATG16 complex and the LC3-lipidation system (Mizushima 
et al. 2001). The ATG12-ATG5-ATG16 complex locates on the isolation membrane 
(Mizushima et al. 2001), as the vesicle membrane surrounds cargo for degradation. In 
addition, the product of the LC3 lipidation, LC3-II, localises to the autophagosome, on 
both the inner and outer membranes (Weidberg et al. 2010). LC3-II on the outer 
membrane is removed by ATG4 after autophagosome formation (Yu et al. 2012), 
whereas LC3-II is degraded on the inner membrane after lysosomal fusion. 
The ATG12-ATG5-ATG16 complex is created when ubiquitin-like ATG12 is covalently 
conjugated to ATG5, using E1-like enzyme ATG7, and E2-like enzyme ATG10 
(Mizushima et al. 2001). ATG16 associates with the ATG12-ATG5 complex. The 
second ubiquitin-like conjugation system leads to the lipidation of LC3-I (or lipidation of 
homologues GABARAP and GATE-16). LC3-I is conjugated to 
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phosphatidylethanolamine (PE), by E1-like enzyme ATG7, and E2-like enzyme ATG3 
(Ichimura et al. 2000). Additionally, the ATG12-ATG5-ATG16 complex acts as a 
scaffold E3-like enzyme in this lipidation process (Mizushima et al. 2007). A schematic 
of both conjugation processes is shown in Figure 1.2.  
 
Both conjugation systems may promote membrane elongation, however are thought to 
be more important in the closure of the autophagosome. When elongation is nearly 
complete the ATG12-ATG5-ATG16 complex departs from the membrane (Mizushima 
et al. 2001). Each side of the elongating vesicle membrane is joined by membrane 
scission (Knorr et al. 2015). Once circularisation is complete an autophagosome, with a 
characteristic double membrane, is formed, harbouring enclosed cargo for degradation.  
The next stage of the autophagy pathway is the fusion of a lysosome to the outer 
membrane of the autophagosome, forming an autolysosome. In mammals an extra 
step can occur before lysosomal fusion, autophagosomes can fuse with early or late 
endosomes forming amphisomes (Strømhaug & Seglen 1993). This adds another layer 
of complexity through linking the endosomal and autophagic pathways. It is currently 
unknown exactly how autophagosomes dock with lysosomes, although in yeast it is 
shown that SNARE proteins are involved in trafficking to the vacuole (Fischer von 
 
 
Figure 1.2 Ubiquitin-like conjugation systems in LC3-II lipidation 
ATG12-ATG5 covalent conjugation requires E1-like ATG7 and E2-like ATG10. 
ATG12-ATG5 associates with ATG16. Lipidation of LC3-I with 
phosphatidylethanolamine (PE), requires E1-like ATG7 and E2-like ATG3, and 
the ATG12-ATG5-ATG16 complex acts as an E3-like scaffold to promote lipidation  
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Mollard & Stevens 1999). The vacuole is comparable to a mammalian lysosome. In 
addition, in a study using Drosophila melanogaster, a SNARE protein, Syntaxin 17 has 
been identified on autophagosome membranes (Krämer 2013), indicating SNARE 
protein involvement. Until recently it was thought that the ATG12-ATG5-ATG16 and 
LC3 conjugation systems were required for autophagosome elongation. Interestingly, 
autophagosomes have been observed in cells deficient of the autophagy conjugations 
systems, (using syntaxin 17 as an autophagosome marker rather than LC3-II). 
However, these autophagosomes (formed without the conjugation system) had a 
reduced rate of degradation of the inner autophagosomal membrane. This suggests 
the conjugation systems are required for efficient degradation of the inner membrane 
after lysosomal fusion (Tsuboyama et al. 2016). 
The final step of the pathway is the degradation of cargo. This occurs with the release 
of acid hydrolases from the lysosome which gain access to the cargo after degradation 
of the former autophagosome inner membrane (Klionsky 2007). The acid hydrolases 
then degrade the contents of the autolysosome (Tanida 2011). After degradation the 
autolysosome components are recycled. Vesicles from the autolysosome bud off and 
can become mature lysosomes (Yu et al. 2010). In terms of the fate of degraded cargo, 
Atg22 has been shown to be an amino acid efluxer in yeast (Yang et al. 2006). Spinster 
is a potential sugar efluxer, which is additionally required for re-formation and 
acidification of lysosomes (Rong et al. 2011).   
Regulation of macroautophagy induction 
The autophagy pathway is highly regulated, and can be induced for example in 
starvation conditions, by sensing of a reduction in cellular nutrition and increased 
cellular stress. The protein kinase mTOR, as described above, is a regulator of 
autophagy induction, which is found in two complexes, mTOR complex 1 (mTORC1) 
and mTORC2, however, mTORC1 is important in starvation induced autophagy 
induction. The nutrients available in the cellular environment are monitored by sensing 
of amino acid availability, where Rag GTPases regulate mTORC1 activity (Sancak et 
al. 2008). Additionally, a reduction in cellular energy levels, in terms of ATP and AMP, 
causes the activation of (AMP-dependent protein kinase) AMPK, which indirectly leads 
to inhibition of mTOR, leading to autophagy induction (Shaw et al. 2004). In addition to 
nutrients, cellular stress is also monitored. Insulin signalling negatively regulates 
autophagy induction through mTORC1 (Naito et al. 2013). Another cellular stress, 
hypoxia induces autophagy through mTORC1 signalling, although the pathway which 
includes REDD2, is not completely understood (Sofer et al. 2005). Together these 
reports highlight how a wide variety of signals of cellular energy and health are 
monitored and used to induce/inhibit autophagy through mTOR dependent pathways.  
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Figure 1.3 The autophagy pathway 
Autophagy induction signals lead to the activation of the ULK-1 complex 
through inhibition of mTOR. The ULK-1 complex then binds to the PI3K 
complex, leading to the formation of an isolation membrane.  Elongation of the 
characteristic double membrane requires both the ATG12-ATG5-ATG16 and 
LC3 conjugation systems, which engulfs cargo for degradation, eventually 
resulting in the formation of an autophagosome. The autophagosome can fuse 
with early or late endosomes to form amphisomes, then both autophagosomes 
and amphisomes can fuse with lysosomes to form an autolysosome.  Acid 
hydrolases are released from the lysosome which degrade the inner 
membrane and cargo which can then be recycled, in addition to the 
autolysosome constituents. 
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Isolation membrane 
Vesicle elongation 
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Table 1.1: Autophagy proteins, interactions and their role in autophagy 
 
Protein 
 
Interactions 
 
Role in autophagy 
 
mTOR 
 
- ULK-1: inhibitor of ULK-
1 complex activation 
Negative regulator of autophagy 
which can be activated or 
inactivated by autophagy inducers 
or inhibitors. Inhibition leads to 
autophagy. 
 
ULK-1 
complex 
 
- mTOR: which inhibits 
activation 
 
- PI3K complex 
 
 
Usually inhibited by mTOR, so 
when mTOR inhibition ceases the 
complex becomes activated 
- Complex includes; ULK-1, 
FIP200, Atg13 and Atg101 
 
PI3K  
complex 
 
-  ULK-1 complex 
 
 
Binds to ULK-1 complex after 
activation. May form a PAS 
structure in mammals. 
- Complex includes; Class 
IIIPI3K/Vsp34, p150/Vsp15, 
Beclin 1, Atg14(L)  and 
AMBRA1 
 
ATG12-ATG5-
ATG16 
complex 
 
Binds to the isolation 
membrane 
 
Elongation of the isolation 
membrane 
 
LC3 lipidation 
complex 
LC3-II (the product of the 
complex) binds to the 
isolation membrane 
 
Elongation of the isolation 
membrane 
 
SNARE 
proteins 
Potentially provide 
interactions between the 
lysosome and the 
autophagosome 
 
Potentially involved in lysosomal 
fusion 
 
Table 1.1: Table highlights key proteins and protein complexes used in the autophagy 
pathway which are described in detail in this section 1.4.3. The interactions of each 
complex/protein with other autophagy proteins and the role in autophagy induction is 
described.  
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1.4.4 Selective autophagy  
Autophagy is largely a non-specific pathway induced by starvation, however within 
macroautophagy, there is also the capacity for selective autophagy where specific 
cargo, pathogens, protein aggregates or organelles are directly targeted for 
degradation. In selective autophagy, autophagy receptor proteins interact with both 
autophagic machinery and the specific ubiquitinated cargo, to initiate autophagic 
degradation. Autophagy receptors recognise and bind cargo through ubiquitin-binding 
domains (UBDs). Selective autophagy requires ubiquitination of cargo for degradation. 
This is mediated by ubiquitin ligase, for example the role of parkin in mitophagy 
(Popovic & Dikic 2012). Autophagy receptors can then also bind to autophagosome 
marker LC3, through LC3 interacting regions (LIRs). Therefore, autophagy receptors 
selectively collect and transport cargo towards LC3 marked autophagosomes for 
degradation (Popovic & Dikic 2012; Rogov et al. 2014). Multiple autophagy receptors 
have been described, including p62 (also known as sequestosome 1, SQSTM1), 
optineurin (OPTN), nuclear dot protein 52 (NDP52) and neighbour of Brca1 gene 
(NBR1).  A well-studied example of selective autophagy is mitophagy, whereby parkin, 
a ubiquitin ligase, is recruited to damaged mitochondria by Pink1, and here parkin can 
ubiquitinate the mitochondria, which leads to autophagy receptor, p62 recruitment, and 
ultimately autophagic degradation of the mitochondria (Popovic & Dikic 2012).   
Pathogens resident in the cytoplasm may be ubiquitinated and therefore become 
targets of selective autophagy. An interesting example is Salmonella enterica, here 
phosphorylation of autophagy receptor optineurin (OPTN), led to its increased LC3 
binding affinity, and therefore an increased capacity to induce autophagy and ultimately 
limit cytosolic bacterial replication and survival. Indeed, optineurin deficiency in HeLa 
cells led to increased Salmonella proliferation (Wild et al. 2011). In addition it was 
shown that autophagy receptor NDP52 is used as a host-defence against S. enterica to 
promote pathogen degradation (Thurston et al. 2009). Therefore, multiple autophagy 
receptors may be utilised against the same ubiquitin coated pathogen.  
In another example, ubiquitin ligase SMURF1 is important in the ubiquitination of 
Mycobacterium tuberculosis, leading to NBR1 and LC3 recruitment. In mice deficient in 
Smurf1, a higher bacterial load and mortality were seen following M. tuberculosis 
infection (Franco et al. 2017). Both p62 and NDP52 autophagy receptors have been 
shown target Shigella flexneri and Listeria monocytogenes for autophagy degradation, 
but in bacterial specific pathways. Shigella is dependent on septin and actin mediated 
mechanisms, (whereby host cell septin caging limits pathogen actin based mobility and 
recruits autophagy machinery to the pathogen), whereas Listeria targeting did not 
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require septin or actin (Mostowy et al. 2011; Mostowy et al. 2010). This is suggestive 
that different pathogens are able to induce alternative selective autophagy pathways. It 
is clear that selective autophagy has an important role in cell mediated clearance of 
unwanted or damaged cargo, and in pathogen clearance.  
1.4.5 Canonical and non-canonical autophagy  
Canonical autophagy is autophagy which employs the use of autophagy proteins to 
assemble the double membrane autophagosome (as described in section 1.4.3). On 
the other hand, non-canonical autophagy is the creation of an autophagosome, without 
the use of all the core autophagy proteins, this can include loss of Beclin (in the PI3K 
complex), ATG5/ATG7, LC3 or ULK1 (Codogno et al. 2011).  
ATG5 and ATG7 independent autophagy has been described, where formation of 
autophagosome and autolysosomes could occur without either protein. In vitro studies 
determined that autophagosome formation occurred in ATG5 or ATG7 deficient MEFs, 
and that this ATG5-independent autophagy responded to autophagy influencing drugs 
and starvation in a similar manner as conventional autophagy. Importantly, the lack of 
ATG5 or ATG7 resulting in a blockage in the creation of LC3-II (LC3-I lipidation) 
(Nishida et al. 2009). Therefore, autophagy processes are not entirely dependent on 
core autophagy genes, perhaps enabled through distinct signalling pathways or high 
redundancy in the autophagy system. A recent report highlighted the importance of 
ATG5-independent autophagy in mitochondrial clearance (Ma et al. 2015). 
Furthermore, ATG5-independent autophagy has been implicated in pathogen 
clearance. Mycobacterium marinum is targeted to autophagosomes lacking LC3-II 
marking, in an ATG5-independent manner (Collins et al. 2009). Furthermore, ATG5-
independent autophagy promotes clearance of pathogenic bacteria within intestinal 
cells (Ra et al. 2016).  
ATG3-independent autophagy is suggested by the formation of autophagosome-like 
structures in atg3-/- mice (Sou et al. 2008). ATG3/ATG7-independent autophagy has 
been demonstrated in Drosophila melanogaster, specifically in mid-gut cell shrinkage 
(which occurs in development). ATG8 (LC3-II) was not lipidated in this system, and it 
was shown that E1-like enzyme UBA-1 is required for mid-gut cell shrinkage, but is not 
involved in lipidation of ATG8 (LC3-I) (Chang et al. 2013).  
Both ATG5 and ATG3 independent autophagy appear to function without lipidation of 
LC3. This has been confirmed in a recent report highlighting that autophagosome and 
autolysosome formation can occur when autophagy conjugation systems are not 
present (Tsuboyama et al. 2016). Together these studies demonstrate that ATG3 and 
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ATG5 are not essential for autophagy, and that LC3-II does not always mark 
autophagosomes.  
1.4.6 Host-pathogen interactions in macroautophagy  
Pathogens often target or subvert specific parts of the immune response for their own 
survival and autophagy is no exception. Autophagy has a role in the host-pathogen 
interactions with bacterial, viral, fungal and protozoan pathogens (Kuballa et al. 2012). 
There are several methods host cells use to recognise and induce autophagy, through 
activation of pathogen recognition receptors (PRRs), such as Toll-like receptors (TLRs; 
which recognise pathogen associated molecular patterns (PAMPs)), through damage 
associated molecular patterns (DAMPs), and directly through pathogen receptors. One 
example is TLR4, which recognises lipopolysaccharide (LPS), found in bacterial cell 
walls. When TLR4 is activated this can inhibit the bacterial mediated arrest of 
phagosome maturation, and bacteria are subsequently targeted to autophagosomal 
degradation (Xu et al. 2007). Furthermore, TLR4 (among other TLR) signalling, has 
been shown to increase Beclin-1 levels (part of the PI3K complex, Table 1), thus 
inducing autophagy (Shi & Kehrl 2008). Therefore, autophagy can be induced through 
recognition of pathogens.  
Autophagy induction plays a crucial role in the front-line innate defence against 
pathogens. Mutations in ATG proteins increase the risk of infection by intracellular 
pathogens (Levine et al. 2011). S. aureus is demonstrated to be degraded through 
autophagy (Amano et al. 2006), and ATG proteins appear to be involved in the ability of 
C. neoformans to cause infection within the host (Qin et al. 2011). This highlights a link 
with both C. neoformans and S. aureus with autophagy, which is discussed in detail in 
section 1.4.7 and 1.4.8. 
The interaction between bacterial pathogens and the autophagy pathway are well 
studied. Autophagy is an effective strategy to eliminate bacteria, however is some 
cases this may be limited to an early time point in infection, before bacteria begin to 
replicate in the cytosol (Py et al. 2007). Bacteria block autophagy for their own end 
using several methods such as, inhibiting autophagy induction, remaining in the 
phagosome by preventing maturation, preventing lysosomal fusion, and concealing 
themselves from the autophagy pathway, as reviewed by Deretic and Levine 2009. 
There is remarkable diversity in the different strategies employed by bacteria to subvert 
or induce autophagy in these circumstances. Some gram-negative bacteria, including 
Porphyromonas gingivalis, and Brucella abortus hide and replicate within vacuoles 
(lysosomes) of the host cell, which are shown to have autophagic marking (Dorn et al. 
2001; Pizarro-Cerdá et al. 1998). It is suggested that remaining in the vacuole 
(lysosome) provides bacteria access to degraded contents such as amino acids, 
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therefore these bacteria may inhabit a niche within the autophagy pathway (Colombo 
2005). Another interesting mechanism is seen in Legionella pneumophila, Coxiella 
burnetii and Salmonella enterica serovar typhimurium infections. Each of these 
pathogens utilise a secretion system to promote autophagy, by injecting autophagy 
inducing proteins into the host cell (Amer & Swanson 2005; Hernandez et al. 2003; 
Gutierrez et al. 2005). From these studies, reviewed in Colombo 2005, it is clear that 
bacteria utilise the autophagic pathway for their own survival.  
Unlike bacteria, fungal pathogens have not been studied at depth in relation to 
autophagy, however there is some evidence of the involvement of autophagy. 
Aspergillus fumigatus phagosomes were shown to be marked with LC3, in Lc3-
assocaited phagocytosis (Martinez et al. 2015). A loss of autophagy, specifically ATG5 
in myeloid cells, in mice infected with Candida albicans led to increased susceptibility 
of infection (Nicola et al. 2012). Therefore, autophagy (or autophagic machinery) is 
employed in response to fungal infections.  
1.4.7 Autophagy in S. aureus infection  
S. aureus interactions with host cell autophagy have been described for several cell 
types, due to the range of cells S. aureus interacts with during infection, for example 
phagocytes after tissue invasion, or keratinocytes during infection of the skin.  
It was demonstrated using HeLa cells that S. aureus resides in an autophagosome, as 
determined through marking of LC3 on a double membrane vesicle, but that the 
autophagosome does not become marked with LAMP-2 or become acidified (Schnaith 
et al. 2007). This suggests that the maturation of the staphylococcal autophagosome is 
inhibited. It was concluded that S. aureus later escapes from the autophagosome into 
the cytoplasm causing host cell death. The host cell death was shown to be autophagy 
dependent, specifically requiring Atg5 (this was not apoptosis due to a lack of caspase 
involvement) (Schnaith et al. 2007). This represents evidence that host cell autophagy 
is beneficial for S. aureus during infection. Where bacteria have escaped the 
autophagosome and reside in the cytoplasm, selective autophagy can result in 
autophagosome enclosure. This occurs for S. aureus, but the bacteria can escape 
autophagosomes, in a manner which results in autophagosome membrane damage 
(Neumann et al. 2016).  
S. aureus has been shown to subvert host cell autophagy to promote its own survival. 
In mouse embryonic fibroblasts (MEFs) deficient in Atg5, a reduction of both bacterial 
replication and the ability to kill the host cell was observed (Schnaith et al. 2007), 
indicating that host Atg5 is helpful for bacterial survival. However the exact opposite 
results were recently found where an increase in bacterial replication occurs in Atg5 
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deficient MEFs (Neumann et al. 2016). This suggests that multiple factors, for example 
bacterial strain, may affect autophagy induction. Interestingly, it was determined that in 
MEFs, which are non-professional phagocytes, PRIP (phospholipase C-related 
catalytically inactive protein) can bind to LC3 and that PRIP is required for autophagy 
mediated degradation of S. aureus. Loss of PRIP promoted bacterial survival and 
proliferation within an LC3 marked vesicle (Harada-Hada et al. 2014). This highlights 
that different cell types may handle S. aureus through different mechanisms.  
In vitro studies on murine macrophages (RAW264.7 cells) determined that TLR2 is 
important in the phagocytosis and activation of autophagy. Using siRNA to target TLR2 
reduces both S. aureus phagocytosis and cell autophagy (Fang et al. 2014). Similarly, 
microglial cells, which are tissue resident macrophages in the CNS, also have 
increased autophagy expression in response to S. aureus. TLR2 is used to sense 
bacterial peptidoglycan (PGN) which results in autophagy dependent host cell death. 
This was demonstrated with injection of PGN into murine brains which led to microglial 
cell death (Arroyo et al. 2013). This suggests that for macrophages, autophagy 
induction is detrimental for the cell survival.  
The importance of the agr locus is clear. The agr locus controls S. aureus virulence 
factor expression in host autophagy activation. It appears that agr virulence factors are 
required to induce autophagy involvement since bacteria deficient in agr were not 
targeted into autophagosomes and did not cause host cell death (Schnaith et al. 2007). 
Similarly in DCs, agr is required to increase autophagosome formation, enabling 
bacterial survival and eventual cellular escape (O’Keeffe et al. 2015), further 
suggesting that autophagy promotes bacterial survival. Interestingly, loss of agr in 
MRSA strains enables persistent infection of keratinocytes, however in this case 
autophagy was induced and was associated with degradation of inflammasomes 
(Soong et al. 2015), perhaps enabling S. aureus to evade keratinocyte mediated 
damage. This highlights that autophagy strategies employed by S. aureus differ 
between infection site/host cell.  
Host cell autophagy can also be beneficial for the host cells. The staphylococcal 
virulence factor, α-hemolysin, creates pores in the plasma membrane of infected cells 
and results in the loss of ATP and amino acids. Autophagy activation may occur in two 
ways. Firstly, through cellular energy sensor AMPK activity which inhibits mTORC1, 
resulting in autophagy. Secondly, eIF2α-kinase GCN2 which acts a nutrient sensor, 
perhaps sensing a lack of amino acids, which results an increase in autophagy (Kloft et 
al. 2010; von Hoven et al. 2012). By blocking autophagy with 3-MA, cells had a 
reduced ability to recover from non-lethal S. aureus infection (Kloft et al. 2010), 
suggesting that autophagy promotes host cell survival from S. aureus α-hemolysin 
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damage. Interestingly, it is suggested that host cell autophagy is able to reduce the 
effects of α-hemolysin through dysregulation of ADAM10 (a disintegrin and 
metallopeptidase domain 10) which is a α-hemolysin receptor (Maurer, Torres, et al. 
2015; Maurer, Reyes-Robles, et al. 2015). Furthermore, IFNγ has been demonstrated 
to induce autophagy to protect keratinocytes from α-hemolysin, through a reduction in 
ADAM10 expression (Brauweiler et al. 2016). This may add another host cell defence 
mechanism towards survival of S. aureus infection.  
Overall the interaction between host cell autophagy and S. aureus is complex. Different 
outcomes may be expected in different cell types, in response to specific bacterial 
strain virulence expression or in different stages of infection.  
 
1.4.8 Autophagy in C. neoformans infection  
C. neoformans has been shown to survive, replicate and even escape from inside 
macrophages, indicating macrophages are a key intracellular niche, important in the 
pathogenesis of cryptococcal infection. Therefore, the limited publications which 
investigate the role of autophagy in cryptococcal infection focus solely on macrophage 
autophagy.  
Autophagy was first linked to cryptococcal infection when capsule components, GalXM 
and GXM, were shown to induce autophagosome formation in murine macrophages 
(Villena et al. 2008), however, this did not reveal whether host macrophage autophagy 
was beneficial to the host or for the cryptococcal cells. Interestingly, it was next shown 
that autophagy proteins, including ATG2a, ATG5 and ATG9, are required for C. 
neoformans growth, through RNAi analysis in murine macrophages, which reduced 
both the uptake, and replication of intracellular cryptococci (Qin et al. 2011), thus 
implicating an autophagy role beneficial for cryptoccocal cells. However, a similar RNAi 
strategy resulting in atg5 deficiency led to reduced macrophage fungistatic ability, 
suggesting that autophagy is important as a host defence (Nicola et al. 2012). In 
contrast, in myeloid specific atg5 deficient mice no increase in susceptibility to 
cryptococcal infection is observed (Nicola et al. 2012), suggesting that myeloid cells do 
not control cryptococcal infection through autophagy in vivo. It was recently 
demonstrated in a murine model that cryptococcal infection leads to an increase in 
phosphorylation of both AMPKα and ULK-1, both proteins which induce autophagy. 
However, deletion of AMPKα in myeloid cells in mice leads to a reduction in fungal 
burden following cryptococcal infection (Pandey et al. 2017) suggesting that AMPKα, 
and therefore autophagy induction in myeloid cells increases susceptibility to 
cryptococcal infection. Contradictory evidence means that further analysis is required.  
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Furthermore, autophagosome marker LC3 has been shown to localised to antibody 
opsonised cryptococcal cells, however, currently no data showing the yeast within a 
double-membrane, only within a single membrane structure exists, despite 
autophagosomes being seen in close proximity (Nicola et al. 2012; Pandey et al. 2017). 
Due to the overlapping roles of autophagy components in different types of autophagy, 
for example between classical, atg5-independent autophagy and in LAP, further 
analysis is required to determine the precise roles autophagic components have in the 
handling and outcome of cryptococcal infection.  
 
In both S. aureus and C. neoformans infections, the role of host cell autophagy in 
infection outcome is unclear. Analysis so far has determined contradicting roles of 
autophagy as both beneficial and detrimental for each pathogen. Therefore the role of 
host cell autophagy in infection is unknown and warrants further investigation. It is 
important to determine whether interactions with autophagy components occur with 
pathogens, and what affect these interactions have of the outcome of autophagy, this 
may be completed through imaging. In vivo analysis in mammals does not enable good 
cellular level imaging, equally in vitro analysis does not provide an environment which 
matches what the pathogens encounter in real infection. For these reasons a different 
model organism was required.  
 
1.5 Zebrafish   
1.5.1 Zebrafish as a model organism 
To study immune function and host-pathogen interactions within vertebrates, Danio 
rerio (zebrafish), make an apt model organism which circumvents limitations of murine 
and in vitro methods. Zebrafish are a worthy model primarily for three key reasons: 
similarity of immune system with vertebrates, genetic manipulation and imaging 
potential, in addition to high genetic homology and high fecundity (Renshaw & Trede 
2012; Goldsmith & Jobin 2012; Meijer et al. 2014; Torraca et al. 2014).   
1.5.2 Zebrafish transgenic reporter lines  
The in vivo imaging potential of zebrafish is particularly convenient as embryos have 
translucent skin, and zebrafish lines without pigmentation are available, allowing 
imaging within whole, live organisms (Goldsmith & Jobin 2012). This factor was initially 
exploited for study of development, but also allows study of host cell-pathogen 
interactions (Renshaw & Trede 2012; Goldsmith & Jobin 2012). Fluorescent strains of 
pathogens can be imaged within the live larvae. Importantly, zebrafish can be 
manipulated specifically for the research at hand to enable fluorescent labelling/tagging 
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of specific tissues, cell types or proteins within individual larvae, allowing cellular 
interactions to be visualised in real time. For example fluorescence can be induced in 
specific cells/tissues through the Gal4-UAS system, whereby a promoter specific to the 
required cell type (e.g. neutrophils) drives Gal4 expression in larvae. When crossed to 
a reporter line, which has a reporter (e.g. GFP) downstream of the UAS enhancer site, 
Gal4 is able to bind to the UAS site (the binding motif of Gal4) and induces GFP 
fluorescence within the promoter specific tissue (Asakawa & Kawakami 2008). Another 
useful tool is the GatewayTM and Tol2 transgenesis system. The Gateway system 
allows efficient cloning of vectors (which may include tissue specific promotors, 
reporter constructs, or fluorescently tagged proteins) into specifically designed 
expression clones which include Tol2 transgenesis sites (Kwan et al. 2007). The 
relative ease, and speed (due to zebrafish high fecundity and low sexual maturity age), 
mean zebrafish is an excellent model for imaging of cellular, sub-cellular and host-
pathogen interactions. 
1.5.3 Genetic manipulation of Zebrafish  
Significantly, the zebrafish genome is fully sequenced and zebrafish have a high 
genetic homology, 70%, with the human genome (Howe et al. 2013) providing good 
translational potential. Accordingly, zebrafish are well placed for genetic study. Genetic 
manipulation, through diverse methods allows gene function to be thoroughly examined 
(Renshaw & Trede 2012; Goldsmith & Jobin 2012). For example, transient gene knock-
down can be achieved through the use of Morpholinos (phosphorodiamidate 
Morpholino oligomers), short ~25bp oligomer molecules which are designed to bind 
and block access to RNA resulting in inhibition of protein production (Summerton & 
Weller 1997).  
For more permanent effects, mutagenesis can be performed. Zinc-finger nucleases 
(ZFN), which cause double stranded DNA breaks, can be customised to insert a frame-
shift mutation. Through customisation of a zinc finger array (specific DNA sequences 
targeted for mutagenesis) which is fused to the nuclease, site specific mutants can be 
created (Foley et al. 2009). Another method of mutagenesis is through the use of 
TALENs (transcription activator-like effector nucleases). Similar to ZFN, sequence 
specific repeats fused to a nuclease enable site specific DNA double stranded breaks 
(Moore et al. 2012). For both ZFN and TALEN mutagenesis DNA breaks are repaired 
by non-homologous end joining, which can result in mutations.  
A recent mutagenesis method is the CRISPR-Cas9 system, whereby Cas9 an 
endogenous bacterial nuclease is directed to specific DNA targets through the use of 
site specific guide RNAs (Hwang et al. 2013). Alternatively, the CRISPR/Cas9 system 
can be used to knock-down gene expression through CRISPR interference (CRISPRi). 
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Here non-functional Cas9 which binds to the target site, but cannot cut the DNA, blocks 
gene expression (Qi et al. 2013). Overall, several efficient methods for genetic 
manipulation exist for zebrafish, enabling gene function to be examined.  
1.5.4 Drug treatment in zebrafish  
In addition to mutagenesis and transgenic approaches, zebrafish can also be treated 
with drugs. Drugs can be administered via immersion, where drugs are added to the 
larvae water, or can be administered through injection. Zebrafish have successfully 
been used for drugs screens (Parng et al. 2002). Importantly, drug treatment enables 
further routes of analysis on zebrafish, useful in varied settings. 
1.5.5 The zebrafish innate immune system  
The zebrafish immune system has high similarity to other vertebrates, including 
humans. Zebrafish have both adaptive and innate immune systems. The innate 
immune system is responsible for initial interactions with invading pathogens, and 
subsequently initiating an appropriate adaptive immune response. The zebrafish model 
enables study of the innate system alone, which is not confounded by adaptive 
immunity because innate and adaptive immune systems develop at different rates. 
Innate cells are present at one day post fertilisation, whereas adaptive immunity does 
not fully develop until 3 weeks post fertilisation (Willett et al. 1999; Herbomel et al. 
1999). 
The zebrafish immune system contains macrophages, neutrophils, lymphocytes, 
eosinophils, dendritic cells and natural killer cells (Renshaw & Trede 2012) all cells are 
also found within vertebrate immune systems. Both macrophages and neutrophils are 
observed in the blood stream at 1dpf (Lieschke et al. 2001). Importantly, phagocytic 
cells are able to phagocytose and successfully degrade a variety of pathogens.  
To enable recognition of pathogens, the zebrafish immune system senses pathogens 
through pattern recognition receptors (PRRs) as in vertebrates. PPRs recognise 
PAMPs (pathogen associated molecular patterns), from pathogen presence, and also 
DAMPS (danger associated molecular patterns), which may result from damage 
caused by pathogens or inflammation. PRRs recognition of PAMPS or DAMPS results 
in the activation of immune pathways responsible for pathogen degradation. Zebrafish 
have similar PPRs to humans, including Toll-like receptors (TLRs) identified through 
BLAST searches (Jault et al. 2004), RIG-like receptors (RLRs) which respond to viral 
infection (Zou et al. 2015), and NOD-like receptors are shown to be important in 
Salmonella resolution in the zebrafish model (Oehlers et al. 2011). Of note, the 
zebrafish does have some altered specificity and number of PPRs (Li et al. 2017). An 
additional arm of the innate immune system is the complement pathway (as discussed 
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in 1.1.2). The complement pathway exists in the zebrafish, indeed all components of 
the mammalian complement system have identified orthologues in the zebrafish 
(Zhang & Cui 2014). Together, these similarities between the innate immune system of 
humans and zebrafish suggest that zebrafish is a good model for vertebrate innate 
immunity.  
In addition to the attributes of zebrafish in vertebrate immunity study, it is important to 
acknowledge the drawbacks of the zebrafish immune model. Although the immune 
system is similar to humans, they are not identical. Additionally the normal human 
response to infection would involve both the innate and adaptive immune systems, 
however, due to differential development rates, and the fact most zebrafish work is 
done under the age of 5 days, adaptive immunity is missing from infection models. 
Therefore translating data from zebrafish studies to humans is difficult, despite 
providing a good basis from which to begin human study. Furthermore, consideration of 
the temperature at which pathogens invade the human body is required. Zebrafish live 
at a temperature of 28°C, not the human body temperature pathogens have evolved to 
infect at. Thus in the study of human pathogens in zebrafish there may be differences 
in pathogen survival and the outcome of disease. Overall however, there are many 
significant factors in favour of the use of zebrafish as a model of vertebrate immunity, 
given interpretation of data, especially in a translational context is carefully examined.   
The innate immune cells which are important in controlling C. neoformans and S. 
aureus infections are macrophages and neutrophils respectively (Feldmesser et al. 
2000; Rigby & DeLeo 2012). The study of the innate immune response in zebrafish, to 
both C. neoformans or S. aureus challenge is neatly separated from the adaptive 
immunity, because innate and adaptive immune systems develop at different rates, 
(Willett et al. 1999; Herbomel et al. 1999). Thus zebrafish make a good model of innate 
vertebrate immunity for C. neoformans and S. aureus infection study.  
 
1.5.6 Study of autophagy in zebrafish  
In choosing a useful and relevant model for in vivo study, it is important to consider 
which experimental tools and procedures useful for study of autophagy function can be 
used in zebrafish. Importantly, autophagy, as a conserved cellular mechanism is known 
to take place in zebrafish. For 70% of human genes, orthologous gene(s) have been 
identified in zebrafish (Howe et al. 2013). Indeed, for core autophagy genes, at least 
one orthologous gene exists (Mathai et al. 2017). Autophagy genes can therefore be 
targeted for the study of gene function and expression, as mentioned above (section 
1.5.2 and 1.5.3). 
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LC3-II is commonly used to analyse autophagy, due to its localisation to 
autophagosomes. The yeast Atg8 protein has multiple homologues in mammals, 
MAP1LC3 (LC3), GABARAP and GATE-16. Humans have four LC3 genes, two 
GABARAP genes and one GATE-16 gene. On the other hand, zebrafish have four Lc3 
genes, three GABARAP genes and one GATE-16 gene (Shpilka et al. 2011). Most 
autophagy studies focus on MAP1LC3B (LC3B), as it is the most studied, and 
consequently often first examined due to the abundance of tools readily available. 
Autophagy genes (particularly LC3C) are maternally expressed in zebrafish, indicating 
a requirement of autophagy during development. Zygotic expression of genes, 
including autophagy genes (particularly LC3B), begins at ~3.5 hours post fertilisation 
(Kane & Kimmel 1993; Mathai et al. 2017) 
Several methods exist to study autophagy in mammals for example: electron 
microscopy of vesicle structure, analysis of degradation of long-lived proteins, analysis 
of delivery of selected material to the lysosome, autophagy marker LC3 localisation, 
and LC3-I to LC3-II lipidation (Mizushima 2004; Mizushima et al. 2010). These 
methods do not include mRNA or protein expression assays. Mizushima et al. 2010 
make a very significant point that although autophagy genes are up-regulated in 
response to autophagy cues, there is no evidence to show that the actual process of 
autophagy (autophagic flux) is up-regulated. Thus, methods such as imaging LC3 
localisation, lipidation and function are more robust than mRNA or protein levels 
measurement, and will provide information on the level of autophagy when carefully 
controlled (Mizushima et al. 2010). It is highly important to consider the level of 
autophagic flux during autophagy measurements, rather than simply the levels/amount 
of autophagy components present. The use of drugs which can block lysosomal fusion 
to the autophagosome are very useful as controls in helping determine changes to 
autophagic flux. 
Several methods have been proven and used specifically for the study of autophagy in 
zebrafish including, generation of reporter lines, microscopy, Lc3 western blots and 
lysotracker staining (He & Klionsky 2010), these methods fit neatly with genetic 
manipulation, adding another dimension to these techniques.  
Lc3 is widely used as an autophagy marker in zebrafish. Lc3 is dispersed cytosolically 
until autophagy induction, where autophagosomes (or Lc3 associated vesicles) can be 
visualised by puncta formation. The imaging of Lc3 localisation to autophagosomes is 
visualised through Lc3 being fluorescently tagged or stained (He & Klionsky 2010). Lc3 
microscopy is particularly useful in host pathogen interactions as pathogens can also 
be fluorescently marked allowing conclusions to be drawn on the location of pathogens 
in relation to autophagosomes (or Lc3 marked vesicles). Lysotracker dye can be used 
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to visualise autolysosomes, through the drop in pH after autophagosome fusion with a 
lysosome (He & Klionsky 2010). It is important to note that lysotracker is not 
autolysosome specific, and will stain other acidic compartments too. Therefore when 
using lysotracker, visualisation of Lc3 using another method is also required. Double 
tagging (GFP and RFP) of Lc3 enables the generation of “traffic-light” Lc3 constructs, 
which are useful in assessing autophagic flux. When expressed in vivo, the GFP tag is 
quenched under acidic conditions. Lc3 experiences acidic conditions when lysosomal 
fusion to the autophagosome occurs. Therefore, comparison of double GFP/RFP 
fluorescence to RFP alone, enables conclusions to be drawn on autophagic flux and 
degradation. Generation of Lc3 tagged zebrafish lines enable cell specific expression 
of tagged Lc3. Of particular interest, phagocytes expressing traffic-light Lc3 were 
generated (PhD thesis Serba, 2016).  
Overall, imaging techniques using autophagy constructs, largely Lc3 based, provide 
analysis of autophagic flux, localisation and dynamics. Lc3 western blots are used to 
monitor the Lc3-I to Lc3-II lipidation process, using Lc3-II production as a marker of 
functional autophagy. An increase in the amount of Lc3-II may indicate increased 
autophagy induction when properly controlled for autophagic flux (He & Klionsky 2010). 
Additionally, p62 is also assessed by western blot, with a loss of p62 protein 
suggesting an increase in autophagy, since p62 is degraded through autophagy 
(Bjørkøy et al. 2009). 
1.5.8 Using the zebrafish model to study infection 
In vitro infection studies enable insight into host-pathogen interactions. However, the in 
vitro situation is very different to an in vivo setting, which may have implications for 
host-pathogen interactions, for example much more complex cytokine signalling or 
steric interactions may alter how pathogens are degraded or are able to survive within 
a host. In order to have improved understanding of the immune response to pathogen 
infection, an in vivo model is favoured. In vivo infection models, such as the mouse 
offer greater understanding of host-pathogen interactions, but have limitations such as 
reduced imaging potential and reduced genetic tools. Zebrafish provide a good animal 
model for infection studies due to their genetic tractability, imaging potential and 
similarity of immune system to humans. The ability to conduct high quality imaging, 
with regulation of gene expression provides an ability to visualise infection dynamics 
and host-pathogen interactions throughout an entire vertebrate organism. As such, 
multiple infection models have been established in zebrafish including bacteria, fungus 
and virus models.  
Importantly, many useful zebrafish transgenic lines have been established to enable 
visualisation of cellular interactions. Of note macrophage and neutrophil lines are used 
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to determine whether pathogens are phagocytosed, and if so whether pathogens are 
degraded, or able to escape the phagocyte and survive extracellularly or survive 
intracellularly. Additionally granuloma formation may be observed. Furthermore, in 
order to observe where pro-inflammatory signalling is occurring, perhaps at sites of 
infection, fluorescent molecules, driven by promoters of molecules such as NF-kB or 
IL1-B, allow visualisation of sites of inflammation  (Kanther et al. 2011; Nguyen-Chi et 
al. 2014). Visualisation of cellular interactions, or signalling molecules enables host-
pathogen interactions to be investigated in detail, within an entire organism.   
Relevant to the study of pathogens using zebrafish, several successful infection 
models have been established. For example, Mycobacterium marinum, a bacterium 
related to Mycobacterium tuberculosis, is a natural pathogen of fish. As such, M. 
marinum is well placed as a translational model of mycobacterial disease being proven 
to replicate within, and cause acute and chronic infection of zebrafish (Prouty et al. 
2003). Another example of a bacterial zebrafish infection model is the model of Shigella 
flexneri, which is further relevant due to the study focus of autophagy. Here S. flexneri 
is shown to infect and cause disease in zebrafish, in addition to causing the induction 
of autophagy (Mostowy et al. 2013). The fungal pathogen Candida albicans was shown 
to induce NF-kB signalling at mucosal epithelial surfaces in the zebrafish model in 
severe infection, although at low infection doses infection is controlled by phagocytes 
(Gratacap et al. 2013). Recently, the route of viral entry to the central nervous system 
was compared between two viruses, (chikungunya  and Sindbis) which although were 
related, showed preferential routes via separate pathways, additionally showing that 
the viral tropism to the CNS was conserved in zebrafish (Passoni et al. 2017). The 
listed pathogens mentioned here are not definitive, many more pathogens such as 
Salmonella typhimurium, Staphylococcus aureus, Cryptococcus neoformans, 
Aspergillus fumigatus, Streptococcus pneumoniae and more have been established in 
a zebrafish infection model. However, the range of pathogen infection models 
established in zebrafish highlight that a diverse range of human (and zoonotic) 
pathogens can be used in the zebrafish model, and can provoke similar pathologies 
and immune responses which occur in human disease. These examples highlight the 
versatility and potential of the zebrafish as an infection model.  
 
1.5.9 Zebrafish as an infection model for S. aureus  
The Staphylococcus aureus zebrafish infection model has previously been well 
established (Prajsnar et al. 2008; Prajsnar et al. 2012). Larvae are infected at 1dpf into 
the yolk sac circulation valley with S. aureus suspended in sterile PBS. A range of 
inoculum doses can be used, with higher doses reducing larval survival more than 
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lower doses, indicating that S. aureus is responsible for larvae death (Prajsnar et al. 
2008), importantly this was completed at 28ºC. Furthermore, using reduced virulence 
S. aureus strains for infection increased larval survival. 
It was determined that phagocytes control S. aureus infection and are responsible for 
clearing infection. This was determined through depletion of myeloid cells, which 
resulted in uncontrolled growth of bacteria. (Prajsnar et al. 2008). In the same model it 
was later shown that neutrophils are a likely intra-cellular niche from which a small 
population of bacteria survive, replicate and ultimately escape to cause an uncontrolled 
infection, in a population “bottle-neck” (Prajsnar et al. 2012). Interestingly, a study 
comparing injection site into the zebrafish indicates that injection into the blood stream 
is more lethal in comparison to localised sites. It was shown that macrophages 
phagocytose more S. aureus, but that the majority of phagocytes which respond are 
neutrophils (Li & Hu 2012). Together these studies highlight that as a model of S. 
aureus bacteraemia, the zebrafish model enables study of the innate immune 
responses, of which neutrophils are particularly important. In contrast to other in vivo S. 
aureus infection models, such as the mouse, the zebrafish offers the opportunity to 
study bacterial growth dynamics, and cellular-bacterial interactions in the entire 
organism, through greater imaging capabilities.  
 
1.5.10 Zebrafish as an infection model for C. neoformans  
The Cryptococcus neoformans zebrafish infection model has previously been 
established by two groups concurrently. Larvae are infected at 2dpf into the yolk sac 
circulation valley with C. neoformans suspended in sterile polyvinylpyrrolidone (PVP) in 
phenol red. C. neoformans was shown to be responsible for increased larval death 
when infected with higher doses, and conversely reduced larval death was observed at 
lower doses (Bojarczuk et al. 2016).  
Several aspects of human cryptococcal infection are recapitulated in the zebrafish, 
including a key role of macrophage phagocytosis in controlling early infection, 
intracellular proliferation within macrophages, and importantly the ability of cryptococcal 
cells to cross into the brain from the blood stream (Tenor et al. 2015; Bojarczuk et al. 
2016). Furthermore, observations made in other models have been confirmed in 
zebrafish. Using a cryptococcal mutant fnx1Δ, which had previously been shown in 
mice to have reduced ability to invade cross the BBB, infection of zebrafish also 
highlighted a reduced ability of cryptococcal invasion into the brain (Tenor et al. 2015). 
Together, these publications demonstrate that the zebrafish is a valid and useful model 
for C. neoformans infection studies. Interestingly, a zebrafish model where 
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cryptococcal spores and fungal cells are injected to compare cryptococcal growth 
dynamics, demonstrated that both types of inoculum cause fungemia and display an 
ability to cross the BBB (Davis et al. 2016). Furthermore, the role of macrophages, (and 
to a smaller extent in endothelial cells for spore inocula), were confirmed to act as 
intracellular niches which led to eventual cryptococcal escape. The role of endothelial 
cells in enabling intracellular spore survival, at sites away from the brain is a novel 
finding demonstrated in the zebrafish model.  
Mammalian cryptococcal infection models have been established, The mammalian 
inhalation infection models do provide a useful route of infection, similar to the infection 
route seen in humans (Price et al. 2011). Non-mammalian invertebrate cryptococcal 
models have also been established, but lack the similarity of vertebrate immune 
system, or susceptibility to infection mean findings may have to be proven in a 
separate model (Harwood & Rao 2014). The zebrafish offers the ability to visualise 
cellular and subcellular interactions and growth dynamics within an entire organism, 
with an innate immune system similar to humans.  
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1.6 Introduction summary 
The selection of zebrafish as a model organism for the study of host cell autophagy 
during infection is well supported through immune system similarity with vertebrates, 
genetic manipulation and imaging potential. Furthermore, the presence of orthologous 
autophagy genes in zebrafish is significant, allow investigation of relevant, and 
potentially translational, research questions.  
Autophagy is known to play a role in host-pathogen interactions, applicable to both C. 
neoformans and S. aureus. Since the autophagy pathway has several key steps which 
can be blocked or subverted by pathogens for their own end, it is interesting to 
question how C. neoformans and S. aureus may avoid or utilise the pathway during 
infection, an area which is yet to be fully defined.  
S. aureus is known to be targeted for degradation through the autophagy pathway 
whilst conversely having a capability to subvert the pathway. This indicates a niche 
within the autophagy pathway that S. aureus can utilise to promote survival. Identifying 
which part of the autophagy pathway S. aureus can block or subvert may lead to 
translational uses in the treatment of infection, in addition to understanding why the 
same mechanism is not always used or successful, although this may be dependent on 
the cell type and bacterial strain.  
For C. neoformans the role of autophagy and interactions of C. neoformans with the 
pathway are not well defined. Particularly because no data has been published 
describing C. neoformans within an autophagosome. It is therefore interesting to 
investigate whether C. neoformans either being degraded by, or subverting, the 
autophagy pathway. Or alternatively whether non-canonical autophagy may lead to the 
interaction of cryptococcal cells with autophagic machinery.  
To conclude, the many attributes of the zebrafish model will be central in the study of 
autophagy as a host defence against both S. aureus and C. neoformans. Despite both 
pathogens being implicated in a pathogen-host interaction with autophagy, the 
interactions with autophagy are yet to be fully defined, providing an exciting area for 
investigation.  
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1.7 Thesis aims 
Important and non-trivial diseases are caused by C. neoformans and S. aureus in 
human infection. Cryptococcal infection is responsible for 15% of AIDS related deaths 
worldwide and can cause cryptococcal meningitis (Rajasingham et al. 2017). In 
addition bacteraemia caused by S. aureus infection has a mortality rate of 20-30% (van 
Hal et al. 2012). Understanding how pathogen infection progresses is important in 
enabling targeted treatment during infection.  
The physiological cause of cortical infarcts in cryptococcal meningitis is unknown, and 
finding the cause may provide a therapeutic target. Limited clinical reports have 
suggested that vascular damage occurs in cryptococcal infection (Aharon-Peretz et al. 
2004; Rosario et al. 2012; Leite et al. 2004), which may develop at locations of 
intravascular cryptococcal growth (Lee et al. 1996; Tenor et al. 2015). Therefore, I 
hypothesised that cryptococcal proliferation may play a role in vascular damage in 
cryptococcal meningitis.  
Similarly, the role of host cell autophagy in the handling of both C. neoformans and S. 
aureus is unclear, but may provide a potential therapeutic target in the treatment of 
these infections. As described above, host autophagy appears to have both beneficial 
and detrimental effects for intracellular C. neoformans or S. aureus. Variations in the 
role of host cell autophagy may be may be dependent on the host cell type and the 
virulence of the pathogen strain. It is therefore worthwhile investigating the role of host 
cell autophagy, both macroautophagy and selective autophagy, in handling of these 
pathogens.  
The aims of this thesis are to:  
1. Investigate the role of cryptococcal proliferation in infection dynamics, vascular 
damage and tissue invasion  
2. Characterise and use zebrafish autophagy mutants to analyse the role of host 
cell autophagy in C. neoformans or S. aureus infection 
3. Generate a p62 zebrafish reporter line to analyse the role of selective 
autophagy in C. neoformans and S. aureus infection 
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Chapter 2 Materials and Methods 
2.1 Materials 
2.1.1 Zebrafish 
The Zebrafish lines used in this study are shown in table 2.1, for wild-type, transgenic 
and mutant lines. The reason the line was used, and the origin of each line.  
Table 2.1: Zebrafish lines 
 
2.1.2 Cryptococcus neoformans 
2.1.2.1 C. neoformans strains 
The C. neoformans strains used in this study are shown in table 2.2 
Table 2.2: Cryptococcus neoformans var grubii strains used in zebrafish 
infection 
Cryptococcus 
neoformans 
Description Origin 
KN99 Wild-type strain (Nielsen et al. 2003) 
KN99 GFP GFP fluorescence (in submission, Gibson 
et al. 2017) 
KN99 mCherry mCherry fluorescence (in submission, Gibson 
et al. 2017) 
H99 Wild-type strain*  (Bojarczuk et al. 2016) 
Ure-1 (KN99) Urease mutant ** (unpublished)  
Sec14 (KN99) Mutant in secretion factor 14 ** (unpublished) 
Pho4 (KN99) Pho4 mutant (phosphate 
acquisition) 
** (unpublished) 
Line Use Origin 
 
AB 
 
Wild-Type 
 
 
Nacre Wild-type with loss of 
pigment cells 
 
atg3sh371 Mutation in atg3 gene Kind gift from Lore 
Lambein) (unpublished) 
atg5 Mutation in atg5 gene Kind gift from Ingham lab 
(unpublished) 
Tg(lyz:RFP.GFP.ZFLc3)SH383 Neutrophil specific traffic 
light Lc3 (GFP and RFP) 
Kind gift from Justyna 
Serba (unpublished) 
Tg(lyz:GFP.p62) Neutrophil specific 
tagged p62 (GFP) 
(This study) 
 
Tg(GalFFCadh)* 
Tg(UAS:TEAL) uq13bh 
 
Vascular endothelial 
cadherin  (TEAL) 
Kind gift from Tim Chico 
(UAS made by Anne 
Lagendijk unpublished, 
Gal4 (Bussmann & Schulte-
Merker 2011)) 
Tg(lyz:nfsB.mCherry)sh260 Neutrophil specific 
nitroreductase and 
mCherry expression 
Renshaw lab 
 (Elks et al. 2011; Pisharath 
et al. 2007) 
 Tg(kdrl:mCherry)S916 Marker of endothelial 
vascular cells 
Johnston lab 
(Krueger et al. 2011) 
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*Use of H99 was swapped to KN99 due to a consensus in the field that H99 was not 
representative of wild-type C. neoformans. 
** From a cryptococcal (KN99) deletion library (University of California, San Francisco, 
2015, Madhani plates) 
 
2.1.2.2 Media used for cryptococcal work 
YPD: Cultures were grown in yeast peptone dextrose (YDP), (Sigma-Aldrich Y1375). 
50g in 1 litre of distilled water. Autoclaved before use. 
PVP in phenol red: Cryptococcal cultures were re-suspended in PVP in phenol red 
(10% Polyvinylpyrrolidone (PVP) Sigma-Aldrich, 0.5% Phenol Red Sigma-Aldrich in 
PBS), where PVP is a polymer which prevents needle blockage in cryptococcal 
injection. Autoclaved before use. 
YDP agar plates: Cryptococcal cultures were stored on YDP agar plates at 4ºC. YPD 
made as above, Agar (Oxoid number 1) was used at 2%. Autoclaved before use. 
 
2.1.3 Staphylococcus aureus 
2.1.3.1 S. aureus strains 
The S. aureus strains used in this study are shown in table 2.3, showing the strain and 
description and required antibiotic.  
Table 2.3: Staphylococcus aureus strains used 
Staphylococcus 
aureus 
Description Origin  Required antibiotic 
 
SH1000 
 
Wild-type strain 
 
Foster lab * 
 
n/a 
SH1000-pMV158-
mCherry 
mCherry 
fluorescence 
(SJF4308)  
Foster lab * 
Tetracycline 
SH1000-pMV158-
GFP 
GFP fluorescence (SJF4405)  
Foster lab * 
Tetracycline 
* The University of Sheffield 
2.1.3.2 Media used for Staphylococcal work 
Brain heart infusion: S. aureus was cultured in Brain heart infusion (BHI) (Oxoid), 37.5g 
in 1 litre distilled water. Autoclaved before use. 
LB: At IMCB, S. aureus was cultured (and plated) using Luria Bertani medium (LB) 
(Sigma-Aldrich). 20g in 1 litre distilled water Autoclaved before use. 
BHI or LB agar plates: S. aureus cultures were stored on LB or BHI agar plates at 4ºC. 
Agar (Oxoid number 1) was used for BHI or LB agar plates. LB or BHI made as above, 
Agar was used at 2%. Autoclaved before use 
 
2.1.4 Media  
2.1.4.1 Phosphate buffered Saline 
Three types of phosphate buffered saline (PBS) used, due to working in two locations, 
and also the concentration of PBS that was available. 
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1. 1x Phosphate buffer saline, (Life technologies 20012-027). 
2. 10x Phosphate buffer saline: (Life technologies AM9625). Diluted to 1x with 
distilled water before use.  
3. PBS tablets: (Oxoid, BR0014G). A single tablet is dissolved per 100ml of 
distilled water, and autoclaved to sterilise before use.  
2.1.4.2 E3  
A 10x stock of E3 (NaCl 5mM, KCl 170µM, CaCl2 330µM, MgSO4 330µM) was 
provided by the aquarium. Distilled water was used to make a 1x dilution, and 
methylene blue (0.00005%) was added. 1x E3 was stored at 28.5ºC 
2.1.4.3 Methyl cellulose 
A 3% methyl cellulose (Sigma-Aldrich) in E3 for solution was used for larvae 
injection. Stored at -20ºC until shortly before use when it was stored at 28.5ºC 
 
2.1.5 Antibiotics 
The antibiotics listed below are used at the working concentration for inside growth 
media (LB or BHI) for liquid cultures and agar plates, for both S. aureus and E. coli 
(competent cell) cultures.  
Table 2.4: Antibiotics used in this study 
Antibiotic Working concentration 
Tetracycline 5µg/ml 
Chloramphenicol 10µg/ml 
Ampicillin 50µg/ml 
Kanamycin 50µg/ml 
 
2.1.6 Western blot solutions 
2.1.6.1 Protein extraction buffer 
0.3M NaCl, 2.5mM EDTA pH8.0, 50mM Tris-HCl pH7.4, 1% octylglucoside, 1 
Complete mini tablet, 1 PhosSTOP tablet, up to 20ml with sterile water 
2.1.6.2 Laemmli buffer 
2x Laemmli buffer: 65.8mM Tris-HCl pH 6.8, SDS (2.1%), Glycerol (26.3%), and 
Bromophenol blue (0.01%). Stored at 4ºC. 50µl BME added to 950µl of 2x Laemmli 
buffer on use. Or, 4x Laemmli buffer: Biorad (1610747) 
2.1.6.3 Running buffer and Transfer Buffer  
10x running buffer: 30.3g Trizma base, 144g glycine, 10g SDS, up to 1 litre with 
distilled water. 1x solution made with distilled water.  
74 
 
10x transfer buffer: 30.3g Trizma base, 144g glycine, up to 1 litre with distilled water, 1x 
solution made with distilled water.  
2.1.6.4 SDS-PAGE gels 
Stack gel (6%): 1ml Acrylamide (30%, Biorad, #1610154), 1.25ml 0.5M Tris-HCL 
pH6.8, 50µl Sodium dodecyl sulphate (SDS) (10%, Biorad #1610416), 3ml distilled 
water, 30µl Ammonium persulfate (APS) (Biorad, #1610700, 10% made fresh in 
distilled water at time of use), 15ul TEMED (Biorad #1610801).  
Resolving gel (12%): 10ml Acrylamide (30%, Biorad, #1610154), 6.25ml 0.5M Tris-HCL 
pH8.8, 250µl Sodium dodecyl sulphate (SDS) (10%, Biorad #1610416), 8.2ml distilled 
water, 250µl Ammonium persulfate (APS) (Biorad, #1610700, 10% made fresh in 
distilled water at time of use), 25µl TEMED (Biorad #1610801). 
2.1.6.5 Protein concentration measurement 
To measure the protein concentration of protein lysate the Bio-Rad Protein Assay Dye 
Reagent Concentrate (#500-0006). A standard curve was made using 10mg/ml BSA 
serial dilutions. BSA dilutions and protein lysate were added to the assay dye and 
absorbance measured at 595nm.  
2.1.6.6 Other western blot reagents  
1. Amersham ECL Prime Western Blotting Detection Reagent (RPN2232) 
2. Amersham hyperfilm (28906836) 
3. PBST: 1x PBS (as above) with 0.1% Tween 20 (Biorad #170653) 
4. Blotting membrane: 0.2um pore size polyvinylidene fluoride (PDVF) membrane 
(Amersham #10600021) 
 
2.1.7 Drugs used in treatment of Zebrafish 
Drug treatments given to zebrafish to manipulate autophagy were used in several 
experiments. The table below lists the drug, the concentration used and the effect the 
drug has on autophagy. Stock solutions were stored at 4ºC or -20ºC, and diluted in E3 
for use. All autophagy drugs were sourced from Sigma-Aldrich. 
Table 2.5: Drug treatments for autophagy manipulation 
 
Drug 
Concentration 
used for 
treatment 
Autophagy 
inducer  
or inhibitor 
 
Mechanism of action 
Chloroquine 2.5 µM Inhibitor Blocks lysosomal fusion to 
autophagosome 
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NH4Cl 100mM Inhibitor Prevents acidification of 
lysosomes 
Bay-K 8644 1 µM Inhibitor Calcium channel agonist 
Rapamycin 1µM Inducer Inhibits mTOR  
3-methyladenine 
 (3-MA) 
10mM Inhibitor Inhibits PI3K 
 
2.1.8 Microscopes 
1. Spinning disc confocal microscope: UltraVIEW VoX spinning disk confocal 
microscope (Perkin Elmer, Cambridge, UK). 405nm, 445nm, 488nm, 514nm, 561nm 
and 640nm lasers were available for excitation. A 40x oil lense (UplanSApo 40x oil (NA 
1.3)) was used for cellular level imaging. GFP, TxRed emission filters were used and 
bright field images were acquired using a Hamamatsu C9100-50 EM-CCD camera. 
Volocity software was used.   
2. Nikon custom widefield: A custom-build wide-field microscope, Nikon Ti-E with a 
CFI Plan Apochromat λ 10X, N.A.0.45 objective lens, a custom built 500 μm Piezo Z-
stage (Mad City Labs, Madison, WI, USA) and using Intensilight fluorescent 
illumination with ET/sputtered series fluorescent filters 49002 and 49008 (Chroma, 
Bellow Falls, VT, USA). NIS software was used.  
3. LSM 700 confocal microscope: Zeiss LSM700 AxioObserver, with an EC Plan-
Neofluar 10x/0.30 M27 lense. 488nm and 639nm lasers were used for excitation. GFP, 
mCherry emission filters were used, and bright field images were also acquired. Zeiss 
zen black software was used.  
2.1.9 Software  
1. Graph pad Prism software (version 7.02) was used for all statistical analysis, as 
described in individual figure legends.  
2. ApE - A plasmid Editor v2.0.45 was used to analyse construct restriction site digests 
3. Lasergene molecular biology suite, a software package was used for sequences 
alignments (MegAlign), sequence editing (SeqBuilder) and sequencing result analysis 
(SeqMan Pro).  
4. Volocity software was used to acquire and analyse imaging (spinning disk confocal 
microscope).  
5. NIS elements software was used to acquire and analyse imaging (Nikon widefield 
microscope). 
6. Zen black software was used to acquire and analyse imaging (spinning disk LSM700 
microscope). 
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7. Image J (FIJI) was used for quantification of fluorescence imaging, RFP or GFP 
vesicles in traffic light Lc3 analysis and for GFP pixel counts in fungal or bacterial 
burden. 
8. EMBL-EBI pairwise sequence alignment, an online sequence alignment tool 
(http://www.ebi.ac.uk/Tools/psa/) used for protein sequences alignment 
 
2.2 Methods 
2.2.1 Zebrafish Procedures 
2.2.1.1 Zebrafish husbandry 
Zebrafish were kept according to UK home office standards with a 14-10 hour light-
dark cycle at within home office approved aquariums at the University of Sheffield. In 
Singapore adult zebrafish were kept according to established standards, with 14-10 
hour light-dark cycle, in the Institute of Molecular and Cell Biology (IMCB), A*Star. 
Zebrafish larvae are kept at 28°C in E3 solution with added methylene blue, and 
anaesthetised with tricaine before experimental techniques where the fish is required to 
be anaesthetised and/or immobilised. Zebrafish lines used throughout this study are 
shown in table 2.1.  Culling of protected animals (>5.2dpf) was completed through a 
home office approved method at the University of Sheffield. All zebrafish larvae used in 
experiments ending at 5.2 days post fertilisation (dpf), were disposed through a home 
office approved method at the University of Sheffield. 10dpf was used as an end point 
at IMCB, unless otherwise stated.  
2.2.1.2 Zebrafish anaesthesia  
Tricaine was used as an anaesthetic before zebrafish experimental work. Larvae were 
anesthetised by immersion in 0.168 mg/mL tricaine in E3 until larval movement was 
no longer observed. Larvae would be maintained in tricaine in E3 until the end of 
experimental procedure. Where required, larval recovery was completed through 
replacing medium with fresh E3 which did not contain tricaine.  
2.1.1.3 Zebrafish line maintenance 
Adult zebrafish lines were maintained by out-crossing to AB wild-types (or in some 
cases nacre wild-type) to ensure zebrafish lines were not inbred. Out-crossing would 
be completed when adults were 1-2 years old to ensure the zebrafish line was 
continued. Where required, fin-clipping of adult zebrafish was completed and 
subsequent genotyping/screening enabled grouping of adult fish by 
genotype/transgenic reporter, important for experimental procedures.  
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2.2.2 Staphylococcus aureus  
2.2.2.1 S. aureus storage: 
S. aureus strains were stored for one month at 4°C after a frozen stock was streaked in 
sterile conditions on to BHI or LB agar plates and grown at 37°C for two days. If 
required the correct antibiotic would be added to the BHI or LB agar before pouring the 
plates (table 2.3). Frozen stocks are kept at -80°C.  
2.2.2.2 S. aureus cultures: 
A single S. aureus SH1000 colony was picked from a plate (brain heart infusion (BHI) 
agar or LB), and was cultured in 10ml BHI medium or LB overnight at 37°C, 250rpm. 
500µl of this overnight culture was then added to 45ml of BHI/LB medium and 
incubated at 37°C, 250rpm until an acceptable optical density (at 600nm) was reached 
(between OD600 0.5 and 1), typically after 1 hour and 40 minutes. If required antibiotics 
were added to both the overnight and used cultures. The bacteria were then pelleted at 
4500rpm, 4°C for 15 minutes. The bacteria were then re-suspended in PBS, using a 
volume to dilute at the required dose, with 2500cfu/nL being standard. Bacteria were 
then incubated on ice for a short period until use.  
2.2.2.3 S. aureus inocula calculation 
In order to determine the approximate inoculum of the bacteria, an approximate 
concentration was calculated using the OD at 600nm. Previously calculated standard 
curves enabled the bacteria to be re-suspended in a volume of PBS required to attain 
the correct inocula.  
To calculate the exact dose injected into larvae, the same needle as used for injections 
was sued to inject 4nl into 1ml of sterile PBS. After vortexing, 10µl drops would be 
placed onto BHI or LB agar plates (with antibiotics if required). The bacteria were left to 
grow at 37ºC overnight. An average of the colony forming units grown in each 10µl 
drop would be used to calculate a more accurate estimated injected dose.  
 
2.3 Cryptococcus neoformans cultures  
2.3.1 C. neoformans Storage: 
C. neoformans strains were stored for one month at 4°C, after a frozen stock was 
streaked on YPD agar plates and grown at 28°C for two days. Frozen stocks were kept 
at -80°C.  
2.3.2 C. neoformans Culture: 
C. neoformans var. grubii strains (table 2.2, above), were  cultured in 2ml yeast 
peptone dextrose (YPD) medium overnight, for 16-18 hours, in a rotator at 28°C, (30°C 
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shaker in Singapore). 1 ml of this culture was then pelleted 6,000rpm, RT for 1 minute 
and re-suspended in 1ml of PBS. This was then diluted in PBS 1:20, and the number of 
C. neoformans cells were counted using a haemocytometer. The same 1ml was then 
then pelleted 6,000rpm, RT for 1 minute and re-suspended in the correct volume of 
polyvinylpyrrolidone (PVP) in phenol red, for 1000cfu/nL. If required, dilutions of 
1000cfu/nL, to make 500cfu/nL, 100cfu/nL and 10cfu/nL were made. 
2.4 Zebrafish microinjection of pathogens 
Zebrafish larvae were de-chorionated (manually the chorion of the embryo was 
carefully removed, using forceps to pull it apart) before micro-injection and 
anaesthetised using tricaine (0.168 mg/mL tricaine in E3). Zebrafish larvae were 
injected into the circulation valley with C. neoformans at ~48 hours post fertilisation 
(hpf), whereas larvae were ~30hpf when injected with S. aureus (Prajsnar et al. 2008; 
Bojarczuk et al. 2016). Larvae were place onto 3.5% methylcellulose in E3 prior to 
injection. Pulled glass needles were then loaded with the correct dose of pathogen, 
placed onto the micromanipulator apparatus and the needle tip broken. The injection 
dose was then determined through use of a graticule, allowing a 1nL drop size to be 
fixed, through manipulation of Pneumatic PicoPump (PV 820P). Larvae were then 
injected with 1nL of the required pathogen dose, and placed into fresh E3 solution and 
kept at 28°C (28.5ºC for S. aureus). 
2.5 Drug treatments 
Where larvae were treated with autophagy inducers and inhibitors, either with or 
without additional pathogen injection, zebrafish were immersed in E3 medium. The 
drugs were then added to the E3 to the correct dose concentration (table 2.5) at 28°C 
for the required length of time. Zebrafish were not anaesthetised for immersion drug 
treatments. 
2.6 Survival analysis 
Larvae which had undergone either injection, drug treatment, both or were non-injected 
controls may have been subject to survival analysis. Zebrafish larvae were checked 
every 24hrs for their survival or mortality. Dead fish were removed, and if required 
stored at -20°C for subsequent genotyping. All zebrafish larvae used in experiments 
were under 5.2 days post fertilisation (dpf) at The University of Sheffield, at which point 
the zebrafish were disposed through a home office approved method. However those 
injected with S. aureus, which were housed at 28.5°C were disposed of by 5dpf.  All 
survival analysis of infection at IMCB in A*Star was completed by 10dpf, unless 
otherwise stated, and were kept at 28°C.  
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2.7 Imaging and analysis 
Imaging was utilised to visualise fluorescent, C. neoformans or S. aureus within 
infected zebrafish. Furthermore, fluorescent zebrafish lines, allow visualising of cell 
types and proteins within transgenic zebrafish and additionally co-localisation of 
pathogens with these cells or proteins. Imaging was completed through use of either a 
custom wide-field fluorescence Nikon microscope, or a spinning disk confocal 
microscope at Sheffield University. A LSM700 microscope was utilised in IMCB. 
Zebrafish were anaesthetised before mounting in 0.8% agarose in 96 glass bottom 
plates, glass bottomed culture dishes or glass slides. E3 with added tricaine was 
placed on top of the fish once mounted.  
Fungal/bacterial burden: Analysis of fluorescent pathogens/cellular components was 
completed using ImageJ/FIJI. NIS images were opened in FIJI. A threshold was set to 
remove background and leave only true signal (completed by eye and all groups were 
blinded). The number of pixels where GFP signal was present were then measured 
using FIJI to give a GFP positive pixel area which could be used for comparison.  
Cryptococcoma definition: Larvae were infected at 2dpf with 25cfu of GFP and 
mCherry cryptococcal cells and a single z-stack image acquired daily until 10dpf. A 
cryptococcoma was defined as a mass of cryptococcal cells and visually determined. A 
mass consisted of at least 3 cryptococcal cells observed in one location in a single z-
stack. 
Larval size analysis: The size of larvae was measured in two locations (Sheffield and 
Singapore). To enable the same method to be used, an image was taken of larvae 
placed within 96 well plates (or similar such as 24 well plate used for older larvae) with 
a ruler in the field of view (using a mobile phone camera). Using ImageJ, the number of 
pixels in a 1cm line was measured for each picture. Lines were drawn to the same size 
of individual larvae and pixel count recorded and size later calculated using the pixel 
count for the 1cm line.    
Heart rate: For analysis of the heart rate of autophagy mutant larvae, the GFP heart 
marker was imaged (using an in-cross of the traffic-light Lc3 line crossed to either atg3 
or atg5 lines). In this case larvae were not given tricaine, and were placed in a small 
volume of E3 for imaging, all completed before 5.2dpf. The heart was imaged at a fast 
speed for a timelapse of 20 to 60 seconds (dependent on whether larvae swam out of 
the field of view). Timelapse videos were analysed on NIS elements and heart beat 
counted for a 20 second period.  
Blood vessel width: The blood vessel width of intersegmental blood vessels in larvae 
was imaged, the tail section of larvae included ~20 blood vessels per larvae. Analysis 
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was completed using NIS elements, using the measure tool, where the software 
calculates size based on the length of a drawn line. The blood vessel width were 
measured at the widest point of the blood vessel or at the site of cryptococcal 
cells/beads. The average size of infected or non-infected blood vessels was calculated 
as a mean for individual larvae for analysis.  
2.8 Genotyping 
Adult zebrafish were fin-clipped and kept in separate tanks whilst genotyping took 
place. The DNA was extracted from the finclips through NaOH (50mM) boiling, and 
after neutralisation with 1M Tris-HCL pH8, the finclips were centrifuged 4000rpm, for 
30mins at 4°C. To amplify the DNA, a PCR of each mutant, atg3 and atg5 using 
primers shown in table (2.6) was completed, using GoTaq G2 Green master mix 
(Promega #M7823).  Zebrafish larvae micro-finclips were also genotyped using the 
same method, in smaller volumes.  
Table 2.6: Primers used for genotyping autophagy mutant fish   
Mutant line Forward primer Reverse primer 
 
atg3SH171 
 
GGCATCTGGAGAAGAAGCAA 
 
CCGAGTTATGAAAGGTGTCCA 
atg5 TTTCTTTCTGTCAATCTGTCAGC CCTCTGCCTTCATGACTTTGAG 
 
Genotyping primers for atg3 and atg5 mutant lines, which have 10bp and 23bp 
deletions respectively, were designed to enable the PCR product sizes of wild-type and 
mutation containing sequences to be discriminated by size through electrophoresis on 
4% or 2.5% agarose gels. Using the different band sizes and patterns the genotype of 
each fish was determined. Band sizes corresponding to each genotype, wild-type, 
heterozygous and homozygous were confirmed with sequencing. atg3 genotyping is 
described in Chapter 4, and atg5 genotyping has been previously established (PhD 
thesis Lambein 2015).  
2.9 Western blotting 
After de-chorionating and de-yolking, zebrafish larvae were homogenized, using a T10 
ULTRA-TURRAX handheld homogenizer, in protein extraction buffer. Debris within the 
samples were pelleted at 14,000rpm, 30s, 4°C, after which the supernatant, containing 
extracted protein, was removed to a fresh Eppendorf, repeated three times. Samples 
were mixed with an equal volume of Laemmli buffer, and heated at 95°C for 10 
minutes. Samples were then loaded into the gel and run at 85V for 25 minutes and 
then 150V for approximately 45 minutes, in running buffer. After 15 minutes incubation 
in transfer buffer, the gel, methanol-activated PVDF and filter paper were assembled in 
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a Trans-blot SD semi-dry transfer cell, at 25V for 25 minutes, or alternatively wet 
transfer kit was used at 110V for 150 minutes. 
The PVDF membrane was then checked for protein with Ponceau S solution, where a 
positive result led to blocking the membrane in 2.5% non-fat milk powder in PBST for at 
least 2 hours or overnight. After washing with PBST, primary antibody diluted in 2.5% 
milk in PBST was placed in a falcon tube with the membrane and rolled overnight. 
Again, after washing with PBST, the secondary antibody in PBST was placed on the 
membrane and rocked at room temperature for 1 hour. Washing of the membrane then 
lead to the application of ECL reagent and the membrane was placed in a 
Hypercassette and covered with Amersham hyperfilm for appropriate time periods. The 
film was developed using an Optimax 2010 x-ray film processor.   
 
Table 2.7: Antibodies used for western blots     
 
 
Antibody 
 
 
Company  
 
Primary 
concentration 
 
Secondary 
concentration 
 
ATG5 
 
Novus Biologicals 
NB110-53818 
 
1/4000 
 
1/10,000 
(Rabbit) 
LC3 Novus Biologicals  
NB100-2220 
1/4000 1/10,000 
(Rabbit) 
β-actin Cell signalling 
Technology  4967S 
1/ 3000 1/50,000 
(Rabbit) 
GFP Abcam 6556 1/4000 1/10,000 
(Rabbit) 
HRP-conjugated anti-
rabbit secondary 
antibody (Sheffield) 
Bethyl Laboratories INC: 
A120-101P 
 
- 
 
1/10,000 
HRP-conjugated anti-
rabbit secondary 
antibody (IMCB) 
 
Amersham  NA934 
 
- 
 
1/10,000 
 
2.10 Reverse Transcription PCR 
Zebrafish embryos at different stages from 1 cell through to 30 dpf, were collected of 
AB wild-type, ATG3+/- and ATG5+/- lines and placed into TRIzol (Ambion 15596018). 
Following homogenisation, RNA was extracted following the TRIzol protocol, re-
suspended in RNAse free water, and stored at -80°C. RNA quality and concentration 
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was measured by Nanodrop (ND-1000) and gel electrophoresis. Synthesis of cDNA 
was completed with the Invitrogen Superscript III kit, with the same concentration of 
RNA used for individual samples within each experiment, typically 400ng RNA in a 20ul 
reaction. Reverse transcription PCR was completed using equal volumes of the cDNA 
generated using GoTaq G2 Green master mix (M7823).  
Two pairs of primers were designed for both atg3 and atg5 zebrafish genes. The first 
pair with both primers located downstream of the mutation site. The second pair the 
forward primer covered the mutation site. Each set of primers have one primer covering 
an exon-exon junction, to ensure amplification of cDNA only.  
Table 2.8: Primers used for reverse transcription PCR 
Underlined sequence represents part of mutation site covered by mutation (see 
appendix 3 for cDNA and primer sites) 
Sequence Forward primer  Reverse primer 
atg3  
after mutation 
 
ATGAGCTGGAGGCCATCATA 
 
ATTCTTCCATGTCTGCCGCC 
atg3  
covering 
mutation 
 
AAGCCCTATCTGCCCAATGAC 
 
TCACCCCTGTAACACCCGA 
atg5 
after mutation 
 
TGGATGGGTCTGCAGAATGAT
AA 
 
CCTCCCTCTTCGGTGGGATA 
atg5 
covering 
mutation 
 
CCTCCCACGGGTCAGTTAC 
 
CTTTGGCTCATCCTCAATGGC 
 
2.11 Traffic light Lc3 DNA injection 
Zebrafish embryos of heterozygous in-crosses of atg3 and atg5 lines, in addition to AB 
wild-type, were injected at the one cell stage with 30ng of traffic-light Lc3 DNA 
construct (pDest395CMV.ZFLc3.polyA), a kind gift from Dr Katherine Henry and Dr 
Angeleen Fleming, pME(RFP.GFP.Lc3) was a kind gift from Dr Angeleen Fleming, Dr 
Katherine Henry performed the recombination reaction to produce pDest(CMV:RFP 
GFP.Lc3) plasmid). The embryos were screened for green fluorescence the following 
day to select successful injections. Importantly fluorescence observed of any kind was 
picked out, due to the possibility of down regulation of the construct within autophagy 
mutant lines. Half of the fish were treated with rapamycin and chloroquine, (table 2.5) 
overnight, and re-treated the following morning. All fish were imaged using the LSM 
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700 scanning confocal, with consistent laser and microscope settings maintained 
throughout all repeats. RFP, GFP and DIC images were taken of the 5th half somite, 
above the yolk. 
Analysis of images was completed using ImageJ. Images were first exported from ZEN 
black software into Tagged Image Format (TIF). For both RFP and GFP channels an 
individual 16-Bit monochrome image was created. The threshold was set to best 
observe only true signal, 0 – 12,800 for the RFP channel and 0-19,700 for the GFP 
channel, and converted to mask. The area corresponding to the half somite was 
selected. Particles were counted based on size 1.6 pixels to infinity, corresponding to 
1um equal to 3.2 pixels, adjusted to start counting from the smallest size being 
equivalent of autophagosome size from 0.5um. Images and genotyping data were not 
matched together until after image analysis of each fish was completed, to ensure this 
analysis was completed blinded to genotype. 
 
2.12 Generation of transgenic zebrafish line 
The generation of the Tg(lyz:GFP.p62) line was completed through use of the 
GatewayTM  system in combination with Tol2 transgenesis. This is described in full 
detail in Chapter 6 and Appendix 1.  
 
2.13 Statistical analysis 
Statistical analysis was completed using GraphPad Prism software (version 7.02) in all 
cases. Unless mentioned within individual figure legends, “n” refers to the number of 
repeats an entire experiment was completed, which includes multiple zebrafish larvae 
in each repeat. Standard deviation is represented by SD.  
Survival analysis: The Log-Rank Mantel-Cox test was used to compare the trend of 
survival between different populations.  
T-tests: Mann-Whitney T-tests were used to test if data are from the same population 
when the data is not a normal distribution (observed by data scatter). Wilcoxon 
matched pairs T-test was used to test if data are from the same population when the 
data is not a normal distribution (observed by data scatter) between two paired data 
sets (e.g. before and after time scale).  
Linear regression: Line of best fit for data points. R2 (between 0 and 1) value 
represents the percentage of points which line on the line, where 1 represents 100% of 
all points lie on the line.  
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Contingency table analysis: The (Pearson’s) Chi-squared test was used to compare 
categorical data of three or more groups. Where low numbers were observed (less 
than 5), or for comparing categorical data in groups of two, the Fischer’s exact test was 
used.  
Analysis of variance: One way ANOVA was used to determine the difference of means 
between two or more groups, with Kruskal-Wallis test for non-parametric data. Two 
way ANOVA was used to determine the difference of means between two or more 
groups, which two variables. Tukey’s test was added to this to compare each mean to 
every other mean.  
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Chapter 3: Results Chapter 1:  
The role of clonal expansion in C. neoformans infection dynamics 
  
3.1 Introduction  
C. neoformans is a human fungal pathogen which has a tropism for the brain, 
ultimately leading to life-threatening cryptococcal meningitis (CM).  After inhalation of 
fungal spores, cryptococcal cells are able escape the lung into the blood, and from the 
blood cross the blood brain barrier (BBB) to gain access to the brain parenchyma.  
C. neoformans is able to cross the BBB using a variety of mechanisms. In vitro data 
demonstrate that C. neoformans is able to actively transcytose through microvascular 
endothelial cells (Chen et al. 2003). It is also suggested that cryptococcal cells are also 
able to pass between tight junctions in the vessel wall, by determining that damage 
occurs to tight junctions through analysis of occludin, a major tight junction 
transmembrane protein, in the presence of C. neoformans (Chen et al. 2003). On the 
other hand, C. neoformans can utilise host defence responses to promote 
dissemination across the BBB. As has been demonstrated through in vivo murine 
studies, cryptococcal cells are able to cross the BBB from within a macrophage, which 
acts as a “Trojan horse” (Charlier et al. 2009; Santiago-Tirado et al. 2017). It is clear 
that a range of methods enable C. neoformans to disseminate across the BBB. Of 
note, in each mechanism described, the cryptococcal cells are within the brain blood 
vessels, highlighting that during infection, cryptococcal cells are present in the brain 
vasculature, and therefore that dissemination occurs when C. neoformans is in close 
contact to the BBB. 
Recent clinical studies have highlighted a potential role of blood vessel damage 
resulting from infection with C. neoformans. A limited number of case reports describe 
cases in which cryptococcal infection and meningitis lead to vasculitis and brain 
vasculature damage, and can ultimately result in infarcts (necrotic tissue resulting from 
a lack of blood supply), (Aharon-Peretz et al. 2004; Rosario et al. 2012; Leite et al. 
2004). Interestingly, cerebral infarcts are observed in meningitis caused by 
tuberculosis, in addition to CM (Lan et al. 2001). This indicates that in infective 
meningitis, blood vessels in the brain are becoming blocked or damaged, potentially 
through physical damage or through toxins released by the pathogen. Furthermore, the 
incidence of cortical infarcts is non-trivial, occurring in 30.3% of cryptococcal meningitis 
cases, most often observed in severe cases (Mishra et al. 2017). This highlights the 
frequent occurrence of infarcts in cryptococcal meningitis. Nevertheless, the 
physiological cause of infarcts in C. neoformans infection is not characterised. 
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Murine models of cryptococcal infection have shown that cryptococcal cells can 
become trapped in brain blood vessels (Shi et al. 2010), suggesting that cryptococcal 
cells cross the BBB after they become trapped in the brain vasculature. Indeed, this 
hypothesis is supported by observations from CM post-mortems showing that 
cryptococcal cells are seen in the brain parenchyma adjacent to brain vessels 
containing cryptococcal cell masses (Lee et al. 1996). The presence of several 
cryptococcal cells in vessels within the brain, located right next to cryptococcal cells in 
the brain parenchyma is suggestive that cryptococcal cells are proliferating in the brain 
vasculature and then disseminating from that location. Furthermore, in the zebrafish C. 
neoformans infection model, dissemination into the brain occurs more often from 
individual brain vessels with high fungal burdens (Tenor et al. 2015). These data 
suggest that cryptococcal proliferation may be involved in cryptococcal cell ability to 
cross the BBB. The role of cryptococcal proliferation as a mechanism of vessel 
damage and dissemination has hitherto not been investigated. It could be hypothesised 
that cryptococcal proliferation from cryptococcal cells trapped in the brain vasculature, 
is causing physical vessel damage leading to dissemination.  
A population “bottleneck” has been described in bacterial pathogenesis, including S. 
aureus and S. enterica (Prajsnar et al. 2012; Grant et al. 2008) . In S. aureus infection, 
the majority of bacteria are efficiently degraded by the host, but a small proportion 
evade host defence mechanisms and reside in an intra-phagocyte niche. Bacteria are 
able to replicate within a neutrophil, escape the neutrophil and eventually lead to 
overwhelming infection in the host (Prajsnar et al. 2012). A population “bottleneck” in 
infection refers to the small proportion of pathogens which ultimately become the fatal 
infectious burden responsible for the uncontrolled infection. The role of a cryptococcal 
population “bottleneck” has not been established. The zebrafish cryptococcal infection 
model demonstrates that cryptococcal cells are able to proliferate within macrophages 
(Bojarczuk et al. 2016). It is possible that a small proportion of cryptococcal cells which 
are not efficiently degraded, reside within macrophages, proliferate and eventually lead 
to uncontrolled infection.  
To investigate the role of clonal expansion and dynamics of cryptococcal infection as a 
mechanism behind vasculature damage and dissemination, an inoculum of two 
fluorescently labelled cryptococcal strains was used to monitor growth dynamics, and 
to determine whether a population bottleneck exists in cryptococcal infection.  
Furthermore, to investigate a role of localised expansion in the vasculature, 
cryptococcal growth in addition to the integrity of the vessel walls was investigated, with 
the aim to discover whether cryptococcal clonal expansion may be involved in a 
mechanism to cross the BBB.  
87 
 
Hypothesis 1: C. neoformans infection has a population “bottleneck” 
Hypothesis 2: Vasculature damage is caused by cryptococcoma formation 
Chapter aims:  
1) To determine if cryptoccocal expansion dynamics from a single or small number 
of cryptococcal cells control infection outcome 
2) To determine if cryptococcal cells become trapped in the vasculature in the 
zebrafish model 
3) To determine if cryptococcal clonal expansion in vasculature leads to 
dissemination into the surrounding tissue 
4) To determine if cryptococcal clonal expansion in the vasculature causes blood 
vessel damage 
 
3.2 Cryptococcal infection progresses without passing through a 
population bottleneck 
A population bottleneck in cryptococcal infection may be present because C. 
neoformans is able to survive and replicate within macrophages. Cryptococcal cells 
which are present in the macrophage niche may be responsible for cryptococcal 
proliferation and uncontrolled infection, and could represent a population bottleneck.  
The dynamics of C. neoformans infection were examined, in regards to a potential 
population bottleneck. A 25cfu mixed inocula of 5:1 GFP:mCherry C. neoformans was 
injected into the circulating blood of AB (wild-type) larvae. A low dose infection was 
used with the aim of determining whether a single or small number of cryptococcal cells 
are responsible for overwhelming infection, expected if a population bottleneck does 
occur in cryptococcal infection. I therefore predict that the majority of fish would be 
majorly infected by a single colour strain if a population bottleneck occurs in 
cryptococcal infection.   
Co-infection with a mixture of two cryptococcal strains (a genetically identical parental 
strain with two different fluorescent markers) demonstrated that multiple fungal cells 
contribute to the progression of infection. In 51.6% of all fish infected, an overwhelming 
infection outcome was determined within 7dpi. In fish which did not reach an 
overwhelming infection, infection may have been effectively cleared, the larvae may 
have died due to handling or infection may have been likely to reach overwhelming 
infection after the experimental time course. The overwhelming infection outcomes 
reached were either predominantly GFP C. neoformans, predominantly mCherry C. 
neoformans, or mixture of GFP and mCherry C. neoformans, as shown in Figure 3.1 A-
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Figure 3.1 A single cryptococcal cell is not responsible for fatal fungal 
burden  
Infection of 2dpf AB larvae with 25cfu of a 5:1 ratio of GFP:mCherry KN99 C. 
neoformans. Larvae were imaged until 8dpf, or death (n=3, in each repeat 7, 10 and 
12 larvae were used) A-C Larvae which have reached a final fatal infection outcome 
from a predominantly GFP and/or mCherry C. neoformans infection, red scale bar 
represents 200µm A Predominantly GFP C. neoformans infection outcome B 
Predominantly mCherry C. neoformans infection outcome C Mixed GFP and 
mCherry C. neoformans infection outcome. D Proportion of each overwhelming 
infection outcome observed, GFP, mCherry or mixed (n=3, 12, 7, and 12 larvae 
were used in each repeat). 
C. The presence of mixed strain overwhelming infection indicates that a single 
cryptococcal cell is not responsible for the final infection outcome. Where 
overwhelming infection was seen, this was composed of predominantly GFP positive 
cryptococci in 56.25% of cases, predominantly mCherry positive cryptococci in 6.25% 
of cases, and a mixture of GFP and mCherry positive cryptococci in 37.5% of the 
cases. (Fig. 3.1 D). These results are unexpected if a single or very small number of 
cryptococcal cells were responsible, where a single colour outcome may expected 
more often. Therefore it is likely that a larger number of individual cells divide and 
contribute to the final fatal burden. 
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Figure 3.2 C.neoformans inoculum ratio does not determine 
uncontrolled infection  
Infection of 2dpf AB larvae with 25cfu of a 5:1 ratio of GFP:mCherry KN99 C. 
neoformans. Larvae were imaged until 8dpf, or death (n=3, in each repeat 7, 10 
and 12 larvae were used) A Actual injected ratios of GFP:mCherry KN99 C. 
neoformans at 2hpi B Actual injected GFP:mCherry ratios for each overwhelming 
outcome (n=3, +/- standard deviation, Man-Whitney t-test ns= not significant, 16 
larvae) C Inoculum ratio of GFP:mCherry, against final GFP:mCherry ratio at 
overwhelming infection stage (Linear regression R2=0.0208, p<0.6081, n=3, 15 
larvae).  
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3.3 Injected inoculum ratio does not determine uncontrolled infection 
outcome 
To investigate whether the actual number of C. neoformans from either the GFP or 
mCherry strain injected into each larvae led to differential infection outcomes, the 
injected strain ratio was calculated through counting of individual cryptococcal cells 
present in each larvae from images acquired at 2hpi. Although a 5:1 ratio of GFP to 
mCherry was prepared for infections, the actual ratios observed within 2 hours of 
infection were varied (Fig. 3.2 A), and in most cases a lower GFP:mCherry ratio was 
observed. Comparing the injected ratios between each final infection outcome 
determined there was no difference in inoculum ratio, (Fig. 3.2 B), indicating that the 
injected ratio does not determine the final infection outcome. Indeed, no significant 
relationship was observed between the injected strain ratios compared with the strain 
ratios at the final infection outcome (Fig. 3.2 C). Taken together these data 
demonstrate that the injected ratio does not determine the final infection outcome.    
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Figure 3.3 Cryptococcoma formation in C.neoformans zebrafish 
infection  
Infection of 2dpf AB larvae with 25cfu of a 5:1 ratio of GFP:mCherry KN99 C. 
neoformans. Larvae were imaged until 8dpf, or death (n=3, in each repeat 7, 10 
and 12 larvae were used) A Representative infection of AB wild-type larvae with 5:1 
ratio of GFP:mCherry KN99 C. neoformans, at 0dpi, 1dpi, 2dpi and 3dpi A I 
Formation of cryptococcal masses (white arrows) at 1dpi A II Final infection 
outcome of high fungal burden at 3dpi. All scale bars represent 200um.  
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3.4 Cryptococcoma formation in infection progression  
The ratio between GFP and mCherry cryptococci in the injected inoculum ratio does 
not determine uncontrolled infection. Therefore time point images of infection were 
studied, and it was observed that cryptococcoma (cryptococcal mass) formation clearly 
preceded progression of infection to a higher fungal burden. The term “cryptococcoma” 
means a mass composed of both cryptococci and immune cells and is generally used 
to refer to cryptococcal granulomas. However in the zebrafish model we often see 
intravascular masses composed of cryptococci, which are best described by the term 
cryptococcoma 
Cryptococcal masses form within the larvae and these precede overwhelming infection, 
as shown in Figure 3.3 A (AI-AII). This example of pathogen growth over time clearly 
demonstrates that initial infection causes the occurrence of small cryptococcal masses 
early in infection. Indeed, in this example, cryptococcal masses of both GFP and 
mCherry are observed at 1dpi, two days before a final overwhelming mixed infection is 
observed at 3dpi.  
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3.5 Cryptococcoma formation precedes uncontrolled infection 
It was noticed that cryptococcoma formation appeared to occur before progression to 
uncontrolled infection. To determine whether cryptococcoma formation is likely involved 
in the progression of infection to a higher fungal burden, the time between formation of 
cryptococcomas and subsequent uncontrolled infection was investigated.  
Cryptococcoma formation infection precedes uncontrolled infection by approximately 2 
days. Cryptococcoma formation was found to occur before overwhelming infection in 
every case, in addition to forming approximately 2 days prior to final infection (Fig. 3.4 
A). This was truly independent of the predominant strain colour of the cryptococci in the 
final infection (Fig. 3.4 B). In fact, no significant difference was observed in the speed 
(between cryptococcoma formation and overwhelming infection outcome) between 
uncontrolled infection outcomes of predominantly GFP, mCherry or mixed C. 
neoformans (Fig 3.4. C). These data suggest that cryptococcoma formation is 
important in infection dynamics and may be responsible for infection outcome.  
If cryptococcomas are responsible for infection outcome, it may be expected that a 
greater number of these cryptococcal masses would lead to an increased speed in 
infection progression. Therefore the number of cryptococcal masses present within 
individual fish was examined. In agreement, a higher number of cryptococcomas was 
associated with a decreased time for overwhelming infection to occur (Fig. 3.4 D). 
Cryptococcal replication is an exponential rate of doubling every 3.2 hours in vitro (Park 
et al. 2010). Therefore infection growth dynamics which follow an exponential decay 
(i.e. a higher number of cryptococcomas decreases the time of infection progression 
and vice versa) was expected. Overall these data suggest that cryptococcoma 
formation is associated with infection progression and lead to overwhelming infection. 
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Figure 3.4 Cryptococcoma formation precedes overwhelming 
infection 
Infection of 2dpf AB larvae with 25cfu of a 5:1 ratio of GFP:mCherry KN99 C. 
neoformans. Larvae were imaged until 8dpf, or death (n=3, in each repeat 7, 10 
and 12 larvae were used) A Day post infection that cryptococcoma was observed 
and when final uncontrolled infection outcome is observed (n=3, 15 larvae, +/- SD, 
Wilcoxon matched pairs test, ****p<0.0001) B Day post infection when 
cryptococcoma is first observed and the final outcome, grouped by final outcome C 
Days between cryptococcoma formation and final outcome grouped by final 
outcome (n=3, 15 larvae, +/-SD, One-way ANOVA, ns= not significant) D The 
number of cryptococcomas observed within individual larvae in comparison to the 
day final overwhelming infection was reached (n=3, 15 larvae, non-linear 
regression, one-phase exponential decay) 
  
3.6 Cryptococcoma formation leads to uncontrolled infection 
To determine whether cryptococcoma formation is important in determining the 
infection outcome, the strain colour of C. neoformans, either GFP or mCherry, within 
individual cryptococcomas was compared with the predominant strain colour of C. 
neoformans in the resultant uncontrolled infection. I hypothesised that if a 
cryptococcoma is important in progression of infection, C. neoformans will be of 
matching fluorescent strains in the initial cryptococcoma(s) observed, as the 
predominant C. neoformans colour in the uncontrolled outcome, within individual 
larvae.  
C. neoformans within cryptococcomas are likely responsible for uncontrolled infection. 
A clear relationship was observed between cryptococcal cell colour in a cryptococcoma 
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Figure 3.5 Cryptococcoma is predictive of overwhelming infection 
Infection of 2dpf AB larvae with 25cfu of a 5:1 ratio of GFP:mCherry KN99 C. 
neoformans. Larvae were imaged until 8dpf, or death (n=3, in each repeat 7, 10 
and 12 larvae were used) A Comparison of the colour (either GFP, mCherry or 
mixed strains) of C. neoformans in cryptococcomas, in relation to the final outcome 
predominant C. neoformans strain colour B Comparison of the colour, either single 
colour or mixed, and the colour of final outcome (n=3, 15 larvae **p<0.01, Fischer’s 
exact test).  
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and the predominant colour of C. neoformans in the final uncontrolled outcome, with 
individual cryptococcoma formation indicative of the final outcome, (Fig. 3.5 A). Indeed, 
a single coloured cryptococcoma is significantly more likely to lead to a single coloured 
final outcome, and conversely, mixed colour cryptococcomas are most likely to cause a 
mixed final outcome (Fig. 3.5 B), further suggesting that cryptococcoma formation is 
important, and may be responsible for infection progression and outcome.  
 
3.7 Localised clonal growth of cryptococci leads to cryptococcoma 
formation and dissemination 
It is likely that C. neoformans within cryptococcomas represent the population of 
cryptococcal cells which are responsible for the final infection outcome. Therefore the 
formation of cryptococcomas was next examined. It was hypothesised that 
cryptococcoma formation is likely caused by localised clonal expansion since it was 
noticed that most cryptococcomas were a single coloured fluorescent strain of C. 
neoformans. In fact, a majority of single coloured cryptococcomas, as shown with 11 of 
16 cryptococcomas observed were a single colour (Fig. 3.5 A, above).  
By analysing how infection progresses over time, it appears that cryptococcomas (likely 
in the vasculature) form through localised clonal expansion (Fig. 3.6). Early in infection, 
a single or few cryptococcal cells appear to become trapped within the vasculature. 
The trapped cryptococcal cells appear to proliferate throughout infection (1dpi to 3dpi) 
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Figure 3.6 Cryptococcoma formation leading to dissemination 
Infection of 2dpf AB larvae with 25cfu of a 5:1 ratio of GFP:mCherry KN99 C. 
neoformans. Larvae were imaged until 8dpf, or death (n=3, in each repeat 7, 10 
and 12 larvae were used). This representative example highlights a predominantly 
mCherry C. neoformans overwhelming infection reached at 4dpi, with only mCherry 
C. neoformans shown in this figure. Infection progression from 0dpi (day of infection 
imaged 2hpi), until 4dpi. Red arrows follows an individual cryptococcoma formation 
and dissemination, panel on the right are a zoomed in on the area of 
cryptococcoma formation, red scale bar represents 200um.  
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and form a cryptococcoma. Finally, I observed that cryptococcal cells appear to spread 
from the vasculature into the surrounding tissue late in infection, when an uncontrolled 
infection outcome is also observed (4dpi) (Fig. 3.6). 
This is a potentially important observation, which suggests that clonal expansion may 
be involved in cryptococcoma formation. Furthermore, the observation that the 
cryptococcal cells are able to invade surrounding tissue suggests that cryptococcal 
proliferation may be involved in cryptococcal dissemination. 
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3.8 Cryptococcal cells become trapped in intersegmental vessels 
The next overarching aim was to determine whether localised clonal expansion at sites 
within the vasculature may lead to dissemination, due to the observation that 
dissemination from inter-segmental vessels into the surrounding somite can occur at 
sites of cryptococcomas.   
However, in order to demonstrate that cryptococcal cells were able to disseminate out 
of the blood vessels, perhaps through formation of cryptococcoma via clonal 
expansion, it was first necessary to show that cryptococcal cells were becoming 
trapped in blood vessels. It has already been demonstrated that cryptococcal cells can 
become trapped within similarly sized brain blood vessels, stopping suddenly, in the 
same manner as inert beads of a similar size using the murine model (Shi et al. 2010), 
likely due to becoming stuck based on size. This indicates that blood vessel size is 
important in trapping of cryptococcal cells.  
To determine if a similar trapping mechanism is observed in zebrafish intersegmental 
vessels, time lapse analysis of larvae was completed immediately after infection with 
25cfu C. neoformans, using the KDRL blood marker line. Indeed, individual 
cryptococcal cells were observed becoming stuck in the vasculature, stopping in a 
similar way as described in the murine model (Shi et al. 2010), moving at a similar 
speed to blood flow and becoming trapped and therefore stopping instantaneously (Fig 
3.7).   
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Figure 3.7 Individual cryptococcal cell trapped in the vasculature 
Infection of KDRL mCherry blood marker transgenic line with 25cfu GFP KN99 C. 
neoformans, imaged immediately after infection A Single cryptococcal cell becomes 
trapped in the vasculature (white arrow), after moving from the bottom of the vessel 
to toward to top (left to right, time points 0.6 seconds),white arrow points at location 
of trapping, n=1. 
  
Although a single cryptococcal cell which is trapped in a blood vessel could lead to 
formation of a cryptococcoma by clonal expansion, it is also plausible that cryptococcal 
cells could be sequentially trapped behind an original cryptococcal cell which was 
C. neoformans 
KDRL Blood vessels 
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Figure 3.8 Cryptococcal blockage and build up in the vessels 
Infection of KDRL mCherry blood marker transgenic line with 200cfu GFP C. 
neoformans, imaged immediately after infection A Initial Cryptococcal cell becomes 
trapped (white arrow) B 72 seconds later, a second cryptococcal cell becomes 
trapped behind the initial one C A further 117 seconds later, a third cryptococcal 
cell becomes trapped behind the first and second (left to right, time points 0.6 
seconds), white arrows track individual cryptococcal cells, n=1. 
C 
BA C. neoformans
KDRL Blood vessels
C. neoformans
KDRL Blood vessels
C. neoformans
KDRL Blood vessels
trapped initially. It might be hypothesised that this would be more likely to occur at 
higher fungal loads, so larvae infected with a higher inoculum of 200cfu were imaged 
immediately after infection. Indeed, it was observed that after a single cryptococcal cell 
became trapped in the vasculature, another two cryptococcal cells became 
subsequently trapped (Fig. 3.8). Importantly, cryptococcal masses were observed soon 
after infection at higher inoculum, indicating a separate mechanism of cryptococcoma 
formation within the vasculature, through a build-up of cryptococcal cells, at high fungal 
burdens.   
 
However, in larvae infected with a low cryptococcal inocula (25cfu), in mixed 
cryptococcal fluorescent strain infection experiments, the majority of cryptococcomas 
were a single colour. This suggests that, at lower fungal burdens, a single or very small 
number cryptococcal cells are responsible for cryptococcoma formation. This is 
because, at a higher inocula where cryptococcal cells become trapped behind each 
other mixed cryptococcoma formation may be expected to occur frequently, since the 
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Figure 3.9 Cryptococcoma formation favoured in narrow blood 
vessels 
Infection of 2dpf AB larvae with 25cfu of a 5:1 ratio of GFP:mCherry KN99 C. 
neoformans. Larvae were imaged until 8dpf, or death (n=3, in each repeat 7, 10 
and 12 larvae were used). A Proportion of cryptococcomas observed in small inter-
somal blood vessels, small brain blood vessels, large caudal vein or in other 
locations e.g. yolk, (n=3). B The ratio of GFP:mCherry C.neoformans in the large 
caudal vein in comparison to the fifth intersegmental blood vessel (n=3, *p<0.05, 
+/-SD, paired t-test).  
 
cryptococcal cells which get stuck could be compromised of both cryptococcal 
fluorescent strains. Taken together, these data suggest a potential role of cryptococcal 
clonal expansion in cryptococcoma formation, particularly at low fungal burdens.  
 
3.9 Cryptococcal clonal expansion in small blood vessels 
After determining that cryptococcal cells are trapped in the intersegmental blood 
vessels, I hypothesised that a higher proportion of cryptococcomas would be present in 
narrower blood vessels, where cryptococcal cells are able to become trapped and 
therefore replicate.  
Indeed, 80.36% of cryptococcomas were observed within narrow blood vessels in the 
brain, or intersegmental (between somites) vessels (Fig. 3.9 A), in comparison to the 
larger (wider) sized vessels, such as the caudal vein. In this case, brain and 
intersegmental vessels are of a similar diameter to cryptococcal cells, whereas the 
caudal vein is significantly wider than cryptococci. These data further support the 
observation that cryptococcal cells form cryptococcomas after initial trapping, is 
favoured in narrow blood vessels, followed by localised clonal expansion.  
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Cryptococcoma formation occurs in the early stages of infection. To investigate 
whether clonal expansion is also favourable in smaller blood vessels later in the 
infection, the ratio of GFP:mCherry C. neoformans was compared between narrow 
intersegmental vessels, and the larger (wider) caudal vein, at the final uncontrolled 
infection stage. As shown in Fig. 3.3 A-II (above), it is clear that groups/blocks of single 
coloured strain of cryptococcus are seen in intersegmental vessels, in comparison to 
the mixture of cryptococcal strains in the large caudal vein, in uncontrolled infection. 
Indeed, the ratio of GFP:mCherry was higher in the small vessels, in comparison to the 
large vessels, (Fig. 3.9 B), indicating that a single block of GFP cryptococcal cells was 
most likely to occur in narrow blood vessels. This further supports localised clonal 
expansion occurs in narrow blood vessels, both in early and late stages of infection, 
after a single or small number of cryptococci are trapped in the vasculature.  
3.10 Cryptococcal proliferation as a route of dissemination 
To determine if clonal expansion at sites of cryptococcomas is associated with invasion 
of surrounding tissue, the strain colour of C. neoformans located at tissue invasion 
events were compared to the colour of nearby cryptococcomas in the blood vessels (in 
the original 25cfu mixed infection experiments). Clear examples of cryptococcal tissue 
invasion from the vasculature into the surrounding somite is demonstrated (Fig. 3.10 
A). In every case, the strain colour of C. neoformans in a tissue invasion event was the 
same strain colour as cryptococcal cells in the cryptococcoma at the closest location in 
the vasculature (Fig. 3.10 B). Therefore it is highly probable that cryptococcal masses 
are the source of C. neoformans which invade the surrounding tissue. 
 
Figure 3.10 C. neoformans dissemination events 
Infection of 2dpf AB larvae with 25cfu of a 5:1 ratio of GFP:mCherry KN99 C. 
neoformans. Larvae were imaged until 8dpf, or death (n=3, in each repeat 7, 10 and 
12 larvae were used). A (and AI) representative example of dissemination of C. 
neoformans (mCherry) into the somite surrounding existing mCherry 
cryptococcomas B Comparison of strain colour of C. neoformans in the vasculature 
(GFP or mCherry), and the corresponding colour of nearby (or in the same 
position), dissemination events (n=3, 15 larvae). Red scale bars represent 200um.  
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3.11 Cryptococcomas cause physical vessel damage 
Cryptococcomas close to dissemination events are the likely source of cryptococcal 
cells found in the surrounding tissue, so the mechanism of exactly how C. neoformans 
is able to get out of the vasculature was next investigated. Several mechanisms have 
been demonstrated of how C. neoformans is able to escape the vasculature enabling 
crossing the BBB. These include transcytosis through vascular endothelial cells and 
use of macrophages as Trojan horses.  
Data shown below, indicate that cryptococcal masses present in the blood stream are 
directly responsible for increased vessel width (Fig. 3.13).  Localised clonal expansion 
was shown to be associated with formation of cryptococcoma (Fig. 3.6), which are 
located at sites of dissemination (Fig. 3.10). Therefore I next investigated a potential 
route of cryptococcal dissemination whereby clonal expansion in the vasculature leads 
to vessel wall damage through physically pushing and damaging the vessel wall. 
Vessel integrity at sites of tissue dissemination was examined using a 1000cfu high 
dose infection to enable sufficient visualisation of dissemination events, in the KDRL 
blood vessel marked line. At some sites of dissemination, the vessel wall appeared to 
remain intact, despite C. neoformans being present in the surrounding tissue (Fig. 3.11 
A). This may represent transcytosis events. However, some sites of dissemination 
show damage to the structure of the vessel wall (Fig 3.11 B), resembling bursting of the 
vessel. Indeed, this damage could be caused by physically pushing and damaging the 
vasculature until rupture. Or perhaps a cryptococcal blockage in the vessel causes a 
build-up of pressure leading to bursting close to, or at the site of the cryptococcoma. 
This suggests dissemination events are being caused by both (likely) transcytosis, and 
vessel damage.  
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Figure 3.11 Vasculature dissemination at sites of cryptococcoma 
Infection of KDRL mCherry blood marker transgenic line with 1000cfu GFP C. 
neoformans imaged at 3dpi (n=3, 17 larvae) A Representative image of Intact blood 
vessel, with C. neoformans in the surrounding tissue B Representative image of 
Damaged blood vessels with C. neoformans in surrounding tissue. 
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3.12 Disruption of vascular endothelial cell-cell junctions at sites of 
cryptococcomas 
To further investigate whether the vessel walls are physically damaged, infection of 
1000cfu mCherry C. neoformans into a transgenic vascular endothelium (VE) cadherin 
line was used to determine whether damage occurs between cell-cell junctions in the 
vessel endothelium.  
Similar to the KDRL lines, the VE-Cadherin line highlighted transcytosis events, in 
addition to vessel damage as routes of dissemination. Vessel damage was shown at 
sites of dissemination, where a clear line resembling the endothelium is not seen on 
one side of the vessel, indicating damage to the endothelial layer (Fig. 3.12 A, B). 
Equally, transcytosis events were demonstrated where the vessel wall (VE-Cadherin 
expression) remains intact despite C. neoformans being outside the vasculature (Fig. 
3.12 C, D). Comparison of (likely) transcytosis and vessel damage events demonstrate 
that both routes of dissemination occur at similar rates, with an equal number of 3 
events observed each. Of note, all dissemination events occurred at sites of 
cryptococcal masses.  
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Figure 3.12 Disruption of cell-cell junction integrity at cryptococcoma 
sites 
Infection of vascular-endothelium cadherin GFP cell-cell junction (blood vessel 
marker) transgenic line with 1000cfu mCherry C. neoformans imaged at 3dpi (n=2, 
11 larvae) A-B Representative images of damaged cell-cell junctions in the blood 
vessel endothelial layer at sites of cryptococcoma. C-D Representative images of 
intact cell-cell junctions in the blood vessel endothelial layer, with C. neoformans in 
the surrounding tissue. All scale bars represent 20um. 
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Overall, these data suggest that a previously un-characterised mechanism of 
cryptococcal dissemination occurs at sites of localised clonal expansion, leading to 
vessel damage and escape from the vasculature.  
 
 
 
3.13 Clonal expansion results in vasculature damage 
Vessel damage occurs at sites of cryptococcomas. Cryptococcal cells can become 
trapped in narrow blood vessels and proliferate forming a cryptococcoma. It may be 
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possible that this localised clonal expansion at sites within the vasculature may lead to 
reduced vessel integrity. I hypothesised that vessel damage occurs due to increasing 
size of the cryptococcal mass, due to localised expansion. 
Due to the low occurrence of dissemination events (19 events) at low inocula of 25cfu, 
a large inoculum of 1000cfu C. neoformans was injected into larvae, to enable more 
frequent cryptococcoma formation. Firstly the width of blood vessels in infected larvae, 
with and without C. neoformans masses within were compared at 2hpi, and 
subsequently at 3dpi, to determine whether the presence of a cryptococcoma 
increases the width of the vessel. At 2hpi there is a small but significant increase in 
blood vessel width at the site of cryptococcal masses (Fig. 3.13 A). Furthermore at 3dpf 
a clearly visible and significant increase in size is observed for blood vessels containing 
a cryptococcal mass (Fig. 3.13 B). This provides clear evidence that the cryptococcal 
masses are increasing the size of blood vessels, and this increases over time as 
cryptococcal cells proliferate.  
To determine if the increase in blood vessel width is caused by the presence 
cryptococcal masses, the width of the cryptococcal mass in relation to the vessel width 
(it was located in) was compared. Indeed at both 2hpi and 3dpi, the vessel width was 
proportional to the cryptococcal mass size, (Fig. 3.13 C, D). Furthermore, comparison 
of the sizes of cryptococcal masses, at 2hpi and 3dpf clearly highlight cryptococcal 
mass increases over time. Together these data indicate that cryptococcal masses 
directly influence the blood vessel size, perhaps through physically pushing and 
damaging the vessel wall as localised expansion increases the size of the 
cryptococcoma.  
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Figure 3.13 Cryptococcal proliferation causes damage to the 
vasculature 
A-E: Infection of KDRL mCherry blood marker transgenic line with 1000cfu GFP C. 
neoformans A Average vessel width with and without cryptococcal masses at 2hpi 
(n=3, *p<0.05, unpaired t-test, 17 larvae) B Average vessel width with and without 
cryptococcal masses at 3dpi (n=3, ****p<0.0001, unpaired t-test, 26 larvae) C 
Relationship between C. neoformans mass and vessel width at 2hpi (n=3, linear 
regression, 17 larvae) D Relationship between C. neoformans mass and vessel 
width at 3dpi (n=3, linear regression, 26 larvae) E Average vessel width with and 
without beads present at 3dpi (n=3, *p<0.05, unpaired t-test, 15 larvae). F-G: 
Infection of mCherry C. neoformans with 40kDa FITC Dextran to mark blood 
vessels F Comparison of infected brain vessels width to non-infected corresponding 
brain vessels (three infected fish analysed, +/- SD, ****p<0.0001, paired t-test) G 
Representative image of infected and non-infected brain vessels (Dr Robert J 
Evans), red scale bars represent 200um.  
  
G 
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To further demonstrate that proliferation of cryptoccocal cells, rather than a blockage in 
the blood vessels was responsible for the an increase in blood vessel size and 
resulting vessel integrity damage, inert beads of a similar size (4.5µm) to cryptococcal 
cells were injected into larvae as a control which cannot proliferate. At 3dpf, inert beads 
were observed in intersegmental blood vessels, with a small but significant increase in 
blood vessel size shown (Fig. 3.13 E). Of note, in comparison to C. neoformans 
infection at 3dpi, the average blood vessel width is ~22µm, whereas with beads, an 
average blood vessel width of 10µm is observed, very similar to the 2hpi C. 
neoformans data. This shows that while both beads and cryptococcal cells can become 
trapped in blood vessels, only C. neoformans is able to replicate and form larger 
masses. Cryptococcal growth most likely directly physically interacts with the blood 
vessels, pushing against the vessel wall resulting in damage and increased width of 
blood vessels.  
Finally, blood vessel widening was also observed in the brain. I analysed images of 
larvae injected with C. neoformans in addition to the 40kDa Dextran (to observe the 
blood vessels, experiment performed by Dr Robert J Evans). Similar to the 
intersegmental vessel data, equivalent blood vessels in the brain were enlarged under 
infection conditions (Fig. 3.13 F, G). Importantly this highlights that vessel damage is 
occurring in the brain vasculature, an important site in C. neoformans pathogenicity, 
implicating vascular damage mediated tissue invasion as a route of crossing the BBB. 
 
3.14 Blood vessel width increase at sites without cryptococcoma  
I noticed that blood vessels which were not colonised by C. neoformans at 3dpi, within 
infected larvae, appeared to be larger in width than the size of the non-colonised blood 
vessels at 2hpi (Fig. 13 A, B above). This may suggest that cryptococcal presence 
perhaps virulence factors, could influence the entire vasculature, in addition to physical 
damage at cryptococcoma locations.  
The vessel width in non-infected larvae was compared with the vessel width of non-
colonised vessels in larvae which had been infected with C. neoformans. This was to 
determine if intersegmental blood vessel width was enlarged in vessels not colonised 
with cryptococci, but within infected larvae. At 0dpi, no significant difference between 
blood vessel size was shown (Fig 3.14 A), however, at 3dpi, a significant increase in 
non-colonised vessel width (from infected larvae) in comparison to non-infected larvae 
was shown (Fig 3.14 B). This suggests cryptococcal presence affects the entire 
vasculature. In agreement, larvae injected with inert beads showed no change in 
vessel with at 0dpi (Fig. 3.14 C), and at 3dpi, with a small but significant decrease in 
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Figure 3.14 Cryptococcal infection increases width of non-colonised 
intersegmental blood vessels 
KDRL mCherry blood marker transgenic line with 0cfu or 1000cfu GFP C. 
neoformans A Average vessel width without injection, or without cryptococcal 
masses at 2hpi within (n=3, ns Student’s t-test, 21 non-injected larvae, 17 injected 
larvae) B Average vessel width without injection, or without cryptococcal masses at 
3dpi within (n=3, ****p<0.0001, Student’s t-test, 18 non-injected larvae, 26 injected 
larvae) C Average vessel width without injection, or without inert bead masses at 
2hpi within infected larvae (n=3, ns Student’s t-test, 21 non-injected larvae, 16 
injected larvae) D Average vessel width without injection, or without inert bead 
masses at 3dpi within infected larvae (n=3, *p<0.05, Student’s t-test, 18 non-
injected larvae, 15 injected larvae)  
 
 
vessel width in non-bead-colonised vessels in comparison to non-injected larvae (Fig 
3.14 D).  
The bead injection data suggest blockage alone of some intersegmental blood vessels 
does not increase the vessel width of non-blocked vessels. This suggests that the 
increase observed in vessel width of non-colonised vessels (in C. neoformans 
infection) may be caused by other cryptococcal factors.   
 
107 
 
3.15 Blood vessel width increase in C. neoformans infection lacking 
virulence factors 
An increase in non-colonised intersegmental vessels within C. neoformans infected, 
but not inert bead injected, suggest that cryptococcal factors are damaging the 
vasculature perhaps through virulence factor mediated damage. Three cryptococcal 
mutants deficient for cryptococcal virulence factors, Ure-1 deficient in Urease, Pho4 
deficient in phosphate sensing and acquisition and Sec14 deficient in secretion factor 
14, which is required for secretion of enzymes including virulence factor phospholipase 
b, were chosen for analysis.  
Each cryptococcal mutant has previously been linked to vasculature mediated 
dissemination. Urease is suggested to be important in the trapping of cryptococci in 
blood vessels, and in the transmigration across the vasculature (Shi et al. 2010; 
Olszewski et al. 2004). Pho4 is important for cryptococcal pathogenicity, and in 
dissemination into the brain from the blood stream (Lev et al. 2017). Finally, Sec14 is 
required for the secretion of enzymes, including virulence factor phospholipase b (plb) 
(Chayakulkeeree et al. 2012), which itself is required for cryptococcal dissemination to 
the brain (Noverr et al. 2003). I hypothesised that cryptococcal cells which are deficient 
in dissemination through the vasculature, may be unable to cause vasculature damage, 
due to reduced viability in the bloodstream 
To determine if colonisation of intersegmental cells, in these cryptococcal mutants, also 
leads to vessel damage in a similar mechanism as KN99 C. neoformans, the vessel 
width was compared between blood vessels containing either KN99 (wild-type data as 
above), Sec14, Pho4 or Ure-1 strains and corresponding non-colonised blood vessels 
within infected larvae. Indeed, for each strain, a significant increase in the vessel width 
was found at 3dpi in colonised blood vessels in comparison to non-colonised blood 
vessels (Fig. 3.15 A-D). These data suggest that Sec14, Pho4 and Urease are not 
required by the cryptococci to damage blood vessels through cryptococcal proliferation.  
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Figure 3.15 Cryptococcoma increases blood vessel width when 
infected with mutant cryptococcal stains 
KDRL mCherry blood marker transgenic line with 1000cfu GFP C. neoformans A 
Average vessel width with or without cryptococcal masses in KN99 infection at 3dpi 
within (n=3, ****p<0.0001, Student’s t-test, 26 injected larvae) B Average vessel 
width with or without cryptococcal masses in Sec14 infection at 3dpi within (n=3, 
****p<0.0001, Student’s t-test, 13 injected larvae) C Average vessel width with or 
without cryptococcal masses in Pho4 infection at 3dpi within (n=3, ****p<0.0001, 
Student’s t-test,  15 injected larvae) D Average vessel width with or without 
cryptococcal masses in Ure-1 infection at 3dpi within (n=3, ****p<0.0001, Student’s 
t-test, 15 injected larvae). 
 
I hypothesised that if either of these virulence factors are involved in vasculature 
damage, away from the physical site of trapping or cryptococcoma, the vessel width in 
non-colonised intersegmental vessels would not be increased at 3dpi. However, in 
KN99 (wild-type data same as above), in addition to Sec14, Pho4 and Ure-1, a 
significant increase in the vessel width in non-colonised intersegmental vessels from 
infected larvae was shown in comparison to non-infected larvae (Fig 3.16 A-D). These 
data suggest that urease, Pho4 or Sec14 deficient cryptococcal cells are able to 
increase non-infected vessel width, despite deficiency in cryptococcal virulence factors. 
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Figure 3.16 Increased non-colonised blood vessel width by mutant 
cryptococcal strains  
KDRL mCherry blood marker transgenic line with 0cfu or 1000cfu GFP C. 
neoformans A Average vessel width without cryptococcal masses in KN99 infection 
at 3dpi within (n=3, ****p<0.0001, Student’s t-test, 18 non-injected larvae, 17 
injected larvae) B Average vessel width without cryptococcal masses in Sec14 
infection at 3dpi within (n=3, **p<0.01, Student’s t-test, 18 non-injected larvae, 13 
injected larvae) C Average vessel width without cryptococcal masses in Pho4 
infection at 3dpi within (n=3, ****p<0.0001, Student’s t-test, 18 non-injected larvae, 
15 injected larvae) D Average vessel width without cryptococcal masses in Ure-1 
infection at 3dpi within (n=3, *p<0.05, Student’s t-test, 18 non-injected larvae, 15 
injected larvae) 
 
Overall, these data suggest that blockage of some intersegmental vessels is not 
sufficient to cause increased width of non-colonised vessels. However, cryptococcal 
mutants in key virulence factors, which were able to inflict vessel damage in a similar 
manner to KN99 C. neoformans, were also able to cause an increase in vessel width in 
non-colonised vessels.  
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3.16 Chapter summary 
I have shown a previously uncharacterised mechanism of cryptococcal dissemination. 
Through infection of a mixed ratio of GFP and mCherry C. neoformans strains, I 
demonstrated that the inoculum ratio of each fluorescent strain does not determine the 
predominant colour strain which is causes the fatal infection outcome. Cryptococcal 
masses, which are predictive of final infection outcome, are likely formed through 
entrapment in the vasculature followed by localised clonal expansion. The sites of 
clonal expansion, often in narrow vessels, appear to cause damage to the vasculature, 
which may be involved in progression to dissemination into the surrounding tissue. An 
interesting observation that non-cryptococcal-colonised blood vessel width was also 
increase in infected larvae, and this was shown to not be caused by vessel blockage. 
However analysis of cryptococcal mutants did not reveal a cryptococcal virulence factor 
responsible for increased non-colonised blood vessel width. 
 
3.17 Discussion 
3.17.1 Cryptococcal infection dynamics 
The first aim of this chapter was to determine if cryptoccocal expansion from a single or 
small number of cryptococcal cells determines infection outcome. The role of clonal 
expansion in dissemination has not been studied in C. neoformans infection previously. 
However, clinical reports suggest that cryptococcal proliferation may be involved in 
cryptococcal dissemination across the BBB (Lee et al. 1996). It is also known that for 
both S. aureus and S. enterica infection, a small number of bacteria are responsible for 
overwhelming infection (Grant et al. 2008; Prajsnar et al. 2012). It was therefore 
hypothesised that a small number of cryptococcal cells may be responsible for infection 
outcome.  
A 5:1 ratio of two fluorescently labelled C. neoformans strains (GFP: mCherry) were 
injected into larvae in order to examine infection dynamics, in regards to a potential 
population bottleneck. A low dose of 25cfu was chosen to highlight any clear growth 
dynamics. Three distinct outcomes were observed, uncontrolled infection compromised 
of C. neoformans predominantly of the GFP strain, the mCherry strain, or a mixed 
outcome. The presence of the mixed group, which occurred in 37.5% of cases, 
indicates that a single cryptococcal cell (and clonal progeny) is not responsible for the 
final infection outcome, and does support the suggestion that a small number of cells 
are not responsible. However, presence of mixed cryptococcal strain infection 
outcomes does not provide conclusive evidence that a small number of cryptococcal 
cells are not responsible for entire infection outcome, as seen in the S. aureus 
population bottleneck.   
111 
 
To further investigate the dynamics of infection, the initial inoculum ratio was calculated 
for individual larvae. Importantly, in each fish the inoculum ratio was not 5:1, but ranged 
from ~4.5:1 to ~1:1 (GFP:mCherry). This large range of ratios is likely due to the very 
low number of cryptococcal cells injected, of approximately 25cfu. Indeed, it is 
expected to observe a relatively large range in the number cryptococcal cells injected 
into larvae at small doses (Bojarczuk et al. 2016). To further characterise the clonal 
expansion, it may be informative to infect at different ratios, or a larger dose, in order to 
compare growth dynamics at a relatively more consistent inoculum ratio. Different 
inoculum ratios mean it is not possible to conclude whether clonal expansion from a 
small number of cryptococcal cells is responsible for final ratios based on the 
proportion of final outcome types (GFP, mCherry or mixed) observed alone.  
Comparing initial inoculum with final outcome showed that the injected inoculum does 
not determine the final outcome, clearly demonstrating that the injected strain ratio is 
not responsible for the uncontrolled growth of cryptococcal strains, which results in a 
majority clonal strain of fungal cells. This suggests that only a few cryptococcal cells 
(and clonal progeny) are responsible for uncontrolled infection. However, I cannot 
exclude the possibility that the majority of cryptococcal cells are effectively controlled 
by the immune system, while a small number are not, leading to overwhelming 
infection. Due to the known extracellular proliferation of C. neoformans it may be likely 
that cryptococcal cells which are not phagocytosed by macrophages, cause 
uncontrolled infection through extracellular replication. In fact early macrophage control 
of C. neoformans infection has previously been demonstrated in zebrafish (Bojarczuk 
et al. 2016). In order to examine this, cryptococcal infection dynamics in larvae 
depleted of macrophages could be compared with larvae which have normal 
macrophage function.  
A caveat of this study is that, due to the long time period (2dpf – 9dpf), confocal 
imaging was completed using a single plane (z stack plane) in the larvae, to allow the 
larvae to be as little affected by imaging to have no effect on infection progression. This 
may mean that actual injected ratios could be inaccurate, if some cryptococcal cells 
were not observed during imaging. However, the fluorescent cryptococcal strains are 
bright, so this is unlikely to have occurred often or at all. Of note, this may mean 
inoculum ratios are not truly accurate.  
Only 51.6% of infected fish had cryptococcal infection which became fully systemic. In 
all other cases, fish had cryptoccocal infection, but died before infection became 
overwhelming. It is likely these fish died due to handling and repeated imaging, 
including repeated anaesthetic exposure over the time course, or even normal 
expected death observed at ~15% of a population, rather than cryptococcal infection. 
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For this reason these fish were excluded from the study, with only final overwhelming 
infections considered.  
The first finding in the study of cryptococcal growth dynamics was that initial inoculum 
ratio does not determine the predominant strain which causes the fatal final infection 
outcome. Analysis of infection over time led to the observation that cryptococcal 
masses were present in larvae ~2dpf before final infection outcome. Furthermore, 
cryptococcomas were shown to be predictive of infection outcome in terms of the major 
strain colour (GFP or mCherry), additionally suggesting that clonal expansion from a 
small number of cryptococci are responsible for infection outcome. Finally, the number 
of cryptococcomas within an individual fish was proportional to the speed of infection.  
These data suggest that a small number of cryptococcal cells, which initially form a 
cryptococcoma, are responsible for the overwhelming infection. This suggests similar 
infection dynamics which are seen in bacterial infection occur in cryptococcal infection, 
where a small number of cryptococcal cells results in localised proliferation leading to 
overwhelming infection. For S. aureus infection, bacterial lesions which are formed 
through clonal expansion are observed in the established bottleneck infection (Prajsnar 
et al. 2012). In addition, in Salmonella enterica serovar Typhimurium infection of mice, 
localised clonal expansion is observed at separate locations within the animal (Grant et 
al. 2008). This suggests that dynamics of infection for C. neoformans infection also 
including a stage of localised proliferation.  
Overall these data suggest that, the formation of cryptococcomas is an important stage 
of infection, and may be important in causing uncontrolled infection. Dissection reports 
highlighted that intravascular cryptococcoma (consisting of C. neoformans rather than 
in combination with immune cells) formation occurs in human infection, in addition to 
being observed in murine infection models (Lee et al. 1996; Olszewski et al. 2004). 
Indicating that cryptococcoma formation within the vasculature is seen in human 
clinical infection and occurs in both in murine and zebrafish models, and therefore 
could be important in progression of disease. 
To understand how cryptococcomas determine infection outcome, formation of 
cryptococcomas and whether this is consistent with established mechanisms of 
cryptococcal infection, was investigated with the overarching aim to consider whether 
clonal expansion from these cryptococcal masses may be a mechanism of 
dissemination.  
3.17.2 Cryptococcal cell trapping and cryptococcoma formation 
To establish if cryptococcal cells can become stuck in the vasculature in the zebrafish 
model, trapping of cryptoccocal cells in intersegmental blood vessels was analysed to 
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confirm that trapping can occur in the same way as previously demonstrated in mice. 
Whereby cryptococcal cells become stuck in small/narrow blood vessels of a similar 
size to the cryptococci, when moving by blood flow throughout the vasculature (Shi et 
al. 2010). It is required that cryptococcal cells become trapped in the vasculature, 
before proliferation mediated dissemination can occur. This is supported in the 
observation that cryptococcoma formation occurred most often in small blood vessels. 
However, this is presumed in the low dose infections, because infection was directly 
into the blood stream. To determine whether this mechanism is truly occurring, it was 
required to observe this in a blood marker line.  
Imaging of a recently infected larvae demonstrated that cryptococcal cells can become 
trapped in the larval intersegmental blood vessels. This was observed in the same 
manner as in the mouse model which demonstrated trapping of cryptococcal cells in 
blood vessels of a similar size to the cryptococcal cell (Shi et al. 2010). This is 
suggestive that cryptococcal cells become trapped in the vasculature and form 
cryptococcal masses through clonal expansion. Cryptococcal masses may not have 
been observed in mice, due to shorter imaging time periods. It was reasoned that 
another mechanism of cryptococcoma formation in the vasculature could be due to a 
build-up of cryptococcal cells behind an initial trapped cryptococci. Indeed, this was 
demonstrated using a higher inoculum, but was not observed at the low inoculum. 
Therefore, at low doses, a single cryptococcal cell becoming trapped and proliferating 
locally leads to cryptococcoma formation.   
It is understandable that cryptococcal cells would become trapped in small blood 
vessels. Firstly, the size of the blood vessels, in this case intersegmental vessels, are 
of a similar size (~0.4-10um) to cryptococcal cells (~4-8um). This can explain why 
fewer cryptococcal cells become trapped in the larger caudal vein. Furthermore, in vitro 
and in vivo studies confirmed that C. neoformans becomes “instantaneously trapped” 
rather than undergoing rolling and adhesion steps, which is the mechanism immune 
cells use to stop within the vasculature (Shi et al. 2010). 
Additionally, polystyrene spheres of matching size to cryptococcal cells, and S. 
cerevisiae were observed to become trapped in a similar manner to C. neoformans, 
(Shi et al. 2010) suggesting size may be more important than virulence factors in the 
trapping of cryptococcal cells in brain micro-capillaries. Similarly, inert beads of 4.5µm 
size used in this study were observed stuck within the intersegmental vessels. In 
comparison to cryptococcal cells, fewer beads were trapped in the vasculature, 
perhaps suggesting that cryptococcal factors do promote trapping within vessels in 
some part. However, the cryptococcal cell size is varied, from ~4-8um, and larger cells 
with a width greater than 10um were observed. Injection with larger sized inert beads 
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may lead to increased trapping, and would be an interesting experiment for the future. 
Despite this, is it clear that cryptococcal cells become trapped in the vasculature largely 
based on cell size (the potential role of cryptococcal factors is discussed below). 
An alternative factor may be that macrophages are present in greater numbers in the 
caudal haematopoietic tissue, at the site of the caudal vein. Any cryptococcal cells that 
become trapped in this area may have a greater chance of being phagocytosed and 
degraded than in intersegmental vessels and nearby tissues. Interestingly, in zebrafish 
infection models, immune cell responses appear less pronounced in the brain (or 
immune privileged sites), and it was suggested that capsule induction may enable 
improved immune evasion at later stages of infection (Tenor et al. 2015). It may be 
possible that cryptococcal cells in the caudal vein have a larger risk of macrophage 
interactions, than those in the intersegmental vessels, resulting reduced 
cryptococcoma formation. On the other hand, C. neoformans in the intersegmental 
vessels may largely evade macrophage interactions in early larvae development (due 
to lack of macrophage encounters), leading to their continued survival, by which time 
capsule induction may provide further evasion from immune cell interactions. Analysis 
of the location of macrophage-cryptococcal interactions would be required to confirm 
this possibility.  
It is also possible that cryptococcal factors may have a role in trapping, despite 
evidence that inert beads (this study) and polystyrene spheres become trapped in the 
same manner as cryptococcal cells (Shi et al. 2010). The role of urease in trapping of 
cryptococcal cells in the vasculature is disputed. Analysis of cryptococcal cells lodged 
in vessels (within different organs) was compared soon after inoculation in mice, to 
avoid potential roles of cryptococcal proliferation. Cryptococcal cells lacking urease had 
reduced fungal burden in the brain and lung, which represent organs with closed 
capillary beds, in comparison to cryptococcal cells with functional urease activity 
(Olszewski et al. 2004). In contrast, it has been suggested that urease in most 
important in transmigration out of the vasculature, than being important in the trapping 
of cryptoccocal cells. Co-infection of urease deficient and expressing cryptoccocal 
strains had no difference in trapping in the brain soon after infection (Shi et al. 2010). A 
major difference in these experiments in the initial inocula. It is likely that any role of 
urease in fungal trapping is most important at lower fungal burdens. The reduction in 
brain cfu counts (between urease deficient and expressing strains of C. neoformans) is 
more pronounced at lower fungal burdens (Olszewski et al. 2004). Urease may 
therefore play a role in this project where very low inocula were used. It would be 
interesting to compare trapping and cryptococcoma formation between urease deficient 
and expressing cryptoccocal strains to determine this.  
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Following cryptococcoma formation, overwhelming infection occurs. To understand the 
importance of this, it is important to determine how cryptococcal masses are formed. A 
single or very small number of cryptococcal cells are observed to form a 
cryptococcoma, which is suggested to be localised clonal expansion from within the 
vasculature. Furthermore, later in infection dissemination from the site of the mass 
(presumably in the vasculature), into the surrounding tissue is observed. Firstly, this 
observation implicates localised clonal expansion resulting from a vasculature site as 
responsible for cryptococcoma formation, and resulting in dissemination, the first 
observation of clonal expansion directly leading to dissemination. Clinical dissection 
reports of C. neoformans in the brain parenchyma, located next to brain blood vessels, 
also containing cryptococcal cells  (Lee et al. 1996) may be expected to have formed 
through this mechanism.  
Evidence that cryptococcoma formation is caused by clonal expansion is presented 
where cryptococcoma formation is shown to be resultant of a single/small number of 
cryptococci. Additionally, most cryptococcomas are likely formed by clonal expansion 
from a single colour strain (GFP or mCherry C. neoformans). If multiple cryptococcal 
cells were responsible for cryptococcoma formation, it may be likely that more 
cryptococcomas would contain both GFP and mCherry strains. In bacterial infection in 
zebrafish, also inoculated with two fluorescently marked bacterial strains, single colour 
bacterial lesions formed, (Prajsnar et al. 2012) thought to be generated by a single 
bacterium, due to the lack of mixing. Furthermore, at later time points during infection, 
in small blood vessels, where cryptococcoma formation is likely as discussed above, 
blocks of colour are observed, in correlation to a more mixed colour seen in the larger 
vessels. In Salmonella enterica serovar Typhimurium infection in mice, localised clonal 
expansion is observed in distinct locations in the animal. These subpopulations 
undergo clonal expansion but eventually lead to mixing, due to expansion into the 
blood stream leading to bacteraemia (Grant et al. 2008). This is similar to the 
observation of the single strain (GFP or mCherry C. neoformans) groups/masses seen 
in intersegmental vessels, but where strains are mixed in the larger caudal vein. It may 
be possible a similar mechanism is causing this. Overall, there is clear evidence that 
localised proliferation of cryptococcal cells trapped in the vasculature form clonal 
cryptococcal masses. This appears to be the major mechanism, however as mentioned 
above, a build-up of cryptococcal cells may occur in some cases (more so at higher 
fungal burdens), and could be responsible for the mixed colour cryptococcomas. 
Alternatively, cryptococcoma could be formed when macrophages lyse after 
phagocytosis of several cryptococcal cells, resulting in releasing several cryptococcal 
cells. Indeed, a neutrophil intra-phagocyte niche was demonstrated for S. aureus 
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(Prajsnar et al. 2012). Multiple pathogens are able to survive and replicate within 
macrophages, including Mycobacterium tuberculosis and Legionella pneumophila  (Xu 
& Luo 2013; Schlesinger et al. 2002). Furthermore, it is established that C. neoformans 
can reside, replicate and eventually escape from macrophages. This mechanism has 
not been investigated, and may be informative, as it could be hypothesised that in 
places such as the larger caudal vein, this mechanism may be predominant. However, 
due to the observation of single or small numbers of cryptococcal cells primarily within 
the narrow blood vessels, it is likely that in most cases a trapping mechanism in the 
vasculature is responsible, especially keeping in mind this may be experienced in 
human infection in micro-capillaries the brain vasculature.  
Intra-vascular C. neoformans masses have been shown to be predominantly cleared 
by neutrophils in mice (Sun et al. 2016a; Zhang et al. 2016). Similarly, neutrophils have 
been shown to have an important role in the killing of cryptococcal cells circulating in 
the blood in zebrafish (Davis et al. 2016). C. neoformans are able to become trapped in 
the vasculature in both the brain and lungs. It is shown that improved neutrophil 
recruitment to the lungs results in improved fungal clearance in mice. Furthermore, by 
inducing neutrophil recruitment to the brain (by LPS injection), fungal clearance was 
enhanced (Sun et al. 2016a). This may suggest neutrophil mediated clearance of 
intravascular resident cryptococcal cells could be a therapeutic target, which could 
ultimately reduce fungal dissemination into the brain.  
To conclude, evidence of a mechanism of dissemination from within the vasculature, 
caused by trapping of a single, or small number of cryptococcal cells at each site, 
which then proliferate leading to cryptococcoma formation and eventual dissemination 
is presented. The mechanism of how localised clonal expansion results in 
dissemination was investigated.  
 
3.17.3 C. neoformans dissemination through localised clonal expansion 
To determine if cryptococcal clonal expansion in vasculature leads to dissemination, 
sites of tissue invasion from the 25cfu (5:1 GFP:mCherry) larval infections were 
investigated. Most likely due to the low infection dose, only 19 dissemination events 
were observed in all larvae (15 larvae) which reached an uncontrolled infection. 
Significantly, in all instances of tissue invasion, the colour of the C. neoformans in the 
surrounding tissue was the same colour as the nearby, or same location 
cryptococcoma. These data clearly demonstrate that cryptococcal cells in the sites of 
cryptococcomas are the source of C. neoformans which disseminate at these locations. 
As discussed above localised clonal expansion, which contributes to the formation of 
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cryptococcomas, are the source of cryptococcal cells which then invade surrounding 
tissue. Considering the suggested mechanism to this point, a clear role of localised 
clonal expansion in formation of cryptococcomas, and ultimately dissemination out of 
the vasculature is presented.  
It has been shown that cryptococcal proliferation is not required to cross the BBB, 
using cryptoccocal strains deficient in proliferation still able to gain access to the brain 
parenchyma in mice (Shi et al. 2010), which suggests the proposal that cryptococcal 
proliferation vascular damage is one of multiple cryptococcal dissemination 
mechanisms. Firstly this could be because this study is examining intersegmental 
blood vessels, rather than the brain, although it is unlikely location of blood vessel 
would affect the ability of cryptococcal proliferation mediated dissemination, as 
demonstrated with the observation of vascular cryptococcal growth in the larvae brain. 
Importantly, this current presented clonal expansion mechanism is not the only route it 
is possible for C. neoformans to disseminate from. Indeed it is possible for cryptococcal 
cells to disseminate without the requirement of proliferation using other methods such 
as transcytosis or a macrophage as a Trojan horse. It is likely that clonal expansion as 
a dissemination mechanism is possible, but as is well established, other methods can 
occur in the absence of proliferation.  
Therefore, a role of clonal expansion which results in dissemination is presented, which 
acts in complement with established mechanisms, leading to C. neoformans ability 
disseminate from the vasculature. The mechanism by which clonal expansion leads to 
dissemination is next examined. 
 
3.17.4 Clonal expansion of C. neoformans causes vessel damage 
I have demonstrated a role of localised clonal expansion of a single or few cryptococcal 
cells in the formation of a cryptococcoma which is subsequently associated with 
dissemination out of the vasculature. A logical hypothesis that vasculature damage is 
caused by cryptococcal masses physically damaging vessels was next examined, with 
the aim to determine if cryptococcal clonal expansion causes blood vessel damage as 
a mechanism of dissemination. 
KDRL blood marker larvae infected with 1000cfu of C. neoformans were followed for 
3dpi to examine whether presence of cryptococcal masses in individual intersegmental 
blood vessels may damage the blood vessel. Vessel width was increased in the 
presence of cryptococcoma at 2hpi. This increase was larger by 3dpi, consistent which 
localised clonal expansion and was not observed for inert beads. Importantly, the 
increased size of the vessel was directly proportional to the size of the cryptococcal 
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mass, demonstrating that the cryptococcal mass is responsible for the increased vessel 
width. This is the first report that the size of cryptococcal masses are able to directly 
influence the vasculature, however some evidence that this can occur has been 
suggested in previous studies. Vascular damage resulting in compression of vascular 
endothelial cells, and altered vessel structure caused by C. neoformans was observed 
in mice (Olszewski et al. 2004). Damage to brain blood vessels by C. neoformans has 
been observed in multiple studies, vasculitis is recorded in human dissection reports 
(Lee et al. 1996), vascular distension at sites of cryptococci in zebrafish (Tenor et al. 
2015) and distended capillaries or blocked vessels in mice infection (Olszewski et al. 
2004). These data suggest that the observed vessel damage in this present study is 
conserved in cryptococcal pathogenesis throughout multiple organisms. In fact, in other 
human pathogenic fungal infection clinical case reports vasculature damage occurs in 
Arthrographis kalrae infection and that vasculitis occurs in Candida krusei infection 
(Pichon et al. 2008; Kleinfeld et al. 2013). These reports may suggest that this 
mechanism of cryptococcal vessel damage may be employed by multiple pathogenic 
fungi.  
This current study has focussed on intersegmental vessels of the zebrafish larvae. 
Despite this, it is reasonable that the mechanism of clonal expansion causing 
dissemination will also occur in the brain. Images kindly provided by Dr Robert Evans 
were analysed, demonstrating that blood vessels in the brain are enlarged when C. 
neoformans is present, suggesting that dissemination occurring by this proposed clonal 
expansion mechanism will also occur at the BBB. It would be informative to confirm this 
with further microscopy analysis in the future. 
Vessel integrity was examined to determine whether any damage to blood vessels 
occurs, expected due to the large increase in width of infected blood vessels. 
Unsurprisingly damage was observed using the KDRL blood vessel marker, with 
damage suggesting the vessel was burst, caused by physical damage to the vessel 
wall. Or perhaps a cryptococcal blockage in the vessel causes a build-up of pressure 
leading to bursting close to, or at the site of the cryptococcoma. The fungus 
Arthrographis kalrae which can cause pathogenic human infections, was shown to 
cause a cortical infarct in a case study, furthermore, massive brain vessel damage was 
observed, including necrotising arteries containing massive fungal growth (Pichon et al. 
2008).  It may be likely that vessel damage was caused by physical damage to the 
brain vasculature. Furthermore, a case study of localised vasculitis in a leg ulcer 
caused by Candida krusei infection suggests that vasculature damage caused by 
pathogenic yeast is not limited to the brain (Kleinfeld et al. 2013). These data suggest 
physical damage to the vasculature is occurring in pathogenic fungal infection. 
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Therefore evidence of vessel damage directly due to presence of cryptococcomas is 
demonstrated. The KDRL-mCherry marker visualises the vascular endothelial growth 
factor receptor KDRL, present on endothelial cells in the vasculature. To further 
investigate the vessel wall damage, cell-cell junctions in the vessel walls were next 
investigates.  
The vascular endothelial cell-cell junctions were investigated using the (vascular 
endothelial) VE-Cadherin line, to determine the integrity of potential gaps between 
endothelial cells. Similar to the KDRL line, at places of cryptococcal masses, a clear 
lack of signal (a lack of a clear vessel wall) indicates that vessels which possess cell-
cell junctions are damaged, clearly demonstrating vessel wall damage. Equally, in 
some cases transcytosis was observed, with C. neoformans observed outside the 
vasculature, despite clearly intact cell-cell junctions. Of note, a matching incidence rate 
was observed, albeit at very low occurrences, indicating that transcytosis and vessel 
damage occur are similar levels, as routes of dissemination. Investigation of cell-cell 
junctions in cryptococcal infection has previously indicated that damage may be 
occurring to the vasculature, through demonstration of tight junctions are damaged due 
to the loss of occludin, a major tight junction protein (Chen et al. 2003). It is not 
surprising, therefore, to determine cell-cell junctions are damaged through loss of 
cadherin expression at sites of cryptococcoma in the vasculature. Importantly, both 
transcytosis and vessel damage occurred at sites of clonal expansion. This implicates 
cryptococcoma formation, in both transcytosis and vascular damage mediated 
cryptococcal dissemination out of blood vessels.   
Transcytosis is not only dependent on trapping in the vasculature. As discussed above, 
cryptococcal urease expression is shown to increase transmigration, potentially  more 
important at low fungal burdens (Shi et al. 2010; Olszewski et al. 2004).  In addition to 
urease, another cryptococcal gene FNX1 (facilitated nutritional exit 1) has been linked 
to transmigration, with a reduced ability to transmigrate in vitro, through human brain 
capillary endothelial cells (Tseng et al. 2012). FNX1 deficient cryptococcal cells also 
had a reduced ability to migrate into the brain parenchyma in a zebrafish infection 
model (Tenor et al. 2015). It is important to acknowledge that multiple factors are likely 
important C. neoformans ability to disseminate into the brain. It would be useful to test 
at low inocula, the ability of urease and FNX1 cryptococcal mutants’ ability to invade 
tissue from the vasculature, in regards to proliferation mediated vasculature damage, to 
determine whether proliferation mediated dissemination provides an alternative route of 
dissemination when other routes (e.g. transcytosis), are not available.  
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Infarcts and vasculature damage are observed in cryptococcal meningitis (Mishra et al. 
2017). However, the physiological cause of infarcts is not identified in cryptococcal 
meningitis. The common occurrence of infarcts, seen in ~30% of cases in one clinical 
study, make this an important research area (Mishra et al. 2017). The proposed 
mechanism of vasculature damage demonstrated here may be responsible for causing 
infarcts observed in these cases, through physical damage to the vessel wall, leading 
to loss of tissue blood supply. This may represent an important understanding of 
clinical infarct occurrence in C. neoformans infection, and may be valuable for future 
therapeutic care.  
Infarcts are associated with cryptococcal meningitis, and in meningitis caused by 
bacterial pathogens, S. pneumonia and M. tuberculosis  (Floret et al. 1989; Lan et al. 
2001). It may be possible both fungal and bacterial pathogens share mechanisms 
causing infarcts, although bacteria are much smaller in size, bacteria grow faster and 
can form biofilms which may be similar to cryptococcoma formation. Therefore a 
mechanism dependent on trapping, proliferation resulting in vessel damage may occur 
in bacterial infection. In a clinical study comparing cryptococcal and tuberculosis 
caused meningitis, infarcts were observed in 32% and 47% of cases respectively (Lan 
et al. 2001). Both cryptococcal and tuberculosis meningitis cause vasculitis, and, 
similar to C. neoformans, bacterial lesions are sometimes observed (Rock et al. 2008). 
Similarly, a rabbit model of meningitis caused by Streptococcus pneumoniae leads to 
harmful inflammation and damage of the BBB. However, a reduction in inflammation 
was observed when leukocyte recruitment was inhibited (Tuomanen et al. 1989). This 
suggests that leukocyte recruitment can be detrimental in meningitis. Furthermore, 
mycobacterial infection in rabbits was associated with TNF-α expression (a pro-
inflammatory cytokine), where higher TNF-α expression was linked to increased 
vascular damage in the CNS (Tsenova et al. 1999). BBB damage in bacterial 
meningitis may be linked to harmful inflammation responses. These studies suggest 
distinct mechanisms could be used by C. neoformans in comparison to bacterial 
pathogens, which results in meningitis. However, it may be interesting to study TNF-α 
in cryptococcal meningitis, as a role of inducing vasculitis which could provide a useful 
therapeutic target.   
To conclude, at sites of cryptococcal masses in the vasculature, dissemination occurs, 
through damage to the vasculature, at a similar incidence rate to previously established 
transcytosis.  
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3.17.5 Non-colonised vascular alterations in cryptococcal infection  
It was determined that intersegmental vessel width is increased in non-cryptococcal 
colonised vessels (within infected larvae) in comparison to intersegmental vessels in 
non-infected larvae. However, no increase in non-colonised vessels was observed 
within inert bead injected larvae. These data suggest that the increase in vasculature 
width, not at sites of colonisation, is caused by other cryptococcal factors and not due 
to vessel blockage alone.  
Blockages in some intersegmental vessels, may mean that blood flow and pressure in 
adjacent (i.e. non-colonised vessels) is increased. This may lead to increased demand 
on the individual vessel to enable sufficient blood flow within the larva, leading to 
vessel growth, and therefore blood vessel widening. It has been shown that blood flow 
is essential for the development of blood vessels in mouse models, where blocking 
normal blood cell movement reduced blood vessel development (Lucitti et al. 2007). 
Since these current experiments were conducted until 5dpf, if might be expected that 
blood vessel development may promote the growth of un-obstructed vessels at this 
age. In zebrafish which have a blocked aorta, nearby vessels re-develop to enable 
sufficient blood flow (Gray et al. 2007). It would be interesting to determine whether 
blocking blood flow in multiple intersegmental blood vessels induces increased 
development on adjacent blood vessels, in a similar manner as in cryptococcal 
infection. If it is possible to occlude certain vessels, perhaps using a laser to seal 
vessels, analysis of blood vessel development may highlight this.  
However, due to the data presented showing non-colonised blood vessels are not 
increased in width, within larvae infected with inert beads, it may be possible that 
cryptoccocal mediated factors induce the increased vessel width. Importantly, fewer 
inert beads were trapped in comparison to C. neoformans, and since only cryptococcal 
cells can proliferate, the blockages caused by inert beads were smaller. It is therefore 
possible that the lack of increase in width of non-colonised vessels in bead injected 
larvae, may be due to a reduced extent of blockages. In order to quantify this, using 
increased inocula and larger sizes of inert beads to produce much larger vessel 
blockages must be tested. It may be possible that the extent of vascular blockage is 
very important in this observation.  
Cryptococcal mutants in urease, phosphate acquisition and secretion of enzymes 
including virulence factor phospholipase b, have all been linked to cryptococcal 
dissemination, and were therefore chosen for analysis of the ability to cause 
vasculature damage at the site of infection. These mutants were additionally analysed 
to determine whether loss of these virulence factors led to a reduced vessel width size 
in non-colonised vessels. Importantly, the strains used in these presented data were 
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taken from a cryptococcal (KN99) deletion library (University of California, San 
Francisco, 2015, Madhani plates), and were not tested to ensure the mutant was in fact 
deficient in the required virulence factor. The library was used, rather than existing 
mutants, to match the KN99 cryptococcal strain used in all experiments. It is very 
important to determine whether the cryptococcal mutants are true mutants by 
sequencing, and western blot analysis in order to prove these data are representative 
of each mutation. This makes it impossible to truly conclude any observations using 
these strains until this analysis is complete.  
Each cryptococcal mutant was able to form masses in the vasculature, which led to 
increased vessel size at the site of the cryptococcoma. This is very interesting, 
because each mutant has previously been shown to have reduce ability to invade the 
brain, but importantly, this ability was never totally blocked. Transmigration ability of 
urease deficient cryptococcal cells across the murine BBB was roughly reduced to a 
fifth in comparison to cells with urease expression (Shi et al. 2010), suggesting that 
urease is useful but not required for dissemination out of the bloodstream. An 
extremely minimal number of Pho4 cryptococcal mutants were able to migrate into the 
brain in mice, in comparison to many cryptococcal cells (4 orders of magnitude) which 
were Pho4 competent (Lev et al. 2017), interestingly in these infections Pho4 
cryptococcal mutants were not detected in the blood. In this study, dissemination can 
occur without Pho4, but it is likely that reduced fungal viability leads to reduced fungal 
burden during infection. Reduced viability of a Pho4 cryptococcal strain was previously  
demonstrated (Lev et al. 2017). In Sec14 mutant cryptococcal infection in mice, no 
dissemination into the brain occurred by 7dpf, whereas dissemination did occur for 
wild-type strains. However, by 19dpi, dissemination was observed after infection with a 
Sec14 deficient strain (Chayakulkeeree et al. 2012). Therefore, trapping in the 
vasculature, growth, physical vasculature damage and tissue dissemination, presents 
an alternative approach for cryptococcal cells to disseminate out of the blood stream. It 
appears that the varied mechanisms of cryptococcal dissemination into the brain 
enable dissemination even when some routes are unavailable.  
Cryptococcal mutants were able to increase the vessel size of non-colonised vessels 
within infected larvae. This suggests that urease, phosphate acquisition and secretion 
of phospholipase b do not cause increased vessel width in non-colonised vessels, 
away from the cryptococcoma site. Urease may be linked to vasculature damage due 
to urease production of ammonia which may be damaging to the endothelial cells 
(Morrow & Fraser 2013), but this may be limited to the site of the cryptococcoma. It 
would be interesting to analyse the type of dissemination events in urease deficient 
cryptococcoma, in correlation with the type of vasculature damage. It may be likely that 
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transcytosis occurs more often due to a reduction in vessel damage. It is not surprising 
that Pho4 does not alter vasculature damage, as phosphate acquisition it is important 
in the viability of cryptococcal cells. Sec14 is important in the secretion of 
phospholipase b (Chayakulkeeree et al. 2012). Fungal cell wall integrity of C. 
neoformans is maintained by phospholipase b, which could decrease the ability of 
Sec14 cryptococcomas to inflict physical damage onto the blood vessel wall (Siafakas 
et al. 2007).  
It may be possible that alternative cryptococcal virulence factors may directly target 
blood vessel walls, leading to vasculature damage. In pathogenic infection, vasculitis 
has been shown to occur from toxins. In fact when streptococcal and staphylococcal 
toxins were repeatedly injected into a rabbit’s arteries, vasculitis was observed (Abe et 
al. 1998). In Aspergillus fumigates human infection, expression of virulence factor 
elastase can degrade blood vessel walls (Ben-Ami et al. 2010). In future, further 
analysis of alternative virulence factors of C. neoformans, may provide an explanation 
for the non-colonised vessel expansion.  
 
3.18 Chapter summary  
A previously unknown dissemination mechanism of C. neoformans infection is 
demonstrated. Through investigation of infection dynamics, the formation of 
cryptococcal masses, by clonal expansion after trapping in the vasculature was 
demonstrated. It was next shown that at sites of C. neoformans proliferation 
dissemination events occur, through vasculature damage.  
Cryptococcal mediated damage to the vasculature was observed by cryptococcal 
mutants which may be unable to disseminate in established routes (e.g. 
transmigration). Therefore, cryptococcal dissemination through vasculature damage 
likely represents one of multiple route of dissemination.  
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Chapter 4: Results Chapter 2 
Characterisation of zebrafish autophagy mutants  
 
4.1 Chapter introduction  
Autophagy mutants were created in two key autophagy genes, atg3 and atg5.  These 
genes were selected for mutagenesis due to their important role early in the formation 
of the autophagosome and due to the likely impact of their loss being significant in 
blocking autophagy downstream of autophagosome formation. As discussed previously 
(see section 1.6), these two genes are key in each of the two ubiquitin-like conjugation 
processes, important in the elongation of the autophagosome double membrane and 
are responsible for LC3-I lipidation. Indeed, according to current dogma, it would be 
expected that loss of either of these genes would abolish lipidation of LC3-I. 
Corresponding mouse mutant models exist for both Atg3 and Atg5 genes. Both Atg3-/- 
and Atg5-/- mice are neonatal lethal (Kuma et al. 2004; Sou et al. 2008). The Atg5-/- 
mice exhibit a suckling defect however the life expectancy of these murine models can 
be extended through force feeding, but only by several hours (Kuma et al. 2004). 
Furthermore, LC3-II production is lost in Atg3 null and Atg5 null mice. These mouse 
models implicate both genes as important in development. In zebrafish, morpholino 
data suggests that a lack of nutrients, potentially caused by the knock-down of 
autophagy through atg5, leads to damaged cardiac tissue during development, and it 
may be this which ultimately leads to death of zebrafish larvae (Lee et al. 2014). 
It is unknown what effect a deletion mutation in atg3 or atg5 will cause in the zebrafish. 
Due to the neonatal lethality following the loss of either Atg3 or Atg5, in murine models, 
a similar survival phenotype may be expected in the zebrafish. Furthermore, the 
potential effects of lack of nutrients which could be caused by disruption of autophagy, 
especially during development, may affect the viability and growth of the larvae. For 
these reasons, characterisation of each mutation is very important to understand what 
mutation phenotypes exists, before infection studies could be interpreted.  
 
Hypothesis: Autophagy is downregulated, or non-functional in atg3-/- and atg5-/- 
zebrafish.  
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Chapter aims:  
1. Define the phenotype of mutants in autophagy genes atg3 and atg5 
2. Determine whether autophagy atg3 “mutant” fish are deficient in atg3 
expression 
3. Determine whether autophagy atg5 “mutant” fish are deficient in atg5 
expression 
4. Ascertain whether autophagy is reduced in the atg3 and atg5 mutant larvae 
 
4.2 Characterisation of the autophagy mutant lines 
Zebrafish lines with induced mutations in atg3 and atg5 were generated. Former lab 
members in the Ingham Lab at IMCB used Zinc Finger Nuclease technology to 
generate the atg5. Former PhD student Lore Lambein, in the Renshaw lab used 
TALEN mutagenesis to generate the atg3sh371. These fish have genomic lesions 
disrupting the reading frame of atg3 and atg5 genes. However, genomic lesions 
generated in this way do not always lead to null phenotypes, due to alternative splicing 
or to genetic compensation. It is therefore critical to ensure mutant fish were truly 
deficient in autophagy and to determine whether absence of a key autophagy gene 
leads to a specific phenotype in zebrafish.  
 
4.2.1 Analysis of predicted effect of autophagy mutations 
atg3:  
The zebrafish genome has one copy of the atg3 gene found on chromosome 6, made 
up of 12 coding exons, which has a single transcript, coding for a protein which is 
comprised of 317 amino acids. The zebrafish atg3 gene is orthologous to the human 
ATG3 gene. EMBL-EBI pairwise sequence alignment (using protein for the alignment) 
of the zebrafish Atg3 protein (ENSDARP00000041303.7) against human ATG3 protein 
(ENSP00000283290.5) shows 83.6% identity between protein sequences (Fig. 4.1 A). 
The atg3 mutant zebrafish line was previously made at Sheffield University through 
TALEN mutagenesis, which resulted in a 10bp deletion in exon 4. The predicted protein 
sequence resulting from the 10bp mutation site was aligned against the full atg3 
zebrafish protein, using MegAlign (Fig. 4.1 B), showing a predicted STOP within 21 
bases of the mutation site. Thus, the atg3 mutation is predicted to code for a truncated 
protein, only 71 amino acids long compared to 317 amino acids in the full length 
protein, suggesting it is unlikely to function normally. 
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atg5:  
The zebrafish atg5 gene is on chromosome 16 and has 7 coding exons. The zebrafish 
genome has one copy of the atg5 gene, which is orthologous to the human gene, and 
while the zebrafish has 2 transcripts, they both encode the same 275 amino acid 
protein sequence, with the difference in sequence in the UTR. An EMBL-EBI pairwise 
sequence alignment (using protein sequences for the alignment) of zebrafish Atg5 
(ENSDARP00000124077.1) protein sequence against the human ATG5 
(ENSP00000358072.3) protein shows 80.9 % identity (Fig. 4.2 A). The atg5 zebrafish 
line was previously made in Singapore, IMCB, A*Star Labs, through zinc finger 
mutagenesis, which resulted in a 23bp deletion in exon 3. Since exon three is found in 
both coding transcripts, it is predicted the mutation would affect both transcripts. The 
predicted protein sequence resulting from the 23bp mutation site is aligned against the 
full atg5 zebrafish protein, using MegAlign (Fig.4.2 B), highlighting a predicted STOP 
within 12 bases after the mutation site. Thus, the atg5 mutation is also predicted to 
code for a truncated protein, 43 amino acids in length, shorter than the 275 seen 
normally, again suggesting this protein would not function.  
 
 
 
 
  
127 
 
A 
Zebrafish Atg3  [ENSDARP00000041303.7] 83.6% identity 
Human ATG3   [ENSP00000283290.5] 
 
B 
Zebrafish Atg3  [ENSDARP00000041303.7]  
Atg3 coding missing 10bp deletion= ATG3 predicted 10bp mutation protein 
sequence 
 
Figure 4.1 10bp deletion in atg3 is predicted to code for truncated 
protein 
A EMBL-EBI pairwise sequence alignment of zebrafish Atg3 protein against human 
ATG3 protein, showing the zebrafish protein has 83.6% identity to the human 
protein. B MegAlign protein alignment of zebrafish Atg3 against zebrafish ATG3 
with 10bp mutation predicted sequence. Black shading indicates where the 
predicted mutation residues do not match the zebrafish atg3 residues. An early 
STOP, shown by a “.” (red box), is predicted leading to a predicted protein of 71 
amino acids.  
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A 
Zebrafish Atg5  [ENSDARP00000124077.1]  80.9% identity 
Human ATG5   [ENSP00000358072.3] 
 
B 
Zebrafish Atg5  [ENSDARP00000124077.1] 
Atg5 coding missing 23bp deletion= ATG3 predicted 23bp mutation protein 
sequence 
 
 
Figure 4.2 23bp deletion in atg5 is predicted to code for truncated 
protein 
A EMBL-EBI pairwise sequence alignment of zebrafish Atg5 protein against human 
ATG5 protein showing the zebrafish protein has 80.9% identity to the human protein. 
B MegAlign protein alignment of zebrafish Atg5 against zebrafish ATG5 with 23bp 
mutation predicted sequence. Black shading indicates where the predicted mutation 
residues do not match the zebrafish atg3 residues. An early STOP, shown by a “.” 
(red box), is predicted leading to a predicted protein of 43 amino acids.  
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Figure 4.3 atg3 PCR genotyping correlates with sequencing   
A Expected band size for each genotype, 245bp as wild-type, and 235bp with the 
mutation present A-C is heterozygous, wild-type and homozygous B Corresponding 
sequencing data of the genotyped fish A-C, with the 10bp mutation site marked. 
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4.2.2 Optimising atg3 genotyping 
The atg3 mutation causes a 10bp deletion. Previously established genotyping methods 
were unreliable so a new genotyping protocol was created. Primers were designed 
either side of the mutation site, leading to a total PCR product size of 245bp. Therefore 
the homozygous mutant would have a PCR product of 235bp, and heterozygous of 
both 245bp and 235bp. The PCR products were then run on a high percentage 
agarose gel (4%), to allow separation of the 10bp size.  Examples of the PCR product 
band sizes expected for each genotype (Fig 4.3 A) were chosen for sequencing to 
determine if the band sizes were accurate in determining genotype. Sequencing data 
matched with expected band sizes for each genotype (Fig. 4.3 B). This genotyping 
protocol was used in following experiments. A genotyping protocol was previously 
established for the atg5 mutation (PhD thesis Lambein, 2015), which was followed in 
this project.   
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4.2.3 Survival of autophagy mutants 
 
The survival of mutant fish was first investigated due to the noteworthy absence of 
adult homozygous fish resulting from the first raised heterozygous in-crosses, found for 
both atg3 and atg5 lines which had been raised to adulthood (Fig. 4.4 A). The survival 
of these fish had been monitored at 30dpf, before genotyping at 78dpf. Due to no 
change in survival from 30dpf until 78dpf, it was possible to conclude that no 
homozygous fish survived past 30dpf for atg3 and atg5 fish (Fig 4.4 B). Furthermore, 
the decrease in survival at 30dpf was greater than the expected normal loss rate of 
15%, and was a further ~25% decreased, as shown in (Fig. 4.4 A), which suggests the 
homozygous fish did not survive as well as wild-type or heterozygous fish. Importantly, 
absence of homozygous adults suggests that both atg3 and atg5 are required for 
zebrafish survival. It was therefore necessary to determine how long, if at all, 
homozygous larvae are viable.  
To confirm whether survival was reduced in homozygous mutants, survival of larvae 
from an in-cross of both atg3+/- or atg5+/- mutant fish was assessed at 5dpf to identify 
a potential additional reduction in survival of ~25% above expected death, perhaps due 
to the homozygous mutants dying according to Mendelian proportions (as indicated by 
the adult survival data). Survival of the atg3 and atg5 homozygous larvae until 5dpf 
does not show reduced survival more than normal expected loss (Fig. 4.4 C). This 
suggests that homozygous mutants are viable until 5dpf. To check atg3 and atg5 
homozygous viability at 5dpf, fish were genotyped and grouped accordingly showing 
that homozygous mutants for both atg3 and atg5 are viable at 5dpf (Fig. 4.4 D), in 
addition they are present at Mendelian ratios. Homozygous survival at 5dpf and their 
absence by 30dpf suggests that homozygous fish lose viability between 5 and 30dpf.  
Next, to compare larval survival between 5dpf and 30dpf, fish from either atg3, or atg5, 
in-crosses were placed into three groups, to be culled and genotyped at either 10, 20 
or 30dpf. The comparison of the ratio of homozygous, heterozygous and wild-type 
siblings by genotype at these time points show a significant reduction in homozygous 
fish numbers over time for both atg3 mutants from 20dpf (Fig. 4.4 E) and atg5 mutants 
by 30dpf (Fig. 4.4 F), in comparison to expected Mendelian ratios while heterozygous 
survival is normal. Importantly, this decrease in survival may suggest that the 
autophagy genes which are missing are required for survival, but only at a later stage 
in development.  
Interestingly, there are very rare viable atg5 homozygous fish at 30dpf, indeed, only 2 
viable homozygous adult fish have been found. In one case the atg5-/- fish has 
survived until at least 226 dpf, (at the time of writing). These fish may represent larvae 
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Figure 4.4 Autophagy mutant zebrafish have a survival defect 
A Survival of 90 atg3, and 100 atg5 larvae raised from heterozygous in-crosses. 
Line A represents normal expected loss, Line B represents a further 25% loss. B 
The genotype of raised fish of atg3 and atg5 mutants in comparison to expected in-
cross (36 atg3 larvae, and 45 atg5 larvae). C Survival of atg3, atg5 and AB wild-
type larvae to 5dpf (n=3, 282 atg3 and 1,430 atg5 larvae). D Genotype of fish at 
5dpf, where line A represents normal expected loss and line B represents a further 
25% loss, (ns = no significant difference, Pearson’s chi-squared test, n=3, 90 larvae 
for atg3 and atg5). E Genotype of an ATG3 in-cross at three time points, 10, 20 and 
30dpf, in comparison to the expected in-cross, (Pearson’s chi-squared test, * 
p<0.05, **p<0.01, n=3, 217 atg3 larvae). F Genotype of an ATG5 in-cross at three 
time points, 10, 20 and 30dpf, in comparison to the expected in-cross, (Pearson’s 
chi-squared test, * p<0.05, n=3, 221 atg5 larvae). 
which have alternative genetic adaptations which enable survival past 30dpf, despite 
the loss of atg5.  
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The reduced survival of homozygous atg3 and atg5 mutant fish may be anticipated due 
to the essential roles of autophagy in cellular component re-cycling, development and 
cell homeostasis, so it is imperative to next determine whether these fish are truly 
deficient in autophagy and at what stage, in addition to investigating the cause of the 
mutant’s death.  
 
4.2.4 Maternal contribution of autophagy genes 
Survival data suggests that in zebrafish, both atg3 and atg5 autophagy mutations are 
lethal, at a stage in development starting at 10-20dpf. Interestingly this is different to 
equivalent mouse models which are neonatal lethal (Kuma et al. 2004; Sou et al. 
2008), and even further different from equivalent mouse models lacking maternal 
contribution which do not survive past the 4-8 cell stage (Tsukamoto et al. 2008). It 
therefore may be possible maternal contribution enables the viability of zebrafish 
homozygous mutants to a certain stage.  
To determine whether maternal contribution of atg3 and atg5 mRNA occurs, larvae 
were grouped into developmental stages, total RNA was collected and cDNA was 
subsequently synthesised. This cDNA was then used for reverse transcription PCR 
analysis, where the occurrence of a PCR product indicates mRNA presence. Two sets 
of primers for each mutation were designed. One primer pair covered the site of the 
mutation, which would not be present in the homozygous mutants. The second primer 
pair was designed against a separate location in the each gene (atg3 or atg5), distant 
from the mutation site. This pair was used as a control to ensure the collected mRNA 
and subsequently synthesised cDNA were good quality.  
The first question addressed was whether maternal contribution occurs for both atg3 
and atg5. It is established that zebrafish zygotic transcription begins at ~3hpf (Kane & 
Kimmel 1993). Therefore, AB wild-type fish at very early developmental stages, before 
zygotic transcription begins, were used. The mRNA of atg3 and atg5 are both present 
from the one cell stage onwards, observed for both sets of primers (Fig 4.5 A-D), 
suggesting that both atg3 and atg5 mRNAs are maternally contributed. Presence of 
mRNA continues until 30dpf, showing that at no point during development mRNA is 
absent for these genes, with zygotic transcription starting before maternal mRNA is 
depleted.  
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Figure 4.5 atg3 and atg5 transcript is present in AB wild-types from 
the single cell stage 
Reverse transcription of cDNA synthesized from RNA extracted from AB wild-type 
fish at different ages, from 1 cell to 30dpf, ~20 larvae used for each time point for 
RNA extraction. A Reverse transcription of ATG3, using primers not at the mutation 
site. Correct expected band size of 213bp. B Reverse transcription of ATG5, using 
primers not at the mutation site. Correct expected band size of 83bp. C Reverse 
transcription of ATG3, using primers over the mutation site. Correct expected band 
size of 169bp. D Reverse transcription of ATG5, using primers over the mutation 
site. Correct expected band size of 583bp.  
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Zebrafish mutant lines were next examined to determine whether homozygous 
zebrafish experience the loss of atg3 mRNA and atg5 mRNA, after maternal 
contribution had ablated. The cDNA synthesised from RNA collected from homozygous 
mutants at 2, 5, 10, 20 and 30dpf was used for reverse transcription PCR analysis, with 
an AB wild-type 5dpf control used to ensure the PCR reaction worked. In addition, 
these experiments determine the age when wild-type maternal mRNA is lost. Wild-type 
mRNA for each gene is no longer present in homozygous mutants at 2dpf for atg5 and 
2dpf for atg3 (Fig. 4.6 A, B). It therefore may be expected that deleterious survival 
effects of each mutation may become apparent after these ages in homozygous larvae, 
with the loss of ability to transcribe fresh protein from maternal mRNA. Survival data 
showing homozygous mutant survival is normal until 5dpf is consistent with this.   
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Figure 4.6 Transcript presence of atg3 and atg5 is lost in homozygous 
mutants 
Reverse transcription of cDNA synthesized from RNA extracted from, ~10-20 larvae 
used for each time point A ATG3 homozygous fish, and B ATG5 homozygous fish, 
and control AB wild-type fish at different ages, from 2dpf to 30dpf. A Reverse 
transcription of ATG3, using primers not at the mutation site with correct expected 
band size of 213bp and primers over the mutation site with correct band size of 
169bp.  B Reverse transcription of ATG5, using primers not at the mutation site 
with a correct expected band size of 83bp and using primers over the mutation site 
with correct expected band size of 583bp.  
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4.2.5 Presence of Atg5 protein      
The presence of Atg5 protein was examined to determine whether the atg5 mutation 
was effective in resulting in loss of Atg5 protein, or produces a truncated and non-
functional protein, as anticipated from expected mutation effects in Fig 4.2, above,  
First, protein lysate from an atg5 in-cross of wild-type siblings, heterozygous and 
homozygous fish at 8dpf was examined, a time-point chosen as a likely age that 
maternal contribution would have subsided. Atg5 protein was not present in the 
homozygous atg5 fish (Fig. 4.7 A), indicating that by 8dpf homozygous fish are truly 
deficient of Atg5 protein.  
Maternal mRNA is present at 2dpf in atg5 null larvae. To determine whether maternally 
contributed mRNA transcribed by the zygote led to the presence of Atg5 protein, an 
earlier time-point of 2dpf was examined. At 2dpf Atg5 protein is present in the 
homozygous zebrafish (Fig. 4.7 B). Considering that maternally contributed mRNA is 
likely present at 2dpf (as suggested above in Fig 4.5 and 4.6), it is expected Atg5 
protein is present at 2dpf in homozygous fish. The comparison of the presence of Atg5 
protein at 8dpf and 2dpf demonstrate that the mutation is effective, with maternally 
encoded protein depleted by 8dpf, after maternal contribution has subsided. Taken 
together this protein analysis demonstrates that maternal contribution of Atg5 protein 
through synthesis of donated mRNA is concluded by 8dpf. 
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Figure 4.7 Atg5 protein is present at 2dpf, but lost at 8dpf 
A ATG5 fish grouped by genotype at 8dpf, of three biological repeats AI-AIII. β-
actin loading control and ATG5 antibody which recognises the ATG5-ATG12. B 
ATG5 fish grouped by genotype at 2dpf, with two biological repeats BI-BII. β-actin 
loading control and ATG5 antibody which recognises the ATG5-ATG12. 
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Unfortunately, there is currently no published antibody against atg3 which works 
successfully on zebrafish lysate according to literature searches at the time of 
experimental work. Attempts using a human atg3 antibody which was made against an 
antigen on the C-terminal of the protein, highly similar to the zebrafish protein, proved 
unsuccessful.   
 
4.2.6 Measuring Lc3 levels in autophagy mutants  
To determine if homozygous mutant fish have reduced autophagy function, Lc3 was 
chosen as a marker of functional autophagy machinery. Both atg3 and atg5 are 
involved in the production of Lc3-II from Lc3-I, it therefore might be expected that 
mutation of either atg3 or atg5 would reduce or stop Lc3-II production. Indeed, 
corresponding mouse models show a reduction in the presence of LC3-II (Kuma et al. 
2004; Sou et al. 2008). Two methods of LC3-II detection were used; 1) imaging of 
mutant fish expressing “traffic-light Lc3” at 2dpf, and 2), western blot using fish lysate at 
a later age of 8dpf. 
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1. Traffic light Lc3 injections 
The first method used to analyse autophagy function was through injection of “traffic-
light” Lc3. The plasmid (pDEST395.CMV.ZFLc3.PolyA, a kind gift from Dr Angeleen 
Fleming and Dr Katherine Henry, pME(RFP.GFP.Lc3) was a kind gift from Dr Angeleen 
Fleming, Dr Katherine Henry performed the recombination reaction to 
produce pDest(CMV:RFP.GFP.Lc3) plasmid), containing Lc3 tagged with both GFP 
and RFP. The fluorescence of GFP is quenched in an acidic environment, which leads 
to a colour change with only RFP visible within the autolysosome or acidic vesicles. A 
change of GFP/RFP to RFP may be suggestive of fusion of autophagosomes with 
lysosomes, this colour change was used as a read-out of functional autophagy. 
The plasmid was injected into a heterozygous in-cross of either atg3 or atg5 mutants at 
the one cell stage. Fish were then imaged after incubation overnight, with or without 
treatment of rapamycin and chloroquine. Rapamycin induces autophagy, whereas 
chloroquine blocks autophagosome maturation. This combination of drugs is commonly 
used to both induce autophagy and subsequently block autophagosome maturation, 
essentially trapping acidic vesicles from autophagic turnover. After imaging, fish were 
grouped according to genotype, after blinded analysis, whereby Lc3 associated 
vesicles, both GFP and RFP, were counted using ImageJ, to enable comparison of 
vesicle number.  
First, in atg3 fish not injected with the Lc3 construct as a control, neither RFP nor GFP 
vesicles were observed. In addition, this was consistent if the fish were pre-treated with 
rapamycin and chloroquine (Fig 4.8 A, B). For atg3 larvae with construct injected, RFP 
vesicles were seen at a similar number in all genotypes. Furthermore, when pre-treated 
with rapamycin and chloroquine, no significant change in the number of RFP vesicles is 
observed (Fig 4.8 C). GFP vesicles observed in larvae in all atg3 genotypes had a 
consistent number of vesicles (Fig. 4.8 D). No significant change in the number of atg3 
GFP vesicles in larvae treated with rapamycin and chloroquine was observed between 
any genotypes (Fig. 4.8 D).  
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Figure 4.8 Lc3 vesicles are present in atg3 mutants 
A ATG3 fish with or without rapamycin and chloroquine treatment, grouped by 
genotype. Vesicles which were RFP positive were counted. (n=8, 73 larvae, not 
significant, Two-way ANOVA Tukey’s test). B ATG3 fish with or without rapamycin 
and chloroquine treatment, grouped by genotype. Vesicles which were GFP positive 
were counted. (n=8, 73 larvae, not significant, Two-way ANOVA Tukey’s test). C 
ATG3 fish which had been injected with a traffic light Lc3 construct, with or without 
rapamycin and chloroquine treatment, grouped by genotype. Vesicles which were 
RFP positive were counted. (n=8, 73 larvae with treatment, 77 larvae without 
treatment, not significant, Two-way ANOVA Tukey’s test). D ATG3 fish which had 
been injected with a traffic light Lc3 construct, with or without rapamycin and 
chloroquine treatment, grouped by genotype. Vesicles which were GFP positive 
were counted. (n=8, 73 larvae with treatment, 77 larvae without treatment, not 
significant, Two-way ANOVA Tukey’s test).  
 
Similarly, the atg5 data show atg5 fish not injected with the Lc3 construct have neither 
RFP nor GFP vesicles, and that this was observed with and without pre-treatment of 
rapamycin and chloroquine (Fig. 4.9 A, B). For atg5 injected with the construct, RFP 
vesicles were seen at a similar number in wild-type, heterozygous and homozygous 
fish. For pre-treatment with rapamycin and chloroquine, no significant difference in the 
number of RFP vesicles are observed for all genotypes (Fig 4.9 C). atg5 GFP vesicles 
in all genotypes were at a consistent number (Fig. 4.9 D), in agreement with this, atg5 
fish treated with rapamycin and chloroquine show similar numbers of GFP positive 
vesicles in all genotypes (Fig 4.9 D).  
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Figure 4.9 Lc3 vesicles are present in atg5 mutants 
A ATG5 fish with or without rapamycin and chloroquine treatment, grouped by 
genotype. Vesicles which were RFP positive were counted. (n=3, 16 larvae, not 
significant, Two-way ANOVA Tukey’s test). B ATG5 fish with or without rapamycin 
and chloroquine treatment, grouped by genotype. Vesicles which were GFP 
positive were counted. (n=3, 13 larvae not significant, Two-way ANOVA Tukey’s 
test). C ATG5 fish which had been injected with a traffic light Lc3 construct, with or 
without rapamycin and chloroquine treatment, grouped by genotype. Vesicles which 
were RFP positive were counted. (n=7, 71 larvae with treatment, 80 larvae without 
treatment, not significant, Two-way ANOVA Tukey’s test). D ATG5 fish which had 
been injected with a traffic light Lc3 construct, with or without rapamycin and 
chloroquine treatment, grouped by genotype. Vesicles which were GFP positive 
were counted. (n=7, 71 larvae with treatment, 80 larvae without treatment, not 
significant, Two-way ANOVA Tukey’s test).  
  
I did not identify any differences between GFP or RFP vesicles between any genotype, 
with or without pre-treatment of autophagy enhancing and blocking drugs. Therefore, 
these traffic-light Lc3 DNA injection data suggest that Lc3 associated vesicles are 
formed to a similar extent in both atg3 and atg5 homozygous mutants as heterozygous 
and wild-type siblings, and suggests that Lc3-II is present within homozygous mutants 
at 2dpf. At 2dpf, a non-significant difference in autophagy function may be expected, 
due to the known presence of maternal mRNA and protein present in the larvae.  
Analysis of RFP or GFP alone was completed to determine whether a complete loss of 
Lc3-II lipidation was observed in autophagy mutant larvae. To compare autophagic 
flux, the ratio of RFP (acidic) and GFP vesicles was compared. This is useful to 
determine whether autophagy is functional in comparison to analysis of RFP or GFP 
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vesicles alone, as it considers autophagic flux. As above rapamycin and chloroquine 
treatment was used to monitor autophagic flux. A higher ratio of RFP:GFP vesicles 
indicates that autophagy is functional, as most Lc3 associated vesicles have become 
acidic. On the other hand a low RFP:GFP ratio indicates that most Lc3 associated 
vesicles are not acidic and therefore suggests that autophagy is not functioning as 
expected. The RFP:GFP ratio was not-significantly different between atg3 
homozygous, heterozygous or wild-type siblings with or without rapamycin and 
chloroquine treatment (Fig 4.10 A). Similarly, no significant difference between the 
RFP:GFP ratio for atg5 homozygous, heterozygous or wild-type siblings with or without 
rapamycin and chloroquine treatment (Fig 4.10 B). This may be caused by the young 
age of these larvae, which at 2dpf at the day of imaging still have maternally 
contributed mRNA which may enable normal autophagy function.  
 
 
2. Western blots:  
Western blot analysis of Lc3-II was used to determine if mutant fish were deficient in 
autophagy at 8dpf. The 8dpf time point was chosen as an age where the maternal 
effects may be expected to have diminished and residual autophagy proteins depleted.  
Micro fin-clipping (Wilkinson et al. 2013)  of in-crosses of atg3 and atg5 lines at 5dpf 
enabled genotyping to be completed by 8dpf, where fish were grouped by genotype, 
either wild-type siblings, heterozygous or homozygous, and protein extracted. In 
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Figure 4.10 The ratio of RFP to GFP Lc3 vesicles is not altered in atg3 
or atg5 mutants 
A atg3 fish with or without rapamycin and chloroquine treatment, grouped by 
genotype. The ratio of RFP positive vesicles to GFP vesicles in individual fish was 
calculated (n=8, 73 larvae with treatment, 77 larvae without treatment, Two-way 
ANOVA (Tukey’s test) not significant). B atg5 fish with or without rapamycin and 
chloroquine treatment, grouped by genotype. The ratio of RFP positive vesicles to 
GFP vesicles in individual fish was calculated (n=7, 71 larvae with treatment, 80 
larvae without treatment, Two-way ANOVA (Tukey’s test) not significant).  
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addition to these groups, wild-type AB controls with and without NH4Cl treatment were 
used. NH4Cl treatment blocks lysosomal fusion to autophagosomes through change in 
the pH of lysosomes and has been demonstrated to be effective on zebrafish (Hart & 
Young 1991), acting as a positive control of increased Lc3-II levels. Human embryonic 
kidney 293 (HEK293) cells were used as an additional control between human and 
zebrafish lysate.  
Western blots with an LC3 antibody designed against human LC3 is expected to 
recognise both lipidated and non-lipidated forms of LC3. However, the antibody does 
not easily recognise zebrafish Lc3-I, but does identify Lc3-II. Confirmation that the 
zebrafish protein was Lc3-II rather than Lc3-I was highlighted by the use of human cell 
lysate, which does identify both LC3-I and LC3-II, with the LC3-II the same size at the 
zebrafish Lc3-II. To further confirm the zebrafish lysate Lc3-II band is truly the lipidated 
form, the NH4Cl treated group have a larger band indicating an increase in Lc3-II 
levels. For these reasons, the lower band recognised by the antibody is likely to be 
Lc3-II. The loading control used was β-actin.  
atg3 western blots, demonstrate that Lc3-II is present in homozygous mutants at 8dpf 
in three separate biological repeats (Fig. 4.11 A, B, C). Quantification to adjust for 
slightly unequal protein loading allowed calculation of the relative Lc3-II levels, showing 
that Lc3-II is on average increased in the atg3 homozygous mutants in relation to the 
wild-type siblings and heterozygous larvae (Fig. 4.11 D). Similarly, atg5 western blots, 
with an atg5 in-cross grouped by genotype, demonstrate that Lc3-II is present in 
homozygous mutants at 8dpf, in three separate biological repeats (Fig. 4.11 E, F, G). 
Calculation of the relative Lc3-II levels show that Lc3-II is slightly increased in the atg5 
homozygous mutants, in relation to the wild-type siblings and heterozygous larvae (Fig. 
4.11 H), but to a lesser extent than atg3 homozygous larvae.   
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Despite either an atg3 or atg5 mutation being present, Lc3-II presence in the 8dpf 
zebrafish western blots, regardless of genotype, raised an interesting question of the 
mechanism of lipidation of Lc3. According to recent literature, and importantly 
corresponding mutant mouse models, Lc3 would not be expected to be lipidated 
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Figure 4.11 Lc3-II is present in atg3 and atg5 mutants 
A-C Three biological repeats of ATG3 western blots using β-actin as a loading 
control and LC3 antibody to detect fish Lc3-II. D Relative Lc3-II levels in ATG3 
heterozygous and homozygous larvae, compared to wild-type siblings and 
accounting for un-equal loading. E-G Three biological repeats of ATG5 western 
blots using β-actin as a loading control and Lc3 antibody to detect fish Lc3-II. H 
Relative Lc3-II levels in ATG5 heterozygous and homozygous larvae, compared to 
wild-type siblings and accounting for un-equal loading.  
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without these core autophagic components (Kuma et al. 2004; Sou et al. 2008). 
However, an increase in Lc3-II levels can be due to an increase in Lc3-II synthesis, or 
be due to reduced autophagic turnover. For this reason, autophagy enhancing and 
blocking drugs were used to assess autophagic flux.  
 
4.2.7 Autophagic turnover of Lc3-II in zebrafish mutants 
It is unexpected that Lc3-II levels would be the same or increased in homozygous fish 
at 8dpf, a time when Atg3 or Atg5 protein is expected to be depleted. Autophagy 
components are degraded in the process of autophagy, meaning that autophagic flux 
must be considered. Double treatment with rapamycin and chloroquine enable 
autophagic flux to be examined. Rapamycin acts to induce and therefore increase 
autophagy, whereas chloroquine blocks lysosomal fusion, acting to block autophagy. It 
would be expected that a fish able to produce more Lc3-II (wild-type) would have more 
Lc3-II than fish unable to produce more Lc3-II (homozygous) in treatment conditions. 
To see if this holds true in terms of Lc3-II protein in fish, Lc3 western blots were 
performed with or without rapamycin and chloroquine treatment in all genotype groups 
(Fig 4.12).  
Levels of Lc3-II in atg3 fish showed a slight reduction in Lc3-II levels in wild-type and 
heterozygous fish with rapamycin and chloroquine treatment than without, whereas a 
small increase in Lc3-II levels were seen for homozygous treated fish (Fig 4.12 A-D). 
This supports that Lc3-II is present in atg3 homozygous fish. Of note, the wild-type and 
heterozygous Lc3-II levels did not increase as expected with drugs treatment. This may 
suggest autophagic turnover is occurring, which is not observed for homozygous 
larvae, suggestive that autophagy function is impaired in atg3 null mutants. 
In atg5 fish, Lc3-II was slightly increased following rapamycin and chloroquine 
treatment in all genotypes (Fig. 4.12 E-H). This provides further evidence that atg5 
homozygous fish have Lc3-II present. Again, wild-type and heterozygous fish did not 
have an increase in Lc3-II levels as expected in two repeats, but a large increase was 
seen for one repeat in each genotype, but not seen in homozygous fish. High variability 
is hard to explain, but may suggest that atg5 homozygous fish have defects in 
regulation of autophagy. 
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Figure 4.12 Lc3-II is present in atg3 and atg5 mutants following 
autophagy induction 
RC: rapamycin and chloroquine treated A-C Three biological repeats of ATG3 
western blots using β-actin as a loading control and LC3 antibody to detect fish 
Lc3-II D Relative Lc3-II levels in ATG3 heterozygous and homozygous larvae, 
compared to corresponding genotype without RC treatment, and accounting for 
un-equal loading. E-G Three biological repeats of ATG5 western blots using β-
actin as a loading control and LC3 antibody to detect fish Lc3-II. H Relative Lc3-
II levels in ATG5 heterozygous and homozygous larvae, compared to 
corresponding genotype without RC treatment, and accounting for un-equal 
loading.  
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4.2.8 Phenotype analysis of autophagy mutant fish  
Observations of a substantial survival defect in atg3 and atg5 homozygous mutants 
indicate that each autophagy mutation has a significant effect on zebrafish health. 
Furthermore, for atg5 mutants, the lack of Atg5 protein is likely responsible for this 
increased mortality. Further characterisation of the autophagy mutants was undertaken 
with the aim to ascertain the cause of death for homozygous mutants.  
 
Firstly, the size of zebrafish was used as an indicator of the ability of the zebrafish to 
grow normally in addition to ability to feed, due to the comparable mouse autophagy 
mutant models which display a suckling defect. Furthermore, size may also be an 
indication of the ability of the zebrafish to recycle cellular components, if homozygous 
fish were able to feed normally. Zebrafish were measured at time points, 2dpf, 5dpf, 
10dpf, 20dpf and 30dpf, and subsequently genotyped and grouped. Importantly data 
was collected in IMCB in Singapore, and some in Sheffield, UK. The aquarium at IMCB 
is thought to have a higher pathogenic load in comparison to Sheffield University (Dr 
Claire Allen, personal communication), so data is represented separately.  
 
Data collected at IMCB, which represent single groups of larvae raised in individual 
tanks highlight a clear size defect at 30dpf in atg3 and atg5 homozygous mutants (Fig. 
4.13 and Fig. 4.14 respectively), but no significant difference in size at 2dpf, 5dpf, 
10dpf or 20dpf. Heterozygous mutants do not have a reduced size at any time point, in 
keeping with their normal survival data. Furthermore, these data further support the 
homozygous survival defect through lack of viable mutants, as shown through reduced 
homozygous numbers available to study, from time points 10dpf and later. In order to 
consider growth over time, the average size of larvae, grouped by genotype at each 
time point is shown in Figure 4.13 F and Figure 4.14 F, for atg3 and atg5 respectively. 
Growth appears to be at matching rates for homozygous mutants, wild-type siblings 
and heterozygous mutants until 10dpf, where growth appears to arrest for homozygous 
mutants only.  
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Figure 4.13 Autophagy atg3 mutant zebrafish have a reduced size  
The size of individual zebrafish larvae grouped by ATG3 genotype at different time 
points: A 2dpf (48 larvae), B 5dpf (48 larvae), C 10dpf (48 larvae), D 20dpf (47 
larvae), E 30dpf (21 larvae), (Data collected in Singapore, n=1, Mann-Whitney T-
test *p<0.05, error bars +/-SD). F Average size of zebrafish grouped by genotype 
over time (Data collected in Singapore, n=1, error bars +/- SD).  
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Figure 4.14 Autophagy atg5 mutant zebrafish have a reduced size 
The size of individual zebrafish larvae grouped by ATG3 genotype at different time 
points: A 2dpf (48 larvae), B 5dpf (48 larvae), C 10dpf (48 larvae), D 20dpf (47 
larvae), E 30dpf (15 larvae), (Data collected in Singapore, n=1, Mann-Whitney T-
test, ns, error bars +/-SD). F Average size of zebrafish grouped by genotype over 
time (Data collected in Singapore, n=1, error bars +/- SD).  
  
In direct comparison to these data collected in IMCB, Singapore, are the size of 
autophagy mutants housed in Sheffield University’s Aquarium (Fig. 4.15 and 4.16). 
These data represent three tanks containing 30 larvae raised until 10, 20 or 30dpf 
when size was measured, at or under 5dpf were not raised in tanks.  
A clear size reduction is observed at 30dpf for atg3 mutants in comparison to wild-type 
siblings, which is not apparent at 2, 5, 10 or 20 dpf (Fig. 4.15). On the other hand, atg5 
mutants have significantly reduced size at 20 and 30dpf, but not at 2, 5, or 10 dpf (Fig. 
4.16). For both atg3 and atg5 heterozygous larvae no change in size is seen at any 
age.  
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Figure 4.15 Autophagy atg3 mutant zebrafish have a reduced size 
The size of individual zebrafish larvae grouped by ATG3 genotype at different time 
points: A 2dpf (37 larvae), B 5dpf (126 larvae), C 10dpf (86 larvae), D 20dpf (65 
larvae), E 30dpf (72 larvae), (Data collected at the University of Sheffield, n=3, 
Mann-Whitney T-test ****p<0.0001, error bars +/-SD). F Average size of zebrafish 
grouped by genotype over time (Data collected at the University of Sheffield, n=3).  
 
 
 
Growth curves differ from larvae grown in IMCB in that for both atg3 and atg5 
homozygous mutant’s growth appears to match heterozygous and wild-type sibling 
growth until 20dpf, where growth becomes reduced (Fig. 4.15 F and Fig 4.16 F 
respectively). This change in growth is delayed in comparison to IMCB grown larvae 
which match growth only until 10dpf (Fig. 4.13 F and Fig. 4.14 F), for atg3 and atg5 
respectively. This may represent a better environment for larvae growth at the 
University of Sheffield. Reduced size of homozygous fish from 10dpf, or 20dpf onwards 
is indicative of a lack of nutrients available for the fish to grow. This could be due to a 
lack of ability to recycle nutrients, or a feeding defect.  
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Figure 4.16 Autophagy atg5 mutant zebrafish have a reduced size  
The size of individual zebrafish larvae grouped by ATG5 genotype at different time 
points: A 2dpf (64 larvae), B 5dpf (111 larvae), C 10dpf (74 larvae), D 20dpf (71 
larvae), E 30dpf (77 larvae), (Data collected at the University of Sheffield, n=3, 
Mann-Whitney T-test, **p<0.01, ****p<0.0001, error bars +/-SD). F Average size of 
zebrafish grouped by genotype over time (Data collected at the University of 
Sheffield, n=3). 
  
The ability of zebrafish to feed would be expected to lead to a nutrient deficit which 
could be responsible for the inability of the zebrafish to grow normally. This may be an  
expected outcome of both atg3 and atg5 mutations, due to Atg5 deficient mice which 
have a suckling defect (Kuma et al. 2004). Feeding was monitored at 15, 20, 25 and 
30dpf at the Sheffield University. These time points were chosen as an age where 
larvae are fed a mixture of small dried food (a mix of Gemma 75 and Zebrafeed 100-
200), and the larger sized live Artemia (brine shrimp) which are red. Importantly, larvae 
must have a properly developed mouth to hunt and eat Artemia. It is possible to directly 
observe if zebrafish are eating normally by observing whether any red colour from the 
Artemia are seen within the larvae’s digestive system. For both atg3 and atg5 
heterozygous in-crosses, at all time points, 100% of zebrafish were observed to have 
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Figure 4.17 Autophagy atg3 mutant heart rate is not changed 
The heart beats (per 20 seconds) of individual zebrafish larvae grouped by atg3 
genotype at different time points: A 2dpf (n=3, 30 larvae, One-way ANOVA test 
(Kruskal-Wallis test), not-significant error bars +/-SD)., B 5dpf, (n=2, 32 larvae, 
One-way ANOVA test (Kruskal-Wallis test), not-significant error bars +/-SD).  
 
eaten paramecia. As all fish were able to feed normally, this suggests that homozygous 
fish are able to feed normally, and therefore, any size difference is likely not caused by 
an inability to feed. 
The potential that a lack of nutrients available for growth, potentially caused by the 
autophagy mutation, was next considered. A study on autophagy  in zebrafish 
development using morpholinos suggested that cardiac tissue in zebrafish is lacking in 
amino acids (Lee et al. 2014), and this is suggested to be caused by a reduction in 
recycling of cellular components for which both atg3 and atg5 are required. To 
determine if the heart muscle was functioning normally in the larvae, the autophagy 
mutant lines were each crossed to the neutrophil specific traffic light Lc3 line, which 
includes a fluorescent GFP heart marker. Time-lapse imaging of the hearts of non-
anesthetised fish at time points at 2dpf and 5dpf were analysed. After analysis, fish 
were genotyped and grouped.  
The heart rate was not significantly different between homozygous, heterozygous or 
wild-type sibling atg3 larvae at 2dpf (Fig 4.17 A) or at 5dpf (Fig 4.17 B). Similarly, there 
was no significant difference between atg5 larvae of any genotype at 2dpf (Fig 4.18 A), 
or at 5dpf (Fig 4.18 B).  This suggests that cardiac tissue at 2 and 5dpf in atg3 and atg5 
mutants is functioning normally, and therefore does not suggest cardiac tissue is 
lacking amino acids. It would be useful to monitor the heart rate of larvae at later 
stages in development, for example after maternally contribution effects subside, 
unfortunately time restrictions did not allow for this.  
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Figure 4.18 Autophagy atg5 mutant heart rate is not changed 
The heart beats (per 20 seconds) of individual zebrafish larvae grouped by atg3 
genotype at different time points: A 2dpf (n=4, 60 larvae, One-way ANOVA test 
(Kruskal-Wallis test), not-significant error bars +/-SD)., B 5dpf, (n=5, 65 larvae, 
One-way ANOVA test (Kruskal-Wallis test), not-significant error bars +/-SD).  
  
 
4.2.9 Effect of starvation on survival of mutant fish 
The survival defect in atg3-/- and atg5-/- mutant fish, in addition to the reduction in 
growth shown above, indicates that both zebrafish lines may have impaired autophagy, 
despite Lc3-II presence until at least 8dpf. Since atg3-/- and atg5-/- mouse models are 
lethal in the neonatal period, the corresponding fish models may be expected to cause 
death at an earlier stage than 30dpf. An explanation for this could be the difference in 
immediate starvation conditions experienced by the different models throughout 
development. Being mammals, mice risk immediate starvation after birth, which is 
usually avoided by suckling. In atg5 deficient mice this immediate starvation, combined 
with a mutation-dependent suckling defect, places pressure on the autophagy pathway 
to provide essential nutrients (Kuma et al. 2004). Interestingly, even when the mouse 
mutants are force fed, to overcome the suckling defect, survival is only extended by a 
maximum of 25 hours (Kuma et al. 2004). In comparison, zebrafish do not experience 
starvation until 7dpf due to the presence of the yolk (Jardine & Litvak 2003). In addition, 
it might be that fish may not require autophagy so intensely due to a lower metabolic 
rate (van de Pol et al. 2017).  For these reasons, the effect of withholding food from 
autophagy mutants may increase the demand on autophagy and therefore enhance the 
effect of the mutation on zebrafish survival.  
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Figure 4.19 Autophagy mutant zebrafish survival under starvation 
conditions is not reduced 
A Survival of atg3 zebrafish grouped by genotype, food withheld (n=3, 178 larvae, 
no significance Log-Rank Mantel-Cox). B Survival of atg5 zebrafish grouped by 
genotype, food withheld (n=3, 174 larvae, no significance Log-Rank Mantel-Cox). 
Completed at IMCB in Singapore. 
Food was withheld from larvae from fertilisation to a maximum of 20dpf, where larvae 
would be expected to experience starvation from ~7-11dpf, when the yolk as a food 
source is fully depleted (animal work completed in Singapore was completed under the 
Institutional Animal Care and Use Committee (IACUC) guidelines, under locally 
ethically approved IACUC protocol number 140977). Dead larvae were collected and 
genotyped. In all cases, larvae did not survive beyond 16dpf (Fig. 4.19 A, B). Survival 
of larvae from the atg3 heterozygous in-cross was not significantly different between 
wild-type siblings, heterozygous or homozygous larvae (Fig.  4.19 A). Survival of larvae 
from an atg5 heterozygous in-cross was not significantly different in homozygous 
offspring compared to wild-type siblings and heterozygous fish, although more death 
events occurred ~4/5 days earlier than atg3 mutants, primarily in atg5 homozygous 
larvae (Fig. 4.19 B). These data suggest a defect in autophagy in atg5 mutants, since 
atg5 homozygous fish have earlier deaths under starvation conditions. 
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4.2.10 Summary of characterisation of autophagy mutant zebrafish 
Autophagy mutant fish show a clear survival defect. The cause of this defect may be a 
lack of available nutrients, as suggested by the reduction in homozygous mutant 
survival at 20dpf and reduced size in mutants after 20dpf. Indeed this is supported by 
earlier death of mutant larvae under starvation conditions, a traditional inducer of 
autophagy. However, Lc3-II, a marker of autophagosomes, is present in both 
autophagy mutants at 8dpf, indicating lipidation of Lc3, and perhaps some types of 
autophagy, are still functional in the homozygous mutants.  
 
 
4.3 Discussion 
4.3.1 Phenotype of autophagy mutants 
The first aim of this chapter was to define any phenotype exhibited by autophagy 
mutant larvae. Determining that atg3 and atg5 homozygous mutants did not survive 
until adulthood highlights a severe survival defect. Indeed, further characterisation 
demonstrated that atg3 and atg5 homozygous mutants have significantly reduced 
survival by 20 and 30dpf respectively. Heterozygous fish for both atg3 and atg5 larvae 
survival matched wild-type survival. Corresponding murine autophagy deficient mice 
represent well studied, in vivo animal models, useful in comparison of potential 
phenotypes. Heterozygous mouse survival of each mutation was also normal (Kuma et 
al. 2004; Sou et al. 2008), indicating that a single allele of each gene is sufficient for 
autophagic requirements in both zebrafish and mice. 
In zebrafish a clear survival phenotype is demonstrated, in that atg3 and atg5 
homozygous fish are not able to survive as long as wild-type siblings, and suggests 
both mutations have delayed deleterious effects. A survival defect has also been 
demonstrated in atg3 deficiency in D. melanogaster, where RNAi was used to block 
atg3 function leading to a shorter lifespan (Tóth et al. 2008), indicating autophagy is 
important in animal survival. Interestingly, mutant survival in zebrafish (and in atg3 
deficient drosophila) survival is quite different to the corresponding atg3 and atg5 
mouse mutants which are lethal earlier, in the neonatal period (Kuma et al. 2004; Sou 
et al. 2008). A potential explanation for the different timeframes of mortality in mouse 
and zebrafish models could be caused by differences in autophagy requirements 
during murine and zebrafish development. Alternatively, a significant lung defect is 
described for atg5 deficient mice, which causes increased alveolar epithelial cell 
thickness which may present a barrier to gas exchange (Cheong et al. 2014). It is 
possible inefficient gas exchange in the lung could cause or contribute to an earlier 
death of murine autophagy mutants. Furthermore, the atg5 deficient mice neonatal 
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death is rescued when atg5 is expressed in neurons, indicating that the cause of death 
in mice may be caused by neuronal dysfunction (Yoshii et al. 2016).  
The severe atg3 or atg5 homozygous survival defect is statistically significant by 20 or 
30dpf respectively. Interestingly, expected mendelian ratios occur for both atg3 and 
atg5 heterozygous in-crosses, which concurs with corresponding mouse models (Kuma 
et al. 2004; Sou et al. 2008). Survival of homozygous larvae appears to be normal until 
5-10dpf. It may be likely for both murine and zebrafish models that animal survival, until 
autophagy is under stress, is made possible through maternal contribution. In both atg3 
and atg5 mutants wild-type coding mRNA (with no mutation) is present until at least 
2dpf. For atg5-/- larvae, Atg5 protein was present at 2dpf. These data suggest maternal 
contribution enables functional protein production, and it would therefore be expected 
that autophagy could function normally.  
In exception to this, two homozygous atg5 mutants have been able to survive much 
later than other atg5-/- larvae, one until 226 dpf (at the time of writing). Interestingly, a 
single atg5 deficient mouse was able to survive longer than most atg5 null mice, (9 
days rather than 1). These rare animals suggest that genetic adaptations can occur 
which enable survival further than is otherwise possible. It would be interesting to study 
these animals to determine whether other autophagy-related genes are up-regulated 
which may compensate for a loss in atg5.  
Mammals, including mice, after birth undergo immediate starvation, which may place 
autophagy, required to recycle nutrients needed in starvation conditions, under 
immediate pressure until feeding. Using GFP-LC3 reporter mice, it was determined that 
autophagy is used to a very low extent in the embryo, however within 30 minutes of 
birth the neonates have a massive up-regulation of autophagy, determined through 
huge up-regulation of GFP-LC3 “dots” only present in the mice after birth, rather than 
during the embryonic period (Kuma et al. 2004). It was then demonstrated that 
autophagy is responsible for providing amino acids (but not other potential nutrients 
such as blood glucose), through comparison of plasma level of amino acids in wild-type 
and atg5 deficient mice, which were significantly reduced in autophagy deficient mice 
(Kuma et al. 2004). A reduction in amino acids has also been demonstrated in atg3 and 
atg7 deficient mice in a similar manner (Sou et al. 2008; Komatsu et al. 2005). 
Therefore, autophagy is key in providing amino acids in murine neonates throughout 
the immediate starvation experienced after birth.  
On the other hand, zebrafish have a yolk-food source which is used as a food source 
until 5dpf when the larvae can begin to feed, although the yolk may supplement 
alternative food sources until 7dpf (Jardine & Litvak 2003). Zebrafish also have a lower 
154 
 
metabolic rate than mammals, primarily due to the fact that mammals must use 
comparatively much more energy to generate heat and for movement, whereas 
zebrafish do not need to generate heat, and swimming requires less energy (van de 
Pol et al. 2017). The yolk food source, and lower metabolic rate, may stop the 
immediate starvation and pressure on the autophagic system in zebrafish, which the 
atg3-/- and atg5-/- mice experience.   
To test whether differences in growth are caused by a potential lack of nutrients caused 
by autophagy deficiency, particularly after ~7-11dpf when the yolk food source is 
depleted, the size of homozygous, heterozygous and wild-type siblings was measured.  
For both atg3 and atg5 homozygous mutants at ages of 2dpf, 5dpf and 10dpf there was 
no significant difference in size in comparison to heterozygous and wild-type siblings. 
Data collected in IMCB in Singapore suggests that at 20dpf a reduction in size is seen 
for atg3 homozygous mutants, and by 30dpf this is significantly reduced. A reduction in 
size is also seen for atg5 homozygous larvae at 30dpf. The lack of viable homozygous 
fish at these later time points led to fewer data points for collection, but further 
highlights the homozygous survival defect. These data suggest that homozygous 
mutants are not able to grow normally, with growth affected after 10dpf, in line with yolk 
depletion. It is therefore tempting to suggest that growth is reduced due to a lack of 
cellular recycling through autophagy. Size analysis of autophagy mutants at The 
University of Sheffield highlighted a significant reduction in size at 30dpf for atg3 
homozygous larvae, and at 20 and 30dpf for atg5 larvae. These data suggest that size 
is not reduced until after 20dpf, later than found at IMCB, Singapore.  
Of note, there are some discrepancies in the size data collected in each aquariums 
used at IMCB in Singapore and at The University of Sheffield (TUOS) in the UK. Firstly, 
more homozygous mutants are viable at the 20dpf and 30dpf time points at TUOS in 
comparison to IMCB, suggesting improved survival of homozygous fish. Further 
supporting this, the size difference appears to be more pronounced at IMCB, with all 
homozygous fish at the 20 and 30dpf being smaller sized. At TUOS, there are some 
homozygous fish present at these later time points which are not clearly smaller in size. 
Improved survival and increased size of homozygous mutants could be caused by 
differences between the aquaria. In IMCB, there is potentially a higher pathogenic load 
in the water, with pathogen Pseudoloma neurophilia known to be present (Mohd Agus 
Bin Abdul Raman, personal communication). It is difficult to confirm whether pathogen 
load is different between aquaria, but any differences in pathogen load and the 
microflora may have an unknown impact on the development of the survival/growth 
phenotype. The presence of more pathogens may put increased pressure on fish, and 
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perhaps both autophagy homozygous fish are less able to deal with these pathogens, 
therefore highlighting size and survival defects to a greater degree than TUOS.  
An explanation of why homozygous fish are smaller in size is a potential feeding defect. 
In fact, the corresponding Atg5 autophagy mouse models have a suckling defect, which 
if force fed, does increase the lifespan of the mice for several hours (Kuma et al. 2004). 
This does suggest that a lack of nutrients is at least in part responsible for the murine 
neonatal deaths. It therefore could be possible that in zebrafish a feeding defect may 
also be present. To determine whether homozygous autophagy mutants had a feeding 
defect, paramecia which are red in colour, was observed in the digestive system by 
eye. In all cases all fish were seen to have eaten paramecia, irrespective of size and 
genotype. If all fish were able to eat paramecia, it is unlikely there is a feeding defect. 
However, to be sure this is true, further quantification is needed. In this case, the fact 
that all fish actively hunt and eat paramecia is very suggestive that feeding is normal.  
A further consideration for differences in larval growth is the type of food which is 
available. In IMCB (Singapore) the larvae are provided with Zeigler larval (AHAB, USA) 
that ranges from 150 micron to 250 micron from 5-30dpf. In comparison TOUS 
aquarium fed larvae a mixture of small dried food from 50-100 microns (a mix of 
Gemma 75 and Zebrafeed 100-200), and the larger sized live Artemia (brine shrimp) in 
the same age range. It could be possible that the different availability of food offers 
different nutritional value, and leads to different growth rates, and perhaps improved 
growth in seen under the TOUS feeding regime. Further analysis of the growth rates 
according to feeding regime would be required to confirm this.   
The survival and growth defects which appear to become important after the yolk food 
source is depleted are suggestive that after 10dpf, both atg3 and atg5 mutations 
become deleterious, perhaps due to lack of nutrients. For zebrafish, a feeding defect 
can likely be excluded, after visually determining that all fish are able to feed normally. 
To determine whether a lack of nutrients may be affecting cardiac tissue and therefore 
causing death in zebrafish, heart function was next studied.  
Morpholino data show that atg5 knockdown in zebrafish leads to defects in cardiac 
tissue development, and later, reduced survival (Lee et al. 2014). Furthermore, atg5-/- 
mice have defect in heart beat which is likely caused by a lack of available amino 
acids, presumably resulting from underprovided autophagy. In fact in wild-type mice, 
cardiac tissue was shown to increase autophagy use massively after birth (Kuma et al. 
2004; Lee et al. 2014). It was therefore hypothesised that cardiac function may be 
changed in homozygous mutants, and this may be a cause of early death.  
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Heart function was studied by imaging a heterozygous in-cross of each autophagy 
mutant, which had previously been crossed to the traffic light Lc3 neutrophil line, which 
has a fluorescent heart marker. After imaging, heart rates were compared between 
genotype. At 2 and 5dpf, both atg3 and atg5 homozygous heart rates were not different 
in comparison to wild-type and heterozygous fish. Unfortunately, due to time restraints 
heart rates were not monitored at later time points. Although these data suggest that a 
cardiac defect is not caused by each atg3 or atg5 mutations, study at later time points 
is required, as maternal contribution, (shown here to be present in each mutant) may 
enable normal autophagy, amino acid production and ultimately survival until a later 
time point. Furthermore, analysis of the amino acid content of the blood plasma in 
autophagy mutants may by an important experiment to reveal whether zebrafish 
deficient in atg3 or atg5 lack have reduced amino acids, and whether this is turn could 
lead to a cardiac problems. 
To further implicate the autophagy mutations as responsible for the survival defects 
and reduced growth, the autophagic system was put under additional pressure through 
larval starvation conditions. Fish survival was monitored until 20dpf, with starvation 
expected to start by 7-11dpf when the yolk is depleted. The maximum survival seen 
was 16dpf regardless of genotype. A significant reduction in survival was not seen for 
atg3 or atg5 homozygous mutants, however atg5 homozygous fish did exhibit earlier 
death ~4/5 days before most deaths at 16dpf. Of note earlier atg5 homozygous deaths 
were observed in each of the three repeats, it may be likely further analysis may lead to 
statistical significance. This may suggest that atg5 is important for extended survival 
under starvation conditions. In non-suckling conditions atg5+/+ mice had significantly 
longer survival in comparison to atg5-/- which suggests that autophagy is important in 
providing nutrients under starvation conditions. As starvation is a common autophagy 
stressor which appears to enhance the survival defect, these data suggest the 
zebrafish atg5 mutation is reducing autophagy perhaps leading to a lack of amino acids 
and subsequent death, although further analysis of nutrients (amino acids) available 
would be required to prove this hypothesis.  
Additionally, atg5 independent autophagy is functional without LC3 lipidation (Nishida 
et al. 2009), which could occur in both atg3 and atg5 mutants, indicating that 
autophagy can be accomplished by alternative pathways. Atg5 independent autophagy 
may be essential to provide nutrients for larvae when classical autophagy is unable to. 
It would be very interesting to specifically target Atg5 independent autophagy in larval 
development to order to determine whether nutrients are provided through this 
pathway.  
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To conclude, both atg3 and atg5 homozygous mutants exhibit a clear survival defect. 
This survival defect may be caused by a lack of nutrients, normally made available via 
autophagy, leading to growth and cardiac defect which ultimately cause death. In fact, 
a clear growth defect is observed for both mutants, which is likely not caused by 
feeding defects. Furthermore, stressing autophagy through starvation appeared to 
enhance the survival defect in atg5 homozygous larvae, associating lack of nutrients as 
a cause of the survival defect. However further analysis, focussing on amino acid 
availability, and cardiac function would be extremely useful for future investigation. 
 
4.3.2 Autophagy mutation effects at the transcriptional and translational level 
The second aim of this chapter was to determine whether atg3 and atg5 autophagy 
mutant fish are deficient in Atg3 or Atg5 protein respectively. The mutations expected 
effects were first analysed, predicting that both deletion mutations cause an early 
translation stop, leading to truncated and non-functional proteins.  
The predicted Atg3-/- protein size was 71 amino acids in length, significantly shorter 
than the usual 317 amino acid protein. For the atg5-/-, the predicted protein size was 
43 amino acids, also significantly shorter than the 275 normally translated. In both 
cases a large majority of the protein is predicted to be missing, leading to the deduction 
that the severely truncated protein would be non-functional. As an obvious example, 
the atg5 mutation would lead to the loss of lysine 130 (Ohsumi et al. 1998), which is 
crucial for the conjugation of atg5 to atg12, and required for autophagy. Furthermore, 
degradation of non-functional, miss-folded protein occurs under normal conditions, and 
this may remove any truncated protein which may be produced. For these reasons, the 
predicted mutation effects are likely to lead to missing, or non-functional proteins.  
mRNA which has premature STOP codons are targeted for degradation through 
nonsense mediated decay (Wittkopp et al. 2009). This will reduce the amount of mRNA 
present in the mutant fish available for translation and reduces the likelihood that 
truncated protein will be translated from mutant mRNA. However, there is some debate 
on how efficient nonsense mediated decay is in zebrafish. Although all key genes 
required for non-sense mediated decay are present in zebrafish (Wittkopp et al. 2009). 
To determine whether mRNA either containing the deletion sites (wild-type), or missing 
the deletion sites (mutant) is present in both atg3 and atg5 mutants, the presence of 
mRNA (with or without the deletion site) was compared. Equally, this analysis enabled 
to comparison of maternally contributed mRNA, which would not contain the mutation 
site.  
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Firstly, wild-type fish were shown to have both expression of both atg3 and atg5 mRNA 
from the single cell stage, with no lapse in presence at any time point until at least 
30dpf. Presence of atg3 and atg5 genes at the very early stages in development show 
that each gene is maternally contributed, considering that zygotic transcription does not 
start until ~3hpf (Kane & Kimmel 1993). The homozygous mutants were analysed 
using two pairs of primers, one over the mutation site and one away from the mutation 
site, with the aim to see a PCR product for primers only away from the mutation site. 
This is to determine whether “wild-type” maternal mRNA is present in the mutants. 
Indeed, for atg3 and atg5 homozygous larvae the presence of maternal mRNA is lost 
by 5dpf. Interestingly, the presence of mRNA containing the mutation is present at all 
ages, indicating that nonsense mediated decay is not effectively removing all the 
mRNA containing early translational stop in both atg3 and atg5 mutants, additionally 
agreeing with the suggestion that zebrafish nonsense mediated decay is not efficient. 
It is important to note that the primers which were designed to cover the mutation site 
do not detect a loss of transcript, since the primers would not be able to bind due 
missing sequence (the missing mutation site). It is therefore likely that “mutant” cDNA 
is present in these larvae, which is also observed using the primer pair away from the 
mutation site. However these data do suggest wild-type cDNA (containing the mutation 
site) is not present in the homozygous larvae after 5dpf, (see appendix 3 for primer 
location on atg3 and atg5 cDNA sequences). It would be useful in the future to use 
additional primer binding sites, e.g. before, overlapping the mutation site (in addition to 
covering and after) the mutation site to enable improved understanding of what 
transcripts are present.  
Maternal contribution may reduce deleterious effects through enabling normal Atg3 or 
Atg5 production until at least 2 dpf. This may partially explain why both corresponding 
mouse and zebrafish models survive past embryogenesis, since both models have 
maternal contribution. In a murine model it was demonstrated that an oocyte deficient 
in atg5, fertilised with atg5-/- sperm did not survive past the 4-8 cell stage (Tsukamoto 
et al. 2008). In this case maternally contributed atg5 was not present, and clearly 
highlights that autophagy is important at very early stages in development, and 
specifically requires atg5. However, the lack of “wild-type” mRNA does not mean that 
protein, previously transcribed from maternally contributed mRNA is also absent, the 
protein may be long lived, and therefore provide longer lasting functional autophagy.  
Unfortunately, an antibody which can recognise zebrafish Atg3 has not been described 
and my attempts at using an ATG3 antibody raised against human protein were 
unsuccessful. Despite an antibody being unavailable for Atg3, it may be likely that due 
to the similar survival and size defects observed, in addition to only having a mutated 
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copy of mRNA after 2dpf, that protein is may not be present at 8dpf, as shown for atg5-
/- larvae. To fully prove that the atg3 mutation results in the loss of Atg3 protein, this 
would be a key experiment to complete in future. 
The antibody used for the atg5 western blots was made against the first 50 residues of 
the human ATG5 protein. Whilst the zebrafish protein has 81% identify to the human 
protein, for the first 50 residues, the expected mutation effect would lead to 
discrepancies by the 39th residue, with an expected STOP by the 43rd. This means that 
the antibody might not recognise any truncated protein produced. However, the wild-
type full-length protein (determined by size) is shown to be recognised in the atg5 
western blots. If the mutation was not effective in stopping production of full length 
atg5, this protein would still be present at later stages. For this reason, the data 
showing Atg5 protein absence at 8dpf suggests that the atg5 mutation is effective in 
causing a loss of Atg5 protein production.  
The ATG5 antibody used recognised the ATG5-ATG12 complex, rather than ATG5 
alone. This is because the ATG5-ATG12 complex contains a stable covalent bond, 
which is not broken during SDS-PAGE. Therefore, any free Atg5 should be recognised 
by the antibody, however, a band was not observed at the correct Atg5 size, 
suggesting in zebrafish in vivo, Atg5 is predominantly in complex with ATG12. In fact, 
free Atg5 (the full length form which can conjugate to ATG12) is not highly present in 
comparison to the ATG5-ATG12 complex, or a truncated Atg5 (used in apoptosis) 
during zebrafish development (Hu et al. 2011). It was suggested that Atg5 protein self-
regulates atg5 expression only when Atg5 protein levels are low, (Hu et al. 2011), and 
therefore Atg5 is likely to be in the complex rather than free in the cell. Ultimately, if 
Atg5 is not present, it cannot be found in complex with Atg12 either, and therefore 
using the Atg5-Atg12 complex as a marker for whether Atg5 is present is valid. Using 
this human ATG5 antibody, the presence of Atg5 protein was compared between atg5 
wild-type sibling, heterozygous and homozygous fish at 8dpf. The age of 8dpf was 
chosen as an age that any maternal contribution effects would have subsided. Indeed, 
at 8dpf it was shown that Atg5 protein was lost in homozygous mutants. It can be 
concluded that atg5 homozygous fish are deficient in Atg5 protein by 8dpf.  
The role of maternally contributed mRNA makes dissecting the mutation’s deleterious 
effects difficult. I have shown that before 5dpf, maternally contributed mRNA is present 
in atg5 homozygous fish and it is therefore likely functional Atg5 protein is present at 
early time points. To determine if this was true, Atg5 protein in wild-type siblings, 
heterozygous and homozygous was shown to be present at 2dpf. It does appear the 
amount of Atg5 protein may be reduced in homozygous mutants, suggesting less 
protein is present. However, the presence of Atg5 protein at early stages may account 
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for improved viability of the atg5 homozygous mutants. This is supported by the fact 
that maternal contribution of atg5 is required for development past the 4-8 cell stage in 
mice (Tsukamoto et al. 2008)  
To conclude atg5 homozygous fish have Atg5 protein present at 2dpf, which is present 
due to maternally contributed mRNA, but by 8dpf, homozygous mutants no longer have 
Atg5 protein. Although protein was not compared for atg3 mutants, the maternally 
contributed wild-type mRNA is absent by 5dpf in homozygous fish, suggestive that 
Atg3 protein will be lost. 
4.3.3 Autophagy mutation effects on autophagy 
Although there is evidence that both atg3 and atg5 mutations are likely effective in 
inhibiting coding protein from being synthesised, especially so for atg5 mutants, the 
effect each mutation has on autophagy is unknown. The next aim of this chapter was to 
ascertain whether autophagy is changed in atg3 or atg5 mutant larvae.  
LC3 a widely used autophagosome marker, used to analyse autophagy. Therefore, Lc3 
was used as a readout for any changed autophagy levels in each homozygous mutant. 
Two methods were used to analyse Lc3 in zebrafish, DNA traffic-light Lc3 injections, 
and Lc3 western blots. Furthermore, rapamycin and chloroquine treatments were used 
to simultaneously upregulate and block autophagy, to allow any changes in autophagic 
flux to be determined.  
Firstly, (using traffic light Lc3) for both atg3 and atg5 homozygous mutants at 2dpf, no 
change in autophagic vesicle number was observed in comparison to wild-type siblings 
and heterozygous larvae, through analysis of both RFP or GFP positive vesicles, likely 
to be autophagosomes. Maternal contribution which is shown in this study to be 
present at 2dpf, is a likely explanation for the ability of zebrafish to produce Lc3-II 
marked vesicles at this age.  Unexpectedly, the rapamycin and chloroquine treatment 
did not show a large increase in Lc3-associated vesicles. The ineffective drug 
treatments may be due to drug concentration (being too low), or that the drugs had 
expired. It is unlikely the drug concentration used was too low as the same 
concentration had previously been published as an effective working dose, and has 
been tried and tested within the lab. However there may be genetic and/or 
environmental differences (e.g. different aquaria) which may mean fish used in these 
experiments may respond differently to drugs. Fresh drugs, potentially at increased 
dosage are required to test this.    
Assessing the ratio of RFP:GFP vesicles was used to investigate autophagic flux, 
where a high ratio indicates autophagy is functional. By comparing the ratio of RFP to 
GFP positive vesicles, it is possible to determine whether most Lc3-II marked vesicles 
161 
 
have become acidic (RFP). A higher ratio indicates autophagy is functional, whereas a 
lower ratio suggests autophagy has reduced functionality. No significant changes were 
found between this ratio, in atg3 or atg5 homozygous, heterozygous and wild-type 
siblings with or without rapamycin and chloroquine treatment. Similar to above, this 
indicates that autophagy is functional in all genotypes at 2dpf, likely caused by 
maternal contribution. Testing of fresh drugs may be useful for further analysis.  
GFP-LC3 “dots” in heart tissue were absent in atg3-/- and atg5-/- mice (Sou et al. 2008; 
Kuma et al. 2004), suggesting a difference in LC3 production between model animals. 
It would be interesting to determine whether the cardiac tissue in zebrafish lack Lc3 
puncta, and equally if the muscle tissue in mice do have LC3 puncta, which may 
represent tissue specific autophagy requirements. However, it is also possible that the 
different development and resulting autophagy stress could lead to differences in Lc3 
presence.   
Overall, the traffic light Lc3 data do conclusively demonstrate that Lc3-II is present in 
2dpf homozygous mutants. After showing that maternal mRNA, is present in larvae at 
2dpf for both atg3 and atg5 and for Atg5 protein is present, this result is somewhat 
expected as Lc3-II lipidation would be possible at this time point. Next a later stage of 
larvae development was analysed.  
Western blot analysis was completed on larvae at 8dpf, clearly demonstrating that for 
both atg3 and atg5 homozygous mutants Lc3-II was present at equal, (if not slightly 
increased) levels in comparison to wild-type larvae. Importantly, the LC3 antibody is 
capable of recognising both LC3-I and LC3-II. Using a human control, of HEK 293 
cells, in which both forms are recognised, in addition to a positive control of AB wild-
type treated with NH4Cl, known to increase LC3-II production (Hart & Young 1991), it is 
clear in the zebrafish Lc3-II is the protein being recognised. At very long exposures the 
higher Lc3-I band can be seen in zebrafish lysate, but due to the lower Lc3-II band 
being comparatively much brighter it is not often possible to clearly visualise.  
Although there is evidence that the Lc3 band observed in the western blots is Lc3-II, it 
is possible this is not correct. Identifying a protein band as either Lc3-II, Lc3-I or Lc3 is 
difficult, especially since the antibody used can recognise all forms. The human form of 
Lc3-II may run at a different size to the zebrafish form and additionally prolonged NH4Cl 
treatment (such as overnight treatment used in this study) may result in autophagy-
inhibitory feedback loops which could result in an increase of Lc3-I. For these reasons 
the Lc3 band observed could be Lc3-I rather than Lc3-II. In order to fully confirm that 
the band observed is Lc3-II, using multiple durations of drug treatments which may be 
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expected to cause a build-up of Lc3-II at short durations, and a build-up of Lc3-I at long 
durations, would be very useful in confirming which form of Lc3 is being observed.  
Homozygous atg3 and atg5 larvae having comparative levels of Lc3-II at 8dpf was 
unexpected, due to the absence of wild-type mRNA, and protein for Atg5, by this stage 
in development. This is in contrast to corresponding mouse models, where using 
mouse embryonic fibroblast (MEF) cells extracted from atg3-/- or atg5-/- mice, LC3-II 
presence was shown to be depleted by western blot analysis, and a band representing 
LC3-I was present (Kuma et al. 2004; Sou et al. 2008), a clear indication that 
autophagy is not functional. According to literature searches, there is not another 
protein which is known to physically lipidate LC3-I, as Atg3 does acting as an E2-like 
enzyme (Nath et al. 2014; Tanida et al. 2002). Similarly, Atg5 acting as an E3-like 
enzyme (in the ATG5-ATG12-ATG16 complex) is thought to be crucial for LC3-II 
production (Fujita et al. 2008). Furthermore, in atg3 deficient mice, autophagosome-like 
structures were observed, which were determined to be the unclosed autophagosome-
like vesicles, but not auto-lysosomes, which suggests autophagosome formation 
requires a functional LC3 conjugation system in vivo (Sou et al. 2008), this may 
suggest that autophagy conjugation systems are important in the closing of 
autophagosome and/or lysosome fusion, and not required for initiation or elongation 
steps of autophagy.  
This suggests that an unidentified protein may be responsible lipidating Lc3-I in 
zebrafish. Lc3-II was present in cultured zebrafish cells taken from larvae injected with 
morpholinos targeting atg5, atg7 or beclin 1 (Lee et al. 2014), suggesting that Lc3-II 
can be produced in zebrafish autophagy mutants. Although this was completed using 
primary cell cultures which may reduce the effect of morpholinos, these data suggest 
that zebrafish cells may have alternative methods of Lc3-I lipidation. However, 
according to recent literature searches alternative Lc3 lipidation strategies are not 
described. Targeted approaches to examine a potential role of other E2 enzymes may 
lead to the discovery of how Lc3-II lipidation is occurring.  
Of particular interest, a recent publication has demonstrated autolysosome formation in 
the absence of both the ATG5-ATG12 and LC3 conjugation systems, contrary to 
established belief, suggesting that atg3 and atg5 may not be essential for 
autolysosome formation (Tsuboyama et al. 2016). In atg3 KO cells, which were 
deficient of LC3-II, lysosomal fusion could still occur, at a only slightly reduced speed 
(Tsuboyama et al. 2016). Although this does not explain the presence of Lc3-II in the 
autophagy deficient larvae, it highlights that Lc3 may not be an accurate 
autophagosome marker, and suggests that autophagy can occur in a process where 
Lc3-II may not be used (and therefore degraded through autophagy). Analysis using 
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syntaxin-17 (the autophagosome marker used in their study) may prove that autophagy 
occurs without Lc3-II involvement in zebrafish.  
Furthermore, analysis of specific roles of other Lc3 homologues (such as GABARAP or 
GATE-16) may be important as key to determine the true importance of Lc3 lipidation. 
It may be discovered that these homologues are important in the LC3-II independent 
autophagy described by Tsuboyama et al 2016. For example, in Atg3 deficient mice an 
increase in GATE-16 (non-lipidated) protein level is observed (Sou et al. 2008). This 
could suggest non-lipidated GATE-16 is performing a redundancy type role in 
autophagy deficient mice, which perhaps enables some autophagy processes to occur 
even when Lc3-I (or Lc3 homologue) lipidation cannot. Targeted deletion of GATE-16 
(or other Lc3 homologues) in addition to ATG conjugation may affect the biogenesis of 
syntaxin-17 positive autophagosomes. 
Importantly this current study only proves Atg5 protein is missing at 8dpf, not Atg3. 
Using larvae at later developmental ages, such as 10 - 30dpf for Lc3 western blots may 
highlight a reduction in Lc3-I lipidation, and provide evidence that maternally 
contributed Atg3 or Atg5 is longer lasting in fish, which presumably degrades over time 
leading to survival and growth defects. Indeed, Lc3 western blots on larval mutants at 
an age where survival and growth defects are observed would be extremely useful in 
determining if Lc3-II is lipidated via an alternative pathway.  
Testing Lc3-II presence in larvae, after treatment with both rapamycin and chloroquine, 
was completed to investigate autophagic flux as mentioned above. Fish were grouped 
by genotype, with or without drug treatment. Independent of genotype, no large change 
in Lc3-II levels for the atg3 larvae was observed. Similarly, for atg5 over three 
biological repeats no large changes were seen, however for a single repeat in both 
wild-type siblings and heterozygous, both with drug treatment a large increase in Lc3-II 
levels were observed. This may represent that in these repeats the drug treatment was 
more effective. Although speculative, this may suggest that the homozygous larvae 
have reduced autophagy in the biological repeat where drug treatment appeared 
effective, since a single repeat showing more Lc3-II was not seen for homozygous 
larvae. As discussed above these results could indicate that the rapamycin and 
chloroquine were not consistently effective. It is however possible to conclude that at 
8dpf Lc3-II is present in the larvae, however improved drug treatments are needed to 
analyse autophagic flux, for example using fresh drugs, or increased drug 
concentrations. If drug treatments were more effective under improved conditions, 
more lipidation of Lc3-I may be caused by rapamycin treatment, if autophagy mutants 
could not lipidate Lc3-I as effectively as wild-type siblings, a comparatively reduced 
amount of Lc3-II would be expected.  
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To determine how long lasting any residual Atg5 may be present for, assuming 
lipidation must be completed through Atg3/Atg5 dependant conjugation systems, 
analysis of Lc3-II presence in homozygous larvae at older ages, for example 20 or 
30dpf, may highlight a difference in Lc3-II levels. This would be particularly interesting 
considering mutant survival is significantly longer than maternal contribution, and any 
residual Atg5 may be sufficient (in Lc3 lipidation) to meet the required autophagic 
demands in zebrafish development. This does assume that LC3-II is autophagy 
specific, when in fact LC3-II can mark single membranes in LC3 associated 
phagocytosis (LAP) (Sanjuan et al. 2007). However, LC3 must be lipidated in LAP 
which still raises the question of how Lc3-I is lipidated in zebrafish. Furthermore, both 
atg3 and atg5 are used in the lipidation of LC3-I which is trafficked to LAP phagosomes 
(Martinez et al. 2015). Although LC3-II levels may be expected to change in response 
to autophagy induction or blockage, because LC3 is not specific to autophagy and is 
not required for autophagosome formation (Tsuboyama et al. 2016), it is possible other 
un-identified factors are responsible for zebrafish Lc3-I lipidation, perhaps an 
alternative E2-like protein is able to lipidate Lc3-I as suggested above 
Any blockage in autophagy conjugation systems would be expected to result in a loss 
of Lc3-II levels. The expected effect of each mutation was a reduction in Lc3 lipidation, 
since both atg3 and atg5 are key genes in the lipidation of Lc3. These expected results 
are not observed in either the atg3 or atg5 zebrafish mutants. The important roles of 
autophagy are diverse, including in development, infection, starvation and recycling, 
which may lead to high redundancy within the pathway. However, the importance of 
atg3 and atg5 are clearly represented in both zebrafish and murine deficient models 
reduced survival (Kuma et al. 2004; Sou et al. 2008). Furthermore, in the atg5-/- mouse 
model which does not receive any maternally contributed protein, the embryo does not 
survive past the 4-8 cell stage (Tsukamoto et al. 2008). atg5 independent autophagy 
has previously been reported (Nishida et al. 2009), indicating a functional autophagy 
pathway which can circumvent classical autophagy components. It is important to 
consider that any mutation effect, is a single part of a large, interconnected and 
redundant system. For example, in atg5-independent autophagy, or in autophagosome 
formation which does not require LC3 lipidation (Nishida et al. 2009; Tsuboyama et al. 
2016). This high redundancy may allow the zebrafish mutant to survive longer than 
expected, despite the importance of the specific gene which is mutated.  
The presence of Lc3-II at similar levels is suggestive that autophagy is functional, 
perhaps high redundancy within the pathway may account for the lack of atg3 or atg5 
dependant Lc3 lipidation, residual protein, or un-identified E2-like proteins as discussed 
above. For this reason, in addition to non-specificity, Lc3 is not a marker that can be 
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used to interpret autophagy function alone. To further verify autophagy as up-regulated 
and down-regulated, a combination of autophagy related markers, such as p62 or 
syntaxin-17, would be very useful to assess.  
Despite the presence of Lc3-II, survival and growth defects in each autophagy mutant 
suggest that lack of atg3 or atg5 is causing autophagy related defects. The other 
method used to assess whether the autophagy mutants were in fact deficient in 
autophagy, was the study of survival under starvation conditions. As discussed above 
(section 4.3.1), for atg5 homozygous mutants, earlier deaths under starvation 
conditions suggests that autophagy is deficient, although the reduced larval survival 
was not significant. In future comparison of amino acid availability in autophagy mutant 
larvae may provide evidence that survival and growth defects are caused by an 
autophagy mediated lack of amino acid supply, as shown for atg3, atg5 and atg7 
mutant mice (Sou et al. 2008; Komatsu et al. 2005; Kuma et al. 2004). This would 
provide clear evidence of an autophagy mediated phenotype.  
As described above, the yolk food source, and lower metabolic rate (due to no heat 
generation and swimming), may stop the immediate starvation and pressure on the 
autophagic system in zebrafish, which the atg3-/- and atg5-/- mice, as mammals 
experience (Jardine & Litvak 2003; van de Pol et al. 2017). Zebrafish may therefore 
have less reliance on autophagy during development, which may enable comparatively 
longer survival than autophagy deficient mammals, perhaps enables through the 
presence of residual protein. It is important to analyse Lc3-II levels at stages when 
autophagy mutants display the growth/survival defect (~20-30dpf), to determine if at 
later developmental stages Lc3-I lipidation is reduced and may be responsible for these 
phenotypes, perhaps through lack of amino acid recycling.  
To conclude, using Lc3 as a marker of autophagy does not sufficiently prove any 
difference in autophagy levels in zebrafish larvae, although does provide evidence that 
Lc3-II is present at 2dpf and 8dpf, indicating that some autophagy is functional in the 
mutants. In fact these data raise a potentially very interesting question of exactly how 
Lc3-I is being lipidated in atg3 and atg5 deficient larvae when considering the key 
proteins involved in this step are missing, demonstrated conclusively for Atg5.  
 
4.4 Chapter summary 
Both atg3 and atg5 homozygous mutants display a severe survival defect at 20-30dpf, 
in addition to a growth defect starting at ~20dpf. Similar survival defects are displayed 
in other autophagy deficient models, suggestive that autophagy mutations are 
responsible for these phenotypes. Further analysis into amino acid availability and 
166 
 
cardiac function are required to validate this. Maternal contribution occurs for both 
mutants and may enable embryonic survival, however by 5dpf maternal mRNA is lost, 
and at 8dpf Atg5 protein is lost. These data suggest that each mutation is effective in 
causing atg3 or atg5 deficiency in zebrafish. Interestingly, Lc3-II is present at both 2dpf 
and 8dpf. Lc3-II presence at 2dpf may be enabled through maternal contribution, 
however at 8dpf (for atg5 at least), Lc3-II is not expected. Further, investigation into 
how the lipidation Lc3-I is possible in these mutants presents an exciting opportunity for 
the future.  
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Chapter 5: Results chapter 3 
Using zebrafish autophagy mutants to study the role of autophagy 
in S. aureus and C. neoformans infection 
 
5.1 Chapter introduction  
Autophagy is a cellular self-degradation process which has been implicated in the 
handling of several pathogens. Selective autophagy, specifically leading to the 
degradation of pathogens, is termed xenophagy. In some cases autophagy is important 
for ultimate degradation of the pathogen, however it is also possible that the pathogen 
exploits host cell autophagy to promote its own survival.   
S. aureus has been shown to interact with host cell autophagy in multiple cell types. S. 
aureus is known to reside in autophagosomes with LC3 recruitment (Schnaith et al. 
2007) and to interact with selective autophagy receptor p62 (Neumann et al. 2016). 
Whether host cell autophagy is beneficial for the bacteria or host cell is unclear, with 
evidence suggesting both (introduced in section 1.4.7). Differences in the role of host 
cell autophagy may be determined according to host cell type and bacterial virulence 
factor expression.  
The role of host cell autophagy in C. neoformans infection has not been as well 
studied, although there is limited data suggesting that C. neoformans containing 
phagosomes can recruit autophagic components (Nicola et al. 2012). Furthermore, C. 
neoformans replication is reduced under conditions where host autophagy is non-
functional (Qin et al. 2011; Nicola et al. 2012). Despite this, C. neoformans has never 
been visualised within a double-membrane vesicle. This may suggest that any role of 
autophagic components in cryptococcal infection is separate to autophagosome 
formation, although autophagosome formation cannot be ruled out. For both S. aureus 
and C. neoformans, there is evidence to suggest that host autophagy is beneficial for 
pathogen survival, however the mechanism of these interactions and the role they play 
in infection outcome are not fully characterised. 
Zebrafish infection has been established for both S. aureus and C. neoformans. 
Importantly, tools available for studying autophagy in zebrafish are also established, 
with mutant and transgenic lines available. Initial S. aureus infection studies used 
morpholino experimental approaches to study autophagy gene expression. 
Morpholinos (phosphorodiamidate Morpholino oligomers) are short ~25bp oligomer 
molecules which are designed to bind and block access to RNA resulting in inhibition of 
protein production. Morpholinos were designed to target specific autophagy gene 
expression, and used to knock-down autophagy gene function at the translational level. 
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Although some potential changes in infection survival were suggested for an atg16 
knock-down, for key autophagy genes atg3 and atg5, no change in infection survival 
was observed (PhD thesis, Lambein, 2015). Potential reasons for this could be the 
short-lived effects of morpholinos, off-target effects, or their true lack of efficacy. 
Therefore, morpholino based experiments do not adequately determine whether knock-
down of specific autophagy genes affects survival during infection. For this reason 
autophagy mutant lines were established.  
 
Hypothesis: Phagocyte control of S. aureus and C. neoformans infection, will be altered 
in atg3-/- and atg5-/- zebrafish in comparison to larvae with competent autophagy.  
 
Chapter aims:  
1) Establish if S. aureus is handled by the autophagy pathway, specifically in 
regards to the role of both atg3 and atg5 
2) Establish if C. neoformans is handled by the autophagy pathway, specifically in 
regards to the role of both atg3 and atg5 
 
This chapter aims to use autophagy zebrafish mutants in key autophagy genes, in 
addition to relevant autophagy transgenic lines, to dissect the role of host autophagy in 
response to S. aureus and C. neoformans infection.   
 
atg3 and atg5 autophagy mutants were established to test if key autophagy genes 
have an important role in the host-pathogen interaction of both S. aureus, and C. 
neoformans infection. Both atg3 and atg5 mutations lead to a survival defect and 
growth defect. However, because Lc3-II is present in the larvae, it is possible that some 
autophagy is functional. It is therefore significant that for the atg5 mutants, by 8dpf, 
there is no detectable Atg5 protein within the zebrafish. This does indicate that the 
mutation is effective in stopping the production of Atg5 protein. Due to the similar 
phenotype of both mutants, it seems likely that the atg3 mutation is also effective in this 
regard. Autophagy is known to be important in pathogen handling, or as a route of 
pathogen subversion. Here, using zebrafish lacking key autophagy genes, the role 
each gene plays in infection by either S. aureus or C. neoformans is examined. 
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5.2 Infection of autophagy mutants: 
5.2.1 Inoculum dependant survival  
Zebrafish models of infection of S. aureus and C. neoformans have been well 
established previously (Prajsnar et al. 2008; Bojarczuk et al. 2016), and the same 
infection protocols were followed. To ensure personal proficiency in infection, inoculum 
dependant survival curves were completed.  
First, C. neoformans was injected at inocula of 0, 10, 100, 500 or 1000cfu at 2dpf and 
larval survival was monitored for 3 days. The range of infection inocula was chosen to 
be likely to cause different larval survival outcomes, as indicated by previously 
established C. neoformans infections (Bojarczuk et al. 2016). S. aureus was injected at 
inocula of 0, 1-600, 1200-1800 or 1800-2400cfu at 1dpf and survival monitored for 4 
days. Grouped inocula were used, rather than exact inocula, due to the difficulties in 
calculating exact inoculum at the time of infection. The exact inoculum was determined 
subsequently through counting of colony forming units (of diluted injected doses) grown 
overnight, as described in the materials and methods. Different S. aureus inocula were 
chosen as likely to lead to differential survival outcomes as established previously 
(Prajsnar et al. 2008).  
Survival of larvae was reduced when infected with C. neoformans at higher fungal 
inocula in comparison to reduced inocula. Survival of larvae infected with 500 and 
1000cfu was significantly reduced in comparison to non-infected larvae (Fig. 5.1 A). S. 
aureus infection leads to large differences in larval survival, an inoculum lower than 
1200cfu leads to a larval survival of more than 50%, whereas infection with more than 
1200cfu leads to larval survival of less than 50%. Survival is significantly reduced for 
each infection dose, in comparison to non-infected fish (Fig. 5.1 B).   
Importantly, these data show that zebrafish mortality is proportional to the pathogen 
load, and therefore it is the pathogen, rather than needle or handling related injuries, 
causing death, allowing the subsequent infection studies in autophagy mutants to 
exclude non-pathogen related death.  
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Figure 5.1 Larval survival of C. neoformans or S. aureus infection is 
dependent on inoculum 
A Survival of AB wild-type fish infected with different inoculums of C. neoformans at 
2dpf (** p<0.01, n=5 Log-Rank Mantel-Cox, 30-89 larvae per inoculum) B Survival 
of AB wild-type fish infected with different inocula of S. aureus at 1dpf (**p<0.01, 
****p<0.0001, n=5, Log-Rank Mantel-Cox 23-96 larvae per inoculum).  
  
5.2.2 Survival of autophagy mutants under infection 
Survival of both atg3 and atg5 zebrafish lines was first examined, to determine if larval 
survival is changed in the homozygous mutants under infection conditions. Duration of 
infection was increased beyond 5dpf, to allow infection to be followed over a time 
period when protein derived from the maternal contribution should be absent from 
homozygous mutants (Fig. 4.6, above).  
In the first instance, C. neoformans infection of autophagy mutants was followed over 
an extended duration, to investigate whether an obvious difference in survival would be 
seen. It might be expected that a different survival would be observed in 25% 
(representing the homozygous mutants) of a heterozygous in-cross, according to 
Mendelian genetics. S. aureus infection of atg3 and atg5 mutants was previously 
performed using abscess formation as an endpoint, with no difference in infection 
outcome observed (PhD thesis Lambein, 2015). Similarly, C. neoformans infection of 
larvae from a heterozygous in-cross of either atg3 or atg5 lines did not reveal any 
significant difference in survival in comparison to infected AB wild-type larvae (Fig. 5.2 
A).  
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Figure 5.2 Larval survival is not reduced in atg3 or atg5 heterozygous 
in-crosses in C. neoformans infection 
A Survival of atg3 and atg5 heterozygous fish in-crosses infected with 1000cfu 
KN99 C. neoformans, or without infection (not significant, n=3 Log-Rank Mantel-
Cox, 36-62 larvae per group). Infection followed until 10dpf completed at IMCB in 
Singapore.  
  
An obvious change in larval survival was not seen using heterozygous in-crosses of 
either autophagy zebrafish line. This suggests that a dramatic difference in survival 
was not observed for infected homozygous mutants. Next, survival of both atg3 and 
atg5 infected with C. neoformans or S. aureus was examined by genotype group, after 
larval death or experimental endpoint, to investigate any less dramatic changes in 
larval survival.  
In all cases, non-infected larval survival was high, independent of genotype, 
demonstrating that larvae death is caused by infection. C. neoformans infection of an 
atg3 heterozygous in-cross shows similar survival for all infected fish, including AB 
wild-type fish (Fig. 5.3 A), no significant difference in larval survival was observed for 
any infection genotype. Thus, survival of homozygous atg3 fish in C. neoformans 
infection is not changed.  
Survival of atg5 homozygous larvae is significantly reduced compared to infected AB 
wild-type larvae, however is not significantly reduced in comparison to wild-type 
siblings in the C. neoformans infection of an atg5 heterozygous in-cross (Fig. 5.3 B). 
Infected wild-type siblings are better controls than ABs, being closer genetically to the 
homozygous mutants. Therefore, survival is not changed for atg5 homozygous mutants 
in C. neoformans infection. 
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Figure 5.3 Larval survival is not reduced for atg3 or atg5 mutants in C. 
neoformans infection 
A Survival of atg3 heterozygous fish in-crosses infected with 500cfu KN99 C. 
neoformans, or without infection (not significant, n=3 Log-Rank Mantel-Cox, 16-25 
larvae per infected group). B Survival of atg5 heterozygous fish in-crosses infected 
with 500cfu KN99 C. neoformans, or without infection (ns=not significant, 
***p<0.001, n=3, Log-Rank Mantel-Cox 29-75 larvae per infected group). Infection 
followed until 10dpf completed at IMCB in Singapore.  
Larval survival with infection of S. aureus was next considered. For both atg3 and atg5 
heterozygous in-cross experiments, PBS control injections showed high larval survival. 
In both atg3 and atg5 S. aureus infections larval survival was low, as compared to 
Figure 5.1 which show higher larval survival at 3dpf at comparative doses, than seen in 
these experiments, completed in IMCB.  
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Figure 5.4 Larval survival is improved for atg3 but not atg5 mutants in 
S. aureus infection 
A Survival of atg3 heterozygous fish in-crosses infected with ~2500cfu SH1000 GFP 
S. aureus, or control PBS infection (*p<0.05, **p<0.01, n=6, Log-Rank Mantel-Cox, 
11-68 larvae per infection group). B Survival of atg5 heterozygous fish in-crosses 
infected with ~2500cfu SH1000 GFP S. aureus, or control PBS infection (not 
significant, n=6, Log-Rank Mantel-Cox, 22-100 larvae per infection group). Infection 
followed until 10dpf completed at IMCB in Singapore.  
Despite overall low larval survival, infection of the atg3 heterozygous larvae shows that 
both homozygous and heterozygous fish have significantly better survival than wild-
type siblings (Fig. 5.4 A). This indicates that atg3 homozygous and heterozygous fish 
have improved survival in S. aureus infection. In contrast, survival of atg5 homozygous 
zebrafish is not significantly different to wild-type siblings (Fig. 5.4 B). Therefore atg5 
homozygous fish do not have changed survival under S. aureus infection.  
 
Although an increase in larval survival was observed for both heterozygous and 
homozygous atg3 larvae, no change was seen for atg5 homozygous mutants in S. 
aureus infection. Infection with C. neoformans highlighted no change in infection 
outcome for either atg3 or atg5 autophagy mutant. I hypothesised that by putting 
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additional pressure on larval autophagy, any larval survival changes caused by 
infection may be amplified, which are not observed in the experimental conditions 
normally used.  
5.2.3 Infection under starvation conditions 
Starvation is a useful autophagy activator, which leads to an increase in autophagy, 
and increased turnover of autophagic machinery. Larval starvation (without infection), 
reduced the survival of atg5 homozygous mutants, indicating that pressuring 
autophagy through lack of nutrients increases the pressure on autophagy, as shown 
above, (Fig. 4.19). A role of atg3 and atg5 in clearance of infection may become 
apparent through combined infection and lack of nutrients. Next, the survival of larvae 
under both infection and starvation conditions was investigated to determine if any 
survival changes are amplified.  
A lower dose of each pathogen was used in these cases, 100cfu for C. neoformans, 
and 500cfu of S. aureus, to ensure that enough fish would survive until 7-11dpf when 
the yolk food source is depleted. An atg3 or atg5 heterozygous in-cross was used, with 
no AB wild-type controls. This was due to the valid wild-type siblings acting as control 
which are present in the heterozygous in-cross, this reduced the need to use AB wild-
type fish in this procedure, (animal work completed in Singapore under the Institutional 
Animal Care and Use Committee (IACUC) guidelines, under locally ethically approved 
IACUC protocol number 140977). 
Survival was not significantly different between atg3 wild-type siblings, heterozygous or 
homozygous larvae in C. neoformans infection and starvation conditions (Fig. 5.5 A). 
Survival was also not significantly different between atg5 wild-type siblings, 
heterozygous or homozygous larvae in C. neoformans infection and starvation 
conditions, (Fig. 5.5 B), however the atg5 homozygous mutants show a (non-
significant) trend towards reduced survival after 7dpf.  
Only a small proportion of fish were able to survive until after 11dpf under S. aureus 
infection. For atg3 starvation and S. aureus infection data, similar to the C. neoformans 
data, no significant difference was seen in larval survival between genotypes (Fig. 5.6 
A). Larval survival was not significantly different between atg5 homozygous, 
heterozygous or wild-type siblings in dual starvation and S. aureus infection (Fig. 5.6 
B). Overall these data suggest for atg3 homozygous fish, no significant changes in 
larval survival occur, for both S. aureus and C. neoformans infection.  
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Figure 5.5 Autophagy mutant survival is not changed in C.neoformans 
infection in starvation conditions 
A Larval survival from atg3 heterozygous fish in-crosses infected with 100cfu C. 
neoformans (not significant, n=5, Log-Rank Mantel-Cox. 24-88 larvae per group). B 
Survival of atg5 heterozygous fish in-crosses infected with 100cfu C. neoformans 
(not significant, n=4, Log-Rank Mantel-Cox, 26-56 larvae per group). Infection 
under starvation conditions followed until 20dpf completed at IMCB in Singapore.  
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Figure 5.6 Autophagy mutant survival is not changed in S. aureus 
infection in starvation conditions 
A Larval survival from atg3 heterozygous fish in-crosses infected with 500cfu S. 
aureus (not significant, n=4, Log-Rank Mantel-Cox, 13-54 larvae per group). B 
Survival of atg5 heterozygous fish in-crosses infected with 500cfu S. aureus (not 
significant, n=3, Log-Rank Mantel-Cox, 19-48 larvae per group). Infection under 
starvation conditions followed until 20dpf completed at IMCB in Singapore.  
 
Under non-infection starvation conditions an earlier larvae death of ~4-5 days was 
seen for atg5 homozygous larvae (Fig 4.19 above). For atg5 homozygous fish, a trend 
towards reduced survival of larvae was seen after 7dpf in C. neoformans infection with 
starvation, which may be expected due to starvation conditions alone. No difference 
was seen in atg5 homozygous larval survival for S. aureus infection with starvation. 
This may indicate a slight improvement in atg5 homozygous larval survival during S. 
aureus infection, considering under non-infection starvation experiments, reduced 
survival is seen. However, due to the much earlier timeframe of death in S. aureus 
infection, this requires further investigation, perhaps using a lower dose to enable 
survival to later time points.   
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Figure 5.7 Autophagy mutant survival is not changed in C.neoformans 
infection at 20dpf 
A Larval survival from atg3 heterozygous fish in-crosses infected with 1000cfu C. 
neoformans (not significant, n=4, Log-Rank Mantel-Cox, 13-39 larvae per group). B 
Survival of atg5 heterozygous fish in-crosses infected with 1000cfu C. neoformans 
(not significant, n=6, Log-Rank Mantel-Cox, 4-24 larvae per group). Infection at 
20dpf followed until 40dpf completed at IMCB in Singapore.  
5.2.4 Infection at later time points 
Data from starvation and infection survival experiments showed no significant changes 
in survival for the homozygous autophagy mutants. Both atg3 and atg5 homozygous 
mutants show reduced survival under normal feeding conditions by 20dpf (Fig. 4.4, 
above). I hypothesised that the effects of these mutations on responses to infection will 
be more prominent following infection at 20dpf.  
These data remain preliminary, because although multiple repeats (of at least 4) were 
completed in all cases, the number of homozygous mutants viable at 20dpf was very 
low, leading to low numbers for analysis. Unfortunately, time constraints did not allow 
for further repeats.  
Infection of 1000cfu C. neoformans at 20dpf led to similar survival between atg3 
homozygous, wild-type siblings and heterozygous larvae (Fig. 5.7 A). Similarly, survival 
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Figure 5.8 Autophagy mutant survival is not changed in S. aureus 
infection at 20dpf 
A Larval survival from atg3 heterozygous fish in-crosses infected with 2500cfu S. 
aureus (not significant, n=5, Log-Rank Mantel-Cox, 4-54 larvae per group). B 
Survival of atg5 heterozygous fish in-crosses infected with 2500cfu S. aureus (n=4, 
Log-Rank Mantel-Cox, 1-44 larvae per group). Infection at 20dpf followed until 
40dpf completed at IMCB in Singapore. 
of homozygous atg5 mutant larvae was not significantly different to wild-type or 
heterozygous larval survival, although a (non-significant) trend towards reduced 
survival is shown for atg5 homozygotes (Fig. 5.7 B).  
Larval survival was not significantly different for atg3 homozygous fish in comparison to 
wild-type or heterozygous fish, under infection of 2500cfu S.aureus (Fig. 5.8 A). On the 
other hand, for atg5 S. aureus infection at 20dpf, a difference was determined between 
homozygous mutants larval survival, and both wild-type siblings and heterozygous 
larvae (Fig. 5.8B). However, the homozygous group consists of a single fish so data 
from more homozygous fish would needed to confirm this result.  
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Overall, larvae survival was not drastically different for either S. aureus or C. 
neoformans infection in atg3 or atg5 mutants, a major change in survival outcome may 
have been expected if atg3 or atg5 play an important role in the outcome of host-
pathogen interactions. However, an alternative reason why survival is not changed in 
infected larvae could be due two reasons. Firstly, early in infection maternal 
contribution may enable normal atg3 or atg5 levels in the larvae resulting in normal (not 
lacking atg3 or atg5) host-pathogen handling. Secondly, later in development, the 
survival defect which is already causing homozygous death independently of infection 
may override any defects in handling of pathogens, leading to earlier death. For these 
reasons, using autophagy mutant larval survival outcome of infection alone to assess 
the role of atg3 or atg5 may not provide clear answers.  
 
5.2.5 Fungal and bacterial burden 
To determine if C. neoformans or S. aureus infection is able to cause death to a similar 
extent in autophagy deficient fish as wild-type fish, the fungal and bacterial burden 
within atg3 and atg5 larvae was compared. I hypothesised that if atg3 or atg5 are 
important in pathogen clearance, homozygous autophagy mutant larvae may have an 
increased fungal or bacterial burden during infection, in comparison to wild-type larvae. 
Additionally autophagy mutants may also have a lower pathogen burden which is able 
to cause to larval death. 
The bacterial burden was measured in larvae at 0dpi (1dpf) to 4dpi (5dpf) in atg3 and 
atg5 after infection of 2500cfu of S. aureus into heterozygous in-crosses. There is no 
significant difference between atg3 homozygous, heterozygous and wild-type siblings 
bacterial burden at any time point (Fig 5.9 A) indicating that bacterial burden is similar 
in all genotypes. The bacterial burden the day before death was compared to discover 
if a reduced bacterial burden in homozygous larvae may cause death in comparison to 
wild-type siblings. However, there was no significant difference between the bacterial 
burden preceding death between any atg3 genotype (Fig 5.9 B). This indicates that 
atg3 homozygous mutants do not have an increased bacterial burden during infection, 
and that a similar bacterial burden to wild-type siblings causes death.  
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Figure 5.9 Lethal bacterial burden is not different for autophagy 
mutant larvae 
2500cfu of GFP S. aureus, injected into atg3 or atg5 heterozygous in-crosses, 
imaged at 0dpi, 1dpi, 2dpi, 3dpi and 4dpi. GFP positive pixels represent the GFP 
positive bacteria within individual larvae. A Bacterial burden of atg3 heterozygous 
fish, average at each time point (n=3, 63 larvae, +/- SD, not significant Two-way 
ANOVA, Tukey’s test) B Bacterial burden of atg3 heterozygous fish, of larvae which 
died on between 1dpi and 5dpi (n=3, 32 larvae, +/- SD, not significant One-way 
ANOVA, Kruskal-Wallis test) C Bacterial burden of atg5 heterozygous fish, average 
at each time point (n=3, 37 larvae, +/- SD, not significant Two-way ANOVA, Tukey’s 
test) D Bacterial burden of atg5 heterozygous fish, of larvae which died on between 
1dpi and 5dpi (n=3, 23 larvae, +/- SD, not significant One-way ANOVA, Kruskal-
Wallis test)    
 
 
Similarly, there is no significant difference between the bacterial burden of atg5 
homozygous, heterozygous and wild-type at any time point (Fig 5.9 C) indicating that 
bacterial burden is similar in all atg5 genotypes. There was also no significant 
difference in the bacterial burden preceding death between any atg5 genotype (Fig 5.9 
D). This indicates that atg5 homozygous mutants do not have an increased bacterial 
burden during infection, and larvae death is caused by a similar bacterial burden to 
wild-type siblings.   
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Figure 5.10 Lethal fungal burden is not different for autophagy mutant 
larvae 
1000cfu of GFP C. neoformans, injected into atg3 or atg5 heterozygous in-crosses, 
imaged at 0dpi, 1dpi, 2dpi and 3dpi. GFP positive pixels represent the GFP positive 
cryptococcal cells within individual larvae. A Fungal burden of atg3 heterozygous 
fish, average at each time point (n=3, 64 larvae, +/- SD, *p<0.05, ***<p<0.001 Two-
way ANOVA, Tukey’s test at 5dpf) B Fungal burden of atg3 heterozygous fish, of 
larvae which died on between 1dpi and 5dpi (n=3, 42 larvae, +/- SD, not significant 
One-way ANOVA, Kruskal-Wallis test) C Fungal burden of atg5 heterozygous fish, 
average at each time point (n=3, 48 larvae, +/- SD, not significant Two-way 
ANOVA, Tukey’s test) D Fungal burden of atg5 heterozygous fish, of larvae which 
died on between 1dpi and 5dpi (n=3, 19 larvae, +/- SD, not significant One-way 
ANOVA, Kruskal-Wallis test)    
 
Next, the fungal burden was measured in larvae at 0dpi (2dpf) to 3dpi (5dpf) in atg3 
and atg5 after infection of 1000cfu of C. neoformans into heterozygous in-crosses. 
There is no significant difference between atg3 homozygous, heterozygous and wild-
type siblings fungal burden at 0dpf to 4dpf. However at 5dpf (3dpi) there is a significant 
decrease in fungal burden in atg3 homozygous and atg3 heterozygous larvae in 
comparison to wild-type siblings (Fig 5.10 A) indicating that fungal burden is similar in 
all genotypes until later in infection. This may suggest that host atg3 is useful for fungal 
survival and growth. Furthermore, there was no significant difference between the 
fungal burdens preceding death between any atg3 genotype (Fig 5.10 B). This 
indicates that atg3 homozygous mutants do not have an increased fungal burden 
during early infection, but that a similar bacterial burden to wild-type siblings causes 
larvae death.  
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There was no significant difference between the fungal burden of atg5 homozygous, 
heterozygous and wild-type at any time point (Fig 5.10 C) indicating that fungal burden 
is similar in all atg5 genotypes throughout infection. No significant difference in the 
fungal burden preceding death between any atg5 genotype was observed (Fig 5.10 B). 
This indicates that atg5 homozygous mutants do not have an increased fungal burden 
during infection, and homozygous larval death is caused by a similar fungal burden to 
wild-type siblings.   
Analysis of the fungal and bacterial burden suggest that during infection both atg3 and 
atg5 are not important in controlling S. aureus or C. neoformans infection. Furthermore, 
these data suggest that host larvae deficient in atg3 or atg5 were not susceptible to 
infection at lower burdens than wild-type siblings.  
 
ATG5 infection with 3-MA treatment 
3-Methyladenine (3-MA) is an autophagy inhibitor (which acts to inhibit autophagy at 
the PI3K complex) which is known to inhibit ATG5-independent autophagy in addition 
to canonical macroautophagy (Juenemann & Reits 2012). To determine whether atg5 
independent autophagy is functional in atg5 mutants, and therefore providing a route of 
autophagy mediated host clearance, any further potential changes in larval survival or 
fungal/bacterial burden, under both 3-MA treatment and infection were investigated.  
In all cases an atg5 heterozygous in-cross was used. No change in survival is seen 
between control atg5 larvae and 3-MA treated larvae, suggesting 3-MA treatment does 
not kill larvae. However, a significant reduction in survival is observed for S. aureus 
infected larvae in comparison to both control and 3-MA treated larvae (Fig 5.11 A). This 
highlights that S. aureus is causing mortality of larvae.  However, no significant 
difference between atg5 homozygous, heterozygous or wild-type larvae treated with 3-
MA and also infected with S. aureus was observed (Fig 5.11 B). As no change in 
survival is seen in homozygous larvae, this suggests that atg5 independent autophagy 
is not crucial to larval survival of S. aureus infection. Of note, more repeats are required 
for this due to the low number of larvae within some genotype groups.  
No change in survival was observed between atg5 non-injected larvae, atg5 larvae 
treated with 3-MA, or atg5 larvae infected with C. neoformans (Fig 5.11 C). It may be 
expected that larvae infected with C. neoformans may have had a higher mortality. In 
atg5 larvae treated with 3-MA and infected with C. neoformans, no significant 
difference in survival was observed between any genotype (Fig 5.11 D). This suggests 
that atg5 independent autophagy is not important in larval survival of C. neoformans 
within atg5 deficient fish. 
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Figure 5.11 No difference in survival in infected atg5 autophagy 
mutant larvae treated with 3-MA 
A Survival of atg5 heterozygous fish, atg3 larvae treated with 3-MA, or atg3 infected 
with 2500cfu S. aureus (**p<0.01, ****p<0.001, n=3, Log-Rank Mantel-Cox, 23-28 
larvae per group) B Survival of atg5 heterozygous fish infected with 2500cfu S. 
aureus grouped by genotype (n=3, not significant Log-Rank Mantel-Cox, 4-12 
larvae per group). C Survival of atg5 heterozygous fish, atg5 larvae treated with 3-
MA, or atg5 infected with 1000cfu C. neoformans (not significant, n=3, Log-Rank 
Mantel-Cox, 27-32 larvae per group). D Survival of atg5 heterozygous fish infected 
with 1000cfu C. neoformans (not significant, n=3, Log-Rank Mantel-Cox, 11-24 
larvae per group).  
 
 
 
Preliminary data of the bacterial burden of atg5 S. aureus infected and 3-MA treated 
larvae, grouped by genotype over time highlights an increase in bacterial burden in 
homozygous larvae at 2dpf and 5dpf (Fig 5.12 A). This may represent larvae which are 
moribund due to extremely high bacterial burden, which in S. aureus infection can 
occur at 2dpf. To determine whether different extremes of bacterial burden causes 
different death outcomes between genotypes, the bacterial burden (the day before 
death) of larvae which died before 5dpf were compared. No significant difference in 
bacterial burden between atg5 homozygous, heterozygous or wild-type siblings was 
found, (Fig 5.12 B) suggesting that all genotypes are equally susceptible to bacterial 
infection. Of note, limited data was collected due to time restrictions and further 
investigation may lead to statistical significance of a potential trend towards a higher 
bacterial burden in homozygous larvae.  
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Figure 5.12 No difference in fungal or bacterial burden in atg5 
autophagy mutant larvae treated with 3-MA 
A Bacterial burden of atg5 heterozygous fish treated with 3-MA and infected with 
2500cfu S. aureus (n=2, 3-5 larvae per group) B Bacterial burden from the day 
before death of atg5 heterozygous fish treated with 3-MA and infected with 2500cfu 
S. aureus (n=2, not significant one-way ANOVA, 2-3 larvae per group) C Fungal 
burden of atg5 heterozygous fish treated with 3-MA and infected with 1000cfu C. 
neoformans (n=3, 11-24 larvae per group) D Fungal burden from the day before 
death of atg5 heterozygous fish treated with 3-MA and infected with 1000cfu C. 
neoformans (n=3, not significant one-way ANOVA, 3-8 larvae per group)  
Preliminary data of the fungal burden of atg5 C. neoformans infected and 3-MA treated 
larvae, grouped by genotype over time highlights an increase in fungal burden in all 
genotypes through the time course of infection to 5dpf, especially in homozygous and 
heterozygous larvae (Fig 5.12 C). This likely represents growth of fungal cells within 
the larvae over time. To determine whether different cases of fungal burden causes 
different death outcomes between genotypes, the fungal burden the day before death, 
in larvae which died before 5dpf, was compared.  
 
No significant difference in fungal burden between atg5 homozygous, heterozygous or 
wild-type siblings was found, (Fig 5.12 D) suggesting that all genotypes are equally 
susceptible to C. neoformans infection. Similarly, further analysis may lead to statistical 
significance for an apparent trend towards a higher fungal burden observed in 
homozygous larvae.    
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5.2.6 S. aureus and C. neoformans handling by autophagy in neutrophils 
Autophagy has been demonstrated to be involved in the host-pathogen interactions for 
both S. aureus and C. neoformans (see sections 1.4.7, 1.4.8). Analysis of mutant larval 
survival after infection with either S. aureus or C. neoformans provided limited insight 
into the role of autophagy during infection. This may be due to the multiple potential 
consequences of the autophagy mutations, which is clearly demonstrated with reduced 
survival under non-infection conditions. Therefore, pathogen interactions with the host 
were next examined at the cellular level.  
The role of neutrophil autophagy was examined in both S. aureus and C. neoformans 
infections. A neutrophil specific traffic-light Lc3 reporter zebrafish line was infected with 
pathogen (2500cfu of S. aureus or 1000cfu of C. neoformans), at 2dpf, and images 
were acquired 2 hours post infection, and a further 24 hours later (26hpi), to allow 
changes in Lc3 recruitment/involvement in pathogen interactions to be compared.  
Neutrophil handling of S. aureus involves Lc3 recruitment 
The number of neutrophils which contain bacteria is significantly reduced from 0dpi to 
1dpi (Fig 5.13 A, B), suggesting that neutrophils are able to efficiently degrade S. 
aureus or that the bacteria escapes from neutrophils. S. aureus is shown to reside in 
vesicles in the majority of cases, but can reside in the cytoplasm at both 0dpi and 1dpi 
(Fig 5.13 C). However, the vesicles which contain bacteria are significantly reduced in 
number by 1dpi, suggesting that bacteria are degraded before 1dpi (Fig 5.13 D). A 
limited number of bacteria were observed in the cytoplasm at 0dpi and 1dpi (Fig. 5.13 
E), these may represent bacteria which have escaped the phagosome. These data 
highlight how S. aureus interacts with neutrophils in the first two days of infection, and 
suggests that the majority of bacteria is likely killed and degraded within the neutrophil 
after being phagocytosed. 
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Figure 5.13 Neutrophil handling of S. aureus results in bacterial 
clearance 
2500cfu of GFP S. aureus injected into Tg(LyzC:RFP.GFP.Lc3), larvae imaged in 
the CHT at 2hpi (0dpi) and 26hpi (1dpi). A The number of infected or non-infected 
neutrophils at 0dpi and 1dpi (****p<0.0001 Chi Square test, n=3, 17 0dpi larvae, 11 
1dpi larvae) B The proportion of infected or non-infected neutrophils at 0dpi and 
(****p<0.0001 Chi Square test, n=3, 17 0dpi larvae, 11 1dpi larvae) C The location of 
S. aureus, either in a vesicle or in the cytoplasm (ns, Chi Square test, n=3, 17 0dpi 
larvae, 11 1dpi larvae) D The number of S. aureus events observed in a vesicle at 
0dpi or 1dpi (**p<0.01 Mann-Whitney T-test, n=3, 17 0dpi larvae, 11 1dpi larvae) E 
The number of S. aureus events observed in the cytoplasm at 0dpi or 1dpi (n=3, 17 
0dpi larvae, 11 1dpi larvae) 
 
The recruitment of Lc3 to S. aureus contained in neutrophil vesicles was next 
examined, to determine whether a difference in Lc3 recruitment occurs in autophagy 
deficient larvae. Unfortunately the number of cytoplasmic S. aureus was not analysed 
due to a lack of data points. Similarly, data was analysed for 0dpi, but not at 1dpi due 
to a lack of data points. This is likely due to the clearance of bacteria under normal 
circumstances, further repeats may enable analysis in the future.  
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Figure 5.14 Lc3 can mark S. aureus vesicles or cytoplasmic bacteria 
2500cfu of GFP S. aureus injected into Tg(LyzC:RFP.GFP.Lc3), larvae imaged in 
the CHT at 2hpi (0dpi) and 26hpi (1dpi). White arrows point to specific examples, A 
S. aureus with Lc3 marking the entire vesicle, scale 9um B S. aureus without 
Lc3 marking the entire vesicle, scale 5.8um, C vesicle containing S. aureus 
with Lc3 puncta, scale 5.8um D S. aureus in the cytoplasm with no Lc3 co-
localisation, scale 9um, E S. aureus in the cytoplasm with Lc3 co-
localisation, scale 5.8um. 
Lc3 association with S. aureus was investigated to highlight any role of autophagy (Lc3 
recruitment) in bacterial clearance. Multiple Lc3 interactions were observed during S. 
aureus infection of the neutrophil specific Lc3 reporter larvae. S. aureus which had 
been phagocytosed was observed in neutrophil vesicles, with or without Lc3 marking 
the entire vesicle, as shown in Figure 5.14 A, B. Vesicles containing S. aureus may 
also have Lc3 puncta (Figure 5.14 C). Additionally, S. aureus was observed in the 
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Figure 5.15 Lc3 can associate to S. aureus in neutrophil infection 
2500cfu of GFP S. aureus injected into Tg(lyzC:RFP.GFP.Lc3), larvae imaged in 
the CHT at 2hpi (0dpi) and 26hpi (1dpi). A Lc3 association to the entire S. aureus 
vesicle at 0dpi and 1dpi (ns, Fisher’s test, n =3, 17 0dpi larvae, 11 1dpi larvae) B 
The number of S. aureus vesicles with Lc3 puncta  (*p<0.05, Fisher’s test, n =3, 17 
0dpi larvae, 11 1dpi larvae) C The number of S. aureus events in the cytoplasm 
with Lc3 puncta at 0dpi and 1dpi (ns, Fisher’s test, n =3, 17 0dpi larvae, 11 1dpi 
larvae).  
cytoplasm of the neutrophil, and these bacteria may also be co-localised with Lc3 
puncta. (Figure 5.14 D, E). This highlights that Lc3 is involved in neutrophil handling of 
S. aureus, in multiple ways.   
Lc3 is associated with the entire vesicle in the majority (77%) of vesicles containing 
bacteria at 0dpi, which is not significantly different at (50%) at 1dpi (Fig 5.15 A). This 
highlights that early in infection, Lc3 is recruited to the S. aureus vesicle in the majority 
of cases and therefore suggests that autophagy machinery is involved in the host 
neutrophils response to S. aureus. Vesicles containing S. aureus are significantly more 
likely to have Lc3 puncta associated at 0dpi, (Fig 5.15 B), although most bacteria is 
cleared by 1dpi. However, there is no significant change in the association of Lc3 
puncta to S. aureus in the cytoplasm over time (Fig 5.15 C). Together these data 
suggest Lc3 associates with S. aureus vesicles, and due to the lack of S. aureus at 
1dpi, likely marks vesicles before degradation or bacterial escape.  
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Figure 5.16 Neutrophil ablation does not alter fungal burden 
1000cfu of GFP C. neoformans injected into Tg(lyz:nsfB:mCherry), larvae imaged at 
3dpi (5dpf)). A The number of neutrophils present 3dpi in control and metronidazole 
treated larvae (**p<0.01 Mann-Whitney t-test, n=2, 10-14 larvae per group) B The 
GFP positive pixels (fungal burden) at 3dpi in control and metronidazole treated 
larvae (ns, Mann-Whitney t-test, n=2, 15-27 larvae per group) 
 
 
Neutrophil handling of C. neoformans involves Lc3 recruitment 
Neutrophil handling of C. neoformans is not thought to be important in the infection 
outcome of cryptococcal infection, with macrophages thought to be key in fungal 
control. To determine whether neutrophils are important in the control of cryptococcal 
infection is the present study, C. neoformans was injected into Tg(lyz:nsfB-mCherry) 
larvae, which have the nsfB gene expressed in neutrophils. The nsfB gene encodes 
nitroreductase which converts pro-drug metronidazole into a cytotoxic metabolite which 
kills the cell it is expressed in, and therefore treatment of larvae with metronidazole can 
leads to specific ablation of neutrophils (Pisharath et al. 2007).  
The ability of metronidazole treatment to ablate neutrophils was first confirmed, 
preliminary data shows at 3dpi a significant reduction in the number of neutrophils 
within each larvae is shown for metronidazole treated larvae in comparison to non-
treated larvae (Fig. 5.16 A). However, preliminary data shows that at 3dpi the fungal 
burden was not changed in larvae treated with metronidazole (Fig. 5.16 B). These data 
suggest that neutrophil ablation does not affect fungal growth in zebrafish. 
 
Multiple Lc3 interactions were observed after C. neoformans infection of the neutrophil 
specific Lc3 reporter larvae. Cryptococcal cells which had been phagocytosed were 
observed in neutrophil vesicles, with or without Lc3 marking the entire vesicle, as 
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Figure 5.17 Lc3 can mark C. neoformans vesicles  
1000cfu of GFP C. neoformans injected into Tg(LyzC:RFP.GFP.Lc3), larvae imaged 
in the CHT at 2hpi (0dpi) and 26hpi (1dpi). White arrows point at specific examples 
A C.neoformans with Lc3 marking the entire vesicle, scale 17um B C. 
neoformans without Lc3 marking the entire vesicle, scale 9um C vesicle 
containing C. neoformans with Lc3 puncta, scale 5.8um D C. neoformans 
was observed surrounded by RFP fluorescence, but not GFP, scale 5.8um.  
 
B
A
C
D
shown in Figure 5.17 A, B. Vesicles containing cryptococci may also have Lc3 puncta 
(Figure 5.17 C). This highlights that Lc3 is involved in neutrophil handling of C. 
neoformans. Interestingly, in some cases C. neoformans was observed surrounded by 
RFP fluorescence, but not GFP (Fig 5.17 D). It is tempting to propose that this 
represents Lc3 on the acidic inside of a cryptococcal vesicle, perhaps resulting from a 
recently lysed neutrophil.  
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Figure 5.18 Neutrophil handling of C. neoformans 
1000cfu of GFP C. neoformans injected into Tg(LyzC:RFP.GFP.Lc3), larvae 
imaged in the CHT at 2hpi (0dpi) and 26hpi (1dpi). A The number of infected or 
non-infected neutrophils at 0dpi and 1dpi (***p<0.001 Fisher’s test, n=3, 24 0dpi 
larvae, 14 1dpi larvae) B The proportion of infected or non-infected neutrophils at 
0dpi and (***p<0.001 Fisher’s test, n=3, 24 0dpi larvae, 14 1dpi larvae) C The 
number of cryptococcal cells observed within neutrophils at 0dpi and 1 dpi (ns, 
Mann-Whitney t-test, n=3, 24 0dpi larvae, 14 1dpi larvae) D The number of C. 
neoformans events observed in a RFP positive vesicle at 0dpi or 1dpi (ns Fisher’s 
test, n=3, 24 0dpi larvae, 14 1dpi larvae)  E The number of C. neoformans events 
observed in RFP vesicles 0dpi or 1dpi.  
 
A significant reduction of the number of neutrophils which contain cryptococcal cells is 
observed between 0dpi and 1dpi (Fig. 5.18 A, B), which may indicate fungal clearance 
from within the neutrophil, or an increase in overall neutrophil number. No significant 
increase in cryptococcal cells was observed within individual neutrophils (Fig 5.18 C) 
which suggests that intracellular growth or additional phagocytosis does not occur. 
Cryptococcal cells within RFP positive (but not GFP) vesicles, are observed on 0 and 
1dpi, but more often on 1dpi, although not significantly (Fig. 5.18 D). The number of 
cryptococcal cells observed within a single RFP positive neutrophil is increased at 1dpi 
compared to 0dpi (Fig. 5.18 E). Together these data suggest that C. neoformans is 
phagocytosed by neutrophils during infection. The limited data on RFP positive vesicles 
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Figure 5.19 Lc3 is present on C. neoformans vesicles during infection 
1000cfu of GFP C. neoformans injected into Tg(LyzC:RFP.GFP.Lc3), larvae 
imaged in the CHT at 2hpi (0dpi) and 26hpi (1dpi). A The number of Lc3 associated 
C. neoformans vesicles at 0dpi and 1dpi (****p<0.0001 Fisher’s test, n=3, 24 0dpi 
larvae, 14 1dpi larvae) B The proportion of Lc3 associated to C. neoformans 
vesicles at 0dpi and 1dpi (****p<0.0001 Fisher’s test, n=3, 24 0dpi larvae, 14 1dpi 
larvae) C The number of Lc3 puncta associated to C. neoformans vesicles at 0dpi 
and 1dpi (*p<0.05 Fisher’s test, n=3, 24 0dpi larvae, 14 1dpi larvae) 
may suggest that a larger number of fungal cells within individual neutrophils, seen on 
1dpi, results in the occurrence RFP positive neutrophils/vesicles.  
Lc3 was observed to associate with entire cryptoccocal vesicles and as puncta which 
associate to the cryptococcal vesicle (Fig. 5.17). The number of cryptococcal vesicles 
marked by Lc3 significantly decreases from 0dpi to 1dpi (Fig. 5.19 A, B). Similarly, Lc3 
puncta associated with cryptococcal vesicles is significantly decreased from 0dpi to 
1dpi (Fig. 5.19 C). These data suggest that Lc3 mark cryptococcal vesicles early in 
infection, and perhaps suggests that Lc3 marked vesicles are degraded during 
infection. 
 
Overall, it is clear that for both S. aureus and C. neoformans infection Lc3 can mark 
both pathogens’ vesicles in neutrophils, and for both pathogens there is a reduction in 
Lc3 association throughout infection. This implicates autophagic machinery, Lc3, in the 
neutrophil host response to S. aureus and C. neoformans infections.  
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5.2.7 Infection of traffic light Lc3 reporter line in autophagy mutant background 
To determine whether Lc3 association to S. aureus and C. neoformans in infection 
(within neutrophils) is important as a host defence or subversion by pathogens, the 
autophagy mutant lines were crossed into the traffic-light Lc3 line. The resulting lines, 
when in-crossed, allow visualisation of RFP.GFP.Lc3 in neutrophils, in addition to being 
atg3 or atg5 homozygous, heterozygous or wild-type siblings. The effects of the lack of 
atg3 or atg5 on Lc3 recruitment to each pathogen is next investigated.  
Autophagy mutant neutrophil handling of S. aureus 
Neutrophils were able to phagocytose S. aureus in atg3 homozygous, heterozygous 
and wild-type siblings, no significant difference in the number of infected neutrophils 
between any genotype was found at each time point, however a significant reduction in 
infected neutrophils was observed between 0dpi and 1dpi for the same genotype group 
(Fig. 5.20 A, B). Similarly, neutrophils were able to phagocytose S. aureus in all atg5 
genotypes, at a similar rate within the same time points of 0dpi and 1dpi, but a 
significantly reduced number of infected neutrophils was observed for corresponding 
genotypes between 0dpi and 1dpi (Fig. 5.20 C, D). This suggests that neutrophils in 
atg3 and atg5 homozygous mutants phagocytose S. aureus at similar rates throughout 
the time infection time course, which includes a reduction of infected neutrophils at 1dpi 
from 0dpi, (which was also observed in the non-mutant background) (Fig 5.13 A, B 
above).  
Lc3 recruitment is significantly reduced to S. aureus containing vesicles in neutrophils 
from atg3 homozygous in comparison to wild-type siblings (Fig. 5.21 A, B). This 
suggests that Lc3 is not efficiently recruited to S. aureus vesicles when atg3 is missing. 
Interestingly, the atg3 heterozygous larvae also have significantly reduced Lc3 
recruitment to S. aureus vesicles, this may suggest that heterozygous larvae have Lc3 
recruitment defects. Lc3 recruitment is significantly reduced to S. aureus containing 
vesicles in neutrophils from atg5 homozygous mutants, in comparison to both 
heterozygous and wild-type siblings (Fig. 5.21 C, D). This suggests that Lc3 
recruitment does not efficiently mark S. aureus vesicles under atg5 deficient conditions.  
Although neutrophils in atg3 or atg5 homozygous appear to phagocytose at a similar 
rate throughout infection, leading to a similar number of infected vs non-infected 
neutrophils in comparison to wild-type siblings, any changes in Lc3 recruitment could 
be caused by differences in the amount of phagocytosed material and subsequent 
availability of Lc3. For example, if a neutrophil contained 6 S. aureus vesicles, fewer 
vesicles may be marked by Lc3 in comparison to a neutrophil containing 2 S. aureus  
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Figure 5.20 Neutrophil handing is not changed in S. aureus infection 
in autophagy mutants 
2500cfu of GFP S. aureus injected into an incross of either atg3+/-* 
Tg(LyzC:RFP.GFP.Lc3), or atg5+/-*Tg(LyzC:RFP.GFP.Lc3), larvae imaged in the 
CHT at 2hpi (0dpi) and 26hpi (1dpi). A The number of infected or non-infected 
neutrophils in atg3+/-* Tg(LyzC:RFP.GFP.Lc3), grouped by genotype at 0dpi and 
1dpi (n=3, 17 larvae at 0dpi, and 20 larvae at 1dpi, **<p0.01, ***p<0.001, 
****p<0.0001 Fisher’s exact test) B The proportion of infected or non-infected 
neutrophils in atg3+/-* Tg(LyzC:RFP.GFP.Lc3), grouped by genotype at 0dpi and 
1dpi (n=3, 17 larvae at 0dpi, and 20 larvae at 1dpi, **<p0.01, ***p<0.001, 
****p<0.0001 Fisher’s exact test) C The number of infected or non-infected 
neutrophils in atg5+/-* Tg(LyzC:RFP.GFP.Lc3), grouped by genotype at 0dpi and 
1dpi (n=3, 24 larvae at 0dpi, and 19 larvae at 1dpi, ***p<0.001, ****p<0.0001 
Fisher’s exact test) D The proportion of infected or non-infected neutrophils in 
atg5+/-* Tg(LyzC:RFP.GFP.Lc3), grouped by genotype at 0dpi and 1dpi (n=3, 24 
larvae at 0dpi, and 19 larvae at 1dpi, ***p<0.001, ****p<0.0001 Fisher’s exact test) 
 
 
 
vesicles. The number of S. aureus vesicles within neutrophils was compared to 
determine whether neutrophils from atg3 or atg5 homozygous larvae phagocytose S. 
aureus in similar quantities.  
 
No significant difference in the number of S. aureus containing vesicles was observed 
for homozygous, heterozygous or wild-type siblings for either atg3 (Fig. 5.22 A), or atg5 
larvae (Fig. 5.22 B). This suggests that the reduction Lc3 recruitment in autophagy 
mutants is not caused by differences in the amount of S. aureus phagocytosed.  
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Figure 5.21 Lc3 recruitment is reduced to S. aureus vesicles in 
autophagy mutants 
2500cfu of GFP S. aureus injected into an incross of either atg3+/-* 
Tg(LyzC:RFP.GFP.Lc3), or atg5+/-*Tg(LyzC:RFP.GFP.Lc3), larvae imaged in the 
CHT at 2hpi (0dpi) and 26hpi (1dpi). A The number of S. aureus containing 
vesicles in neutrophils with or without Lc3 recruitment in atg3+/-* 
Tg(LyzC:RFP.GFP.Lc3), grouped by genotype at 0dpi (n=3, 17 larvae at 0dpi, 
***p<0.001, ****p<0.0001 Fisher’s exact test) B The proportion of S. aureus 
containing vesicles in neutrophils with or without Lc3 recruitment in atg3+/-
*Tg(LyzC:RFP.GFP.Lc3), grouped by genotype at 0dpi (n=3, 17 larvae at 0dpi, 
**p<0.01, ***p<0.001 Fisher’s exact test) C The number of S. aureus containing 
vesicles in neutrophils with or without Lc3 recruitment in atg5+/-
*Tg(LyzC:RFP.GFP.Lc3), grouped by genotype at 0dpi (n=3, 24 larvae at 0dpi, 
****p<0.0001 Fisher’s exact test) D The proportion of S. aureus containing vesicles 
in neutrophils with or without Lc3 recruitment in in atg5+/-*Tg(LyzC:RFP.GFP.Lc3), 
grouped by genotype at 0dpi (n=3, 24 larvae at 0dpi, ****p<0.0001 Fisher’s exact 
test) 
  
 
Together these data suggest that a similar number and proportion of neutrophils 
phagocytose S. aureus throughout infection, and that the amount of S. aureus 
phagocytosed is similar for atg3 or atg5 larvae of homozygous, heterozygous and wild-
type genotypes. This suggests that the reduction in Lc3 recruitment to S. aureus 
vesicles in neutrophils of atg5 homozygous, and in atg3 heterozygous and 
homozygous larvae, is not caused by differences in phagocytic ability of neutrophils. 
Although a reduction of Lc3 recruitment is observed in autophagy mutants, any 
potential differences in the outcome of S. aureus residing in Lc3 negative or Lc3 
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Figure 5.22 The number of S. aureus vesicles contained within 
neutrophils is not changed in autophagy mutants 
2500cfu of GFP S. aureus injected into an incross of either atg3+/-* 
Tg(LyzC:RFP.GFP.Lc3), or atg5+/-*Tg(LyzC:RFP.GFP.Lc3), larvae imaged in the 
CHT at 2hpi (0dpi). A The number of S. aureus vesicles contained within individual 
neutrophils from an in-cross of atg3+/-*Tg(LyzC:RFP.GFP.Lc3) grouped by 
genotype, imaged at 0dpi (n=3, 17 larvae, not significant, One-way ANOVA 
(Kruskal-Wallis test, +/- SD) B The number of S. aureus vesicles contained within 
individual neutrophils from an in-cross of atg5+/-*Tg(LyzC:RFP.GFP.Lc3) grouped 
by genotype, imaged at 0dpi (n=3, 24 larvae, not significant, One-way ANOVA 
(Kruskal-Wallis test, +/- SD) 
 
positive vesicles, for example increased bacterial survival or escape from 
vesicles/neutrophils, presents an exciting research area, which unfortunately could not 
be further investigated due to time restrictions.  
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Autophagy mutant neutrophil handling of C. neoformans 
Neutrophils were able to phagocytose C. neoformans in atg3 homozygous, 
heterozygous and wild-type siblings, no significant difference in the number of infected 
neutrophils between any genotype was found at each time point of 0dpi or 1dpi. 
However, for atg3 heterozygous larvae a significant difference in the proportion of 
infected, non-infected and RFP-only positive neutrophils was observed between 0dpi 
and 1dpi, with a reduction in infected neutrophils (Fig. 5.23 A, B). The number of non-
infected neutrophils is not significantly changed by 1dpi for homozygous and wild-type 
siblings, although an increase in RFP-only positive neutrophils was observed.  
Neutrophils were able to phagocytose C. neoformans in all atg5 genotypes, with no 
significant difference in the proportion of infected, non-infected or RFP-only positive 
neutrophils within the same time points of 0dpi or 1dpi in any genotype (Fig 5.23 C, D). 
For atg5 homozygous, heterozygous and wild-type siblings, a significant change in the 
proportion of infected, non-infected or RFP-only positive neutrophils between 0dpi and 
1dpi (for corresponding genotypes), was observed, with a reduction in infected 
neutrophils and increase in RFP-only neutrophils.  
These data suggest that neutrophils in atg3 and atg5 homozygous mutants 
phagocytose C. neoformans at similar rates as neutrophils from wild-type and 
heterozygous larvae, throughout the time infection time course. This includes a 
reduction of infected neutrophils and increase in RFP-only positive neutrophils at 1dpi 
from 0dpi, (as observed in the non-mutant background) (Fig. 5.18 above).  
The recruitment of Lc3 to C. neoformans vesicles within neutrophils was next 
examined, to determine whether a difference in Lc3 recruitment occurs in autophagy 
deficient larvae. There was a significant decrease in Lc3 marking of C. neoformans 
vesicles of atg3 heterozygous and homozygous larvae in comparison to wild-type 
larvae at 0dpi, but not significant changes between genotypes at 1dpi (Fig. 5.24 A, B). 
However, between 0 and 1dpi, a significant decrease in Lc3 positive cryptococcal 
vesicles was observed only for wild-type larvae (Fig 5.24 A, B). These data suggest 
that early in infection atg3 deficiency may reduce Lc3 marking of cryptococcal vesicles, 
but by 1dpi no difference is observed, despite a decrease in Lc3 positive vesicles 
observed over time for wild-type siblings.   
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Figure 5.23 Neutrophil handing is not changed in C. neoformans 
infection in autophagy mutants 
1000cfu of GFP C. neoformans injected into an incross of either atg3+/-* 
Tg(LyzC:RFP.GFP.Lc3), or atg5+/-*Tg(LyzC:RFP.GFP.Lc3), larvae imaged in the 
CHT at 2hpi (0dpi) and 26hpi (1dpi). A The number of infected or non-infected 
neutrophils in atg3+/-*Tg(LyzC:RFP.GFP.Lc3), grouped by genotype at 0dpi and 
1dpi (n=3, 16 larvae at 0dpi, and 19 larvae at 1dpi, **<p0.01, Chi square test)  B 
The proportion of infected or non-infected neutrophils in atg3+/-
*Tg(LyzC:RFP.GFP.Lc3), grouped by genotype at 0dpi and 1dpi (n=3, 16 larvae at 
0dpi, and 19 larvae at 1dpi, **<p0.01, Chi square test) C The number of infected or 
non-infected neutrophils in atg5+/-* Tg(LyzC:RFP.GFP.Lc3), grouped by genotype at 
0dpi and 1dpi (n=3, 32 larvae at 0dpi, and 19 larvae at 1dpi, **p<0.01, ***p<0.001, 
Chi square test) D The proportion of infected or non-infected neutrophils in atg5+/-* 
Tg(LyzC:RFP.GFP.Lc3), grouped by genotype at 0dpi and 1dpi (n=3, 32 larvae at 
0dpi, and 19 larvae at 1dpi, **p<0.01, ***p<0.001, Chi square test) 
  
 
Similarly, a significant decrease in Lc3 marking of C. neoformans vesicles was seen for  
atg5 heterozygous and homozygous larvae in comparison to wild-type larvae at 0dpi, 
but not significant changes between genotypes at 1dpi (Fig. 5.24 C, D). Again, between 
0 and 1dpi, a significant decrease in Lc3 positive cryptococcal vesicles was observed 
only for wild-type larvae (Fig. 5.24 C, D). These data suggest that early in infection atg5 
deficiency may also reduce Lc3 marking of cryptococcal vesicles. 
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Figure 5.24 Lc3 recruitment is reduced to C.neoformans vesicles in 
autophagy mutants 
1000cfu of GFP C. neoformans injected into an incross of either atg3+/-* 
Tg(LyzC:RFP.GFP.Lc3), or atg5+/-*Tg(LyzC:RFP.GFP.Lc3), larvae imaged in the 
CHT at 2hpi (0dpi) and 26hpi (1dpi). A The number of C. neoformans containing 
vesicles in neutrophils with or without Lc3 recruitment in atg3+/-
*Tg(LyzC:RFP.GFP.Lc3), grouped by genotype at 0dpi and 1dpi (n=3, 16 larvae at 
0dpi, and 19 larvae at 1dpi, *p<0.05, **p<0.01, Fisher’s exact test) B The proportion 
of C. neoformans containing vesicles in neutrophils with or without Lc3 recruitment 
in atg3+/-*Tg(LyzC:RFP.GFP.Lc3), grouped by genotype at 0dpi and 1dpi (n=3, 16 
larvae at 0dpi, and 19 larvae at 1dpi,, *p<0.05, **p<0.01, Fisher’s exact test)  C The 
number of C. neoformans containing vesicles in neutrophils with or without Lc3 
recruitment in atg5+/-*Tg(LyzC:RFP.GFP.Lc3), grouped by genotype at 0dpi and 
1dpi (n=3, 32 larvae at 0dpi, and 19 larvae at 1dpi, *p<0.05, ****p<0.0001 Fisher’s 
exact test) D The proportion of C. neoformans containing vesicles in neutrophils 
with or without Lc3 recruitment in atg5+/-*Tg(LyzC:RFP.GFP.Lc3), grouped by 
genotype at 0dpi and 1dpi (n=3, 32 larvae at 0dpi, and 19 larvae at 1dpi, *p<0.05, 
****p<0.0001 Fisher’s exact test) 
  
Neutrophils in atg3 or atg5 homozygous appear to phagocytose C. neoformans at 0dpi 
and 1dpi, leading to a similar number of infected vs non-infected neutrophils in 
comparison to wild-type siblings. The number of cryptococcal vesicles within individual 
neutrophils were compared to determine if any changes in Lc3 recruitment may be 
caused by differences in the amount of phagocytosed material and subsequent 
availability of Lc3. 
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Figure 5.25 The number of C. neoformans vesicles within neutrophils 
is not changed in autophagy mutants 
1000cfu of GFP C. neoformans injected into an incross of either atg3+/-* 
Tg(LyzC:RFP.GFP.Lc3), or atg5+/-*Tg(LyzC:RFP.GFP.Lc3), larvae imaged in the 
CHT at 2hpi (0dpi) and 26hpi (1dpi). A The number of C. neoformans vesicles 
contained within individual neutrophils from an in-cross of atg3+/-
*Tg(LyzC:RFP.GFP.Lc3) grouped by genotype, imaged at 0dpi and 1dpi (n=3, 16 
larvae at 0dpi, and 19 larvae at 1dpi, not significant Two-way ANOVA, +/- SD) B 
The number of C. neoformans vesicles contained within individual neutrophils from 
an in-cross of atg5+/-*Tg(LyzC:RFP.GFP.Lc3) grouped by genotype, imaged at 0dpi 
and 1dpi (n=3, 32 larvae at 0dpi, and 19 larvae at 1dpi not significant, Two-way 
ANOVA, +/- SD) 
 
No significant difference in the number of cryptococcal cells neutrophils contained was 
found for atg3 or atg5 larvae in any genotype, at 0dpi or 1dpi and at 1dpi in RFP 
positive neutrophils (Fig. 5.25 A, B). This suggests that the reduction of Lc3 marking of 
cryptococcal vesicles in autophagy mutants is not due to the amount of cryptococcal 
cells neutrophils contain.  
 
Together these data suggest that a similar number and proportion of neutrophils 
phagocytose C. neoformans throughout infection, and that the number of cryptococcal 
cells phagocytosed is similar for atg3 or atg5 larvae of homozygous, heterozygous and 
wild-type genotypes. This suggests that the reduction in Lc3 recruitment to C. 
neoformans vesicles in neutrophils of atg5 homozygous and heterozygous larvae, and 
in atg3 heterozygous and homozygous larvae, at 0dpi, is not caused by differences in 
phagocytic ability of neutrophils.  
A reduction of Lc3 recruitment to C. neoformans is observed in autophagy mutants at 
0dpi. However, potential differences in the outcome of C. neoformans residing in Lc3 
negative or Lc3 positive vesicles, for example in vomocytosis, or cryptococcal 
replication, presents an exciting future research area, which unfortunately could not be 
further investigated due to time restrictions.  
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5.2.8 Summary of infection of autophagy mutants 
No significant change in larval survival is observed for either atg3 or atg5 larvae 
following C. neoformans infection. This was also observed for atg5 S. aureus infection. 
An increase of larval survival in S. aureus infection is seen for atg3 homozygous and 
heterozygous fish. Next, further pressure was applied to the autophagy pathways 
through starvation. Under starvation conditions no significant changes in survival, after 
S. aureus and C. neoformans infection, was observed for atg3 or atg5 homozygous 
fish. Larval survival data may be complicated by off-target effects of the mutation which 
cause larval death without infection.  
Fungal and bacterial burdens highlighted no significant difference between genotype 
and pathogen handling. However, preliminary data on fungal and bacterial burden with 
3-MA treatment suggested an increase in pathogen load in atg5 homozygous mutants, 
but requires further analysis.  
Analysis of neutrophil cellular interactions may enable analysis which can circumvent 
the off target effects in both autophagy mutants which likely confounds larval survival 
analysis. A significant reduction in recruitment to Lc3 vesicles was observed for both 
autophagy mutants on the day of infection for both S. aureus and C. neoformans 
infection. 
 
5.3 Chapter discussion 
5.3.1 The role of host autophagy in handling of S. aureus  
The first aim of this chapter was to establish whether S. aureus is handled by the 
autophagy pathway, specifically in regards to a role for both atg3 and atg5. Although a 
reduction in autophagy levels in the mutants has not been clearly defined using Lc3 as 
an autophagy marker (chapter 4), it is still possible to use the autophagy mutants which 
do exhibit a clear phenotype linked to autophagy, to establish whether lack of atg3 or 
atg5 have any effect on pathogen handling. 
Autophagy mutant survival of S. aureus infection 
Firstly, inoculum dependant dose was shown to directly reduce larval survival infected 
with increasing numbers of S. aureus colony forming units. Previous data from a former 
lab member analysed the role of autophagy in S. aureus infection using bacterial loci 
as an endpoint of infection due to difficulties in genotyping fish after death. Using this 
end point, no change in bacterial infection was identified in atg3 or atg5 mutants (PhD 
thesis Lambein, 2015). However, by modifying the genotyping protocol for the atg3 
mutants to avoid a restriction site digest, genotyping of larvae which had died was 
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possible. Survival as an endpoint of infection may enable differences in fish survival 
during bacteraemia to be determined, which were not possible using the bacterial loci. 
Using heterozygous in-crosses of each mutant, larval survival of bacterial infection of 
~2500cfu was followed for 10dpf at IMCB. The infection time frame was extended from 
a maximum of 5dpf, to enable infection to be followed at time points after maternal 
contribution would end (see Chapter 4), where autophagic components may be under 
greater pressure. Of note, larval survival of S. aureus infection in autophagy mutants 
was overall very low irrespective of genotype, in comparison to the dose survival 
curves completed at the University of Sheffield. An explanation could be due to the 
difference in aquaria, as discussed above (see Chapter 4 discussion), where a higher 
pathogenic load or altered feeding regimes may explain differences between these 
experiments due to overall fish health and survival differences. However, the reduced 
survival of infected larvae meant that most fish did not survive longer than 4dpf, 
potentially when maternally contributed mRNA may still be present. It would be 
informative in future to use an even lower dose of S. aureus, or to infect at a later time, 
to enable the majority of fish to survive to a time point when maternal effects would 
have subsided. 
There was no difference in survival of atg5 heterozygous in-cross larvae infected with 
S. aureus between homozygous mutants, wild-type siblings or heterozygous larvae. On 
the other hand, atg3 homozygous mutants and heterozygous larvae had significantly 
improved survival in comparison to wild-type siblings. Improved survival also seen in 
heterozygous, (not only homozygous) larvae suggests that normal atg3 levels may be 
dependent on both alleles presence. These data suggest that atg3 is important during 
S. aureus infection. It could be suggested that S. aureus uses autophagy which 
requires atg3, for its own survival, therefore when host autophagy is reduced S. aureus 
has reduced intracellular survival capabilities.  
In an alternative in vivo S. aureus infection model, S. aureus infection in mice that were 
deficient in autophagy, specifically in ATG16 and LC3, an increase in lethality following 
bacterial infection was observed, despite a reduced bacterial burden (Maurer, Torres, 
et al. 2015).  It was shown that a bacterial toxin (α-hemolysin) was responsible for 
lethality and autophagy enables tolerance (reduced susceptibility) of S. aureus 
(Maurer, Torres, et al. 2015). This suggests that host cell autophagy is beneficial for 
bacteria, since loss of autophagy reduced bacterial burden, (in agreement with the 
improved atg3 homozygous larvae survival after S. aureus infection data presented 
here), but equally autophagy is beneficial for the host enabling tolerance of a damaging 
toxin.  
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It has also been shown that host autophagy is required by S. aureus for improved 
bacterial replication and host bacterial control in vitro. This was demonstrated using 
mouse embryonic fibroblasts (MEFs) deficient in atg5-/-, whereby S. aureus had a 
reduced ability to replicate intracellularly in comparison to cells with atg5 present 
(Schnaith et al. 2007). Interestingly, zebrafish that lack atg5 did not have improved 
larval survival against S. aureus infection, suggesting that host atg3 rather than atg5 is 
important for bacterial survival in my model. This is interesting due to the closely 
related roles of atg3 and atg5 in the lipidation of LC3 and autophagosome formation. A 
similar effect on larval survival caused by S. aureus infection may be expected 
between atg3 and atg5 homozygous mutants.  
However, an alternative study highlighted that autophagy was not useful for bacterial 
survival, where in atg5-/- MEFs had increased bacterial replication in comparison to 
atg5+/+ cells (Neumann et al. 2016). This indicates that the autophagy acting 
beneficially for S. aureus is likely very complex, where multiple factors may affect 
autophagy induction. A difference between these opposing studies is the bacterial 
strain used, which could cause these differences. Indeed, any differences in virulence 
factor expression could alter how host cell autophagy is affected by bacterial infection, 
such as the virulence factors controlled by the agr locus, which are required for host 
autophagy induction (Schnaith et al. 2007; O’Keeffe et al. 2015). It would be interesting 
to compare different S. aureus strains with and without certain virulence factor 
expressions effect on survival in autophagy mutants. It may be possible to observe 
opposing effects on larval survival depending whether toxins, such as α-hemolysin are 
present.  
Importantly, general reduced survival in these experiments meant that the majority of 
larval infection did not overlap with time points in which larvae mutations may be fully 
effective, due to maternal contribution (see Chapter 4), so does not conclusively show 
that atg3 or atg5 is important for S. aureus survival during infection.   
 
Autophagy mutant survival of S. aureus infection with increased demand on the 
autophagy pathway  
To investigate S. aureus infection when autophagy is under stress, fish were infected 
under starvation conditions, to place autophagy pathways under increased demand. 
Furthermore, larvae were infected with a lower dose of 500cfu in order to attempt to 
allow survival to later time points, specifically after maternal effects may have subsided.  
Despite the reduced inoculum, regardless of genotype, survival by 5dpf was only ~20% 
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for all infected fish, it would be informative in future experiments to inject with a further 
reduced inoculum.  
For both atg3 and atg5 homozygous larvae, no change in survival was found in 
comparison to heterozygous and wild-type siblings after S. aureus infection and 
starvation. This suggests that autophagy is not important in the handling of S. aureus in 
zebrafish. Of note, the role of larval starvation, and the impact this may have on S. 
aureus virulence was not studied. It is possible that in autophagy deficient larvae have 
a reduced supply of nutrients, as are corresponding mouse models (Kuma et al. 2004; 
Sou et al. 2008), which are also unavailable for bacterial use, ultimately leading to a 
reduced bacterial virulence. It would be interesting to compare how bacterial survival 
and virulence is altered in nutrient deprived infection. In fact, in response to extreme 
nutrient starvation of S. aureus, ~99% bacterial death is observed with just a small 
proportion which are able to survive long term under starvation conditions. This small 
proportion of bacterial cells are able to become viable replicative cells when nutrients 
become available (Watson et al. 1998; Clements & Foster 1998). Therefore, it is 
possible that starvation of larvae, may also starve bacteria resulting in reduced 
bacterial virulence. To test this, starved or non-starved larvae could be homogenised, 
and S. aureus bacterial growth in non-starved and starved homogenate compared. 
Both atg3 and atg5 homozygous mutants have reduced survival after 20dpf (chapter 
4). The lack of either atg3 or atg5 is likely to have a more pronounced effect at this 
time, so infection at 20dpf was investigated. It is important to keep in mind that lethal 
mutation effects may override any potential change in survival due to S. aureus 
infection. S. aureus infection (2500cfu) of larvae at 20dpf highlighted no change in 
larval survival for both atg3 and atg5 homozygous mutants. Although atg5 homozygous 
larvae may have reduced survival, but only a single homozygous larvae was infected. 
Unfortunately, after 20dpf, larval survival of atg3 and atg5 mutant homozygous larvae 
is reduced leading to difficulties in infecting enough homozygous larvae to gain 
statistically significant results. These data suggest that at time points where autophagy 
mutations become fatal, infection with S. aureus enhances mortality. Infection at 20dpf 
suggests that atg5 autophagy mutant survival is reduced, but this may also be likely 
due to expected mutation effects at this time point. Indeed, if the homozygous larvae 
are already sick, infection with a pathogen is likely to further reduce survival. It is 
therefore not possible to conclude that this reduced survival is specifically caused by S. 
aureus and any change in host-pathogen interactions caused by the autophagy 
mutation.  
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To conclude, potential small changes in survival for are suggested, but overall S. 
aureus infection studies using the autophagy mutants are difficult to interpret. Early in 
infection, maternal contribution may effectively block any atg3-/- or atg5-/- specific 
effects, and equally later in infection the survival phenotype which is expected under 
non-infection conditions, may override any autophagy mutation effects. Larval survival 
analysis was not very informative as to the role of atg3 and atg5 mutations in S. aureus 
infection. To investigate the role further and avoid complication of survival at early and 
late stages of development, the rate of bacterial growth and the role of autophagy in 
mutants at a cellular level was next investigated.  
 
Bacterial burden in autophagy mutants infected with S. aureus 
The bacterial burden was compared between atg3 or atg5 homozygous, heterozygous 
and wild-type siblings during S. aureus infection. It may be expected that if host 
autophagy is important in the control of bacterial infection a larger bacterial burden 
would be present in homozygous larvae. However, for both atg3 and atg5 homozygous 
mutants, no significant difference in the bacterial burden was observed in comparison 
to heterozygous and wild-type siblings. This suggests that atg3 and atg5 are not 
important in the control of bacterial growth in the entire zebrafish. This may expected 
for bacteria which are able to survive extracellularly, where any alterations in 
autophagy would not affect bacterial growth. However, depletion of host cell (p62 
mediated) autophagy through morpholino injection, was shown to increase zebrafish 
mortality and bacteria burden in Shigella flexneri infection (Mostowy et al. 2013), 
suggesting that autophagy knock-down in larvae can successfully allow observation of 
autophagy mediated pathogen handling at the organismal level.   
Furthermore, the bacterial burden was compared between genotypes at the day before 
larval death, in order to determine whether the amount of bacteria present in larvae that 
causes death may be reduced for the homozygous autophagy mutants. However, there 
was no significant difference in the bacterial burden preceding larval death between 
any atg3 or atg5 genotype before 5dpf. This suggested that larvae deficient in atg3 or 
atg5 do not have increased susceptibility to S. aureus infection, and that deficient 
autophagy does not enable increased bacterial growth. Furthermore, the role of host 
cell autophagy as beneficial or detrimental for S. aureus is unclear, with data 
suggesting opposite observations (as discussed in section 1.4.7) and this may be due 
to the type of host cell S. aureus is invading, or the strain of S. aureus.  
Of note these data were collected before 5dpf, and therefore may be unaffected due to 
maternal contribution. It would be very informative to investigate bacterial burden at 
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later time points, which was not possible as infection study at time points later then 
5dpf were not approved in the UK. Overall it is not possible to confidently conclude that 
atg3 and atg5 deficiency does not alter bacterial burden in larvae, due to potential 
maternal contribution effects.  
 
Autophagy mutant survival and bacterial burden of S. aureus infection with blocked 
atg5-independent autophagy 
3-MA is an autophagy inhibitor, which inhibits PI3-Kinase activity, loss of which inhibits 
both classical autophagy and atg5-independent autophagy (Juenemann & Reits 2012). 
Additionally, atg5-independent autophagy has been linked to bacterial clearance. In 
intestinal epithelial cells atg5-independent autophagy is used to inhibit the survival of 
Shigella flexneri (Ra et al. 2016). In Mycobacterium marinum infection only a slight 
reduction in bacterial survival in atg5-/- MEFs was found. However, a role of atg5-
independent autophagy in selective autophagy, in controlling sequestration of bacteria 
residing the cytoplasm has been demonstrated (Collins et al. 2009). It is therefore 
possible that despite atg5 deficiency, some autophagy is still functional in the atg5 
homozygous mutants, which may be important in S. aureus clearance. However, no 
significant difference in larval survival of S. aureus infection with 3-MA treatment 
between any atg5 genotype was shown. This suggests that atg5-independent 
autophagy does not play a role S. aureus infection control. However, larval survival 
analysis after infection, at a whole organism level, may not by informative because 
each autophagy mutation causes reduced survival independently of infection. 
Therefore, the bacterial burden was next analysed.  
The bacterial burden of atg5 homozygous mutants was significantly increased at both 
2dpf and 5dpf in comparison to heterozygous and wild-type siblings. This suggests that 
S. aureus infection is not controlled in atg5 homozygous mutants, also deficient in 
atg5–independent autophagy. In contrast, the bacterial burden, which caused larval 
death, was not significantly different between atg5 genotypes, however additional 
analysis may lead to statistical significance for these preliminary data. Further analysis 
to examine whether 3-MA has any effect on bacterial virulence or viability is required to 
confirm these data.  
These data suggest that atg5 deficiency, coupled with atg5-independent autophagy 
inhibition leads to uncontrolled S. aureus infection. Therefore, host atg5 and/or atg5-
independent autophagy may be important in control of S. aureus infection. However, 
these conclusion require further investigation. For example, 3-MA is also able to block 
classical autophagy, presumably including any autophagy enabled through maternal 
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contribution at this age. It would be very useful to compare the bacterial burden in atg5 
homozygous larvae treated with alternative autophagy drugs, which will not affect 
induction of atg5-independent autophagy, in order to decipher whether atg5-
independent autophagy alone is responsible for control of S. aureus.  
To conclude, further analysis of bacterial burden, at later stages in infection may 
provide evidence that atg3 or atg5 is important in the control of S. aureus infection. 
However, preliminary data do indicate that atg5 and/or atg5-indepednet autophagy is 
important in reducing bacterial burden, further work may provide interesting answer to 
exactly which type of autophagy is responsible.  
Host neutrophil autophagy interactions with S. aureus 
Cellular level interactions of S. aureus with the autophagosome marker Lc3-II in 
neutrophils were next examined, to potentially exclude off-target effects of each 
mutation, for example reduced larval survival. There is still potential that maternally 
encoded protein products could affect these experiments conducted at 2 and 3dpf. 
Neutrophils are a known intracellular niche for S. aureus (Prajsnar et al. 2012), so 
autophagy interactions could present a key host-pathogen interaction which may 
provide host protection, or that could be hijacked for the benefit of S. aureus. 
Firstly S. aureus was injected into larvae with neutrophil specific traffic-light Lc3 
expression, but not in an autophagy mutant background, to determine the normal 
neutrophil Lc3 interactions with S. aureus. The number of infected neutrophils is 
significantly reduced by 1dpi, (in comparison to 2hpi), with the majority of bacteria 
residing within a vesicle rather than cytoplasm at both time points. Finally, the number 
of intracellular bacteria within individual neutrophils significantly decreases over time.  
Neutrophil degradation of the majority of bacteria has been previously demonstrated in 
the zebrafish infection model (Prajsnar et al. 2012), suggesting that most bacteria are 
expected to be degraded. These data indicate that throughout infection, S. aureus is 
phagocytosed by neutrophils, whereby bacteria are likely killed and degraded over 
time, as evidenced by the decrease in number of infected neutrophils and bacteria 
within them. However, although it is known that S. aureus successfully escapes the 
phagosome, there is currently no literature that addressed the dynamics of infection 
(e.g. how often and the speed of bacterial phagosome escape) so it has not been 
possible to compare the rates of phagosome escape of S. aureus that I have measured 
to other studies. 
It is possible that bacterial cells are able to escape neutrophils through the use of 
multiple virulence factors (as introduced in Section 1.4.5). However, since only few 
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extracellular bacterial cells were observed at 1dpi (not quantified) it is more probable 
that bacterial degradation occurs. The limited number of bacteria observed in the 
cytoplasm may represent a small fraction of the bacterial population which have 
escaped the bacterial phagosome, and can persist in the neutrophil as described in S. 
aureus infection in zebrafish previously (Prajsnar et al. 2012).  
The co-localisation of Lc3-II, that was shown to mark an entire staphylococcal vesicle, 
or as puncta on a vesicle to bacteria residing in the cytoplasm, determined that 
autophagic machinery is used in the host neutrophil response to S. aureus. In fact, the 
majority of bacteria that were resident in vesicles, were marked with Lc3 at 0dpi, clearly 
indicating that Lc3 can co-localise to S. aureus. Of note, the transgenic line over 
expresses the traffic light Lc3 construct, so although showing co-localisation can occur, 
it is not possible to conclude from these data whether endogenous Lc3 would mark so 
many vesicles. It is clear, however, that the autophagosome marker Lc3 co-localises to 
S. aureus in neutrophils which has been described before for non-professional 
phagocyte cells (Schnaith et al. 2007; Harada-Hada et al. 2014). Furthermore, an initial 
Lc3 recruitment, which is reduced over time was also observed for S. aureus in HeLa 
cells. Highest Lc3 recruitment of 90% was shown at 3hpi, and a reduction to basal 
levels in Lc3 recruitment seen by 5hpi (Schnaith et al. 2007). This is somewhat similar 
to data presented here but also utilises over expression of a GFP-LC3 vector. Using 
antibody staining of fixed samples in wild-type larvae or cells could confirm 
endogenous Lc3 acts in a similar manner. This Lc3 localisation to S. aureus may 
represent Lc3 recruitment to S. aureus containing autophagosomes, or to Lc3-
assocaited phagosomes (LAP) as seen in Shigella flexneri infection of intestinal cells 
(Campbell-Valois et al. 2015). It is important to determine what type of vesicle S. 
aureus is residing in to be able to characterise whether LAP or autophagy is 
responsible for Lc3 co-localisation.  
Very few bacteria were observed in neutrophils at 1dpi, suggesting bacteria are 
degraded by neutrophils, resultantly, it is difficult to conclude on any changes in Lc3 
localisation over infection. A population bottleneck in S. aureus infection has been 
demonstrated in zebrafish, whereby a small number of bacterial cells evade immune 
cell degradation and are responsible for further uncontrolled infection. Therefore, it 
would be interesting to gather further data to examine whether Lc3 localisation to 
bacteria, particularly to bacteria resident in the cytoplasm, has any role in the bacterial 
population bottleneck process.  
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Autophagy involvement in Lc3 recruitment to S. aureus in neutrophils 
To determine if atg3 or atg5 deficiency alters Lc3 recruitment to S. aureus vesicles at 
0dpi, bacteria were injected into the neutrophil specific traffic light Lc3 line which was 
previously crossed to the atg3 or atg5 mutants. There was no difference in the number 
of neutrophils which were infected, or in the number of bacteria within neutrophils 
between atg3 or atg5 homozygous, heterozygous or wild-type siblings. This suggests 
that neutrophil ability to phagocytose are not detrimentally affected by either atg3 or 
atg5 deficiency. Therefore, since this presented data is early in infection (2hpi), any 
changes in bacterial survival/growth that may occur within autophagy deficient cells 
may not have been observed. Interestingly, when autophagy is blocked, either by 3-MA 
or by siRNA targeting atg5 in human neutrophils, phagocytosis rates were reduced in 
pneumococcal infection (Ullah et al. 2017), although the mechanism behind this was 
not investigated. This suggests that autophagy can promote phagocytosis, but this is 
not suggested in the data presented in this study using S. aureus and may be caused 
by pathogen specific interactions. However, phagocytic ability was not directly studied 
in this study, and further analysis may provide better insight into the link between 
neutrophil autophagy and phagocytic ability.  
A significant reduction of Lc3 localisation to S. aureus vesicles was found for atg5 
homozygous larvae in comparison to heterozygous and wild-type larvae at 0dpi. 
Furthermore, a significant reduction of Lc3 localisation to S. aureus vesicles was found 
for atg3 homozygous and heterozygous larvae in comparison to wild-type larvae at 
0dpi. These data highlight a reduction in Lc3 interactions with S. aureus (within a 
neutrophil) in autophagy deficient larvae, which have not been described before. 
Furthermore, it suggests that in autophagy deficient larvae, the recruitment of Lc3, and 
subsequent loss of Lc3, shown for zebrafish (above) and in HeLa cells (Schnaith et al. 
2007) does not occur. This data is suggestive that both atg3 and atg5 mutants are not 
be able to efficiently produce Lc3-II, required for the marking of membranes, including 
S. aureus vesicles. 
Importantly however, these data only highlight a reduction in Lc3 localisation to S. 
aureus in autophagy mutants. It is impossible to conclude that Lc3 recruitment is 
beneficial or detrimental for the bacteria. To determine if a lack of Lc3 recruitment to S. 
aureus is detrimental for the host, or bacteria, further analysis is required. For example, 
time lapse analysis following the fate of both the neutrophil, and bacteria in autophagy 
mutant larvae may reveal the role of host cell autophagy in S. aureus infection. Indeed, 
the outcome of altered autophagy interactions could present autophagy as a 
therapeutic target in treatment of infection. In order to circumvent larval survival issues, 
it might be useful to collect neutrophils from atg5 larvae of different genotypes, and use 
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in vitro infection methodologies to examine the cellular interaction of Lc3 with S. 
aureus.  
To conclude, Lc3 is shown to co-localise with S. aureus within neutrophils. The host 
Lc3 and S. aureus interaction may represent a host or pathogen derived interaction, 
future studies may reveal autophagy as a potential therapeutic target in S. aureus 
infection. A reduction in Lc3 recruitment to S. aureus in atg3 and atg5 mutants, which is 
not caused by defects in neutrophil phagocytosis, hints that autophagy could be 
manipulated to alter Lc3 interactions with S. aureus. However, it is important to 
determine whether Lc3 recruitment is beneficial to the host, or bacteria, and this 
presents an exciting research topic for the future.  
5.3.2 The role of host autophagy in handling of C. neoformans  
Alongside S. aureus infection, the other aim of this chapter was to determine whether 
C. neoformans is handled by the autophagy pathway, specifically in regards to the role 
of both atg3 and atg5.  
Autophagy mutant survival of C. neoformans infection 
Inoculum dependant death was first proven to be responsible for reduced survival 
using wild-type larvae. This allows later experiments to exclude the possibility that 
handling related injuries cause larval mortality. A relatively high dose of 1000cfu is 
used for C. neoformans infection, which causes ~30-50% larval death at 3dpi, to 
enable visualisation of an increase or decrease in survival.  
Survival of C. neoformans infection was increased to 10dpf (than the normal 5dpf 
endpoint) to extend infection time course until after the maternal contribution is 
expected to have stopped. Heterozygous in-crosses of either atg3 or atg5 homozygous 
mutants showed no significant difference in survival to AB wild-type fish. The aim was 
to determine whether an obvious survival change potentially expected in 25% of each 
heterozygous in-cross was identified. However, as only 25% of larvae were potentially 
homozygous, a non-obvious survival change may not be identified, as is likely in this 
case. Therefore, the survival assay was repeated with individually genotyped larvae.  
To determine if atg3 and atg5 homozygous mutant survival of C. neoformans infection 
was changed, genotyping was performed (after infection experiments were completed) 
for each heterozygous in-cross. No change in survival was observed for atg3 
homozygous larvae in comparison to wild-type siblings and heterozygous larvae. 
Similarly, no significant change in survival was found between atg5 homozygous larvae 
and wild-type siblings or heterozygous. Of note, the survival curves extend to 10dpf, 
(8dpi) later then maternal contribution, with survival reducing at a similar rate 
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independent of genotype over the entire time frame. This suggests that both atg3 and 
atg5 do not affect survival of C. neoformans infection, even after maternal contribution 
will have subsided, however Atg5 protein could be present until a maximum of 7dpf 
(see Chapter 4), at which point fungal burden may be so high that any differences in 
handling in autophagy mutants cannot be determined. These data are in contrast to a 
previous study that suggested that C. neoformans requires host cell autophagy 
(including atg5) for increased replication. This was demonstrated using RNAi to disrupt 
autophagy components in RAW 264.7 macrophages and led to decreased intracellular 
cryptococcal replication (Qin et al. 2011). A major difference between cellular and 
entire animal infections work is the ability of cryptococcal cells to survive and replicate 
outside of macrophages or other phagocytic cells. Furthermore, in myeloid cell specific 
atg5-/- mice no change in susceptibility to cryptococcal infection is observed (Nicola et 
al. 2012). This is in contrast to Candida albicans where mice showed increased 
susceptibility. Therefore, the murine model cryptococcal infection data agrees with data 
presented here, suggesting that at an entire organism level, atg5 deficiency does not 
affect cryptococcal expansion.  
This may be due to extracellular cryptococcal replication, which would not be controlled 
by myeloid cells. In zebrafish cryptococcal infection models, a shift from primarily 
extracellular to primarily intracellular resident cryptococci is seen at early stages of 
infection, although predominantly extracellular cryptococcal cell population is observed 
commonly later in infection (Bojarczuk et al. 2016). This might suggest that any 
influence that autophagy deficiency has on cryptococcal infection would be observed at 
early time points, however many cells are still extracellular. In the myeloid cell specific 
atg5-/- mice, a reduction in the activation of macrophages and inflammation was 
observed in the entire mouse lung following cryptococcal infection. It was also 
demonstrated that cryptococcal growth was increased in activated atg5-/- 
macrophages, (Nicola et al. 2012). Therefore, it is possible that where cryptococcal 
cells are residing intracellularly, activated macrophages may utilise autophagy in the 
host control of C. neoformans. It would be interesting to investigate the cellular 
interactions in both autophagy deficient mutants to determine if this is true in zebrafish, 
and for atg3. 
Autophagy mutant survival of C. neoformans infection with increased demand on the 
autophagy pathway 
To highlight any effects on larval survival autophagy deficiency causes, zebrafish 
autophagy was put under greater stress, using starvation conditions. Therefore, if 
autophagy mutations affect cryptococcal handling, this may be amplified due to an 
increase in autophagic machinery use in the entire larvae. A lower dose of 100cfu of C. 
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neoformans was used to enable larval survival to later stages of infection to after 10dpf, 
when starvation effects may begin (see Chapter 4). Homozygous atg3 mutants showed 
no significant difference in larval survival in comparison to heterozygous and wild-type 
siblings. Equally, no significant difference in survival of atg5 homozygous larvae in 
comparison to heterozygous and wild-type siblings was observed. However, further 
analysis could lead to statistical significance, where atg5 homozygous mutants may 
have reduced survival after ~7-10dpf, this would be in keeping with the observed 
reduction in survival in non-infection starvation experiments, suggesting that atg5 is not 
important in host-C. neoformans interactions. As discussed for S. aureus data above, 
starvation conditions may affect the nutrients available to Cryptococcus, and could 
therefore affect cryptococcal virulence or viability. C. neoformans growth is affected by 
nutrient availability. A lack of nutrients may also be expected in the atg3 or atg5 
zebrafish mutants, much like the corresponding mouse models (Kuma et al. 2004; Sou 
et al. 2008), however this too requires further analysis. This may mean starvation of the 
larvae is also resulting in starvation of the pathogen and therefore analysis is required 
to determine if cryptococcal virulence is reduced.  To test this, starved or non-starved 
larvae could be homogenised, and cryptococcal growth in non-starved and starved 
homogenate compared. 
C. neoformans infection at 20dpf was completed to ascertain whether infection at later 
time points in development leads to changed mutant survival, where the mutation may 
be more effective since maternal contribution will have ablated. At 20dpf, a low number 
of viable homozygous larvae were present meaning further repeats are needed. 
Infection of C. neoformans with 1000cfu showed no change in survival for homozygous 
atg3 larvae in comparison to heterozygous and wild-type siblings. This suggests that 
atg3 is not important in C. neoformans infection. Comparison of atg5 homozygous 
survival showed no significant change in survival in comparison to heterozygous and 
wild-type siblings, although further analysis may lead to statistical significance of 
reduced survival in homozygous larvae. Any reduced survival is likely caused by the 
deleterious effects of the mutation characterised above (see Chapter 4). Taking this 
into consideration, these data suggest atg5 in not important in C. neoformans infection.  
Similar to the S. aureus survival analysis above, larval survival of C. neoformans 
infection is not the most informative assay of host-pathogen interactions, and maternal 
contribution at early infection stages, in addition to survival defect after 20dpf, must be 
taken into consideration. However, in contrast to S. aureus infection, C. neoformans 
infection did progress at a constant rate with survival ~5% at 10dpf. This does allow 
stages between 5-10dpf for analysis free from survival and maternal effects. Although 
some small difference in survival are suggested, again no significant changes were 
213 
 
observed. Overall it is difficult to use survival of infection as a clear readout of 
autophagy if only subtle changes are occurring. No difference in cryptococcal infection 
using entire mice deficient in myeloid atg5 is distinct from clear differences observed 
during cellular analysis of atg5-/- interactions with C. neoformans (Nicola et al. 2012). 
This suggests extracellular cryptococcal growth may conceal changes in infection 
outcome caused by autophagy handling at the cellular level in both zebrafish 
autophagy mutants. For this reason fungal growth dynamics and autophagy cellular 
interactions were next examined.  
 
Fungal burden in autophagy mutants infected with C. neoformans 
The fungal burden was compared between atg3 or atg5 homozygous, heterozygous 
and wild-type siblings during C. neoformans infection. It would be expected that if host 
autophagy is important in the control of cryptococcal infection a larger fungal burden 
would be present in autophagy mutant larvae.  
In fact, at 5dpf, a significant decrease in fungal burden for atg3 heterozygous and 
homozygous larvae, in comparison to wild-type siblings was observed. This suggested 
that host atg3 is useful for fungal replication, and detrimental for the host. Indeed, it is 
reported that C. neoformans requires host cell autophagy for intracellular replication 
(Qin et al. 2011). It was recently demonstrated in vivo that cryptococcal infection leads 
to an increase in phosphorylation of both AMPKα or ULK-1 (both important in the 
initiation of autophagy), and that deletion of AMPKα in myeloid cells in mice leads to a 
reduction in fungal burden after infection (Pandey et al. 2017) suggesting that AMPKα, 
and therefore autophagy induction in myeloid cells increases susceptibility to 
cryptococcal infection.  
However, for atg5 homozygous mutants, no significant difference in the fungal burden 
was observed in comparison to heterozygous and wild-type siblings, suggesting atg5 is 
not important in control of fungal growth. It is difficult to explain why atg3, but not atg5, 
is important in susceptibility to fungal growth, due to their intertwined roles in Lc3 
lipidation and autophagosome formation. Furthermore, these experiments conducted at 
early developmental stages mean that maternal contribution may enable “normal” (atg3 
or atg5) autophagy function. However, the role of autophagy in promoting cryptococcal 
susceptibility may be atg5-independent. No change in cryptococcal susceptibility in 
myeloid atg5 deficient mice was observed (Nicola et al. 2012), but was reduced in 
AMPKα myeloid deficient mice (Pandey et al. 2017). Therefore, atg5-independent 
autophagy in myeloid cells may be responsible for increased susceptibility to 
cryptococcal cells. The ability of C. neoformans to survive and replicate in the 
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extracellular environment, may further complicate this, as cellular autophagic control is 
not able to interact with extracellular fungal cells. For these reasons, it is likely that 
even if atg3 or atg5, are both important in cryptococcal handing within phagocytes, it 
may not efficiently control fungal growth for the entire zebrafish, but may well be 
involved at the cellular level. Analysis of autophagy-cryptococcal interactions at the 
cellular level interactions are therefore required.  
The fungal burden was also compared between mutant genotypes the day before larval 
death, to determine if the number of cryptococcal cells present in larvae causing death 
may be reduced for the homozygous autophagy mutants. No significant difference in 
the fungal burden preceding larval death between any atg3 or atg5 genotype before 
5dpf was observed. This suggests that larvae deficient in atg3 or atg5 do not have 
increased susceptibility to cryptococcal infection, or that deficient autophagy does not 
enable increased fungal growth. Interestingly, previously published in vitro data 
suggest host autophagy is beneficial for cryptoccocal survival and replication (Qin et al. 
2011). It would be interesting to examine the role of host cell autophagy on intracellular 
proliferation in vivo to enable further comparison.  
These analysis were collected between 2dpf and 5dpf, and therefore may be still have 
functional autophagy proteins from maternal contribution (see Chapter 4). It would be 
very informative to investigate fungal burden at later time points, which was not 
possible as infection study at time points later then 5dpf were not ethically approved in 
the UK at the time and could not be completed at IMCB. Overall it is not possible to 
confidently conclude that atg3 and atg5 deficiency does or does not alter fungal burden 
in larvae, due to opposing atg3 data and potential maternal contribution effects.  
Autophagy mutant survival and fungal burden of C. neoformans infection with blocked 
atg5-independent autophagy 
As described above, 3-MA is an autophagy inhibitor, which targets both classical and 
atg5-independent autophagy (Juenemann & Reits 2012). Although atg5-independent 
autophagy has been linked to bacterial clearance in intestinal cells (Ra et al. 2016), 
there are no publications on the role of atg5-independent autophagy in regards to 
fungal pathogens, although as suggested above atg5-independent autophagy may 
increase susceptibility to cryptococcal infection. It is possible that despite atg5 
deficiency, atg5-independent autophagy is functional in the atg5 homozygous mutants, 
which may be useful in fungal clearance. 
No significant difference in larval survival of C. neoformans infection with 3-MA 
treatment between any atg5 genotype was observed. This suggests that atg5-
independent autophagy does not play a role cryptococcal infection control. However, 
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as mentioned before, analysis at a whole organism level may not fully analyse any 
mutation and drugs effects, due to off target mutation effects, so the fungal burden was 
next analysed. The fungal burden of atg5 homozygous mutants was not significantly 
different in comparison to heterozygous and wild-type siblings when treated with 3-MA, 
however, a trend towards increased fungal burden in homozygous (and to an extent 
heterozygous) larvae in comparison to wild-type larvae at 4 and 5dpf exists. Therefore, 
an increase in fungal burden at later time points is suggested. This suggests 
cryptococcal infection is not controlled in atg5 homozygous mutants also deficient in 
atg5–independent autophagy and therefore suggests that atg5 independent autophagy 
is beneficial for the host.   
A preliminary comparison of the fungal burden preceding larval death was not 
significantly different between atg5 genotypes. These data suggest that atg5 
deficiency, coupled with atg5-independent autophagy inhibition can block fungal growth 
as well as wild-type treated larvae. Therefore, host atg5 and/or atg5-independent 
autophagy may be not important in control of C. neoformans infection. As described for 
corresponding S. aureus data, further investigation is required to determine whether 
atg5-independent autophagy alone is responsible for control of C. neoformans.  
In conclusion, further investigation of fungal burden, at later stages in infection may 
provide evidence that atg3 or atg5 is important in the control of cryptococcal infection. 
However, preliminary data do indicate that atg5 and/or atg5-independent autophagy is 
important in reducing C. neoformans burden, further work may provide interesting 
answers to exactly which type of autophagy is responsible, or if opposing roles are 
found.  
Host neutrophil autophagy interactions with cryptococcal cells  
In an attempt to analyse autophagy which may exclude potential off target effects of 
atg3 or atg5 mutations, cellular level interactions of C. neoformans with 
autophagosome marker Lc3-II in neutrophils were investigated. However, this still does 
not exclude the possibility that maternally encoded protein products could be present 
and affect these experiments conducted at 2 and 3dpf. Although macrophages, rather 
than neutrophils are considered a cryptococcal intracellular niche, there is evidence 
that neutrophils play a role in the control of cryptococcal infection. For example in 
myeloperoxidase mediated degradation of cryptococcal cells and in complement 
mediated responses to cryptococci (Sun et al. 2016b; Diamond et al. 1972). Despite 
this, neutrophil ablation data suggests that neutrophils are not required for control of 
fungal burden in these current experiments. While analysis within macrophages may 
have been ideal, suitable transgenic zebrafish lines were not available. Analysis of 
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cryptococcal-autophagy interactions within neutrophils, provides further evidence of 
cryptococcal interactions with neutrophils in a relatively under-studied (in relation to C. 
neoformans) innate immune cell.  
The normal neutrophil Lc3 response to C. neoformans was first investigated by 
cryptococcal injection into larvae with neutrophil specific traffic-light Lc3 expression (not 
in an autophagy mutant background). The number of infected neutrophils, is 
significantly reduced at 1dpi, in comparison to 2hpi, although a similar number of 
neutrophils were analysed, suggesting that some neutrophils have degraded 
cryptococci, or that infected neutrophils were lysed. No significant increase in 
cryptococcal cells inside individual neutrophils over infection time course suggests 
none or limited fungal intracellular proliferation. These data suggest that neutrophils are 
able to effectively phagocytose cryptococcal cells, but that most cryptococcal cells are 
not degraded over time. In mouse models, clearance of intravascular cryptococcal cells 
has been shown require neutrophils (Sun et al. 2016a). Recent zebrafish cryptococcal 
infection data has also shown that neutrophils are important for clearance of 
intravascular cryptococcal cells (Davis et al. 2016). In fact, neutrophil mediated 
phagocytosis and killing of cryptococcal cells was shown to be important in the initial 
infection control, where neutrophil killing is superior to macrophage killing, and in 
control of cryptococcal cells which may escape from macrophage or endothelial cells 
later in infection (Davis et al. 2016). It may be likely that the reason more neutrophils 
are infected very early in infection is because most cryptococcal cells are extracellular, 
enabling neutrophil phagocytosis. 
Of particular interest is the observation of “neutrophils” apparently containing 
cryptococcal cells, but in vesicles that are only RFP positive (rather than double GFP 
and RFP positive). It is tempting to speculate that this RFP fluorescent signal 
represents Lc3 on the inside of a cryptococcal phagosome, perhaps in cases where 
neutrophils have recently lysed, resulting in the loss of cytoplasmic GFP and RFP 
signal. The phagosome may retain its acidity resulting in the quenching of GFP signal 
and RFP signal remaining. Neutrophil phagosomes are not as acidic as macrophage 
phagosomes (Jankowski et al. 2002) and likely do not acidify enough to a pH less than 
6 which is required to quench GFP (Murillo et al. 2001). It would be of interest to 
determine whether these RFP positive vesicles are acidic, perhaps by using pH 
sensitive dyes. This proposition may be supported by the observation that Lc3 
molecules have been detected on cryptococcal cells which have escaped from 
macrophages non-lytically, however lipids which would represent a potential 
phagosome were not present on Lc3 positive cryptococcal cells (Nicola et al. 2012). It 
is unlikely that non-lytic escape is the cause of this interesting observation, since this 
217 
 
requires membrane fusion (Johnston & May 2010), which would not provide an acidic 
environment to provide just an RFP signal. A major difference is the cell type, of 
neutrophils used is this current study in comparison to most cryptococcal studies 
focussing on macrophages. It remains to be determined whether neutrophil lysis may 
be a major escape route for Cryptococcus from neutrophils, which may support this 
hypothesis. Interestingly, a small increase in the number of RFP only neutrophils is 
observed at 1dpi.  Furthermore at 1dpi, an increase in the number of cryptococcal cells 
within RFP positive cells in observed. A large number of cryptococcal cells within the 
majority of RFP positive neutrophils may suggest that plasma membrane lysis could be 
caused by the physical presence of multiple cryptococcal cells. Time lapse imaging 
may provide good evidence of neutrophils lysis, which may also highlight a change 
from RFP/GFP signal to RFP signal alone. If this is proven correct, cryptococcal cells 
able to “hide” within host phagosomes in the extracellular environment may prevent 
phagocytosis and ultimately provide a possible “extra-cellular phagosome niche”, which 
could potentially be an important stage in cryptococcal pathogenesis.   
The co-localisation of Lc3-II to cryptococcal cells shown to mark an entire cryptococcal 
vesicles, or mark as puncta on cryptococcal vesicles, determined that autophagic 
machinery can mark cryptococcal phagosomes in the host neutrophil response to C. 
neoformans. This is consistent with other reports that Lc3 can mark cryptococcal 
vesicles (Nicola et al. 2012; Qin et al. 2011). A small majority of neutrophil cryptococcal 
vesicles were marked with Lc3 at 0dpi, however this was significantly reduced at 1dpi. 
Puncta were also significantly less likely to mark cryptococcal vesicles at 1dpi in 
comparison to 0dpi. These data suggest that an autophagy response occurs after 
phagocytosis of cryptococcal cells in neutrophils. A reduction of Lc3 marking of 
cryptococcal vesicles over time was also demonstrated in macrophage cells in vitro, 
whereby Lc3 marking was lost after 3hpi (Qin et al. 2011). This suggests an immediate 
autophagy response occurs, early after phagocytosis. Of note, the transgenic line over 
expresses the traffic light Lc3 construct, so although showing co-localisation can occur, 
it is not possible to conclude from this data whether endogenous Lc3 would mark as 
many vesicles. It would be very interesting to determine whether Lc3 recruitment in 
beneficial for the host or the fungal cell, and what outcome this may have on infection 
outcome.  
To determine whether atg3 or atg5 deficiency alters Lc3 recruitment to cryptococcal 
vesicles at 0dpi and 1dpi, cryptococcal cells were injected into the neutrophil specific 
traffic light Lc3 line which was previously crossed to the atg3 or atg5 mutants. 
Importantly, no difference in the number of neutrophils which were infected, or to the 
number of yeast cells within neutrophils was found between atg3 or atg5 homozygous, 
218 
 
heterozygous or wild-type siblings at each individual time point. This suggests that 
phagocytosis occurs at a similar rate in neutrophils within larvae of all atg3 or atg5 
genotypes throughout infection. However, between 0dpi and 1dpi, the number of 
infected neutrophils is decreased for all genotypes. This suggests that a reduction in 
phagocytosis occurs later in infection. Together these data suggest that the neutrophil’s 
ability to phagocytose cryptococcal cells is not affected by either atg3 or atg5 
deficiency. Therefore, any changes in Lc3 recruitment are likely not due to inability to 
phagocytose similar amounts of cryptococcal cells. Interestingly in macrophages, an 
atg5 deficiency led to a reduction in phagocytic ability in vitro (Qin et al. 2011), 
highlighting potential different roles of autophagy between macrophages and 
neutrophils, although differences may also be caused by in vitro analysis, for example, 
RNAi may lead to off target effects which may reduce macrophage phagocytic ability. 
An additional difference is that Lc3 recruitment to C. neoformans only occurred in 
macrophages (J774.16 cells), when opsonised with antibody, and not with complement 
(Nicola et al. 2012). In zebrafish, the lack of an adaptive immune system at this larval 
age means that antibodies could not be present. Therefore, non-opsonised or 
complement opsonised cryptococcal cells are phagocytosed by neutrophils at this 
larvae age. This highlights that Lc3 recruitment to phagocytosed cryptococcal cells can 
occur without antibody involvement, in neutrophils.  
A significant reduction of Lc3 localisation to cryptococcal vesicles was found for both 
atg3 and atg5 homozygous and heterozygous larvae in comparison to wild-type larvae 
at 0dpi. However, no significant difference between Lc3 localisation to cryptococcal 
vesicles was found for atg3 or atg5 homozygous and heterozygous larvae in 
comparison to wild-type larvae at 1dpi. The reduction of Lc3 co-localisation at 0dpf for 
atg3 and atg5 homozygous and heterozygous led to no significant change in Lc3 co-
localisation between 0 and 1dpi, which was observed for wild-type larvae, and larvae 
not in either  mutant back-ground. This suggests that autophagy deficiency in single or 
both alleles causes a reduction in Lc3 localisation to C. neoformans phagocytosed by 
neutrophils, early in infection. This has not been demonstrated previously. These data 
are suggestive that both atg3 and atg5 mutants are not be able to efficiently lipidate 
Lc3-I, required for the marking of membranes. Furthermore, in atg3 deficient larvae, a 
reduced fungal burden was observed in comparison to wild-type siblings. Therefore, it 
is plausible that Lc3 recruitment is involved in the host degradation of cryptococcal 
cells, or conversely cryptococcal manipulation of cellular components. Importantly, 
these data only highlight a reduction in Lc3 localisation. In order to determine whether 
a lack of Lc3 recruitment to C. neoformans is detrimental for the host, or bacteria, and if 
Lc3 recruitment is involved as a LAP or autophagy marker, further analysis is required. 
Investigation may reveal a neutrophil niche, or even a neutrophil derived phagosomal 
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niche, for cryptococcal cells which may expand the current dogma that macrophages 
provide the primary intracellular niche in cryptococcal infection.  
A relevant observation, or rather lack of observation, is that no double membrane 
vesicles, which are characteristic of autophagosomes, containing C. neoformans has 
so far been visualised. In fact, in macrophages only single-membrane vesicles have 
been observed to surround C. neoformans, and small double membrane vesicles 
observed only to fuse into this single membrane (Pandey et al. 2017; Nicola et al. 
2012). This may suggest the mechanism of how autophagic machinery can be 
recruited to the single membrane, perhaps suggesting that LAP, rather than classical 
autophagy is involved in cryptococcal handling. Pathogenic fungus Aspergillus 
fumigatus was shown to be targeted to LAP, which is beneficial for the host. (Martinez 
et al. 2015). Furthermore, this may suggest that LAP (which requires both atg3 and 
atg5 for lipidation of Lc3-I which is subsequently trafficked to LAP-phagosomes) 
(Martinez et al. 2015), may be important in future studies, to determine exactly what 
role autophagy machinery is used for during cryptococcal infection. 
To conclude, Lc3 is shown to co-localise with C. neoformans within neutrophils. The 
host Lc3 and cryptococcal co-localisation may represent a host or pathogen derived 
interaction, future studies may reveal autophagy as a mediator in a cryptococcal 
neutrophil niche. A reduction in Lc3 recruitment cryptococcal vesicles in atg3 and atg5 
mutants, which is not caused by defects in neutrophil phagocytosis, suggests that 
autophagic machinery is involved in the neutrophil response to cryptococcal cells. 
However, it is important to determine whether Lc3 recruitment is beneficial to the host, 
or bacteria, and this presents an exciting research topic for the future.  
Of note, only a limited number of publications focussing on the role of host cell 
autophagy in the pathogenesis of C. neoformans exist, and all focus on macrophages. 
While there appears to be an emerging role that cryptococcal cells benefit from host 
cell autophagy, there is also evidence that the activation state of the macrophages 
plays an important role in determining whether autophagy is truly beneficial for the 
cryptococcal cells (Nicola et al. 2012). As evidence is emerging that cryptococcal cells 
can survive and replicate within neutrophils, further analysis into the role of neutrophil 
autophagy, which may have different actions to macrophages, may provide interesting 
insights into the role of host autophagy in the pathogenesis of C. neoformans. 
5.4 Chapter summary 
Overall, larval survival and pathogen burden analysis of both C. neoformans and S. 
aureus infection did not provide any firm conclusions about the role of host cell 
autophagy either as a host defence, or in promoting improved pathogen survival. This 
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is likely due to the atg3 and atg5 zebrafish mutants survival defect, maternal 
contribution, and also the fact that both pathogens can reside extracellularly, which 
would not be affected by changes in host cell autophagy. However, within neutrophils, 
both pathogens had reduced Lc3-II co-localisation in comparison to wild-type controls, 
suggesting that atg3 and atg5 homozygous mutants have a reduction in Lc3-II 
production and/or ability to mark pathogen phagosomes. Further work is required to 
determine whether changes in Lc3-II marking of pathogen phagosomes is beneficial for 
the host or pathogen.   
  
221 
 
Chapter 6: Results chapter 4 
Generation of a selective autophagy receptor reporter line  
 
6.1 Chapter introduction  
Autophagy is the process self-degradation of cellular components, usually engaged for 
cell homeostasis and survival, for example in starvation conditions. Autophagy 
machinery can also be employed in the selective degradation of unwanted cellular 
components including pathogens, termed xenophagy. This selective degradation 
requires the use of adapter molecules, (autophagy receptors) which are able to 
recognise and transport cargo, for example a bacterium, into contact with autophagic 
machinery, for degradation.  
Many selective autophagy receptors (SARs) are able to recognise and bind to 
ubiquitinated cargo. Indeed, four SARs are known to be involved in recognition of 
ubiquitinated pathogens in mammals, including p62 (otherwise known as 
sequestosome 1, SQSTM1), optineurin (OPTN), (nuclear dot protein 52 kDa) NDP52 
and TAX1BP1 (Tax1 Binding Protein 1) (Farré & Subramani 2016). SARs are able to 
bind to LC3 through a LC3-interacting region (LIR), and also to bind ubiquitin, enabling 
the recruitment of ubiquitinated pathogens for autophagic degradation. In vivo analysis 
of p62 localisation has not hitherto been possible, although in vitro systems to monitor 
autophagy molecules have been established (Larsen et al. 2010).  
Neutrophils are a recognised intracellular niche for S. aureus (Prajsnar et al. 2012). 
Recent literature reports that p62 is able to recruit S. aureus residing in the cytoplasm 
to the autophagosome, but once within the autophagosome S. aureus is able survival, 
replicate and eventually to escape the autophagosome and/or host cell for its own 
survival (Neumann et al. 2016; Singh et al. 2017). It will be of interest to visualise the 
dynamics of p62 recruitment to S. aureus, during in vivo infection. 
The role of xenophagy in clearance of fungal pathogens is not established, in fact, the 
term “xenophagy” is only used to describe clearance of bacterial and viral pathogens. It 
was recently reported that C. neoformans is able to manipulate the phagosome it 
resides in, within macrophages, to promote survival and potentially extracellular escape 
via vomocytosis (Smith et al. 2015). It was further demonstrated that LC3 was present 
on the surface of some cryptococcal cells which had escaped macrophage degradation 
(Nicola et al. 2012). Neutrophils are relatively less studied than macrophages in 
cryptococcal infection. However, neutrophils are able to kill C. neoformans, and may 
play a key role in intra-vasculature clearance of fungal cells (Sun et al. 2016a; Diamond 
et al. 1972). Although a role of autophagy in host cell control of cryptococcal infection 
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has not been demonstrated, it would be of interest to discover whether p62 is involved 
in the host control of cryptococcal infections within neutrophils.  
Hypothesis: p62 is involved in the in vivo handling of S. aureus and C. neoformans in 
host neutrophils.  
Chapter aims:  
This chapter aims to create and use a zebrafish p62 reporter line to enable in vivo 
analysis of p62 interactions with pathogens, specifically within neutrophils. 
1. Design and generate a zebrafish p62 reporter line 
2. Determine whether the p62 reporter line shows a neutrophil specific expression, 
and if tagged GFP-p62 fusion protein acts in a similar manner to endogenous 
p62 
3. Establish if p62 is employed by neutrophils in in vivo S. aureus infection 
4. Establish if p62 is employed by neutrophils in in vivo C. neoformans infection 
 
6.2 Zebrafish p62  
To create a zebrafish p62 reporter line, it is important to determine whether human p62 
gene structure and function is conserved in zebrafish. This ensures it is suitable as a 
tool for analysis of situations in which human p62 is known to interact with pathogens.  
Autophagy receptor p62 (sequestosome 1, or SQSTM1) is found in both human and 
zebrafish genomes. In zebrafish, there is a single p62 gene, located on chromosome 
14, which has two coding transcripts, and three non-protein coding transcripts (Silva et 
al. 2014; Mostowy et al. 2013). In comparison, in humans p62 is located on 
chromosome 5 and encodes six coding transcripts. A recent, thorough study compared 
human and zebrafish genomic sequences, transcripts, protein structure and predicted 
protein domain function (Silva et al. 2014). This study highlighted high similarity 
between zebrafish and human p62 protein structure and expression, and suggested 
they likely function in a similar manner. Indeed, the study concluded that zebrafish p62 
would be a good model for human disease, specifically Paget’s disease which is 
caused by mutations in p62 (Chamoux et al. 2009; Silva et al. 2014). Of particular 
interest, both the LIR and ubiquitin-associated (UBA) domains are conserved, with 41% 
and 81% identity respectively (Silva et al. 2014). This suggests that autophagy function 
is conserved and provides basis that generation of a zebrafish reporter line of p62 will 
provide a useful tool to study p62 function which may well be translatable to human 
studies.   
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6.3 Reporter line design and methodology 
The Gateway system was chosen to generate a vector, which would encode a GFP-
p62 reporter, easily inserted into the zebrafish genome through Tol2 transgenesis 
under the neutrophil-specific promoter lyz.   
The GatewayTM system is completed through the generation of entry clones, through 
BP reactions, and the subsequent generation of expression clones through an LR 
reaction. Both BP and LR reactions are based on the use of “att” recombination 
sequences, which enable integration of required DNA sequences into specific locations 
on vectors. The “att” sites were originally isolated from DNA recombination sequences 
in bacteriophage λ, responsible for the location of integration sites of the viral genome 
into the host bacterial genome, through integrase enzyme activity. These “att” sites 
were optimised for recombination of PCR products and vectors for the Gateway 
system. Introduction of small variations in the “att” sequences enable site specific 
recombination, which are numbered 1-4 in the Gateway system. An example of multi-
site Gateway three fragment assembly is shown in Fig 6.1 A.  
The BP reaction places a required DNA sequence, for example a gene, into an entry 
vector. The “attB” sites are added by PCR onto the sequence to be inserted, flanking 
the insert. Corresponding “attP” sites are found on the selected 3’ entry clone. 
Recombination leads to the insertion of the sequence into the entry vector. The “attB” 
and “attP” sites recombine to create “attL” or “attR” sites located each side of the 
inserted sequence on the entry vector.    
The LR reaction places the 5’, middle entry (ME), and 3’ vectors into a selected 
destination vector through the use of location specific complementary attL and attR 
sites (e.g. the attL3 on 3’ entry clone with the attR3 on the destination vector). 
Recombination by the LR clonase enzyme mix, results in the creation of the final 
expression clone.   
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Figure 6.1 Gateway expression clone procedure 
Experimental overview of generation of a three fragment destination vector, 
including entry clone generation by the BP reaction, and expression clone 
generation from LR reactions. Importantly the 5’ sequence, middle entry sequence 
and 3’ sequence (yellow, purple and dark blue respectively) are transferred from a 
PCR product into entry clones, and subsequently transferred into the expression 
clone 
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LR reaction
attB4
attP4
attB1r
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attP2
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attP3
attB1
attP4
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Destination vector
attL4 attR1
attL1 attL2
attR2 attL3
Entry vectors
attB4 attB3
Expression clone
attB1 attB2
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Figure 6.2 Protein structure of p62 
Figure 5, Silva, I. A. L., Conceição, N., Michou, L. and Cancela, M. L. (2014), Can 
zebrafish be a valid model to study Paget's disease of bone?. J. Appl. Ichthyol., 30: 
678–688. doi:10.1111/jai.12523. A Protein domain structure in human and 
zebrafish p62 genes, of note LIR and UBA domains B Protein sequence 
highlighting the similarity of residue sequences and related domain locations 
Permission for reproduction obtained see Appendix 2. 
In the generation of a neutrophil specific, GFP p62 reporter line, the choice and order 
of entry vectors was carefully considered. The structure of the p62 protein, as shown in 
Figure 6.2, shows both LIR and UBA domains are closest to the 3’ end of the 
sequence, in both human and zebrafish. Both LIR and UBA domains are important for 
the function of p62 in selective autophagy. To ensure the fusion tagged GFP would not 
sterically block p62 interactions at the LIR and UBA domains, it was decided to place 
the p62 gene in the 3’ entry vector and GFP in the middle entry vector.    
 
To enable expression of the fusion protein specifically within neutrophils, the lyz 
promoter was chosen to be used in the 5’ entry vector. The p5E-lyz entry clone (Elks et 
al. 2011) and the pME-GFP-nonstop middle entry vectors were chosen. To ensure a 
fusion protein of GFP-p62, this middle entry vector was chosen as it did not contain a 
functional STOP codon. Therefore, it is expected that a protein will be translated from 
the GFP, through the small linker region, and to p62. The destination vector 
pDestTol2CG, was chosen which included Tol2 sites for integration into the genome, in 
addition to a GFP heart marker. The planned methodology is represented in Figure 6.3, 
and expected expression clone, pDest(lyz:GFP.p62) in Figure 6.4. The required p62 3’ 
entry vector, and expression clone pDest(lyz:GFP.p62) were constructed following the 
Multisite GatewayTM three-fragment vector construction kit, as described in detail in the 
Appendix 1. 
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Figure 6.3 Gateway procedure followed in this project 
Experimental procedure followed in this project with vectors used. The 3’ p62 entry 
clone was generated by the BP reaction. The 5’ entry clone (lyz) and middle entry 
clone (GFP) were previously created. Using the pDestTol2CG destination vector for 
the LR reaction, 5’ lyz sequence, middle entry GFP sequence and 3’ p62 sequence 
(yellow, purple and dark blue respectively) were transferred to create the 
expression clone.  
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Figure 6.4 Expected pDest(lyz:GFP.p62) sequence 
A Linear map of the expected pDest(lyz:GFP.p62) sequence, where the red box 
indicates the portion which will code for the fusion GFP-p62 protein (SeqBuilder 
DNASTAR Lasergene suite) B Circular map of the expected pDest(lyz:GFP.p62) 
sequence, where the red circle indicates the portion which will code for the fusion 
GFP-p62 protein (SeqBuilder DNASTAR Lasergene suite). Both maps highlight the 
lyz promoter, GFP and p62 sequence, in addition to the heart marker (cmlc2) driven 
GFP, and ampicillin (ampR) resistance gene sequence. 
A
B
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Figure 6.5 pDest(lyz:GFP.p62) restriction digest  
A Schematic of the pDest(lyz:GFP.p62) construct, with NcoI restriction sites marked 
B Nco1 digest: expected bands observed at 8703bp, 7482bp, 2043bp, and 1331bp  
A
8 Kb
10 Kb
2 Kb
1.2 Kb
1.5 Kb
B
To ensure the final expression clone was correct in size (and sequence), a restriction 
site digest was performed. The NcoI enzyme is able to cut at four specific locations of 
the expected sequence of the pDest(lyz:GFP.p62) expression clone, marked in Fig 6.5 
A. Following an NcoI digest, four fragments of 8703bp, 7482bp, 2043bp, and 1331bp in 
size are expected. The correct band sizes were observed after digestion of the 
pDest(lyz:GFP.p62) vector (Fig. 6.5 B). This suggests that the LR reaction worked as 
expected and yielded the correct expression clone. Additionally, sequencing was 
completed to cover each junction between entry vectors and those joining with the 
destination vector. In all cases, the expected sequence was confirmed. These data 
show the pDest(lyz:GFP.p62) expression clone was successfully generated.    
 
 
6.4 Tol2 synthesis and injection in F0 
In order to insert pDest(lyz:GFP.p62) into the genome of zebrafish, Tol2 mediated 
transgenesis was used. Transposons (DNA transposable elements) are sequences of 
DNA which are able to move position in the genome. Movement of transposons within 
the genome can result in genomic change, such as a mutation. Transposase activity is 
responsible for the insertion of sequences into the genome and can be encoded by the 
transposon. Tol2 is a transposon, originating from in medaka fish. Tol2 encodes a 
transposase (Kawakami et al. 2000), and has been established as a useful transposon 
in the generation of zebrafish transgenic lines, due to its high rate of insertion into the 
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germ line. Tol2 is not found in zebrafish, therefore Tol2 mRNA in co-injected into the 
larvae to enable genomic integration, of sequences containing Tol2 transposon flanking 
sites. The backbone vector used in pDest(lyz:GFP.p62) contains Tol2 flanking sites at 
each side of the sequence to be integrated in the larvae genome.  
To generate Tol2 mRNA, a pT3Tol2 plasmid was used. The DNA pT3Tol2 plasmid was 
linearised through a restriction site digest. Tol2 mRNA was generated by a transcription 
reaction (Ambion T3 mMessage Machine) from the linear pT3Tol2 plasmid. Tol2 mRNA 
integrity was confirmed by Nanodrop and gel electrophoresis, and stored at -80ºC.  
To generate a stable zebrafish line with pDest(lyz:GFP.p62) inserted into the genome. 
Tol2 mRNA and pDest(lyz:GFP.p62) were co-injected into a single cell (at the single 
cell stage) of wild-type AB larvae. A 1nl injection contained 30pg of Tol2 mRNA and 
60pg of pDest(lyz:GFP.p62)  (increased from the standard 30pg after the first test 
resulted in low transient expression). In addition a 1/10 dilution of phenol red in was 
used to confirm injection into the single cell was successful.  
6.5 Transient expression  
At 3 days after injection, larvae were screened on a fluorescence stereomicroscope to 
select larvae which had GFP transiently expressed within neutrophils. Presence of the 
GFP positive heart marker suggests that the integration of the pDest(lyz:GFP.p62)  
construct  was successful. Larvae with a GFP positive heart were selected for further 
screening.  GFP positive cells moving with the blood stream were observed in a small 
number of larvae, which were likely to be neutrophils. Static GFP positive cells located 
in the caudal haematopoietic tissue (CHT) were observed in some larvae were similarly 
believed likely to be neutrophils. In many cases, transient GFP expression was 
observed in the muscle somites, which is seen commonly in zebrafish transgenesis. 
Larvae with positive heart marker and high numbers of likely GFP positive neutrophils 
cells, were raised as potential Tg(lyz:GFP.p62) founders.  
6.6 Founder screening and generation of stable line 
Larvae which had been injected with pDest(lyz:GFP.p62) and raised as potential 
founders, were out-crossed to nacre wild-type. Resulting offspring from each pair were 
screened (as above section in 6.5) for GFP positive cells which were likely to be 
neutrophils. A single founder was identified in which ~70% of offspring contained GFP 
positive heart marker and single cells characteristic of neutrophils. The majority of 
resulting larvae from the founder and nacre cross were raised as an F1 generation of 
Tg(lyz:GFP.p62) line.  
A small fraction of the F1 Tg(lyz:GFP.p62) were used for preliminary image analysis. A 
very small number of larvae were available for use, so infection with S. aureus and C. 
230 
 
 
Figure 6.6 Phagocytosis of S. aureus and C. neoformans 
Preliminary imaging of Tg(lyz:GFP.p62) F1 generation. A mCherry S. aureus 
infection into Tg(lyz:GFP.p62) F1 B mCherry C. neoformans infection 
Tg(lyz:GFP.p62) F1 generation 
Tg(LyzC:GFP.p62)
Tg(LyzC:GFP.p62)
Merge
Merge
S. aureus 
C. neoformans
A
B
neoformans was completed in just two larvae respectively. This assay was chosen to 
determine if phagocytosis occurs, with the hypothesis that phagocytosis events would 
establish that GFP positive cells were phagocytic cells. Indeed, phagocytosis was 
observed for both S. aureus and C. neoformans in GFP positive cells (Fig 6.6 A, B). 
Additionally, it was noticed that GFP puncta were present in both un-infected and 
infected phagocytic cells (Fig 6.6 A), with a uniform cytoplasmic GFP fluorescence 
seen in all GFP positive cells. These may represent p62 puncta at sites of 
autophagosomes within individual phagocytic cells. The uniform cytoplasmic GFP 
fluorescence may represent GFP-p62 not actively being used be the cell resulting in a 
cytoplasmic GFP distribution. Furthermore GFP puncta were seen co-localised with S. 
aureus within the cytoplasm of phagocytic cells (Fig. 6.6 A). Similarly, GFP puncta 
were present on what appear to be C. neoformans vesicles (Fig. 6.6 B). Vesicles were 
believed to be present due to the lack of GFP fluorescence in the location of individual 
cryptococcal cells.   
These preliminary data suggest that the GFP positive cells are phagocytic cells. In 
addition, formation of GFP puncta within GFP positive cells may represent an 
interaction of GFP-p62 with autophagosomes and with pathogens. 
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Figure 6.7 Neutrophil expression of GFP-p62 
Imaging of Tg(lyz:GFP.p62) crossed to Tg(lyz-nsfB-mCherry)sh260 larvae A Co-
localisation of both GFP and mCherry B A single neutrophil expressing both GFP 
and mCherry, with GFP puncta observed. All scale bars represent 21um.  
GFP-p62 positive 
neutrophils
mCherry positive 
neutrophils
MergeDICA
B GFP-p62 positive 
neutrophil
mCherry positive 
neutrophil
Merge
6.7 Characterisation of Tg(lyz:GFP.p62) transgenic line 
It was next important to determine whether the generated Tg(lyz:GFP.p62) expressed 
protein specifically in neutrophils, and whether the tagged protein behaved as 
endogenous p62, before using the line for infection analysis. Characterisation is 
essential because it is possible that GFP fusion to p62 blocks function of the p62, 
perhaps sterically.  
To determine whether the GFP-p62 was being expressed in neutrophils, an out-cross 
of the F1 generation of Tg(lyz:GFP.p62), to a complementary neutrophil line, Tg(lyz-
nsfB-mCherry)sh260 (Prajsnar et al. 2012), which expresses mCherry in the neutrophils 
was completed. High magnification imaging of both GFP and mCherry positive cells 
was completed in larvae. Comparison of the expression of GFP and mCherry 
neutrophils indicate a clear co-expression in neutrophils (Fig 6.7 A). The fluorescence 
intensity is derived from the lyz promoter, which may vary between individual 
neutrophils. Indeed, the fluorescence of GFP and mCherry intensity are matched within 
individual cells. Therefore, GFP fluorescence is being expressed specifically within 
neutrophils.  
On the other hand, where GFP puncta are observed, no corresponding mCherry 
puncta are seen (Fig 6.7 B). This is suggests that GFP puncta are forming in a p62 
dependant manner, rather than a consequence of expression. It is tempting to 
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Figure 6.8 Neutrophil expression of GFP-p62 
Imaging of Tg(lyz:GFP.p62) crossed to Tg(lyz-nsfB-mCherry)sh260 larvae A 
Fluorescence observed of GFP and mCherry within individual neutrophils, imaged a 
high magnification in the caudal haematopoietic tissue, using six representative 
larvae  
speculate that the GFP puncta represent autophagosomes.  
To determine whether the neutrophils were the only GFP positive cells, the number of 
double GFP and mCherry positive cells, or single colour cells were compared. In all 
cases, with a single exception, all cells were double GFP and mCherry positive (Fig 6.8 
A).  These data show GFP-p62 is expressed specifically within neutrophils.  
 
Next, in order to determine whether the GFP tagged p62 was functional, 
Tg(lyz:GFP.p62) larvae were treated with autophagy influencing drugs. The aim was to 
determine whether GFP-p62 responded to changes in autophagy in a similar manner 
as expected of endogenous p62. Larvae were treated with either an autophagy blocker, 
BK8644 to block autophagy, or with rapamycin and chloroquine together (and each 
alone), to monitor autophagic flux. Larvae from the F1 generation were imaged after 24 
hours of drug treatment, however it was noticed that fluorescence intensity was 
variable within individual fish, excluding the possibility of comparing fluorescence 
intensity between larvae in each drug treatment. In addition, fluorescence intensity 
would be dependent on expression of lyz promoter, rather than specifically p62, 
although a disappearance of GFP fluorescence may have represented an increase in 
autophagic flux.  Therefore, the GFP-p62 puncta observed within neutrophils, were 
used as a measure of autophagy.  
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Figure 6.9 Neutrophil expression of GFP-p62 puncta 
Imaging of lyz-GFP-p62 treated with autophagy influencing drugs A Actual number 
of neutrophils observed with puncta, treated with different autophagy influencing 
drugs (not-significant two-way ANOVA, n=3, 15-20 larvae per group) B Percentage 
of neutrophils with puncta present, treated with different autophagy influencing 
drugs (n=3, 15-20 larvae per group)  C Number of puncta observed within individual 
neutrophils, in larvae treated with different autophagy influencing drugs (Error bars 
+/- SD, One-way ANOVA Tukey’s multiple comparisons *p<0.05, ****p<0.001, n=3, 
15-20 larvae per group).  
Puncta representing GFP tagged p62 were used a read-out of the effect of autophagy 
influencing drugs. The number of individual neutrophils containing puncta differs 
according to drug treatments (Fig 6.9 A), actual numbers were included to show that 
each treatment group had fairly similar neutrophil numbers. The same data is 
presented as percentage in Figure 6.9 B, to highlight the difference in ratio of 
neutrophils with/without puncta. Where autophagy is blocked by rapamycin and 
chloroquine, or BK8644, or chloroquine, no change in the number of neutrophil 
containing puncta in comparison to controls is shown. Similarly rapamycin treatment 
led to no change in the number of neutrophils containing puncta. A reduction may have 
been expected if autophagy is up-regulated and p62 molecules are used and degraded 
(Fig 6.9 B). These data do not suggest that GFP-p62 within neutrophils responded 
appropriately to autophagy influencing drugs, suggesting that GFP-p62 acts in a similar 
manner as endogenous p62. 
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I next examined the number of GFP-p62 puncta within individual neutrophils. Of note, 
in non-treated control larvae a large range of puncta were observed, between 0 and 14 
puncta within individual neutrophils (Fig 6.9 C). Following treatment with autophagy 
inhibitor BK8644, the number of puncta in neutrophils observed is significantly 
increased in comparison to non-treated neutrophils (Fig 6.9 C). This is indicative that 
the GFP-p62 is not being degraded through autophagy, acting in a similar manner as 
endogenous p62 would be expected to behave. Rapamycin and chloroquine treatment, 
and chloroquine alone show a similar number of puncta in comparison to controls. 
Rapamycin had no change in puncta number in comparison to controls, but is 
significantly different to BK8644. This may be expected as rapamycin and BK8644 are 
expected to cause opposing effects on p62 a reduction and increase respectively. 
Ultimately, these data are suggestive that GFP-p62 is acting in a similar manner to 
endogenous p62. 
Taken together, these data demonstrate that GFP-p62 in the Tg(lyz:GFP.p62) line is 
expressed specifically within neutrophils and suggests puncta formation/degradation 
responds to autophagy induction.   
 
6.8 Verifying Tg(lyz:GFP.p62) as a fusion protein 
The above analysis suggests that the GFP-p62 fusion protein is indeed influenced by 
autophagy drugs. To further confirm p62 is tagged with GFP a western blot (using an 
anti-GFP antibody) was performed. Zebrafish protein lysate from Tg(lyz:GFP.p62) 
larvae, AB wild-type, Tg(mpx:eGFP)i114 (neutrophil specific GFP) were compared. The 
expectation was that no GFP protein would be present in the AB wild-type, a single 
GFP band at ~27KDa for the Tg(mpx:eGFP)i114, and a single band with a larger size of 
~79KDa representing GFP tagged to p62 in the Tg(lyz:GFP.p62) larvae. The ~79KDa 
predicted size was calculated according to the coding sequence of the GFP-linker-p62 
fusion protein. 
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Figure 6.10 GPF protein in Tg(mpx:eGFP)i114 and Tg(lyz:GFP.p62) 
larvae 
Western blot using anti-GFP antibody on 5dpf AB wild-type, Tg(mpx:eGFP)i114 and 
Tg(lyz:GFP.p62) lysate. Protein ladder used Amersham full range RPN800E 
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A western blotting demonstrated that no GFP is present in AB wild-type larvae as 
expected (Fig. 6.10). In addition, a single GFP band at ~27KDa is observed for the 
Tg(mpx:eGFP)i114 larvae (Fig. 6.10), as expected of GFP present within neutrophils, but 
that is not tagged to another protein. However, multiple bands were observed for 
Tg(lyz:GFP.p62) larvae. A band representing the expected ~79KDa was not observed, 
although a larger size of ~125KDa was seen, in addition to ~62KDa, ~52KDa, ~46KDa, 
a large band at ~27KDa, and ~24KDa (Fig 6.10). The large band at ~27KDa likely 
represents the GFP heart marker protein, which is not a fusion protein.  
 
Antibody company Abcam, advised that in western blots used on human brain protein 
samples, using their anti-p62 antibody (ab31545), four major bands were detected at 
130KDa, 62KDa, 45KDa and 22KDa, with additional bands observed in rat lysate at 
80KDa and 47KDa. This suggests that multiple p62 protein products exist. The 
products observed in human tissue appear to be similar, although not exact matches, 
to the protein product sizes observed in the Tg(lyz:GFP.p62) larvae. This suggests that 
the observation of multiple bands representing GFP-p62 may be expected in zebrafish.  
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6.9 Analysis of S. aureus interaction with p62  
The Tg(lyz:GFP.p62) line was established in order to study in vivo p62 interactions with 
pathogens, specifically within neutrophils. The Tg(lyz:GFP.p62) larvae were injected 
with S. aureus to quantify any association with p62, with bacteria within vesicles or in 
the cytoplasm and whether any p62 associated handling of S. aureus changes over 
infection time course.  
The Tg(lyz:GFP.p62) larvae were injected at 2dpf with 2,500cfu of S. aureus, and 
imaged at 2hpi, and 1dpi (~26hpi). Time points were chosen to compare initial 
pathogen interactions with GFP-p62 with any potential changes later in infection. An 
important initial observation showed that S. aureus is efficiently cleared by the larvae. 
The number of S. aureus events (where bacteria are observed within a neutrophil) 
decreases over time (Fig. 6.11 A). Furthermore, the proportion of infected neutrophils is 
significantly decreased over the infection time course (Fig. 6.11 B). Taken together 
these data suggest that neutrophils effectively degrade S. aureus during infection. 
Additionally, these data support the hypothesis that S. aureus goes through an immune 
cell mediated population “bottleneck”.  
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Figure 6.11 S. aureus clearance over infection time course 
The Tg(lyz:GFP.p62) larvae were injected at 2dpf with 2,500cfu of mCherry S. 
aureus, and imaged at 0dpi (2hpi) and 1dpi (~26hpi). A The number of S. aureus 
events observed within neutrophils at 0dpi and 1dpi (n=3, 14 larvae at 0dpi, and 12 
larvae at 1dpi) B Proportion of neutrophils infected or non-infected with S. aureus at 
0dpi and 1dpi (****p<0.001, Fisher’s exact test, n=3, 14 larvae at 0dpi, and 12 
larvae at 1dpi) 
 
 
The location of S. aureus within individual neutrophils was next examined. It is known 
that when S. aureus is phagocytosed, it will reside in a phagosome. However, S. 
aureus is capable of escaping the vesicle to reside in the cytoplasm. It is known that 
p62 is able to recruit to ubiquitinated pathogens, including S. aureus, but that this 
would only occur when S. aureus is free in the cytoplasm.  Therefore, the location of S. 
aureus was examined.  
It was possible to reason if S. aureus was possibly located in a vesicle, due to the 
presence of a “circular gap” in the disperse cytoplasmic GFP-p62 pattern (as discussed 
above), which most likely represents a vesicle (Fig. 6.12 A). Alternatively, where S. 
aureus was located in an area with diffuse cytoplasmic GFP-p62, it was considered to 
be cytoplasmic (Fig. 6.12 B). 
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Figure 6.12 S. aureus location within Tg(lyz:GFP.p62) neutrophils 
A Representative image of S. aureus observed within a likely “vesicle”, scale 9um B 
representative image of S. aureus observed within the cytoplasm, scale 5.8um C 
The number of S. aureus events observed within vesicles or cytoplasm at 0dpi and 
1dpi (****p<0.001, Fisher’s exact test, n=3, 14 larvae at 0dpi, and 12 larvae at 1dpi) 
D proportion S. aureus events observed within vesicles or cytoplasm at 0dpi and 
1dpi (****p<0.001, Fisher’s exact test, n=3, 14 larvae at 0dpi, and 12 larvae at 1dpi). 
 
 
 
 
The number of S. aureus masses located in a vesicle is reduced over infection, 
whereas the number located in the cytoplasm is relatively constant (Fig. 6.12 C). When 
considering the proportion of S. aureus observed in either the cytoplasm or a vesicle, a 
significant difference in location is observed over time (Fig. 6.12 D), a change of 
predominantly within a vesicle at 2hpi, to predominantly within the cytoplasm at 1dpi. 
These data suggest that whilst the majority of bacteria are degraded by the neutrophils, 
those which survive are found in the cytoplasm, indicating that bacterial survival is 
improved after escaping the phagocytic vesicle.  
To determine if there is a role of p62 in the degradation of S. aureus, the co-localisation 
of GFP-p62 puncta with cytoplasmic bacteria (Fig. 6.13 A) and vesicles containing 
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bacteria (Fig. 6.13 B) was compared. In cases where S. aureus was located in a 
vesicle, multiple puncta, up to 6, were observed. However, in most cases 1 puncta was 
observed (Fig. 6.13 C). The bacteria had been recently phagocytosed, therefore it is 
likely they reside within a phagocytic vesicle. These GFP-p62 puncta may be located 
on phagosomes caused by LC3-associated phagocytosis (LAP), which recruits LC3 to 
the phagocytic vesicle. It is possible that these data represent GFP-p62 which can bind 
to LC3 present on an LAP vesicle. However, it is not possible with these data to 
determine whether p62 puncta are associating with an autophagosome or a phagocytic 
vesicle.  
The change in presence of GFP-p62 puncta on S. aureus containing vesicles over time 
was examined.  The majority of ~70% of S. aureus vesicles had GFP-p62 puncta 
associated at 0dpi (Fig. 6.13 D). However, at 1dpi only 3 S. aureus masses were 
observed within vesicles, with 2 clusters having GFP-p62 associated. No significant 
difference was found between GFP-p62 association at 0dpi and 1dpi (Fig. 6.13 D). 
These data show that most bacteria are either degraded within, or have escaped from 
the vesicle by 1dpi. An association with the majority of S. aureus containing vesicles at 
0dpi may suggest that p62 may play a role in the degradation/escape of S. aureus, 
although further analysis is required.  
The presence of GFP-puncta associated with cytoplasmic S. aureus was compared at 
0dpi and 1dpi. At 0dpi, the majority of S. aureus in the cytoplasm are associated with 
p62, however at 1dpi, the majority do not associate with p62 (Fig. 6.13 E). These data 
could suggest that the minority of S. aureus which are not associated with GFP-p62 at 
0dpi may survive intracellularly, whereas bacteria associated with GFP-p62 may be 
degraded. Taken together, these data suggest that p62 plays a role in clearance of S. 
aureus during in vivo infection.  
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Figure 6.13 S. aureus co-localisation with GFP-p62  
A Representative image of S. aureus observed within a likely “vesicle” with GFP-
p62 puncta localisation, scale 7um B representative image of S. aureus observed 
within the cytoplasm with GFP-p62 puncta localisation, scale 9um C The number of 
p62 puncta observed on individual vesicles containing S. aureus at 0dpi D S. 
aureus within vesicles, co-localised with GFP-p62 at 0dpi and 1dpi (ns, Fisher’s 
exact test, n=3, 14 larvae at 0dpi, and 12 larvae at 1dpi) E S. aureus in the 
cytoplasm, co-localised with GFP-p62 at 0dpi and 1dpi (*p<0.05, Fisher’s exact 
test, n=3, 14 larvae at 0dpi, and 12 larvae at 1dpi) 
 
 
 
 
 
241 
 
In fe c te d  
n e u tro p h il
N o n -in fe c te d
 n e u tro p h il
0
5
1 0
1 5
P
u
n
c
ta
 i
n
 t
h
e
 c
y
to
p
la
s
m
ns
In fe c te d  
n e u tro p h il
N o n -in fe c te d
 n e u tro p h il
0
5
1 0
1 5
P
u
n
c
ta
 i
n
 t
h
e
 c
y
to
p
la
s
m
* *
A B
 
Figure 6.14 Cytoplasmic puncta in S. aureus infected and non-infected 
neutrophils 
A GFP-p62 puncta in the cytoplasm of infected and non-infected at 0dpi (ns, Mann-
Whitney test, n=3, error bars +/- SD, 14 larvae) B GFP-p62 puncta in the cytoplasm 
of infected and non-infected at 1dpi (**p<0.01, Mann-Whitney test, n=3, error bars 
+/- SD, 12 larvae) 
 
 
To consider whether GFP-p62 puncta were being “used-up” in bacterial clearance, the 
number of cytoplasmic GFP-p62 puncta was compared between neutrophils containing 
S. aureus, and those which did not. I hypothesised that under conditions where 
autophagic machinery is used for bacterial clearance (e.g. infected neutrophils), GFP-
p62 puncta would be degraded. At 0dpi, no significant difference was found in the 
number of cytoplasmic puncta in non-infected and infected neutrophils (Fig. 6.14 A). 
However, at 1dpi, a significantly larger number of puncta are observed in non-infected 
neutrophils in comparison to infected neutrophils. These data show a reduction in the 
number of GFP-p62 puncta in infected neutrophils occurs over time. This suggests that 
GFP-p62 is being degraded over time, potentially caused by an increase in autophagic 
turnover in infected neutrophils.  
 
Overall, these data demonstrate that in S. aureus infection, GFP-p62 puncta associate 
with bacteria. Neutrophils appear to be adept at clearance of most bacteria, degrading 
the majority by 1dpi, with largely cytoplasmic resident bacterial population observed at 
1dpi. Cytoplasmic S. aureus may represent the small proportion of bacteria which 
survive in the neutrophil niche (Prajsnar et al. 2012). The proportion of bacteria which 
is cytoplasmic but not associated with GFP-p62 is increased by 1dpi. This may suggest 
that most bacteria are successfully captured and degraded through a p62-autophagy 
dependent mechanism.  
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Figure 6.15 C. neoformans growth over infection time course 
The Tg(lyz:GFP.p62) larvae were injected at 2dpf with 1000cfu of C. neoformans, 
and imaged at 2hpi, and 1dpi (~26hpi). A The number of C. neoformans events 
observed within neutrophils at 0dpi and 1dpi (n=3, 18 larvae at 0dpi, and 12 larvae 
at 1dpi) B Proportion of neutrophils infected or non-infected with C. neoformans at 
0dpi and 1dpi (ns, Fisher’s exact test, n=3, 18 larvae at 0dpi, and 12 larvae at 1dpi) 
6.10 Analysis of C. neoformans interaction with p62 
The interaction of C. neoformans with GFP-puncta was next investigated. The larvae 
were injected with C. neoformans in order to quantify any association with p62 with 
cryptococcal cells within vesicles, and whether changes in p62 association with C. 
neoformans occur through the time course of infection. The Tg(lyz:GFP.p62) larvae 
were injected at 2dpf with 1000cfu of C. neoformans, and imaged at 2hpi, and 1dpi 
(~26hpi). Time points were chosen to compare initial pathogen-p62 interactions with 
any potential changes later in infection.  
Unlike S. aureus, C. neoformans is not efficiently killed in the first 24 hours of infection 
and is only observed within “vesicles” (which lack GFP fluorescence as described 
above). In fact, the number of cryptococcal cells which are observed within neutrophils 
increases from 0dpi to 1dpi (Fig. 6.15 A). This may represent intracellular growth, or 
blood-stream growth which enables further phagocytosis of cryptococcal cells. There is 
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no significant change in the proportion of neutrophils which are infected at 0dpi and 
1dpi, Fig. 6.15 B), at both 0dpi and 1dpi ~25% of neutrophils contain phagocytosed C. 
neoformans. This may suggest that intracellular proliferation of C. neoformans is 
increasing the number of cryptococcal cells observed in individual neutrophils in Figure 
6.15 A. 
I next compared the co-localisation of GFP-p62 puncta with C. neoformans. C. 
neoformans was observed with no GFP-p62 puncta within a “vesicle” (vesicle as 
described for S. aureus), or within cryptococcal vesicle which did have GFP-p62 puncta 
co-localisation (Fig. 6.16 A, B). The number of cryptococcal vesicles which have GFP-
p62 puncta co-localisation is similar at 0dpi and 1dpi (Fig. 6.16 C). The same data 
(shown as a proportion) of cryptococcal vesicles with/without GFP-p62 puncta, shows 
that ~55% of vesicles have associated puncta. There is no significant change in puncta 
co-localisation to cryptococcal vesicles between 0dpi and 1dpi (Fig. 6.16 D). Taken 
together, these data show that GFP-p62 puncta localise to cryptococcal vesicles. 
However, no change in GFP-p62 association to cryptococcal vesicles over the time 
course of infection is observed, and may suggest that cryptococcal mediated 
manipulation of individual vesicles is preventing phagosome degradation.  
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Figure 6.16 C. neoformans co-localisation with GFP-p62  
A Representative image of C. neoformans observed within a likely “vesicle” with no 
GFP-p62 puncta localisation, scale 9um B representative image of C. neoformans 
observed within the cytoplasm with GFP-p62 puncta (white arrow) localisation, 
scale 7um C C. neoformans within vesicles, co-localised with GFP-p62 at 0dpi and 
1dpi (ns, Fisher’s exact test, n=3, 18 larvae at 0dpi, and 12 larvae at 1dpi) D 
Proportion of C. neoformans within vesicles, co-localised with GFP-p62 at 0dpi and 
1dpi (ns, Fisher’s exact test, n=3, 18 larvae at 0dpi, and 12 larvae at 1dpi) 
 
 
 
 
The number of GFP-p62 puncta localised to individual cryptococcal vesicles was 
compared at 0dpi and 1dpi.  The number of cryptococcal cells within individual vesicles 
was measured, to enable comparison of associated puncta in regards to size of the 
vesicle, where more cryptococcal cells increases the size of a vesicle. At 0dpi, a 
maximum of 3 cryptococcal cells are observed within an individual vesicle, with a single 
cell most often seen (Fig. 6.17 A). Furthermore, zero or a single puncta were most 
often observed, with multiple puncta occurring less frequently (Fig. 6.17 A).  
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Figure 6.17 Puncta on C. neoformans vesicles 
The Tg(lyz:GFP.p62) larvae were injected at 2dpf with 1000cfu of C. neoformans, 
and imaged at 2hpi, and 1dpi (~26hpi). A GFP-p62 puncta on C. neoformans 
vesicles at 0dpi (n=3, 18 larvae) B GFP-p62 puncta on C. neoformans vesicles at 
1dpi (n=3, 12 larvae) 
 
 
At 1dpi, the maximum number of cryptococcal cells in an individual vesicle is 6 cells, 
likely representing intra-cellular growth during infection (Fig. 6.17 B). Similar to 0dpi, 
the majority of cryptococcal vesicles have a single or zero GFP-p62 puncta (Fig. 6.17 
B). No change in the number of GFP-p62 puncta over infection (0dpi-1dpi) may 
suggest that cryptococcal cells manipulate their phagosome, which perhaps inhibits the 
ability of p62 to associate/dissociate at that location.  
 
Finally, the presence of GFP-p62 puncta in infected or non-infected neutrophils was 
compared, with the aim to determine whether puncta are “used-up” throughout 
infection. If puncta are “used-up” this may represent autophagy induction during 
cryptococcal infection. At 0dpi, unlike S. aureus, C. neoformans infection induces a 
significant reduction in the number of puncta in the cytoplasm of infected neutrophils 
(Fig. 6.18 A). Similarly, a significant reduction in GFP-p62 puncta presence in infected 
neutrophils was observed at 1dpi (Fig 6.18 B). Overall these data show that a GFP-p62 
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Figure 6.18 Cytoplasmic puncta in C. neoformans infected and non-
infected neutrophils 
A GFP-p62 puncta in the cytoplasm of infected and non-infected at 0dpi 
(****p<0.001, Mann-Whitney test, n=3, error bars +/- SD, 18 larvae) B GFP-p62 
puncta in the cytoplasm of infected and non-infected at 1dpi (****p<0.001, Mann-
Whitney test, n=3, error bars +/- SD, 12 larvae) 
 
 
response does occur quickly in C. neoformans neutrophil infection, however, this 
response remains unchanged over the course of the infection.   
 
6.11 Chapter summary 
The transgenic line Tg(lyz:GFP.p62) was generated through the GatewayTM Tol2 
system, in order to examine whether p62 is involved in the neutrophil handling of S. 
aureus and C. neoformans infection in vivo. It was demonstrated that Tg(lyz:GFP.p62) 
was expressing GFP within neutrophils and that the GFP-p62 was successfully 
translated as a tagged protein. Furthermore, using GFP-p62 puncta as a read-out, it 
was shown that the tagged GFP-p62 likely responds in a similar as may be expected of 
endogenous p62.  
Infection studies were next carried out, where an association of GFP-p62 was 
determined for both S. aureus and C. neoformans. For S. aureus, bacteria were 
efficiently degraded, however those which did survive until 1dpi were significantly less 
likely to associate with GFP-p62. This may indicate that p62 is involved in the 
clearance of S. aureus in neutrophils. While C. neoformans infection did induce a GFP-
p62 association, the effect was constant between 2hpi and 1dpi. This may suggest that 
C. neoformans is manipulating the vesicle to enable survival, and this manipulation 
may inhibit p62 association. 
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6.12 Chapter discussion 
The aim of this chapter was to design, generate and characterise a neutrophil specific 
GFP-p62 reporter line to enable analysis of in vivo interactions of p62 with pathogens.  
6.12.1 Design and generation of a p62 reporter line 
The design and generation of a p62 zebrafish reporter line was the initial aim in this 
chapter.  A single p62 gene is encoded by zebrafish (Silva et al. 2014; Mostowy et al. 
2013), meaning a single reporter was required for in vivo p62 analysis. Due to genome 
duplication events in zebrafish evolution, it is possible that multiple p62 genes may 
have been present, which could have evolved distinct functions in zebrafish requiring 
further analysis (Meyer & Schartl 1999). The p62 gene in zebrafish was confirmed in a 
recent study to be similar in gene sequence, structure, likely domain function and in 
expression (Silva et al. 2014). Furthermore, both LIR and UBA domains, important in 
the autophagy adapter function of p62, are present in the zebrafish p62 (Silva et al. 
2014), therefore it is very likely that the zebrafish p62 gene will function as an 
autophagy receptor. Therefore I concluded that the zebrafish p62 gene would be useful 
in the analysis of p62 function, which could provide findings translational for human 
p62.  
The GatewayTM and Tol2 transgenesis system was chosen to create the p62 reporter 
line. As a reporter line, the p62 protein would be a fusion protein with a fluorescent 
marker, in this case GFP. The structure of p62 gene was carefully considered. The 
location of the LIR and UBA domains are located at the 3’ end of the p62 gene 
sequence. It is possible that placing a linker to a GFP protein at the 3’ end of the p62 
sequence, the GFP could sterically block LIR and UBA domain functions. Although this 
outcome is still potentially possible by placing the GFP protein on the 5’ terminal, it was 
theorised there may be a reduced chance of this occurring. Furthermore, in all 
publications of a successful cell line expression of GFP-p62 fusion protein, it appears 
that the GFP was located on the 5’ end of p62 (Larsen et al. 2010; Pankiv et al. 2007; 
Bjørkøy et al. 2005),  further suggesting that LIR and UBA interactions can still occur 
with a GFP fusion at the 5’ terminus. For these reasons the GFP was designed to be 
tagged to the 5’ terminal of p62.  
The GatewayTM and Tol2 system is a reliable and efficient method of creating reporter 
zebrafish lines. The 3’ entry clone containing zebrafish p62 was created (as in 
appendix 1). Of note, a SNP led to a single residue alteration, albeit to a similar amino 
acid, is present in the p62 sequence used in this reported line. However, it is a 
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confirmed SNP in the zebrafish genome (appendix 1), and therefore is not expected to 
alter the function of p62.  
The expression clone pDEST(lyz:GFP.p62) was created via the multisite GatewayTM 
three fragment assembly system, and inserted into the zebrafish genome through Tol2 
mediated transgenesis. As described above, the p5E-lyz entry clone, pME-GFP-
nonstop and generated p3E-p62 were inserted into pDestTol2CG to create 
pDEST(lyz:GFP.p62). This was expected to produce neutrophil specific expression of 
GFP-p62 fusion protein, in addition to expression of GFP in the heart cells. Restriction 
digests of the pDEST(lyz:GFP.p62), (and sequencing of the plasmid) provided reliable 
evidence that  the expression clone was the correct expected sequence and was 
therefore used for Tol2 transgenesis.  
As described above, following Tol2 transgenesis, a high proportion of injected larvae 
expressed GFP in heart tissue and in neutrophil-like cells, this suggests that the 
transgenesis was successful. As a preliminary analysis of the F0 (Tol2 injected) 
generation, a limited number of larvae were infected with C. neoformans or S. aureus. 
This was completed to attempt to determine whether the GFP positive cells were likely 
to be neutrophils. As potential phagocytic cells, if the GFP positive cells were seen to 
engulf the pathogen, it would be suggested that the GFP fluorescence may be 
neutrophils (although could also be other phagocytic cells). Indeed, phagocytosis of 
each pathogen was observed, indicating the GFP cells were phagocytic cells. 
Additionally, a disperse cytoplasmic fluorescence and puncta fluorescence was 
observed within the GFP positive phagocyte cells, likely representing cytoplasmic GFP-
62 not “in-use” whereas the puncta may represent sites of autophagosomes within 
individual phagocytic cells. Alternatively, puncta may represent aggregates of GFP-
p62. However, a similar cytoplasmic and “dot” (puncta) fluorescence observation was 
seen for all in vitro studies using GFP-p62 (Larsen et al. 2010; Pankiv et al. 2007; 
Bjørkøy et al. 2005), suggesting that this type of expression is expected. Furthermore, 
antibody staining of endogenous p62 in HeLa cells also determined a puncta and 
cytoplasmic distribution of p62 (Bjørkøy et al. 2005). These observations suggest that 
Tol2 transgenesis was successful leading to the raising of these larvae as potential 
founders. Indeed, a founder was identified (screened by analysis of embryos resulting 
from an outcross to nacre wild-type larvae). Similarly, larvae from the founder fish 
expressed GFP in heart tissue and in neutrophil-like cells. It was therefore highly likely 
these cells, (as in the F0 generation), were phagocytic cells.  
To conclude, successful design and generation of a neutrophil specific p62 reporter 
zebrafish line was completed. However, further characterisation was required to 
249 
 
determine whether the GFP signal in GFP expressing phagocytic cells, was truly a 
GFP-p62 fusion.  
 
6.12.2 Characterisation of Tg(lyz:GFP.p62) reporter 
After generation of the Tg(lyz:GFP.p62) reporter line, it was important to further 
characterise the GFP-p62 expression, specifically to determine whether the p62 
reporter line has neutrophil specific expression, and if tagged GFP-p62 fusion protein 
acts in a similar manner as expected of endogenous p62.  
Neutrophil specific GFP-p62 expression 
Neutrophil specificity of GFP-p62 fluorescence was confirmed by crossing the 
Tg(lyz:GFP.p62) reporter line to a complementary fluorescently coloured neutrophil 
transgenic line. This cross was completed using a known mCherry neutrophil specific 
reporter (of nitroreductase gene nfsB), Tg(lyz:nfsB.mCherry)sh260. A clear co-expression 
of GFP signal (GFP-p62) and mCherry signal (nfsB-mCherry) was observed, clearly 
demonstrating that GFP-p62 was being expressed within neutrophils. Indeed, only a 
single cell was observed with single GFP fluorescence, representing 0.92% of all 
compared cells.  Furthermore, the intensity of cytoplasmic signal, either GFP or 
mCherry, was similar within individual cells, indicating that the fluorescence signal was 
being regulated by expression of the lyz promoter, as expected. These data suggest 
that GFP-p62 expressed within neutrophils.  
Of note, the lyz promoter is largely neutrophil specific in zebrafish from 48hpf (Yang et 
al. 2012; Meijer et al. 2008), where before this age some macrophages may also 
express lyz. All experiments using this line were completed after 48hpf and therefore at 
these time-points GFP-p62 will be expressed only within neutrophils. However, 
comparing a lyz driven reporter line to another lyz driven reporter can only validate that 
expression in the same lyz-expressing cells is occurring. As some macrophages may 
express lyz, a comparison to alternative neutrophil promoter transgenic lines, such as 
mpx (neutrophil specific myeloperoxidase promoter) (Renshaw et al. 2006) may be 
useful. However, at 2dpf, lyz and mpx expression matched exactly (Meijer et al. 2008). 
It therefore may be better to test Tg(lyz:GFP.p62) neutrophil specificity using mpx 
histochemistry. However, these data suggest that GFP-p62 expression is specific to 
neutrophils. 
Interestingly, puncta observed in GFP positive cells were GFP positive only, rather than 
both GFP (GFP-p62) and mCherry (nfsB-mCherry). This suggests that GFP puncta 
formation is independent of the lyz promoter. It is tempting to suggest puncta formation 
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is dependent on p62 protein functions. However, it is also possible that GFP-p62 may 
self-aggregate (independent of p62 protein function) and could therefore be the cause 
of GFP puncta formation. Interestingly, mCherry fusion proteins are thought to have an 
increased likelihood of self-aggregation in comparison to GFP fusion proteins (Voigt 
2011). To examine whether GFP-p62 puncta are self-aggregating or dependent on p62 
protein function, puncta were examined when autophagy influencing drugs were 
administered.  
GFP-p62 response to autophagy induction or inhibition 
In order to determine whether GFP-p62 responded to autophagy induction, or 
inhibition, Tg(lyz:GFP.p62) larvae were treated with autophagy inhibiting drugs, 
BK8644 or chloroquine, or with autophagy inducing drug rapamycin, or in combinded 
rapamycin and chloroquine treatment. The aim was to determine whether GFP-p62 
puncta are affected by alterations in autophagy, to examine whether GFP-p62 puncta 
are self-aggregates or caused by p62 functions.  
If GFP-p62 puncta are dependent on the autophagy function of p62, it may be 
expected where autophagy is inhibited, an increase in GFP-p62 puncta would be 
observed, since GFP-p62 would not be degraded by autophagy. Conversely, induction 
of autophagy may increase the rate of GFP-p62 degradation, and therefore a reduction 
in the number of GFP-p62 puncta may be expected.  
Firstly, the number of neutrophils with puncta present in was compared between drug 
treatment groups. No change in the number of neutrophils containing puncta was seen 
between rapamycin, rapamycin and chloroquine treatment, BK8644, chloroquine alone, 
in comparison non-treated larvae. These results do not demonstrate the GFP-p62 
puncta are being affected in terms of formation and degradation in response to 
autophagy influencing drugs. 
The number of puncta within individual neutrophils was compared between treatment 
groups. A significant increase in the number of puncta inside individual neutrophils was 
observed after BK8644 treatment in comparison to non-treated larvae. No change was 
observed between non-treated, rapamycin and chloroquine treatment, chloroquine 
treatments. The BK8644 data do suggest that GFP-p62 puncta respond to autophagy 
influencing drugs, potentially in a manner similar to how endogenous p62 may be 
expected to. It would be useful in future to examine whether ubiquitin in present in the 
GFP-p62 puncta, which may indicate that the puncta are forming through a p62 
mediated mechanism. 
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Importantly, autophagy is known to target protein aggregates for degradation. It is 
therefore possible that if the GFP-p62 is self-aggregating to form these puncta, the 
cellular clearance would also be affected an autophagy dependent manner leading to 
similar expected results. In vitro GFP-p62 fusion protein expression led to the 
observation of both cytoplasmic and “dot” (puncta) types of expression in all studies 
(Larsen et al. 2010; Pankiv et al. 2007; Bjørkøy et al. 2005). This suggests that puncta 
formation is not only seen in vivo as seen in this study, and may be an expected 
expression pattern of p62. As mentioned above antibody staining of endogenous p62 in 
HeLa cells also determined puncta and cytoplasmic distribution of p62 (Bjørkøy et al. 
2005). Furthermore, in vitro expression of “dots” (puncta) was found to be dependent 
on the intact UBA domain in the fusion protein sequence. In vitro GFP-p62 constructs 
deficient in the UBA domain of p62, led to the observation of only cytoplasmic signal 
(Bjørkøy et al. 2005), suggesting puncta formation is dependent of p62 function. 
Interestingly, an increase in the number and size of in vitro GFP-p62 were observed 
when autophagy was inhibited (Bjørkøy et al. 2005), similar to data presented here. 
These data suggest that GFP-p62 puncta formation is caused by p62 function.  
However, an important difference between some in vitro studies is that the cells are 
transiently expressing GFP-p62, (either due to tetracycline inducible expression of a 
stable line, or through transfection). In a stably expressing in vitro line, (expressed at 
approximately 4 fold higher than endogenous p62), an increase in puncta from 5 to 
40% was observed (Bjørkøy et al. 2005). This may explain the large variation of GFP-
p62 puncta observed in non-treated cells. In future it might be informative to analyse 
the rate of GFP-p62 expression in zebrafish in comparison to endogenous p62, 
perhaps by comparing puncta in wild-type larvae using anti-p62 antibodies. 
Furthermore, using live imaging of co-localisation to alternative autophagy markers, for 
example fluorescently tagged LC3, LAMP-1 or sytanxin-17 and the use of pH sensitive 
dyes, would enable visualisation of the interaction dynamics with multiple markers of 
autophagosomes/lysosomes. This would help determine that GFP-p62 puncta were 
truly marking autophagosomes, rather than protein aggregates.  
To conclude, these data suggest that the GFP-p62 puncta are responding according to 
autophagy influence. However, they cannot definitely prove the GFP-p62 puncta are 
acting in a p62 manner.  
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GFP-p62 is a fusion protein 
In order to determine that the GFP signal observed in the larvae was from correctly 
translated GFP-p62 fusion proteins, a western blot was used to analyse the size of the 
GFP proteins, or GFP tagged proteins in larvae. Wild-type control larvae had no GFP 
protein present as expected. Larvae from Tg(mpx:eGFP)i114 which express non-tagged 
GFP, had a single protein size present, at ~27KDa, the correct size of non-tagged 
GFP, also expected.  
The expected size of a GFP-p62 fusion protein was calculated from the sequence, of 
~79KDa. No protein was observed at ~79KDa in protein lysate collected from 
Tg(lyz:GFP.p62), however GFP protein was identified at ~125KDam, ~62KDa, 
~52KDa, ~46KDa, a large band at ~27KDa, and ~24KDa. The large band at ~27KDa 
likely represents the non-tagged GFP heart marker present in this line. As described 
above, antibody company Abcam advised that in western blots used on human brain 
protein samples, using their anti-p62 antibody (ab31545), four major bands were 
detected at 130KDa, 62KDa, 45KDa and 22KDa, with additional bands observed in rat 
lysate at 80KDa and 47KDa. This suggests that multiple p62 protein products exist, 
which are somewhat similar to protein sizes observed in zebrafish. Therefore, the 
observation of multiple bands representing GFP-p62 may be expected in zebrafish.  
However, the reason that the expected band size of 79KDa is not present is not 
explained. Multiple factors can affect the running size of a protein which leads to 
difference in the predicated size and the size actually observed. For example, post-
translational modification (such as phosphorylation), splice variants, relative charge 
and even formation of complexes. The occurrence of multiple sized proteins smaller 
than the expected 79kDa may be caused by splice variants, or potentially from 
transcription starting from in-frame internal methionine’s which may lead to the 
formation of smaller protein products. It is unlikely smaller sized proteins are caused by 
degradation of GFP-p62 as a band sizes are discrete (rather than a smear expected 
when proteins are degraded). Further analysis into the splice variants and internal 
methionine transcription is required to fully understand the formation of smaller sized 
GFP-p62 proteins.  
The ~125KDa size protein may be explained by dimerisation. p62 is known to form 
dimers, which could provide an explanation for the larger protein size observed, 
however the reducing western blot protocol may be expected to cause separation of 
these dimers. It has been reported that the p62 dimer, is highly stable, particularly in 
the presence of ubiquitin (Long et al. 2010). Furthermore, covalent bonds between p62 
oligomers have been shown to form between the PB1 (Phox/Bem 1p) domains 
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(Donohue et al. 2014), which would be able to survive the western blotting protocol. It 
is therefore likely that the ~125kDa size protein represents p62 dimers. Additionally, 
the presence of the ~125KDa protein size suggests that the GFP-p62, in particular the 
PB1 domain, is able to act functionally as may be expected of endogenous p62. 
To conclude, western blot analysis suggests that the Tg(lyz:GFP.p62) is in fact a GFP-
p62 fusion protein, since the anti-GFP antibody used can only recognise proteins with 
GFP encoded, and multiple sized protein were recognised. Multiple p62 protein 
products have been observed human and rat samples, which appear somewhat similar 
in size to the GFP-p62, suggesting that forms of p62 are present in zebrafish. This 
includes p62 dimers, which are present in other animals. Together these data suggest 
that that the GFP-p62 fusion protein is successfully being produced within 
Tg(lyz:GFP.p62) larvae.  
6.12.3 In vivo p62 co-localisation to S. aureus in neutrophils 
The primary aim of this chapter was to use an in vivo zebrafish neutrophil reporter line 
to examine p62 interactions with intracellular pathogens. With the aim to determine 
whether p62 is employed by neutrophils in in vivo S. aureus infection, the host-
pathogen interaction in Tg(lyz:GFP.p62) larvae were examined under S. aureus 
infection. 
The number of neutrophils, which contain S. aureus, declined between 0dpi and 1dpi. 
This is very suggestive that neutrophils effectively degrade bacteria, or alternatively 
that S. aureus escapes neutrophils, perhaps through cell lysis. There was no 
observation that a large number of extracellular bacteria exist at 1dpi, suggesting that 
neutrophils effectively degrade S. aureus in the majority of cases. The presence of a 
small population of bacteria resident in neutrophils at 1dpi, supports the suggestion that 
a population bottleneck is caused in S. aureus infection. Whereby neutrophils provide 
an intraphagocyte niche in which a small proportion of bacteria reside, able to evade 
degradation, and finally escape and cause uncontrolled infection (Prajsnar et al. 2012). 
This assumes most bacteria and phagocytosed and degraded, as these current data 
suggest. Time-lapse analysis of in vivo cellular fates of neutrophils which contain 
bacteria at 1dpi may provide further evidence that bacteria are degraded or that 
bacteria can lyse the host cell. Alternatively, neutrophils could be collected through 
FACs sorting and infected in vitro, to enable individual cells to be monitored for the 
entire infection cycle, which may not be possible in vivo.   
The location of S. aureus within the neutrophils was examined. The role of p62 in its 
ability to bind to ubiquitinated pathogens which are residing in the cytoplasm is 
established, so it was important to determine the location of the bacteria. As described 
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above, disperse cytoplasmic GFP-p62 signal was observed in neutrophil cells. In larvae 
which had been infected with S. aureus, circular “gaps” surrounding some bacteria 
were observed. I reasoned these “gaps” likely represent vesicles in which bacteria are 
contained but do not contain GFP-p62, due to the similarities in size and shape, as 
seen in other lines where the vesicle edges are clearly observed, for example traffic-
light LC3 marked vesicles (see Chapter 5). It could be further reasoned that in an acidic 
environment GFP-p62 fluorescence would be quenched, so these “gaps” may also 
represent acidic vesicles. Importantly, the following data refers to these “gaps” as 
vesicles, despite the fact there are not fully proven to be vesicles. Further analysis to 
confirm vesicle identity is required, for example using electron microscopy, or use of pH 
sensitive dyes.  
The majority of bacteria were resident in vesicles at 0dpi, but by 1dpi the majority of 
bacteria was resident in the cytoplasm (although most bacteria appear to have been 
degraded by 1dpi). Data using the traffic-light Lc3 line (see Chapter 5) agrees with this 
bacterial location data, further suggesting the “gaps” are truly vesicles. It is therefore 
likely that bacteria which escape from vesicles are able to survive longer, potentially by 
escaping vesical mediated degradation. In fact bacteria which escape vesicles, and 
represent the majority of bacteria at 1dpi, may be the bacteria which survive the 
population bottleneck in neutrophils (Prajsnar et al. 2012). To confirm this the fates of 
bacteria which are cytoplasmic residents could be compared with vesicle resident 
bacteria. Perhaps using time-lapse imaging both in vivo and in vitro may (as above), 
may provide evidence for this.  
Importantly, an association of GFP-p62 puncta to S. aureus is clearly demonstrated in 
these data. Interestingly GFP-p62 is seen to localise both to S. aureus vesicles, and to 
cytoplasmic bacteria, which is unexpected as a role of p62 binding to ubiquitinated 
bacteria in the cytoplasm has been described, which no role of p62 being linked to S. 
aureus within vesicles. Ubiquitination of cargo for p62-mediated autophagy degradation 
is required for p62 to recognise and bind cargo, before interacting with autophagosome 
membranes through the LIR domain.  
For bacteria within vesicles, ~70% of vesicles were co-localised with GFP-p62 puncta, 
although 1dpi this was not seen (which may in part be due to bacterial clearance). This 
data suggests that p62 presence on S. aureus vesicles is associated with bacterial 
degradation, however this does not show causality. To determine causality, perhaps in 
vitro analysis using cells deficient in p62, comparison of bacterial location (vesicle or 
cytoplasm) and survival may highlight a role of p62 in S. aureus vesicle degradation.  
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p62 has been well established as binding to ubiquitinated bacteria before localisation to 
LC3 marker autophagosomes, For example it has been demonstrated that p62 is 
involved in Shigella flexneri and Listeria monocytogenes autophagic degradation 
(Mostowy et al. 2011; Mostowy et al. 2010). It may be possible that the vesicles here 
represent autophagosomes, which have formed through selective autophagy 
pathways, after S. aureus has been ubiquitinated. In fact, recent literature reports that 
p62 is able to recruit S. aureus residing in the cytoplasm to an autophagosome 
(Neumann et al. 2016; Singh et al. 2017). This could suggest bacteria escape the 
phagosome after internalisation, p62 is recruited to ubiquitinated bacteria and 
autophagosomes are formed (which represent the GFP-p62 vesicles).  
GFP-p62 marked vesicles may also represent phagosomes, since vesicles are 
observed soon after S. aureus infection, and not often at 1dpi. This could suggest p62 
is being recruited to phagosomes, perhaps marked with LC3 through LAP, where p62 
could potentially bind to through the LIR domain. However, the p62 LIR domain alone 
cannot target to LC3 positive membranes, shown when the LIR domain of p62, fused to 
GFP could not associate to LC3 marked membranes (Donohue et al. 2014), suggesting 
that multiple parts of the protein must be involved. Additionally, p62 is not recruited 
during LAP, for example, p62 is not recruited to Listeria monocytogenes LAP 
phagosomes (Lam et al. 2013). Therefore p62 recruitment is unlikely to represent LAP.  
Despite this, a single incidence of p62 recruitment to a single-membrane has been 
described in the phagocytosis of red blood cells. Where single-membrane phagosome 
recruit LC3-II, p62, NDP52 and NBR1, all components of selective autophagy 
(Santarino et al. 2017). It was further suggested that the UBA, rather than LIR domain 
was required for the association of p62 with single membranes, perhaps to 
ubiquitinated components of the phagosome membrane. Indeed ubiquitin was found 
present on phagocytic cups which could enable p62 recruitment. Finally, p62 
recruitment occurred before LC3-II recruitment to phagosomes, which may in part help 
to up-regulate autophagy pathways resulting in increased autophagy (Santarino et al. 
2017). This suggests that p62 can recruit to phagosomes, independently of LC3-II. This 
might represent observations seen in this current analysis, and perhaps could be due 
to overexpression of GFP-p62. It might be useful to analyse the activity of the p62 and 
lyz promoters, perhaps through a promoter reporter system. Further investigation into 
whether S. aureus vesicles are single or double membrane structures is required to 
determine how GFP-p62 is being recruited, however if single-membrane vesicles are 
determined this may represent the first example of p62 recruitment to a pathogen 
(single membrane) phagosome.  
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For bacteria residing in the cytoplasm, GFP-p62 can co-localise to S. aureus, as 
expected in comparison to recent reports where p62 is shown to recruit ubiquitinated S. 
aureus to autophagosomes (Neumann et al. 2016; Singh et al. 2017). Interestingly, the 
association of GFP-p62 reduces over the infection time-course, perhaps suggesting 
that bacteria associated with GFP-p62 are being degraded, or can escape the 
autophagosome, this would be consistent with recent studies (Neumann et al. 2016; 
Singh et al. 2017). However, association does not prove causality, and (as above), time 
lapse analysis to visualise the degradation/escape of bacteria with/without GFP-p62 
would be essential to determine whether GFP-p62 is leading to bacterial degradation.  
To assess if GFP-p62 may be causing the degradation of S. aureus, the number of 
GFP-p62 puncta within infected and non-infected neutrophils was compared. Since p62 
is degraded along with bacteria in selective autophagy, a reduced number of puncta 
may be expected within infected neutrophils. Indeed, at 1dpi, a reduction in GFP-p62 
puncta was observed specifically within infected neutrophils. This suggests GFP-p62 is 
being degraded in infected neutrophils. It is possible that this is caused not by GFP-p62 
recruitment to ubiquitinated bacteria, but by an increase in autophagy at the whole cell 
level, caused by S. aureus presence, which may be beneficial for the bacteria 
(Neumann et al. 2016; Singh et al. 2017). To prove GFP-p62 degradation is being 
caused specifically by targeting of bacteria, further analysis to allow visualisation of 
entire infection cycles, for example time-lapse, is required. 
To conclude, GFP-p62 puncta associated with cytoplasmic bacteria as expected and 
also with bacteria within vesicles. Further analysis to determine exactly what vesicles 
bacteria are contained in, perhaps using multiple membrane markers (e.g. LC3-II, 
LAMP-1, Syntaxin-17), or electron microscopy to determine if it is single or double 
membrane is important. Together these data suggest cytoplasmic bacteria is targeted 
for autophagosome degradation by GFP-p62, which may represent the co-localisation 
to S. aureus containing vesicles. Furthermore, the likely degradation of most bacteria, 
suggests that those bacteria resident in the cytoplasm may be the source of the S. 
aureus population bottle-neck. Further analysis is required to determine whether the 
evasion of p62-autophagy dependent mechanism may be responsible for the S. aureus 
population bottleneck.  
6.12.4 In vivo p62 co-localisation to C. neoformans in neutrophils 
The next aim of this chapter was to determine whether p62 is employed by neutrophils 
during in vivo cryptococcal infection. Therefore host-pathogen interactions were 
examined in Tg(lyz:GFP.p62) larvae after C. neoformans infection. Importantly, 
extremely limited studies on the role of autophagy and selective autophagy exist for C. 
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neoformans or other fungal pathogens, which makes it difficult to interpret the data 
presented in this study. 
During cryptococcal infection, the number of infected neutrophils was relatively 
constant, with ~25% of neutrophils infected at both 0dpi and 1dpi. In contract to S. 
aureus data, this suggests that C. neoformans in not effectively degraded by 
neutrophils, and cannot escape from neutrophils at 1dpi. Although cryptococcal cells 
are able to escape from macrophages by vomocytosis, a similar mechanism is not 
described for neutrophils. It might be likely cryptococcal cells escape neutrophils by 
lysis. Furthermore, all cryptococcal cells were observed within vesicles (“vesicles” as 
described as “gaps” above). Similarly, identification of the type of vesicle cryptococcal 
cells are in would be useful in the interpretation of this data.  
It appears that cryptococcal cells are able to proliferate within the neutrophil, observed 
with a small increase in the number of cryptococcal cells within individual neutrophils. 
Coupled with the constant rate of ~25% of infected neutrophils, this increase in 
cryptococci may represent intracellular proliferation. Equally this may represent further 
phagocytosis events. In order to prove intracellular replication in neutrophils, time-lapse 
analysis is required. The presence of C. neoformans is able to reduce the killing ability 
of neutrophils, although the mechanism for this is currently unknown (Qureshi et al. 
2011), this may enable the survival of cryptococcal cells within neutrophils.  
Approximately 55% of all cryptococcal vesicles had associated GFP-p62 puncta at both 
0dpi and 1dpi. Unlike S. aureus, it is unlikely that GFP-p62 is marking cryptococcal 
cells for degradation and then recruiting cryptococcal cells to autophagosome for 
degradation. This is because, cryptococcal cells have never been found within double-
membrane vesicles, only within a single membrane vesicle, despite autophagosomes 
being seen in close proximity (Nicola et al. 2012; Pandey et al. 2017). It is therefore 
likely that the vesicles represent a single-membrane vesicle. As described above for S. 
aureus, there is some limited data to suggest that p62 is able to mark phagosomes in a 
UBA mediated binding mechanism to ubiquitinated products on the phagosome, before 
LC3-II is recruited (Santarino et al. 2017). If this is occurring for C. neoformans this 
would be the first evidence of fungal cells being targeted by selective autophagy within 
neutrophils. Clearly much more investigation is required, the type of vesicles C. 
neoformans is residing in must be confirmed. Additionally, over expression my lead to 
GFP-p62 accumulation, the levels of endogenous p62 recruitment could be compared 
by antibody staining.  
Additionally, the fact that association does not change over the infection time course 
may suggest that the phagosome in not able to mature. It has been demonstrated that 
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in macrophages, cryptococcal cells can manipulate the phagosome to promote 
intracellular survival (Smith et al. 2015). Perhaps GFP-p62 is unable to either associate 
or dissociate when the phagosome is manipulated. If 25% of cryptococcal cells are 
able to promote their own survival within neutrophils, coupled with potential intracellular 
replication shown in this study, neutrophils may also present a niche in which 
cryptococcal cells can reside in.  
The number of GFP-p62 puncta present in infected and non-infected neutrophils were 
compared. A significant reduction in the number of GFP-p62 puncta were present in 
infected neutrophils at both 0dpi and 1dpi. This suggests autophagy is induced 
immediately within infected neutrophils, leading to the degradation of GFP-p62.  It has 
been shown that autophagy proteins are required for C. neoformans growth, of 
intracellular cryptococci within macrophages (Qin et al. 2011). Although contradictory 
evidence exists for whether autophagy is beneficial for the host or fungus (see section 
1.6.8), it is tempting to suggest that host cell autophagy is induced in neutrophils upon 
infection, which leads to survival of cryptococcal cells within neutrophils, with the 
increased autophagy removing GFP-p62 puncta from the cell.  
To conclude, GFP-p62 puncta associated with both cryptococcal cells, perhaps un-
expectedly since they likely reside within single membrane vesicles. Further analysis is 
required to confirm a single membrane vesicle contains the cryptococcal cells, for 
example by electron microscopy. Due to the non-changing nature of the cryptococcal 
interactions described here, it would be interesting to follow infection over a long 
timescale, to determine whether GFP-p62 association leads to any differences in 
cryptococcal survival or host cell handling. Together these data suggest ~25% 
cryptococcal cells become marked by GFP-p62, in a static way, perhaps caused by 
cryptococcal manipulation of the phagosome. Further analysis is required to determine 
whether evasion of p62-autophagy is important in the outcome of cryptococcal-
neutrophil interactions.  
 
6.12.5 Chapter summary 
In this chapter a neutrophil specific reporter line was designed and created using the 
GatewayTM and Tol2 transgenesis systems. The GFP-p62 fusion protein appears to be 
expressed exclusively within neutrophils, and responds to autophagy influencing drugs 
in an expected manner. Infection of the Tg(lyz:GFP.p62) with S. aureus suggested that 
p62 associates with cytoplasmic bacteria, leading to autophagosome recruitment. 
However, both S. aureus and C. neoformans within (what appear to be) vesicles, also 
have GFP-p62 recruitment. This may represent an initial observation of p62 recruitment 
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to pathogen vesicle membranes, although could also represent autophagosomes. 
Further analysis is required to determine whether GFP-p62 recruitment to pathogens in 
beneficial to the host or pathogen.    
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7.0 Overall discussion and future work 
7.1 Intravascular cryptococcal proliferation leads to tissue invasion 
Cryptococcal infection can cause cryptococcal meningitis, primarily in 
immunocompromised individuals. Cortical infarcts are observed in severe cases of 
cryptococcal meningitis, and are associated with increased lethality (Mishra et al. 
2017). However, the physiological cause of cortical infarcts in cryptococcal meningitis 
is unknown. Clinical reports have shown that cryptococcal invasion of the brain occurs 
at sites of brain micro-capillaries which contain cryptococcal cells, and that 
cryptococcal infection causes vasculitis (Aharon-Peretz et al. 2004; Leite et al. 2004; 
Rosario et al. 2012). It is possible that vascular damage occurs at sites of cryptococcal 
growth in the brain. I therefore hypothesised that cortical infarcts (in cryptococcal 
meningitis) may be related to vascular damage caused by cryptococcal proliferation. 
The data presented in this study show that cryptococcal cells become trapped in the 
vasculature (likely due to vessel size), in a mechanism similar to that reported in mice 
(Shi et al. 2010). Once trapped in the vasculature, localised cryptococcal proliferation 
causes vessel widening and damage. Subsequently, tissue invasion occurs at sites of 
cryptococcal proliferation. Tissue invasion may be enabled by damage to the vessel 
wall allowing escape or by another mechanism, likely to be transcytosis. Importantly my 
data suggest blood vessels become completely obstructed by resident cryptococcal 
cells, and that vessel wall integrity is lost through physical damage caused by 
cryptococcal proliferation. This may provide a physiological explanation for the cortical 
infarcts observed in cryptococcal meningitis.  
This study also suggests that damage to the vasculature caused by cryptococcal 
proliferation provides an alternative route for cryptococcal cells to invade tissue. This 
may be of particular importance in crossing of the blood brain barrier by cryptococci. I 
propose that cryptococcal proliferation may be a mechanism for escaping the 
vasculature, which occurs in concert with alternative routes, for example by 
transcytosis or via a macrophage Trojan-horse (Charlier et al. 2009; Chen et al. 2003; 
Santiago-Tirado et al. 2017). Interestingly, tissue invasion was observed which did not 
damage vessel wall integrity, and is likely to be transcytosis. However, this occurred in 
this study only at sites of cryptococcal proliferation within the vasculature. This may 
suggest that intra-vascular cryptococcal proliferation also promotes transcytosis 
events, perhaps by promoting cryptococcal cell interactions with vascular endothelial 
cells. This is supported by the observation that cryptococcal invasion of the brain 
occurs in vessels with a high fungal burden (Tenor et al. 2015). It would be interesting 
to determine whether rates of cryptococcal transcytosis out of the vasculature are 
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determined by the number of cryptococcal cells (caused by proliferation) within the 
vessel.   
An interesting observation was that vessel widening occurs at sites away from 
cryptococcal cells. This may represent vasculitis which is observed in cryptococcal 
meningitis (Leite et al. 2004). It was determined that vessel widening (away from 
cryptococcal sites) is likely caused by a cryptococcal factor, because I did not observe 
vessel widening at sites which were not obstructed by inert beads. However, a greater 
number of vessel blockage events may result in greater blood flow forces on 
unobstructed vessels resulting in increased growth/widening. It will be important to 
determine accurately whether vessel widening away from bead blockage can occur at 
higher bead inocula, as a major difference of cryptococcal cells in comparison to beads 
is their ability to proliferate and therefore cause vessel blockage in a larger number of 
intersegmental vessels. This may be assessed easily by injecting a much larger inocula 
of beads.  
Cryptococcal mutants were used to test whether cryptococcal factors influence both 
cryptococcal vascular damage and may cause vessel widening at sites away from 
cryptococcal colonised vessels. All cryptococcal mutants examined were able to cause 
vessel damage at the site of cryptococcal proliferation, suggesting that cryptococcal 
proliferation is the major cause of vessel damage, rather than cryptococcal virulence 
factors. All cryptococcal mutants examined were also able to cause widening in vessels 
not colonised by C. neoformans. This suggests that the particular virulence factors 
which were examined do not affect the entire vasculature. In the future it would be 
exciting to examine many more cryptococcal virulence factors. If a cryptococcal mutant 
does not illicit a widening effect on vessels not colonised by C. neoformans, this may 
represent a virulence factor which may be a useful target in preventing vasculitis in 
cryptococcal meningitis. In turn, this may even reduce brain tissue invasion since 
vascular integrity may be improved in all vessels.  
Overall, a clear mechanism of cryptococcal trapping, proliferation and tissue invasion 
through vascular damage is shown. These data may explain the presence of cortical 
infarcts in cryptococcal meningitis. Examining a potential role of cryptococcal virulence 
factors in causing widespread vascular damage may lead to therapeutic targets in the 
future to reduce clinical vasculitis in cryptococcal meningitis.  
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7.2 Characterisation of autophagy mutant zebrafish  
Autophagy mutant zebrafish were generated to enable analysis of the role of 
autophagy in infection studies. It was important to first investigate whether the 
mutations were effective, and whether the mutations resulted in a loss of autophagy 
function. The genes atg3 and atg5 are both involved in ubiquitin-like conjugation 
processes, ultimately leading to LC3-I lipidation (Mizushima et al. 2001). Lc3-I lipidation 
is important in the formation of the autophagosome. Corresponding autophagy mice 
mutants are not able to produce lipidated Lc3, and have lower levels of amino acids 
(presumably due to lack of autophagy recycling of cellular components) (Kuma et al. 
2004; Sou et al. 2008). Therefore, zebrafish mutants in key autophagy genes atg3 or 
atg5 were expected to result in an inability to lipidate Lc3-I, and be deficient in 
autophagy processes.  
Maternally contributed mRNA was shown to be depleted by 5dpf for both atg3 and atg5 
mutants. At 8dpf, atg5 mutants did not have Atg5 protein. This suggests the mutations 
are effective in eliminating atg3 or atg5 expression. In the future it will be important to 
prove that Atg3 protein is also missing in zebrafish.  
A clear survival defect and a growth defect were observed in both autophagy mutants, 
highlighting a clear phenotype. This differs from corresponding mouse mutants which 
are neonatal lethal (Kuma et al. 2004; Sou et al. 2008). As described in Chapter 4, 
differences in autophagy requirements between mammals and fish, for example 
differences in metabolic rate, may explain this. To prove these phenotypes are caused 
by a lack of autophagy, further work is required. Mouse mutant data suggest reduced 
amino acids may cause reduced survival (Kuma et al. 2004; Sou et al. 2008). It would 
be informative to examine amino acid levels in zebrafish throughout development, to 
determine if a reduction in amino acid availability corresponds to declining survival. 
Further analysis of organs/tissues which require a high autophagic turnover, for 
example cardiac tissue, may suggest a cause of death. Importantly, autophagy mutant 
zebrafish appear to be able to survive for a useful lifespan (in comparison to murine 
models). Therefore zebrafish autophagy mutants may enable in vivo study of 
autophagy which currently cannot be completed in mouse models.  
It is expected that Lc3-I lipidation would not occur in zebrafish autophagy mutants. 
However, Lc3-II was observed at 2dpf and at 8dpf in both mutants. For atg5 mutants 
(and likely for atg3 mutants), this observation is difficult to explain, since by at least 
8dpf (due to lack of Atg5 protein) larvae are not expected to be able lipidated Lc3-I. 
There are two possible explanations, either lipidation is performed by residual maternal 
Atg5, or lipidation is occurring via an Atg3 and Atg5 independent pathway.  
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The first explanation is that, Lc3-I lipidation is truly blocked in autophagy mutants, but 
due to maternal contribution, residual Atg5 is present in the larvae. Throughout 
development this is slowly used up leading to a delayed survival defect. To test this 
easily, Lc3 western blots through larval development after 8dpf and until 30dpf, could 
be used to determine if Lc3-II is reduced over time. This represents a key experiment 
that would be very informative for the future. Interestingly, in Chapter 5, at the cellular 
level, autophagy mutants appear to have a reduction in Lc3 marking of pathogen 
phagosomes. This might suggest that in cells which are actively using autophagy, any 
potential Atg5 protein (resulting from maternal contribution) is used up faster.  
The alternative explanation is that Lc3 lipidation is not blocked in autophagy mutants. 
In this case for atg5 (and likely atg3) this means that lipidation is occurring without the 
ubiquitin-conjugation systems. This raises a major question, of how Lc3-II is being 
produced in autophagy mutants. It may be useful to examine the potential roles of other 
E2-like enzymes in their ability to lipidate Lc3-I. If a separate enzyme was found to 
lipidate Lc3-I this could lead to a significant adjustment in the established autophagy 
pathway mechanisms.  
To conclude, both autophagy mutations (for atg5 and likely for atg3) successfully stop 
expression of key autophagy genes. A significant survival and growth defect caused by 
autophagy mutations is observed. To prove this phenotype is caused by autophagy 
deficiency analysis of amino acid levels is required. Furthermore, it is important to 
determine whether Lc3-I lipidation is truly present in autophagy mutants and if so, 
analysis of alternative lipidation mechanisms would be an exciting focus for the future.  
 
7.3 Does autophagy have a role in S. aureus and C. neoformans handling? 
S. aureus and C. neoformans are both able to reside intracellularly within host cells 
(Prajsnar et al. 2012; Levitz et al. 1999) and both pathogens have reduced replication 
when the host cell is deficient in autophagy (Diamond & Bennett 1973; Schnaith et al. 
2007), suggesting autophagy is beneficial for pathogen growth. On the other hand, 
autophagy can degrade pathogens, which has been demonstrated to occur to S. 
aureus (Harada-Hada et al. 2014). Host cell autophagy appears to be either beneficial 
or detrimental depending on the strain of S. aureus and the type of cell the bacteria is 
residing in (discussed in section 1.4.7). There are limited data on the role of host cell 
autophagy in handling of C. neoformans. It is therefore unclear whether host cell 
autophagy is beneficial to the host or either invading pathogen. 
Overall, using larval survival and bacterial/fungal burden as endpoints to monitor S. 
aureus or C. neoformans infection, I did not highlight autophagy deficiency as either 
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beneficial or detrimental to the pathogen or host. Importantly, both S. aureus and C. 
neoformans are capable of surviving intracellularly and extracellularly. It appears that 
using an entire organism may mask any changes in infection outcome caused by 
autophagy, which would only occur for intracellular pathogens. Analysis of exclusively 
intracellular pathogens is required, to exclude the contribution of extracellular pathogen 
infection dynamics. Overall I am not confident in concluding these data show 
autophagy deficiency does not affect S. aureus or C. neoformans infection. 
An interesting observation was that Lc3-II can mark both S. aureus and C. neoformans 
vesicles in neutrophils soon after infection, and that this reduced over time. This 
suggests that Lc3-assisted phagocytosis (LAP) may play an important role in S. aureus 
and, particularly in C. neoformans infection, since cryptococcal cells are not known to 
reside in double-membrane vesicles. It the future, using electron microscopy to prove a 
single membrane structure is being marked with Lc3 will provide evidence that LAP is a 
host cell autophagy response to S. aureus and C. neoformans.  
Autophagy mutant larvae showed a reduction in Lc3 recruitment to both pathogens in 
neutrophils. However, this shows only that a reduction of Lc3 recruitment occurs in 
autophagy mutant larvae. While this provides evidence the mutants are truly deficient 
in autophagy, it is impossible to conclude what a lack of Lc3 recruitment would cause, 
in terms of pathogen degradation or survival. Unfortunately it was not possible to 
analyse whether reduced recruitment leads to changes in cellular infection outcome. 
This represents vital experimental data which will help determine the role host cell 
autophagy plays in the control of intracellular pathogens.  
After consideration of the data and progress (in terms of clearly determining how host 
cell autophagy affects intracellular pathogens) so far, it would be much more 
productive, and likely more successful, to focus on using time-lapse analysis of 
intracellular interactions of autophagy components with pathogens in autophagy 
mutants. Initial data suggests that Lc3 recruitment to pathogens is reduced in 
autophagy mutants. This opens an opportunity to discover what effect loss of Lc3 has 
on infection outcome, potentially enabling the role of autophagy in intracellular 
pathogen interactions to be determined. The zebrafish model was chosen specifically 
to enable in vivo analysis of host-autophagy pathogens and observe how these 
interactions occur. Using these advantages, future analysis could focus on further Lc3 
interactions, and other autophagy markers, for example p62 using the transgenic line 
generated in this study (Chapter 6). In addition, it would be interesting to compare 
different cells, for example neutrophils, macrophages or endothelial cells to determine 
whether autophagy is utilised or subverted differently, depending on cell type.  
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7.4 Does p62-mediated selective autophagy target S. aureus and C. 
neoformans for degradation? 
A zebrafish line was established, with a GFP-p62 neutrophil specific reporter, to enable 
analysis of p62 interactions with S. aureus and C. neoformans. Expression of GFP-p62 
was shown to be neutrophil specific, and likely to act in a similar manner to 
endogenous p62. It would be informative to further analyse whether GFP-p62 is 
expressed at a similar level and is functionally similar to endogenous p62, in terms of 
promoter expression (since this line is likely over expressing GFP-p62), and in binding 
activity to ubiquitinated cargo and Lc3. It is important to keep in mind that although 
GFP-p62 can co-localise to pathogens, overexpression of GFP-p62 may enable more 
binding than would occur under normal circumstances. To determine whether binding 
activity is similar, co-localisation of pathogens, ubiquitin and Lc3 with p62 in wild-type 
and Tg(lyz:GFP.p62) larvae could be compared by antibody staining and imaging.  
Interestingly, GFP-p62 was recruited to both S. aureus and C. neoformans that had 
been phagocytosed by neutrophils. This is expected for S. aureus, as p62 is known to 
recruit ubiquitinated staphylococci (which have escaped the phagosome) to an 
autophagosome (Neumann et al. 2016; Singh et al. 2017). In fact this co-localisation 
suggests that GFP-p62 is acting in the same way as endogenous p62. This would 
represent the first in vivo reporter line evidence of p62 recruitment to pathogens. It 
would be useful to determine if ubiquitination is occurring on S. aureus within 
neutrophils to further confirm this mechanism.  
GFP-p62 appeared to be recruited to vesicles containing S. aureus or C. neoformans. 
Firstly, it is very important to determine whether these vesicles have a single 
membrane, by electron microscopy or membrane marker localisation. If it is determined 
that GFP-p62 is recruited to a single membrane containing pathogens, this may be the 
first report of this occurring. A single report of p62 binding to phagosomes (before LC3 
recruitment in LAP) had been described for erythrocyte phagocytosis (Santarino et al. 
2017). It has been suggested that p62 binding to a single membrane leads to increased 
LC3-II and ultimately, autophagy-mediated degradation (Santarino et al. 2017). It would 
be informative to prove p62 recruitment to phagosomal membranes occurs and to 
examine what role this may have in pathogen control.  
Overall, these data only show co-localisation and do not provide evidence of the role 
p62 plays in host cell interactions with each pathogens. It would be particularly exciting 
to research this topic further, through use of zebrafish autophagy mutants. It may be 
possible to reduce GFP-p62 binding to pathogens or pathogen vesicles (in these 
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mutants), and determine whether p62 binding is dependent on Lc3-I lipidation. Equally, 
if p62 is able to bind phagosomes independently (in autophagy mutants), this would 
represent a new role of autophagy machinery in degradation of pathogens.  
7.5 Thesis summary 
The zebrafish infection model was used to analyse host-pathogen interactions with S. 
aureus and C. neoformans. This study has progressed the established tissue invasion 
mechanisms of C. neoformans, to include vascular damage caused by cryptococcal 
proliferation, and may even explain the occurrence of cortical infarcts in cryptococcal 
meningitis. It is demonstrated that autophagy components Lc3 and p62 are involved in 
neutrophil handling of S. aureus and C. neoformans. Despite this, the role of autophagy 
in handling S. aureus and C. neoformans and infection outcome is unclear. However, 
through characterisation of autophagy mutants and generation of a p62 reporter line, 
the next stages of future investigation, suggested above, are likely to provide 
informative data on the role of host cell autophagy in neutrophil handling of S. aureus 
and C. neoformans.  
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Figure A1 Amplification of zebrafish p62  
PCR product size of 1360bp seen for PCR amplification of p62 from zebrafish cDNA 
(Ladder: 2-Log ladder N32200S, Forward: ATGTCGATGACAGTGAAA GCTTAC, 
Reverse: CTACTTCTGTTGTCCTGGTGTTTTG). 
1.2Kb
1.5Kb
Appendix 1 
Generation of the 3’ entry vector p3E-p62 
In order to have a stable p62 cDNA sample which could be preserved, and used for 
any further experiments, a sample was inserted into a vector for long term storage. It 
would be important if an exact copy of the cDNA sample was required during the 
experimental procedure or in the future.  
Primers were designed to cover the start ATG and the stop TAG, to enable 
amplification through PCR of the entire zebrafish p62 transcript, excluding the un-
translated regions. It was important to exclude the 5’ UTR (which contains ribosome 
binding sites) to ensure that once the p62 product was integrated into the zebrafish 
genome, translation of just the p62 section would not occur. Using zebrafish cDNA, 
kindly gifted by Dr Abraha G. Kahsay (IMCB, Singapore), p62 was amplified. Larvae of 
5dpf were used to collect RNA and subsequently synthesise cDNA. 5dpf was used as a 
time point when it is known p62 is expressed in zebrafish larvae at least by 48hpf 
(Yogev et al. 2013). The PCR product was run on a gel to determine whether the 
correct size product had been amplified. Indeed, the correct expected band size was 
observed, at 1360bp, corresponding to the entire p62 transcript, excluding the UTR’s 
(Fig A1).  
 
To enable safe storage and easy amplification of the PCR product, it was inserted into 
a pGEMTEasy vector (Fig. A2 A). To enable ligation into the vector an A-tailing 
reaction was first completed. After ligation into the pGEMTEasy (which contains an 
ampicillin resistance gene) vector, the reaction product was transformed into 
competent cells, and then plated out on an LB agar plate. The agar plate contained 
ampicillin, to be selective for the pGEMTEasy colonies only. Additionally X-Gal solution 
was added to the plate, to enable selection of vectors which had the PCR product 
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Figure A2 Insertion of zebrafish p62 into pGEMTEasy  
A Schematic of the pGEMTEasy vector (pGEM-T and pGEM-T-Easy vector 
systems protocol PDF Revised 6.15, TM042). B PCR product size of ~1510bp seen 
for PCR amplification of p62 from pGEMTEasy vector in lanes 1, 3, 5, 7 and 8 
(Ladder: 2-Log ladder N32200S) 
1.2Kb
1.5Kb
A B
inserted, through the colour produced by individual colonies. White colonies are formed 
when insertion of the PCR product is into, and therefore disrupting, the coding 
sequence of β-galactosidase. When β-galactosidase is not disrupted, blue colonies are 
formed, through production of a blue pigment caused by hydrolysis of X-gal on the 
plate, indicative that the PCR product is not inserted.  
Colonies which had an insert (white) were chosen. A PCR using T7 and SP6, primer 
sites present on the pGEMTEasy vector, on either side of the insertion site, to amplify 
the insertion was completed to determine the size of the insertion and if this correlated 
with the size of the P62 product (Fig. A2 B).   
   
The sequence of the inserted PCR products were next examined, it is important the 
sequence is the same as in cDNA. The PCR products of lanes 1,3,5,7 and 8 (Fig. A2 
B), which represent the correct size of 1510bp p62 were next sequenced, using either 
T7 or SP6 primers to enable sequencing of each end of the insertion.  
The vector chosen matched the expected sequence exactly, aside from a single base 
change. The vector chosen had a single residue alteration, GAC to GAA, resulting in a 
Aspartic acid (Asp, D) change to a Glutamic acid (Glu, E), this change is to a very 
similar residue in terms of residue structure and properties, both are amino acids with 
electrically charged side chains, and both are acidic, (Fig A3).  
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Figure A3 Aspartic acid to Glutamic acid change in zebrafish cDNA 
The known p62 sequence (ENSDARG00000075014) compared to sequencing data 
(1-4). 1-2 represent PCR products made using G2 GoTaq polymerase. 3-4 
represent PCR products made using primestar polymerase. Large red box 
highlights the GAC (Asp, D, small red box) codon, which is shown to be GAA in 1-4 
PCR products. 
pP62 sequence
1
2
3
4
 
In all PCR products, this residue change was observed. Due to the presence of this 
Asp to Glu change in all PCR products, it is likely this is not a PCR based error. To be 
sure, a separate polymerase enzyme was tested, with the (Asp to Glu) change seen in 
all PCR products (Fig A3). This divergence from expected p62 sequence may 
represent a Single Nucleotide Polymorphism (SNP). Indeed, a missense SNP (C to A), 
has been recorded (rs504189497 SNP, Ensembl). Therefore, this p62 sequence was 
chosen to be used for the generation of a p62 reporter line. Next an entry clone using 
the Gateway system was generated from this p62 sequence.  
Entry vector generation 
To enable generation of a neutrophil specific, GFP-p62 fusion protein, a 3-prime entry 
vector containing p62 was generated. To do this, a p62 PCR product with flanking 
“attB” sites is required for the BP reaction into the selected 3’ entry clone (pDonrP2r-
P3). Therefore, attB primers were designed according to the Gateway protocol, to 
cover each end of the p62 sequence. The pGEMTEasy vector with the selected and 
sequenced p62 insertion was used for PCR amplification of p62 product with flanking 
attB sites present in the primers, and the size of the product was confirmed by gel 
electrophoresis.  
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The att-site flanked p62 size was correct, this product could be used in the BP reaction. 
Reaction was completed according to GatewayTM protocol, with 50 femtomoles of both 
attB PCR products and the donor vector, pDonrP2r-P3. The BP reaction resulted in 
insertion of the attB flanked p62 product in the donor vector, and creation of resultant 
corresponding L and R sites, known as the entry clone; as shown in the schematic (Fig. 
6.1). It was next necessary to isolate a single copy of the entry clone, and confirm the 
sequence of the p62 and surrounding L and R sites were intact.  
The BP reaction products were transformed into One-shot TOP10 competent cells, and 
plated onto the kanamycin containing LB agar plate, to select entry clones (since the 
pDonrP2r-P3 contains a kanamycin resistance gene). Resultant single colonies were 
chosen for PCR amplification, using M13 forward and reverse primers, which are either 
side of the insert (Fig A4 A), to create a PCR product suitable for sequencing analysis. 
Sequencing analysis enabled a single clone to be selected, which had the same (Asp 
to Glu) difference as found in the original pGEMTEasy p62 insertion (Fig A4 B), in 
addition to a second change. The new change is a TTT to TTC, both of which code for 
phenylalanine (Phe, F), (Fig A4 C). The second change results in coding for the same 
residue, so would not alter protein structure so was considered acceptable for use. 
Therefore, a suitable 3’ entry clone for p62 was created.  
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Figure A4 Entry vector sequencing 
A Schematic of the pDonrP2r-P3 (Multisite Gateway® Three-Fragment Vector 
Construction Kit. Using Gateway® Technology to simultaneously clone multiple DNA 
fragments. Catalog number 12537-023. Revision date 3 January 2012. Publication 
Part number 25-0541 MAN0000299). B Aspartic acid to glutamic acid (red box) 
change in zebrafish cDNA sequenced from selected entry clone in comparison to the 
known p62 sequence (ENSDARG00000075014) C The base pair change of TTC to 
TTT found in the entry clone in comparison to the known p62 sequence 
(ENSDARG00000075014). 
 
B
C
A pP62 sequence
Selected entry 
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pP62 sequence
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Generation of the expression clone pDest(lyz:GFP.p62) 
After generation of the 3’ p62 entry clone, all components required for assembly into 
the destination vector were available. As described in Figure 6.3, the destination vector 
used was pDestTol2CG, the 5’ entry clone used was p5E-lyz, the middle entry clone 
was pME-GFP-nostop, and the generated p3E-p62 vector was used for the 3’ entry 
clone.  
The LR reaction places the 5’, ME, and 3’ vectors into the destination vector through 
the use of location specific “att” recombination sequences. The “att” sites were 
originally in DNA recombination sequences in bacteriophage λ, responsible for the 
location of integration sites of the viral genome into the host bacterial genome, through 
integrase enzyme activity. These “att” sites were optimised for recombination of PCR 
products and vectors for the Gateway system. Small variations in the “att” sequences 
enable site specific recombination, which are numbered 1-4 in the Gateway system. 
These complementary attL and attR sites (e.g. the attL3 on 3’ entry clone with the 
attR3 on the destination vector) are recombined by the LR clonase enzyme mix, 
resulting in the creation of the final destination vector, in this case pDest(lyz:GFP.p62).  
The LR reaction was completed according to GatewayTM protocol, with 10 femtomoles 
of p5E-lyz, pME-GFP-nostop, p3E-p62, and 20 femtomoles of pDestTol2CG. The LR 
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reaction product was transformed into TOP10 competent cells. Ampicillin resistance in 
the destination vector enables selection of vector after transformation. The ccdB gene 
is a “suicide gene” which inhibits the growth of E. coli. The ccdB is present between 
each “att” site on the destination vector and is removed when recombination is 
successful. Therefore any vectors where recombination has not been successful 
cannot grow due to the presence of the ccdB gene.  
Selected colonies were grown overnight in Amp+ve LB enabling collection 
pDest(lyz:GFP.p62) through an mini prep (axyprep). The vector was confirmed as 
pDest(lyz:GFP.p62) with a restriction site digest (Fig 6.5) and sequencing.  
 
  
297 
 
Appendix 2 
A reproduction license was obtained for the reproduction of a figure from (Silva et al. 
2014). The first page of the reproduction license in shown below.  
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Appendix 3 
Zebrafish cDNA sequence of for atg3 and atg5 
atg3 cDNA sequence with RT-PCR primer sites marked 
  
  1 ATGCAGAACGTGATAAACTCGGTGAAAGGCACTGCTCTGGGGGTCGCGGAGTTTTTGACG  60 
  1 ATGCAGAACGTGATAAACTCGGTGAAAGGCACTGCTCTGGGGGTCGCGGAGTTTTTGACG  60 
  1 -M--Q--N--V--I--N--S--V--K--G--T--A--L--G--V--A--E--F--L--T-  20 
 
 61 CCAGTTTTGAAGGAATCTAAATTTAAAGAAACTGGGGTTATAACTCCAGAGGAGTTTGTT 120 
 61 CCAGTTTTGAAGGAATCTAAATTTAAAGAAACTGGGGTTATAACTCCAGAGGAGTTTGTT 120 
 21 -P--V--L--K--E--S--K--F--K--E--T--G--V--I--T--P--E--E--F--V-  40 
 
121 GCAGCAGGAGATCATCTGGTTCATCACTGTCCCACATGGAAATGGGCATCTGGAGAAGAA 180 
121 GCAGCAGGAGATCATCTGGTTCATCACTGTCCCACATGGAAATGGGCATCTGGAGAAGAA 180 
 41 -A--A--G--D--H--L--V--H--H--C--P--T--W--K--W--A--S--G--E--E-  60 
 
181 GCAAAGGTGAAGCCCTATCTGCCCAATGACAAACAGTTCCTATTAACTCGAAACGTTCCA 240 
181 GCAAAGGTGAAGCCCTATCTGCCCAATGACAAACAGTTCCTATTAACTCGAAACGTTCCA 240 
 61 -A--K--V--K--P--Y--L--P--N--D--K--Q--F--L--L--T--R--N--V--P-  80 
 
241 TGTTATAAGCGCTGTAAACAGATGGAGTACTCAGATGAGCTGGAGGCCATCATAGAAGAG 300 
241 TGTTATAAGCGCTGTAAACAGATGGAGTACTCAGATGAGCTGGAGGCCATCATAGAAGAG 300 
 81 -C--Y--K--R--C--K--Q--M--E--Y--S--D--E--L--E--A--I--I--E--E- 100 
 
301 GACGATGGAGATGGCGGATGGGTGGACACCTTTCATAACTCGGGTGTTACAGGGGTGACT 360 
301 GACGATGGAGATGGCGGATGGGTGGACACCTTTCATAACTCGGGTGTTACAGGGGTGACT 360 
101 -D--D--G--D--G--G--W--V--D--T--F--H--N--S--G--V--T--G--V--T- 120 
 
361 GAAGCTGTTCGGGAAATCTCATTGGATAATAAGGATAATATGAATATGAATGTGAAGACG 420 
361 GAAGCTGTTCGGGAAATCTCATTGGATAATAAGGATAATATGAATATGAATGTGAAGACG 420 
121 -E--A--V--R--E--I--S--L--D--N--K--D--N--M--N--M--N--V--K--T- 140 
 
421 GGTGCCTGTGGAAATAGTGGAGATGACGATGATGATGAAGAAGGAGAGGCGGCAGACATG 480 
421 GGTGCCTGTGGAAATAGTGGAGATGACGATGATGATGAAGAAGGAGAGGCGGCAGACATG 480 
141 -G--A--C--G--N--S--G--D--D--D--D--D--E--E--G--E--A--A--D--M- 160 
 
481 GAAGAATATGAAGAAAGTGGACTTTTGGAAACAGATGATGCCACTCTTGACACAAGTAAA 540 
481 GAAGAATATGAAGAAAGTGGACTTTTGGAAACAGATGATGCCACTCTTGACACAAGTAAA 540 
161 -E--E--Y--E--E--S--G--L--L--E--T--D--D--A--T--L--D--T--S--K- 180 
 
541 ATGGCTGATTTAAGTAAAACTAAGGCCGAAGCTGGAGGGGAAGATGCCATTCTACAGACA 600 
541 ATGGCTGATTTAAGTAAAACTAAGGCCGAAGCTGGAGGGGAAGATGCCATTCTACAGACA 600 
181 -M--A--D--L--S--K--T--K--A--E--A--G--G--E--D--A--I--L--Q--T- 200 
 
601 AGAACTTATGACCTGTATATCACATATGACAAATATTACCAGACCCCAAGACTATGGCTG 660 
601 AGAACTTATGACCTGTATATCACATATGACAAATATTACCAGACCCCAAGACTATGGCTG 660 
201 -R--T--Y--D--L--Y--I--T--Y--D--K--Y--Y--Q--T--P--R--L--W--L- 220 
 
661 TTTGGATATGATGAGGACAGACAGCCTCTAACTGTGGATCAGATGTATGAAGACATCAGC 720 
661 TTTGGATATGATGAGGACAGACAGCCTCTAACTGTGGATCAGATGTATGAAGACATCAGC 720 
221 -F--G--Y--D--E--D--R--Q--P--L--T--V--D--Q--M--Y--E--D--I--S- 240 
 
721 CAGGATCATGTTAAAAAAACCGTCACCATTGAGAATCACCCTAATCTCCCTCCACCTGCT 780 
721 CAGGATCATGTTAAAAAAACCGTCACCATTGAGAATCACCCTAATCTCCCTCCACCTGCT 780 
241 -Q--D--H--V--K--K--T--V--T--I--E--N--H--P--N--L--P--P--P--A- 260 
 
781 ATGTGCTCCGTACATCCATGCAGACACGCTGAGGTGATGAAAAAGATTATCGAGACTGTG 840 
781 ATGTGCTCCGTACATCCATGCAGACACGCTGAGGTGATGAAAAAGATTATCGAGACTGTG 840 
261 -M--C--S--V--H--P--C--R--H--A--E--V--M--K--K--I--I--E--T--V- 280 
 
841 GCGGAAGGAGGAGGTGAACTCGGGGTCCATATGTATCTTCTGATTTTCCTGAAATTTGTG 900 
841 GCGGAAGGAGGAGGTGAACTCGGGGTCCATATGTATCTTCTGATTTTCCTGAAATTTGTG 900 
281 -A--E--G--G--G--E--L--G--V--H--M--Y--L--L--I--F--L--K--F--V- 300 
 
901 CAAGCTGTCATTCCAACAATAGAGTACGATTACACAAGGCATTTCACCATGTAG       954 
901 CAAGCTGTCATTCCAACAATAGAGTACGATTACACAAGGCATTTCACCATGTAG       954 
301 -Q--A--V--I--P--T--I--E--Y--D--Y--T--R--H--F--T--M--*-       317 
 
 
atg3 mutation site 
primers away from mutation site 
primers over mutation site 
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atg5 cDNA sequence with RT-PCR primer sites marked 
  1 ATGATAATGGCAGATGACAAGGATGTGCTTCGAGATGTTTGGTTTGGAAGGATACCCGCC  60 
  1 ATGATAATGGCAGATGACAAGGATGTGCTTCGAGATGTTTGGTTTGGAAGGATACCCGCC  60 
  1 -M--I--M--A--D--D--K--D--V--L--R--D--V--W--F--G--R--I--P--A-  20 
 
 61 TGTTTCACACTGTCTCCAGACGAAACCACAGAGAGAGAGGCAGAACCCTACTATCTGCTC 120 
 61 TGTTTCACACTGTCTCCAGACGAAACCACAGAGAGAGAGGCAGAACCCTACTATCTGCTC 120 
 21 -C--F--T--L--S--P--D--E--T--T--E--R--E--A--E--P--Y--Y--L--L-  40 
 
121 CTCCCACGGGTCAGTTACCTGACACTAGTCACTGATAAAGTCAAGAAACATTTTCTCAAA 180 
121 CTCCCACGGGTCAGTTACCTGACACTAGTCACTGATAAAGTCAAGAAACATTTTCTCAAA 180 
 41 -L--P--R--V--S--Y--L--T--L--V--T--D--K--V--K--K--H--F--L--K-  60 
 
181 GTCATGAAGGCAGAGGATGTGGAGGAAATGTGGTTTGAACACGAGGGAACGCCTCTTAAA 240 
181 GTCATGAAGGCAGAGGATGTGGAGGAAATGTGGTTTGAACACGAGGGAACGCCTCTTAAA 240 
 61 -V--M--K--A--E--D--V--E--E--M--W--F--E--H--E--G--T--P--L--K-  80 
 
241 TGGCACTATCCCATTGGTGTGTTGTTCGACCTCCATGCTTCAAACTCCGCTCTGCCCTGG 300 
241 TGGCACTATCCCATTGGTGTGTTGTTCGACCTCCATGCTTCAAACTCCGCTCTGCCCTGG 300 
 81 -W--H--Y--P--I--G--V--L--F--D--L--H--A--S--N--S--A--L--P--W- 100 
 
301 AATATCACAGTGCACTTCAAGAACTTCCCAGAACAAGACTTGCTTCACTGCTCAACAAAC 360 
301 AATATCACAGTGCACTTCAAGAACTTCCCAGAACAAGACTTGCTTCACTGCTCAACAAAC 360 
101 -N--I--T--V--H--F--K--N--F--P--E--Q--D--L--L--H--C--S--T--N- 120 
 
361 TCTGTGATAGAAGCACATTTCATGTCTTGCATTAAAGAGGCCGATGCACTCAAACATAAA 420 
361 TCTGTGATAGAAGCACATTTCATGTCTTGCATTAAAGAGGCCGATGCACTCAAACATAAA 420 
121 -S--V--I--E--A--H--F--M--S--C--I--K--E--A--D--A--L--K--H--K- 140 
 
421 GGCCAGGTCATCAACGATATGCAGAAGAAAGACCATAAACAACTGTGGATGGGTCTGCAG 480 
421 GGCCAGGTCATCAACGATATGCAGAAGAAAGACCATAAACAACTGTGGATGGGTCTGCAG 480 
141 -G--Q--V--I--N--D--M--Q--K--K--D--H--K--Q--L--W--M--G--L--Q- 160 
 
481 AATGATAAATTTGACCAGTTCTGGGCCATGAATCGCAAACTCATGGAGTATCCCACCGAA 540 
481 AATGATAAATTTGACCAGTTCTGGGCCATGAATCGCAAACTCATGGAGTATCCCACCGAA 540 
161 -N--D--K--F--D--Q--F--W--A--M--N--R--K--L--M--E--Y--P--T--E- 180 
 
541 GAGGGAGGCTTTCGGTATATCCCCTTTAGAATATATCAGACTATGAGTGACAGACCATTC 600 
541 GAGGGAGGCTTTCGGTATATCCCCTTTAGAATATATCAGACTATGAGTGACAGACCATTC 600 
181 -E--G--G--F--R--Y--I--P--F--R--I--Y--Q--T--M--S--D--R--P--F- 200 
 
601 ATCCAGACGCTCTTCCGACCAGTGTCTTCTGAAGGCCAAGCGCTTACACTGGGAGACCTG 660 
601 ATCCAGACGCTCTTCCGACCAGTGTCTTCTGAAGGCCAAGCGCTTACACTGGGAGACCTG 660 
201 -I--Q--T--L--F--R--P--V--S--S--E--G--Q--A--L--T--L--G--D--L- 220 
 
661 CTGAAGGAGCTGTTTCCTGCTGCCATTGAGGATGAGCCAAAGAAATTCCAGGTTATGATT 720 
661 CTGAAGGAGCTGTTTCCTGCTGCCATTGAGGATGAGCCAAAGAAATTCCAGGTTATGATT 720 
221 -L--K--E--L--F--P--A--A--I--E--D--E--P--K--K--F--Q--V--M--I- 240 
 
721 CACGGCATTGAACCCCTGCTAGAGACGCCCATCCAGTGGCTAAGTGAACACTTGAGCCAC 780 
721 CACGGCATTGAACCCCTGCTAGAGACGCCCATCCAGTGGCTAAGTGAACACTTGAGCCAC 780 
241 -H--G--I--E--P--L--L--E--T--P--I--Q--W--L--S--E--H--L--S--H- 260 
 
781 CCCGACAACTTTCTCCACATCAGCATCATCCCTGCACCGAGTGACTGA             828 
781 CCCGACAACTTTCTCCACATCAGCATCATCCCTGCACCGAGTGACTGA             828 
261 -P--D--N--F--L--H--I--S--I--I--P--A--P--S--D--*-             275 
 
 
atg5 mutation site 
primers away from mutation site 
primers over mutation site 
 
